User Image Cart Icon 0 Search Image

Sphingolipids

  1. Sphingolipids in food and the emerging importance of Sphingolipids to nutrition
  2. Functions of Sphingolipids and Sphingolipid breakdown products in cellular regulation
  3. Sphingolipid metabolism and cell growth regulation
  4. Sphingolipids—the enigmatic lipid class: biochemistry, physiology, and pathophysiology
  5. Sphingolipids
  6. Yeast Sphingolipids
  7. Sphingolipids with inositolphosphate-containing head groups.
  8. Phases and phase transitions of the Sphingolipids
  9. The role of Sphingolipids in the process of signal transduction
  10. Sphingolipids—their metabolic pathways and the pathobiochemistry of neurodegenerative diseases
  11. Sphingolipid long chain bases
  12. Sphingolipids in atherosclerosis and vascular biology
  13. Molecular arrangements in Sphingolipids. The crystal structure of cerebroside
  14. Sphingolipid organization in biomembranes: what physical studies of model membranes reveal
  15. Importance of Sphingolipids and inhibitors of Sphingolipid metabolism as components of animal diets
  16. Sphingolipids Are Potential Heat Stress Signals inSaccharomyces
  17. Sphingolipid FUNCTIONS IN SACCHAROMYCES CEREVISIAE: Comparison to Mammals
  18. Khafrefungin, a novel inhibitor of Sphingolipid synthesis
  19. Sphingolipid transport in eukaryotic cells
  20. Structure and function of Sphingolipid-and cholesterol-rich membrane rafts
  21. Sorting of Sphingolipids in epithelial (Madin-Darby canine kidney) cells.
  22. Involvement of yeast Sphingolipids in the heat stress response of Saccharomyces cerevisiae
  23. Metabolism and functional effects of Sphingolipids in blood cells
  24. Biosynthesis of Sphingolipids: dihydroceramide and not sphinganine is desaturated by cultured cells
  25. Different Sphingolipids show differential partitioning into Sphingolipid/cholesterol-rich domains in lipid bilayers
  26. Role of Sphingolipid-mediated cell death in neurodegenerative diseases
  27. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of Sphingolipid synthesis delays barrier recovery after acute perturbation.
  28. Caveolae, DIGs, and the dynamics of Sphingolipid—cholesterol microdomains
  29. Inhibition of Sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme
  30. Viridiofungins, novel inhibitors of Sphingolipid synthesis
  31. Uptake and metabolism of Sphingolipids in isolated intestinal loops of mice
  32. Methods for methanolysis of Sphingolipids and direct determination of long‐chain bases by gas chromatography
  33. The phosphoinositol Sphingolipids of Saccharomyces cerevisiae are highly localized in the plasma membrane
  34. Regulation of epidermal Sphingolipid synthesis by permeability barrier function.
  35. Lipid biochemistry: functions of glycerolipids and Sphingolipids in cellular signaling
  36. Sphingolipids
  37. Improved reagent for trimethylsilylation of Sphingolipid bases
  38. A regulatory role for Sphingolipids in neuronal growth: inhibition of Sphingolipid synthesis and degradation have opposite effects on axonal branching
  39. Cell regulation by sphingosine and more complex Sphingolipids
  40. Sphingolipids: metabolism and cell signalling
  41. Sphingolipids as receptor modulators: an overview
  42. Variations among cell lines in the synthesis of Sphingolipids in de novo and recycling pathways
  43. Interaction of influenza virus haemagglutinin with Sphingolipid–cholesterol membrane domains via its transmembrane domain
  44. Effects of cholesterol depletion by cyclodextrin on the Sphingolipid microdomains of the plasma membrane
  45. Activator proteins and topology of lysosomal Sphingolipid catabolism
  46. Biochemical studies in Niemann-Pick disease I. Major Sphingolipids of liver and spleen
  47. Sphingolipid composition in Bacteroides species
  48. ELO2 and ELO3, Homologues of theSaccharomyces cerevisiae ELO1 Gene, Function in Fatty Acid Elongation and Are Required for Sphingolipid Formation
  49. Qualitative microanalysis and estimation of Sphingolipid bases
  50. Molecular arrangements in Sphingolipids Conformation and hydrogen bonding of ceramide and their implication on membrane stability and permeability
  51. Molecular arrangements in Sphingolipids. Crystal structure of N-tetracosanoylphytosphingosine
  52. Role of dietary Sphingolipids and inhibitors of Sphingolipid metabolism in cancer and other diseases
  53. Effect of essential fatty acid deficiency on the epidermal Sphingolipids of the rat
  54. Age-and sex-dependent change in stratum corneum Sphingolipids
  55. On the origin of Sphingolipid/cholesterol-rich detergent-insoluble cell membranes: physiological concentrations of cholesterol and Sphingolipid induce formation of a …
  56. … disruption of the mouse Sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple Sphingolipids
  57. Sphingolipid metabolites: members of a new class of lipid second messengers
  58. Sphingolipids and Glycerolipids. I.: Chemical structures and ionophoretic activities of soyacerebrosides I and II from soybean
  59. A Sphingolipid having a novel type of ceramide and lacto-N-fucopentaose III
  60. Membrane fusion of Semliki Forest virus requires Sphingolipids in the target membrane.
  61. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids
  62. Sphingolipids are essential for the growth of Chinese hamster ovary cells. Restoration of the growth of a mutant defective in sphingoid base biosynthesis by …
  63. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the Sphingolipid signaling cascade in cardiac cell death.
  64. Broad screening test for Sphingolipid-storage diseases
  65. Biochemistry of the Sphingolipids. XVIII. Complete structure of tetrasaccharide phytoglycolipid
  66. Sphingolipid Metabolism in Bacteroideaceae
  67. Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion.
  68. The long-chain sphingoid base of Sphingolipids is acylated at the cytosolic surface of the endoplasmic reticulum in rat liver
  69. Mutant strains of Saccharomyces cerevisiae lacking Sphingolipids synthesize novel inositol glycerophospholipids that mimic Sphingolipid structures.
  70. Molecular arrangements of Sphingolipids. The monolayer behaviour of ceramides
  71. Coding of two Sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus
  72. Cloned mammalian neutral sphingomyelinase: functions in Sphingolipid signaling?
  73. Inhibition of carnitine palmitoyltransferase I augments Sphingolipid synthesis and palmitate-induced apoptosis
  74. Role of a new mammalian gene family in the biosynthesis of very long chain fatty acids and Sphingolipids
  75. Cloning and characterization of LCB1, a Saccharomyces gene required for biosynthesis of the long-chain base component of Sphingolipids
  76. Mutation in the Sphingolipid activator protein 2 in a patient with a variant of Gaucher disease
  77. Sphingolipid activator proteins are required for epidermal permeability barrier formation
  78. Syringomycin action gene SYR2 is essential for Sphingolipid 4-hydroxylation in Saccharomyces cerevisiae
  79. Molecular diversity of Sphingolipid signalling
  80. Phenotypes of Sphingolipid-dependent strains of Saccharomyces cerevisiae
  81. Sphingolipid–cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells
  82. Metabolism and selected functions of Sphingolipids in the yeast Saccharomyces cerevisiae
  83. Sphingolipids in lower animals
  84. Sphingolipids in wheat grain
  85. Molecular arrangements in Sphingolipids. Thermotropic phase behaviour of tetracosanoylphytosphingosine
  86. Cholesterol modulates membrane traffic along the endocytic pathway in Sphingolipid-storage diseases
  87. Fumonisin-and AAL-toxin-induced disruption of Sphingolipid metabolism with accumulation of free sphingoid bases
  88. Sphingolipids in immature and mature soybeans
  89. A Sphingolipid desaturase from higher plants: identification of a new cytochrome b 5fusion protein
  90. Characterization of Sphingolipids in spinach leaves
  91. Evidence for disruption of Sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins
  92. Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived Sphingolipids to the chlamydial inclusion.
  93. Topology of Sphingolipid galactosyltransferases in ER and Golgi: transbilayer movement of monohexosyl Sphingolipids is required for higher glycoSphingolipid …
  94. Enzymatic abnormalities in diseases of Sphingolipid metabolism
  95. Studies on Sphingolipids. VII. Synthesis and configuration of natural sphingomyelins
  96. Sphingolipid synthesis as a target for antifungal drugs: complementation of the inositol phosphorylceramide synthase defect in a mutant strain of …
  97. Inhibition of Sphingolipid synthesis affects axonal outgrowth in cultured hippocampal neurons
  98. Sphingolipids and cell function
  99. The LCB2 gene of Saccharomyces and the related LCB1 gene encode subunits of serine palmitoyltransferase, the initial enzyme in Sphingolipid synthesis.
  100. A procedure for fractionation of Sphingolipid classes by solid-phase extraction on aminopropyl cartridges
  101. Inhibition of Sphingolipid Synthesis by Cycloserine In Vitro and In Vivo
  102. Host cell‐derived Sphingolipids are required for the intracellular growth of Chlamydia trachomatis
  103. Cholesterol and Sphingolipid enhance the Triton X-100 insolubility of glycosylphosphatidylinositol-anchored proteins by promoting the formation of detergent …
  104. Use of Sphingolipid analogs: benefits and risks
  105. Sphingolipid metabolism in cultured fibroblasts: microscopic and biochemical studies employing a fluorescent ceramide analogue.
  106. Simultaneous deficiency of Sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene.
  107. Sphingolipids of the stratum corneum and lamellar granules of fetal rat epidemis
  108. Dietary fumonisin B1 induces disruption of Sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity
  109. Sphingolipids signal heat stress-induced ubiquitin-dependent proteolysis
  110. Fumonisin inhibition of de novo Sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells
  111. The fatty acid composition of brain Sphingolipids: sphingomyelin, ceramide, cerebroside, and cerebroside sulfate
  112. A long-term feeding of Sphingolipids affected the levels of plasma cholesterol and hepatic triacylglycerol but not tissue phospholipids and Sphingolipids
  113. Sphingolipid hydrolase activator proteins and their precursors
  114. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo Sphingolipid biosynthesis in cultured neurons in situ.
  115. Conformational studies of Sphingolipids by NMR spectroscopy. II. Sphingomyelin
  116. Warfarin administration reduces synthesis of sulfatides and other Sphingolipids in mouse brain
  117. Membrane traffic in Sphingolipid storage diseases
  118. Effects of dietary Sphingolipids on levels of serum and liver lipids in rats
  119. Sphingolipids of human skeletal muscle
  120. A simple and novel method for tritium labeling of gangliosides and other Sphingolipids
  121. Sphingolipid long-chain-base auxotrophs of Saccharomyces cerevisiae: genetics, physiology, and a method for their selection
  122. Sphingolipid-enriched membrane domains from rat cerebellar granule cells differentiated in culture: a compositional study
  123. Fumonisins: fungal toxins that shed light on Sphingolipid function
  124. … ceramide analogue for studying membrane traffic in animal cells: accumulation at the Golgi apparatus results in altered spectral properties of the Sphingolipid …
  125. Increases in serum sphingosine and sphinganine and decreases in complex Sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by …
  126. On the character and functions of Sphingolipids.
  127. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined Sphingolipidoses
  128. Both Sphingolipids and Cholesterol Participate in the Detergent Insolubility of Alkaline Phosphatase, a Glycosylphosphatidylinositol-anchored Protein, in …
  129. A gene encoding a Sphingolipid biosynthesis enzyme determines the sensitivity of Saccharomyces cerevisiae to an antifungal plant defensin from dahlia (Dahlia …
  130. Human and Murine Serine‐Palmitoyl‐CoA Transferase: Cloning, Expression and Characterization of the Key Enzyme in Sphingolipid Synthesis
  131. Fumonisin toxicity and Sphingolipid biosynthesis
  132. Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol-and Sphingolipid-containing liposomes
  133. Characterization, quantification and subcellular localization of inositol‐containing Sphingolipids of the yeast, Saccharomyces cerevisiae
  134. Prion rods contain small amounts of two host Sphingolipids as revealed by thin-layer chromatography and mass spectrometry
  135. Chemistry and metabolism of Sphingolipids. 3-Oxo derivatives of N-acetylsphingosine and N-acetyldihydrosphingosine
  136. Effects of a Sphingolipid synthesis inhibitor on membrane transport through the secretory pathway
  137. Further characterization of Δ8-Sphingolipid desaturases from higher plants
  138. Secretion of Sphingolipid hydrolase activator precursor, prosaposin
  139. The human multidrug resistance protein MRP1 translocates Sphingolipid analogs across the plasma membrane
  140. The lysosomal localization of Sphingolipid hydrolases
  141. Sli2 (Ypk1), a homologue of mammalian protein kinase SGK, is a downstream kinase in the Sphingolipid-mediated signaling pathway of yeast
  142. Sphingolipids in bean leaves (Phaseolus vulgaris)
  143. Elevated sphingoid bases and complex Sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity
  144. The role of Sphingolipids in the control of skeletal muscle function: a review
  145. Cerebrosides A and C, Sphingolipid elicitors of hypersensitive cell death and phytoalexin accumulation in rice plants
  146. Simultaneous quantitative determination method for Sphingolipid metabolites by liquid chromatography/ionspray ionization tandem mass spectrometry
  147. Chimeras of Δ6-fatty acid and Δ8-Sphingolipid desaturases
  148. Isolation and composition of inositolphosphorylceramide-type Sphingolipids of hyphal forms of Candida albicans
  149. Rustmicin, a potent antifungal agent, inhibits Sphingolipid synthesis at inositol phosphoceramide synthase
  150. A mammalian homolog of the yeast LCB1 encodes a component of serine palmitoyltransferase, the enzyme catalyzing the first step in Sphingolipid synthesis
  151. Endotoxin and cytokines increase hepatic Sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin
  152. Effects of intravenous fumonisin B1 in rabbits: Nephrotoxicityxs and Sphingolipid alterations
  153. Isolation of six novel phosphoinositol-containing Sphingolipids from tobacco leaves
  154. Aberrant Sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy
  155. Insolubility of lipids in triton X-100: physical origin and relationship to Sphingolipid/cholesterol membrane domains (rafts)
  156. Isolation of mutant Saccharomyces cerevisiae strains that survive without Sphingolipids
  157. Sphingolipid synthesis as a target for chemotherapy against malaria parasites.
  158. Analysis of Phosphorylated Sphingolipid Long-Chain Bases Reveals Potential Roles in Heat Stress and Growth Control in Saccharomyces
  159. Enzymatic Hydrolysis of Sphingolipids: II. HYDROLYSIS OF SPHINGOMYELIN BY AN ENZYME FROM RAT BRAIN
  160. Dietary sphingomyelin and other Sphingolipids in health and disease
  161. Prosaposin deficiency: Further characterization of the Sphingolipid activator protein-deficient sibs: Multiple glycolipid elevations (including lactosylceramidosis), partial …
  162. Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and Sphingolipids
  163. Brave little yeast, please guide us to Thebes: Sphingolipid function in S. cerevisiae
  164. Modulation of protein kinase C and diverse cell functions by sphingosine—a pharmacologically interesting compound linking Sphingolipids and signal transduction
  165. Conformational studies of Sphingolipids by NMR spectroscopy. I. Dihydrosphingomyelin
  166. A suppressor gene that enables Saccharomyces cerevisiae to grow without making Sphingolipids encodes a protein that resembles an Escherichia coli fatty …
  167. Fumonisin B1-induced Sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol-anchored folate receptor
  168. Inositol phosphorylceramide, a novel substance and the chief member of a major group of yeast Sphingolipids containing a single inositol phosphate
  169. Topical Sphingolipids in antisepsis and antifungal therapy
  170. Sphingolipid trafficking—sorted out?
  171. Signaling through Sphingolipid microdomains of the plasma membrane: the concept of signaling platform
  172. Interaction of earthworm hemolysin with lipid membranes requires Sphingolipids
  173. Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo
  174. Activation of Sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging
  175. Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase cascades
  176. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (Sphingolipid activator proteins)
  177. Identification of a Saccharomyces gene, LCB3, necessary for incorporation of exogenous long chain bases into Sphingolipids
  178. Sphingolipids: second messengers, mediators and raft constituents in signaling
  179. Sphingolipid signalling domains floating on rafts or buried in caves?
  180. Lysosomal proteolysis of prosaposin, the precursor of saposins (Sphingolipid activator proteins): its mechanism and inhibition by ganglioside
  181. Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions
  182. Stratum corneum Sphingolipids and free amino acids in experimentally-induced scaly skin
  183. Sphingolipid composition of human platelets
  184. Sphingolipid Biosynthesis de Novo by Rat Hepatocytes in Culture.: CERAMIDE AND SPHINGOMYELIN ARE ASSOCIATED WITH, BUT NOT REQUIRED FOR …
  185. Induction and suppression of endothelial cell apoptosis by Sphingolipids: a possible in vitro model for cell-cell interactions between platelets and endothelial cells
  186. Dual Roles of Sphingolipids in Signaling of the Escape from and Onset of Apoptosis in a Mouse Cytotoxic T-cell Line, CTLL-2 (∗)
  187. Use of BODIPY‐labeled Sphingolipids to Study Membrane Traffic along the Endocytic Pathwaya
  188. Sphingolipids: their role in intracellular signaling and renal growth.
  189. Intracellular translocation of fluorescent Sphingolipids in cultured fibroblasts: endogenously synthesized sphingomyelin and glucocerebroside analogues pass through …
  190. Biosynthesis of phosphoinositol-containing Sphingolipids from phosphatidylinositol by a membrane preparation from Saccharomyces cerevisiae
  191. Sphingolipid regulation of female gonadal cell apoptosis
  192. Sphingolipid-mediated signal transduction
  193. Sphingolipid Metabolism: Sphingoid Analogs, Sphingolipid Activator Proteins, and the Pathology of the Cella
  194. Differential expression of Sphingolipids in MRP1 overexpressing HT29 cells
  195. Disruption of Sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with …
  196. Sphingolipids and cell signalling
  197. Guanosine diphosphatase is required for protein and Sphingolipid glycosylation in the Golgi lumen of Saccharomyces cerevisiae
  198. Coupling of the p75 Neurotrophin Receptor to Sphingolipid Signalinga
  199. Specificity of inhibitors of serine palmitoyltransferase (SPT), a key enzyme in Sphingolipid biosynthesis, in intact cells: a novel evaluation system using an SPT …
  200. Modulation of Sphingolipid biosynthesis in primary cultured neurons by long chain bases.
  201. Sphingolipid biosynthesis in cultured neurons: Down‐regulation of serine palmitoyltransferase by sphingoid bases
  202. Activation of the de novo biosynthesis of Sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis
  203. The binding of botulinum toxin to membrane lipids: Sphingolipids, steroids and fatty acids
  204. Inhibition of fungal Sphingolipid biosynthesis by rustmicin, galbonolide B and their new 21-hydroxy analogs
  205. Advances in the signal transduction of ceramide and related Sphingolipids
  206. Synthetic studies on Sphingolipids. VI. The total syntheses of cerasine and phrenosine
  207. Glutamate-induced neuronal death in primary cultures of cerebellar granule cells: protection by synthetic derivatives of endogenous Sphingolipids.
  208. Syringomycin E Inhibition of Saccharomyces cerevisiae: Requirement for Biosynthesis of Sphingolipids with Very-Long-Chain Fatty Acids and Mannose- and …
  209. Fumonisin B1 alters Sphingolipid metabolism and disrupts the barrier function of endothelial cells in culture
  210. Isolation and structural determination of new Sphingolipids and pharmacological activity of africanene and other metabolites from Sinularia leptoclados
  211. De Novo Synthesis of Sphingolipids Is Required for Cell Survival by Down-Regulating c-Jun N-Terminal Kinase in Drosophila Imaginal Discs
  212. Sphingolipid synthesis: identification and characterization of mammalian cDNAs encoding the Lcb2 subunit of serine palmitoyltransferase
  213. Inhibition of Sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide
  214. Enzymic hydrolysis of Sphingolipids. VIII. Purification and properties of rat brain ceramidase
  215. Modulation of nanotube formation by structural modifications of Sphingolipids
  216. Differential Roles of de Novo Sphingolipid Biosynthesis and Turnover in the “Burst” of Free Sphingosine and Sphinganine, and Their 1-Phosphates and N …
  217. Sphingolipid synthesis and membrane formation byPlasmodium
  218. Influence of Sphingolipids on T lymphocyte activation
  219. Enantiodivergent Biosynthesis of the Dimeric Sphingolipid Oceanapiside from the Marine Sponge Oceanapia phillipensis. Determination of Remote Stereochemistry
  220. THE CHARACTERIZATION OF Sphingolipids FROM NEURONS AND ASTROGLIA OF IMMATURE RAT BRAIN1
  221. Sphingoid base 1-phosphate phosphatase: a key regulator of Sphingolipid metabolism and stress response
  222. Distribution of saposin proteins (Sphingolipid activator proteins) in lysosomal storage and other diseases.
  223. Stimulatory effect of certain plant Sphingolipids on fruiting of Schizophyllum commune.
  224. Antifungals targeted to Sphingolipid synthesis: focus on inositol phosphorylceramide synthase
  225. Biochemistry of the Sphingolipids: XII. conversion of cerebrosides to ceramides and sphingosine; structure of Gaucher cerebroside
  226. Characterization of Sphingolipids from mycopathogens: factors correlating with expression of 2-hydroxy fatty acyl (E)-Δ3-unsaturation in cerebrosides of …
  227. A stereocontrolled, efficient synthetic route to bioactive Sphingolipids: synthesis of phytosphingosine and phytoceramides from unsaturated ester precursors via cyclic …
  228. Sphingolipids as mediators of effects of platelet-derived growth factor in vascular smooth muscle cells
  229. Sphingolipid metabolism in the regulation of bioactive molecules
  230. Biosynthesis of brain Sphingolipids and myelin accumulation in the mouse
  231. Investigation of Sphingolipids in pea seeds
  232. Suppressor gene analysis reveals an essential role for Sphingolipids in transport of glycosylphosphatidylinositol-anchored proteins in Saccharomyces cerevisiae
  233. Lipid phosphate phosphohydrolase-1 degrades exogenous glycerolipid and Sphingolipid phosphate esters
  234. Sphingolipids stimulate cell growth via MAP kinase activation in osteoblastic cells
  235. Molecular cloning and characterization of SCaMPER, a Sphingolipid Ca2+ release-mediating protein from endoplasmic reticulum.
  236. Sorting of Sphingolipids in the endocytic pathway of HT29 cells.
  237. Structures of the normal unsaturated fatty acids of brain Sphingolipids
  238. Phytosphingosine groups as quantitatively significant components of the Sphingolipids of the mucosa of the small intestines of some mammalian species
  239. Structure Elucidation of Sphingolipids from the Mycopathogen Paracoccidioides brasiliensis:  An Immunodominant β-Galactofuranose Residue Is Carried by a Novel …
  240. Inhibition of Sphingolipid biosynthesis in rat primary hepatocyte cultures by fumonisin B1 and other structurally related compounds
  241. Requirement of Sphingolipid α-hydroxylation for fungicidal action of syringomycin E
  242. Gas chromatography and mass spectrometry of Sphingolipid bases. Characterization of sphinga-4, 14-dienine from plasma sphingomyelin
  243. Pathological study of mice with total deficiency of Sphingolipid activator proteins (SAP knockout mice)
  244. Inhibition of cholesterol and Sphingolipid synthesis causes paradoxical effects on permeability barrier homeostasis
  245. … Are Sorted in Sub-Apical Compartments in HepG2 Cells: A Role for Non-Golgi–Related Intracellular Sites in the Polarized Distribution of (Glyco) Sphingolipids
  246. Long-chain bases in the Sphingolipids of atherosclerotic human aorta
  247. Cells defective in Sphingolipids biosynthesis express low amounts of muscle nicotinic acetylcholine receptor
  248. Oligomerization of Vibrio cholerae cytolysin yields a pentameric pore and has a dual specificity for cholesterol and Sphingolipids in the target membrane
  249. Regulation of cytochrome P450 expression by Sphingolipids
  250. Sphingolipid biosynthesis is necessary for dendrite growth and survival of cerebellar Purkinje cells in culture
  251. Sphingolipid levels in catfish consuming Fusarium moniliforme corn culture material containing fumonisins
  252. Distribution of Sphingolipids in Bacteroides species
  253. Sphingolipids and phospholipids of myelin in multiple sclerosis
  254. Dual parallel mass spectrometers for analysis of Sphingolipid, glycerophospholipid and plasmalogen molecular species
  255. Sphingolipids activate membrane fusion of Semliki Forest virus in a stereospecific manner
  256. Metabolism of Sphingolipids by normal and atherosclerotic aorta of squirrel monkeys
  257. Implication of Sphingolipid metabolism in the stability of the Golgi apparatus
  258. Sphingolipid second messengers: tumor suppressor lipids
  259. Sphingosine-1-phosphate: a platelet-activating Sphingolipid released from agonist-stimulated human platelets
  260. Polarized Sphingolipid transport from the subapical compartment: evidence for distinct Sphingolipid domains
  261. Species of Sphingolipids in rice grain
  262. Sterols and Sphingolipids strongly affect the growth of fusion pores induced by the hemagglutinin of influenza virus
  263. Rapid and sensitive determination of sphingosine bases and Sphingolipids with fluorescamine
  264. Sphingolipid transport in mitotic HeLa cells.
  265. Disruption of Sphingolipid metabolism in small intestines, liver and kidney of mice dosed subcutaneously with fumonisin B1
  266. Second messengers: Sphingolipid signalling
  267. Sphingolipids of mushrooms
  268. Early fumonisin B1 toxicity in relation to disrupted Sphingolipid metabolism in male BALB/c mice
  269. Biochemistry of the Sphingolipids. XV. Structure of Phytosphingosine and Dehydrophytosphingosine*
  270. Tumor necrosis factor induces ceramide oscillations and negatively controls Sphingolipid synthases by caspases in apoptotic Kym-1 cells
  271. Sphingolipids as differential regulators of cellular signalling processes
  272. Lactosylceramide galactosidase: comparison with other Sphingolipid hydrolases in developing rat brain
  273. Characterization of enzymatic synthesis of Sphingolipid long-chain bases in Saccharomyces cerevisiae: mutant strains exhibiting long-chain-base auxotrophy are …
  274. Sphingolipids and cholesterol modulate membrane susceptibility to cytosolic phospholipase A2
  275. Formation of high-axial-ratio-microstructures from natural and synthetic Sphingolipids
  276. Metabolic effects of short‐chain ceramide and glucosylceramide on Sphingolipids and protein kinase C
  277. Detection of Sphingomonas spp in soil by PCR and Sphingolipid biomarker analysis
  278. Sphingolipids of a cestode Metroliasthes coturnix
  279. Further studies on Sphingolipids in wheat grain
  280. Lipid second messengers derived from glycerolipids and Sphingolipids, and their role in smooth muscle function
  281. Sphingolipid metabolism in leukemic leukocytes
  282. Do the long fatty acid chains of Sphingolipids interdigitate across the center of a bilayer of shorter chain symmetric phospholipids?
  283. Complete removal of Sphingolipids from the plasma membrane disrupts cell to substratum adhesion of mouse melanoma cells
  284. Sphingolipid base metabolism. Partial purification and properties of sphinganine kinase of brain.
  285. An improved separation of Sphingolipids by thin-layer chromatography.
  286. Biosynthesis of Sphingolipid bases: II. Keto intermediates in synthesis of sphingosine and dihydrosphingosine by cell-free extracts of Hansenula ciferri
  287. … Proportion of Adenomas versus Adenocarcinomas in CF1 Mice Treated with 1,2-Dimethylhydrazine: Implications for Dietary Sphingolipids and Colon Carcinogenesis
  288. (−)‐Rhizochalin is a Dimeric Enantiomorphic (2R)‐Sphingolipid: Absolute Configuration of Pseudo‐C2v‐Symmetric Bis‐2‐amino‐3‐alkanols by CD
  289. Sphingolipid signaling in gonadal development and function
  290. Carbohydrate structures of three novel phosphoinositol-containing Sphingolipids from the yeast Histoplasma capsulatum
  291. The assay of Sphingolipid hydrolases in white blood cells with labelled natural substrates
  292. Biosynthesis and metabolic degradation of Sphingolipids not containing sialic acid
  293. Insertion in the mRNA of a metachromatic leukodystrophy patient with Sphingolipid activator protein-1 deficiency.
  294. Fusion of Semliki Forest virus with cholesterol-containing liposomes at low pH: a specific requirement for Sphingolipids
  295. Mannose 6-phosphate-independent membrane association of cathepsin D, glucocerebrosidase, and Sphingolipid-activating protein in HepG2 cells.
  296. A temperature-sensitive mammalian cell mutant with thermolabile serine palmitoyltransferase for the Sphingolipid biosynthesis.
  297. Synthetic Studies on Sphingolipids. X.1 Synthesis of Psychosine2
  298. Effect of vitamin K depletion and restoration on Sphingolipid metabolism in Bacteroides melaninogenicus
  299. The polar-lipid composition of the Sphingolipid-producing bacterium Flectobacillus major
  300. The gene coding for a Sphingolipid activator protein, SAP-1, is on human chromosome 10
  301. … -insoluble GPI–anchored Proteins Are Apically Sorted in Fischer Rat Thyroid Cells, but Interference with Cholesterol or Sphingolipids Differentially Affects Detergent …
  302. Suppressors of the Ca (2+)-sensitive yeast mutant (csg2) identify genes involved in Sphingolipid biosynthesis. Cloning and characterization of SCS1, a gene required …
  303. Aspects on structure and function of Sphingolipids in cell surface membranes
  304. Regulation of mitogen-activated protein kinases by Sphingolipid products in oligodendrocytes
  305. Experimental animal model for mucopolysaccharidosis: suramin-induced glycosaminoglycan and Sphingolipid accumulation in the rat.
  306. The Sphingolipid composition of human renal carcinoma
  307. Sphingolipid-dependent fusion of Semliki Forest virus with cholesterol-containing liposomes requires both the 3-hydroxyl group and the double bond of the …
  308. Experimental studies on the pathogenesis of leucodystrophies I. The effect of intracerebrally injected Sphingolipids in the rat’s brain
  309. Actin filaments and microtubules are involved in different membrane traffic pathways that transport Sphingolipids to the apical surface of polarized HepG2 cells
  310. Determination of the structures of Sphingolipid bases by combined gas chromatography-mass spectrometry
  311. Mass spectra of permethyl derivatives of glyco-Sphingolipids
  312. Sphingolipid transport to the apical plasma membrane domain in human hepatoma cells is controlled by PKC and PKA activity: a correlation with cell polarity in …
  313. Occurrence of novel antigenic phosphoinositol-containing Sphingolipids in the pathogenic yeast Histoplasma capsulatum
  314. Characterization of Sphingolipid long-chain base kinase in Arabidopsis thaliana
  315. Sphingolipid metabolism and cell signaling
  316. The distribution of lipids in the human nervous system. IV. Fatty acid composition of major Sphingolipids of human infant brain
  317. Mg2+ modulates membrane Sphingolipid and lipid second messenger levels in vascular smooth muscle cells
  318. Functional roles of sphingosine, sphingosine 1-phosphate, and methylsphingosines: in regard to membrane Sphingolipid signaling pathways
  319. The characterization of Sphingolipids of oligodendroglia from calf brain
  320. Detection of a point mutation in Sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophy
  321. Characterization of a novel intracellular Sphingolipid-gated Ca (2+)-permeable channel from rat basophilic leukemia cells.
  322. Identification of a novel sequence involved in lysosomal sorting of the Sphingolipid activator protein prosaposin
  323. Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical and …
  324. Biochemistry of Sphingolipids: IV. Some new paper chromatographic systems for the characterization of Sphingolipids
  325. Synthetic studies on Sphingolipids. V. The synthesis of dihydrocerebrosides
  326. Biosynthesis, Processing, and Targeting of Sphingolipid Activator Protein (SAP) Precursor in Cultured Human Fibroblasts: MANNOSE 6-PHOSPHATE …
  327. Studies on the production of Sphingolipid bases by the yeast, Hansenula ciferri
  328. Processing of Sphingolipid activator proteins and the topology of lysosomal digestion.
  329. Disruption of Sphingolipid metabolism in non-human primates consuming diets of fumonisin-containing Fusarium moniliforme culture material
  330. Sphingolipid metabolism in organotypic mouse keratinocyte cultures
  331. Biochemical, immunological, and structural studies on a Sphingolipid activator protein (SAP-1)
  332. Intracellular lipid heterogeneity caused by topology of synthesis and specificity in transport. Example: Sphingolipids
  333. The biochemistry of Sphingolipid storage diseases
  334. Inhibition of Ca2+ release channel (ryanodine receptor) activity by Sphingolipid bases: mechanism of action
  335. cis-4-Methylsphingosine decreases Sphingolipid biosynthesis by specifically interfering with serine palmitoyltransferase activity in primary cultured neurons
  336. Sphingolipids inhibit insulin and phorbol ester stimulated uptake of 2-deoxyglucose
  337. Sphingolipid classes and their molecular species in wheat flour
  338. Induction of apoptosis using Sphingolipids activates a chloride current in Xenopus laevis oocytes
  339. Sphingolipid antibodies in sera of animals and patients with central nervous system lesions.
  340. … -L-threonine, in cultured hippocampal neurons: exogenous L-serine is required for the synthesis of neuronal phosphatidyl-L-serine and Sphingolipids
  341. Effects of fusarium moniliforme isolates on tissue and serum Sphingolipid concentrations in horses.
  342. Apical sorting of bovine enteropeptidase does not involve detergent-resistant association with Sphingolipid-cholesterol rafts
  343. Disruption of Sphingolipid metabolism and induction of equine leukoencephalomalacia by Fusarium proliferatum culture material containing fumonisin B2 or B3
  344. In vivo conversion of labeled fatty acids to the Sphingolipid fatty acids in rat brain
  345. Enzymic hydrolysis of Sphingolipids. Hydrolysis of ceramide glucoside by an enzyme from ox brain
  346. Accumulation of Sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by …
  347. SEC14-dependent Secretion inSaccharomyces cerevisiae: NONDEPENDENCE ON Sphingolipid SYNTHESIS-COUPLED DIACYLGLYCEROL …
  348. Enzymic hydrolysis of Sphingolipids: Hydrolysis of ceramide lactoside by an enzyme from rat brain
  349. AAL‐toxin, a potent natural herbicide which disrupts Sphingolipid metabolism of plants
  350. Synthetic Studies on Sphingolipids.1 III.2 The Synthesis of Dihydrosphingomyelin3
  351. [35] Isolation and characterization of novel inhibitors of Sphingolipid synthesis: Australifungin, viridiofungins, rustmicin, and khafrefungin
  352. Chemistry and Metabolism of Sphingolipids. On the Biosynthesis of Phytosphingosine by Yeast*
  353. Vitamin K stimulation of Sphingolipid synthesis
  354. The isolation and partial characterization of two novel Sphingolipids from Neurospora crassa: di (inositolphosphoryl) ceramide and [(gal) 3glu] ceramide
  355. Sphingolipid activator proteins (SAPs) in neuronal ceroid lipofuscinoses (NCL)
  356. Mixed membranes of Sphingolipids and glycerolipids as studied by spin-label ESR spectroscopy. A search for domain formation
  357. On the formation of alpha-hydroxy fatty acids. Evidence for a direct hydroxylation of nonhydroxy fatty acid-containing Sphingolipids.
  358. Assignment of the gene for human Sphingolipid activator protein-2 (SAP-2) to chromosome 10.
  359. Models of stratum corneum intercellular membranes: the Sphingolipid headgroup is a determinant of phase behavior in mixed lipid dispersions
  360. Synthesis and processing of Sphingolipid activator protein-2 (SAP-2) in cultured human fibroblasts.
  361. Gas liquid chromatographic analysis of sphingosine bases in Sphingolipids of human normal and multiple sclerosis cerebral white matter
  362. Molecular cloning of a human co-β-glucosidase cDNA: evidence that four Sphingolipid hydrolase activator proteins are encoded by single genes in humans and rats
  363. Structure elucidation of australifungin, a potent inhibitor of sphinganine N-acyltransferase in Sphingolipid biosynthesis from Sporormiella australis
  364. Inhibition of Sphingolipid synthesis: effects on glycoSphingolipid—GPI-anchored protein microdomains
  365. The role of Sphingolipids in the maintenance of fibroblast morphology: the inhibition of protrusional activity, cell spreading, and cytokinesis induced by …
  366. Sphingosine 1-phosphate, a bioactive Sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum
  367. Stimulation of erythroblast maturation in vitro by Sphingolipids
  368. Nucleotide sequence of cloned cDNA for human Sphingolipid activator protein 1 precursor.
  369. Quaking mouse: in vitro studies of brain Sphingolipid biosynthesis
  370. Additional biochemical findings in a patient and fetal sibling with a genetic defect in the Sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a …
  371. [14C] Ceramide Synthesis by Sphingolipid CeramideN-Deacylase: New Assay for Ceramidase Activity Detection
  372. Studies of the action of ceramide-like substances (d- andl-PDMP) on Sphingolipid glycosyltransferases and purified lactosylceramide synthase
  373. The differential regulation of cyclic AMP by sphingomyelin-derived lipids and the modulation of Sphingolipid-stimulated extracellular signal regulated kinase-2 in …
  374. Polarized Sphingolipid transport from the subapical compartment changes during cell polarity development
  375. Characterization of neutral Sphingolipids and gangliosides from chicken liver
  376. Localization of epidermal Sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements
  377. Sphingolipids of the fungiPhycomycetes blakesleeanus andFusarium lini
  378. Semisynthetic Sphingolipids prevent protein kinase C translocation and neuronal damage in the perifocal area following a photochemically induced thrombotic brain …
  379. Alteration of Sphingolipid metabolism in leukocytes from patients with the Chediak–Higashi syndrome
  380. Long chain base and fatty acid compositions of equine kidney Sphingolipids
  381. Hydrolysis of lactosylceramide by human galactosylceramidase and GM1‐β‐galactosidase in a detergent‐free system and its stimulation by Sphingolipid activator proteins, sap …
  382. Effect of tricyclic antidepressants on sphingomyelinase and other Sphingolipid hydrolases in C6 cultured glioma cells
  383. Enzymatic hydrolysis of Sphingolipids VII. Hydrolysis of gangliosides by a neuraminidase from calf brain
  384. Sphingolipids and their precursors in human brain (normal and MS)
  385. Identification of the binding and activating sites of the Sphingolipid activator protein, saposin C, with glucocerebrosidase
  386. Association of Src-family protein tyrosine kinases with Sphingolipids in rat cerebellar granule cells differentiated in culture
  387. Sphingolipids of influenza viruses
  388. Regulatory Roles for Sphingolipids in the Growth of Polarized Neuronsa
  389. Calcium signalling by G protein-coupled Sphingolipid receptors in bovine aortic endothelial cells
  390. Inhibition of Sphingolipid synthesis, but not degradation, alters the rate of dendrite growth in cultured hippocampal neurons
  391. Accumulation of Sphingolipid activator proteins (SAPs) A and D in granular osmiophilic deposits in miniature Schnauzer dogs with ceroid-lipofuscinosis
  392. Molecular arrangements in Sphingolipids: crystal structure of the ceramide N-(2D, 3D-dihydroxyoctadecanoyl)-phytosphingosine
  393. Characterization of cytotoxicity induced by Sphingolipids in multidrug-resistant leukemia cells
  394. Sphingolipid-gated Ca2+ Release from Intracellular Stores of Endothelial Cells Is Mediated by a Novel Ca2+-permeable Channel (∗)
  395. Synthesis of mannose-(inositol-P) 2-ceramide, the major Sphingolipid in Saccharomyces cerevisiae, requires the IPT1 (YDR072c) gene
  396. D-Serine inhibits serine palmitoyltransferase, the enzyme catalyzing the initial step of Sphingolipid biosynthesis
  397. Sphingolipid transport from the trans‐Golgi network to the apical surface in permeabilized MDCK cells
  398. Biochemistry of the Sphingolipids. XVII. The Nature of the Oligosaccharide Component of Phytoglycolipid*
  399. Mass spectra of complex molecules i. Chemical ionization of Sphingolipids
  400. Enhancement of hydrolytic activity of Sphingolipid ceramide N-deacylase in the aqueous–organic biphasic system
  401. Sphingolipid activator proteins in the neuronal ceroid-lipofuscinoses: an immunological study
  402. Involvement of Sphingolipids metabolites in cellular proliferation modulated by ganglioside GM1
  403. … by the reverse hydrolysis reaction of Sphingolipid ceramide N-deacylase as substrates for assay of Sphingolipid-degrading enzymes and for detection of Sphingolipid …
  404. A rapid method for quantifying free sphingoid bases and complex Sphingolipids in microgram amounts of cells following exposure to fumonisin B1
  405. Application of delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry for analysis of Sphingolipids in tissues from …
  406. 1-Methylthiodihydroceramide, a novel analog of dihydroceramide, stimulates sphinganine degradation resulting in decreased de novo Sphingolipid …
  407. Modulation by Sphingolipids of calcium signals evoked by epidermal growth factor.
  408. Biosynthesis of Sphingolipid Bases: III. ISOLATION AND CHARACTERIZATION OF KETONIC INTERMEDIATES IN THE SYNTHESIS OF SPHINGOSINE AND …
  409. Use of photoactivatable Sphingolipid analogues to monitor lipid transport in mammalian cells
  410. Comparison of the Sphingolipid Content of Rumen Bacteroides Species
  411. THE FATTY ACID COMPOSITION OF Sphingolipids FROM BOVINE CNS AXONS AND MYELIN1
  412. Cytotoxic effects of Sphingolipids as single or multi-modality agents on human melanoma and soft tissue sarcoma in vitro
  413. Studies on Sphingolipids. VIII. Separation of the Diastereoisomeric Dihydrosphingosines. A Simplified Synthesis1
  414. Alteration in Sphingolipid metabolism: bioassays for fumonisin‐and ISP‐I‐like activity in tissues, cells and other matrices
  415. Hariamide, a Novel Sulfated Sphingolipid from a Zoanthus sp. of the Indian Coast
  416. Biosynthesis of Sphingolipid bases: IV. The biosynthetic origin of sphingosine in Hansenula ciferri
  417. Sphingolipid biosynthesis by rat liver cells: effects of serine, fatty acids and lipoproteins
  418. Formation of Extracellular Sphingolipids by Microorganisms: IV. Pilot-Plant Production of Tetraacetylphytosphingosine by Hansenula ciferrii
  419. Sphingolipid metabolism during human platelet activation
  420. Sphingolipid metabolism during infection of human fibroblasts by herpes simplex virus type 1
  421. Structural characterization of Sphingolipids in leafy stems of rice
  422. α-Hydroxy fatty acids in Sphingolipids of Tetrahymena
  423. Sphingolipid actions on sodium and calcium currents of rat ventricular myocytes
  424. Intracellular transport of inositol-containing Sphingolipids in the yeast, Saccharomyces cerevisiae
  425. The quantitative analysis of Sphingolipids by determination of long chain base as the trinitrobenzene sulfonic acid derivative
  426. Synthetic studies on Sphingolipids. XI. Synthesis of cytolipin H and analogous lactosides
  427. Sphingolipid long-chain base synthesis in plants (characterization of serine palmitoyltransferase activity in squash fruit microsomes)
  428. Synthetic studies on Sphingolipids. XII. Synthesis of sphingosinephosphorylcholine
  429. Distinct interactions among GPI-anchored, transmembrane and membrane associated intracellular proteins, and Sphingolipids in lymphocyte and endothelial …
  430. Inborn errors of Sphingolipid metabolism
  431. Experimental studies on the pathogenesis of leucodystrophies: II. The effect of Sphingolipids on various cell types in cultures from the nervous system
  432. [47] Sphingolipid photoaffinity labels
  433. Sphingolipids and glycerolipids. IV. Syntheses and ionophoretic activities of several analogues of soya-cerebroside II, a calcium ionophoretic sphingoglycolipid …
  434. A lysosomal storage disorder in mice characterized by the accumulation of several Sphingolipids.
  435. Simplified derivatization for determining Sphingolipid fatty acyl composition by gas chromatography—mass spectrometry
  436. A non-glycosylated and functionally deficient mutant (N215H) of the Sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD)
  437. Further study of structural components of the pyridine insoluble Sphingolipid from Corbicula, Corbicula sandai and the distribution in other species
  438. Chromatography of Sphingolipids of human brain
  439. Metastable phase behavior of a Sphingolipid analogue
  440. Low molecular weight proteins in secondary lysosomes as activators of different Sphingolipid hydrolases
  441. An apical-type trafficking pathway is present in cultured oligodendrocytes but the Sphingolipid-enriched myelin membrane is the target of a basolateral-type pathway
  442. Internalization and sorting of plasma membrane Sphingolipid analogues in differentiating oligodendrocytes
  443. … Blocks Brefeldin A–induced Retrograde Membrane Transport from Golgi to ER: Evidence for Involvement of Calcium Homeostasis and Dissociation from Sphingolipid …
  444. Induced mouse models of abnormal Sphingolipid metabolism
  445. Phosphonosphingoglycolipid, a novel Sphingolipid from the viscera of Turbo cornutus.
  446. Regional localization of the gene coding for Sphingolipid activator protein SAP-1 on human chromosome 10
  447. Ceramide phosphorylglycerol phosphate a new Sphingolipid found in bacteria
  448. Epithelial Sphingolipid sorting allows for extensive variation of the fatty acyl chain and the sphingosine backbone
  449. Effect of suramin on the activities of degradative enzymes of Sphingolipids in rats.
  450. … , and ItsArabidopsis thaliana Homolog That Lacks the Cytochromeb 5 Domain Both Function in the α-Hydroxylation of Sphingolipid-associated Very Long …
  451. Intracellular trafficking of glycoSphingolipids: role of Sphingolipid activator proteins in the topology of endocytosis and lysosomal digestion
  452. The mechanism for a 33-nucleotide insertion in mRNA causing Sphingolipid activator protein (SAP-1)-deficient metachromatic leukodystrophy
  453. Phosphatidylinositol phosphate, phosphatidylinositol bisphosphate, and the phosphoinositol Sphingolipids are found in the plasma membrane and stimulate the …
  454. [51] Estimating Sphingolipid metabolism and trafficking in cultured cells using radiolabeled compounds
  455. Ceramide accumulation is associated with increased apoptotic cell death in cultured fibroblasts of Sphingolipid activator protein‐deficient mouse but not in fibroblasts …
  456. Expression of the three alternative forms of the Sphingolipid activator protein precursor in baby hamster kidney cells and functional assays in a cell culture …
  457. Sphingolipid deficiency induces hypersensitivity of CD14, a glycosyl phosphatidylinositol-anchored protein, to phosphatidylinositol-specific phospholipase C
  458. Biochemistry of Shellfish Lipids X. Isolation of a Sphingolipid Containing 2-Monomethylalnino-ethylphosphonic Acid from Shellfish
  459. … modulated targeting of the EDG-1 receptor to plasmalemmal caveolae: eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in Sphingolipid …
  460. Sphingolipid biosynthesis and vitamin K metabolism in Bacteroides melaninogenicus
  461. Partitioning of exchangeable fluorescent phospholipids and Sphingolipids between different lipid bilayer environments
  462. An apparent association between glycosylphosphatidylinositol-anchored proteins and a Sphingolipid in Tetrahymena mimbres
  463. Induction of programmed cell death and immunosuppression by exogenous Sphingolipids are separate processes
  464. Sphingolipids as messengers of cell
  465. Intermixing of dipalmitoylphosphatidylcholine with phospho-and Sphingolipids bearing highly asymmetric hydrocarbon chains
  466. Sphingolipids and phospholipids in microsomes and myelin from normal and pathological brains
  467. Stimulation of lysosomal sphingomyelin degradation by Sphingolipid activator proteins
  468. Sphingolipids in fruit bodies of the basidiomycete Lactarius deliciosus
  469. Phase behavior of carbamyloxyphosphatidylcholine, a Sphingolipid analogue
  470. Phenotypic changes in 3T3 cells associated with the change of Sphingolipid synthesis by a ceramide analog, 2-decanoylamino-3-morpholino-1-phenylpropanol …
  471. L-cycloserine, an inhibitor of Sphingolipid biosynthesis, inhibits HIV-1 cytopathic effects, replication, and infectivity
  472. Concentrations of an activator protein for Sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
  473. Cell cycle control of PDGF‐induced Ca2+ signaling through modulation of Sphingolipid metabolism
  474. Screening of fungal species for fumonisin production andfumonisin-like disruption of Sphingolipid biosynthesis
  475. Immunocytochemical localization of Sphingolipid activator protein 2 (SAP-2) in normal and SAP-deficient fibroblasts.
  476. Molecular cloning of the Sphingolipid activator protein—1 (SAP-1), the sulfatide sulfatase activator
  477. THE CHEMISTRY OF THE LIPIDS OF POSTHEMOLYTIC RESIDUE OR STROMA OF ERYTHROCYTES VI. Sphingolipids OF ERYTHROCYTES WITH RESPECT …
  478. Synthetic studies on Sphingolipids. IV. The synthesis of sphingomyelin
  479. Oral administration of semisynthetic Sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism
  480. Inhibition of Sphingolipid synthesis down-modulates CD4 expression by peripheral blood T lymphocytes and T lymphoma cells
  481. Human Sphingolipid activator protein-1 and Sphingolipid activator protein-2 are encoded by the same gene.
  482. Biosynthesis of phospholipids and Sphingolipids from acetoacetate and glucose in different regions of developing brain in vivo
  483. Prepartion of Sphingolipid fatty acid methyl esters for determination by gas—liquid chromatography
  484. Involvement of Sphingolipids in the endothelin-1 signal transduction mechanism in rat brain
  485. Orientation measurements on ordered multibilayers of phospholipids and Sphingolipids from synthetic and natural origin by ATR Fourier transform infrared …
  486. Disorders of Sphingolipid metabolism
  487. [29] Sphingolipid hydrolases and activator proteins
  488. … derivatives are transported by a vacuolar-network of Plasmodium falciparum and their anti-malarial activities are additive with toxic Sphingolipid analogues that block …
  489. [15] Enzymes of Sphingolipid metabolism in plants
  490. Modulation of human saposin B Sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides.
  491. Sphingolipid activator proteins in a human hereditary renal disease with deposition of disialogangliosides
  492. Enzymatic Hydrolysis of Sphingolipids. VI. Hydrolysis of Ceramide Glycosides by Calf Brain β-N-Acetylhexosaminidase*
  493. Sphingolipids in blood platelets of the pig
  494. Distinct roles for Sphingolipids and glycoSphingolipids at different stages of neuronal development.
  495. Expression of Sphingolipid activator protein gene in brain and systemic organs of developing mice
  496. Characterization of neutral Sphingolipids from chicken erythrocytes.
  497. Assays for transmembrane movement of Sphingolipids
  498. Sphingolipid metabolism, apoptosis and resistance to cytotoxic agents: can we interfere?
  499. Long-chain bases in the Sphingolipids of bovine milk and kidney, rumen bacteria, rumen protozoa, hay and concentrate
  500. Long chain fatty acid deficits in brain myelin Sphingolipids of undernourished rat pups
  501. Structural characterization of Sphingolipids in wheat grain
  502. Epithelial Sphingolipid sorting is insensitive to reorganization of the Golgi by nocodazole, but is abolished by monensin in MDCK cells and by brefeldin A in Caco-2 …
  503. Sphingolipid activator proteins (SAPs) are stored together with glycoSphingolipids in the infantile neuronal ceroid‐lipofuscinosis (INCL)
  504. Jimpy mouse: In vitro studies of brain Sphingolipid biosynthesis
  505. Chemistry and metabolism of Sphingolipids. Chemical synthesis of 2-amino-1-hydroxyoctadecan-3-one (3-oxosphinganine)
  506. Enzymatic Synthesis of 14C-GlycoSphingolipids by Reverse Hydrolysis Reaction of Sphingolipid Ceramide N-Deacylase: Detection of Endoglycoceramidase Activity …
  507. Structural study of the oligosaccharide moieties of Sphingolipid activator proteins, saposins A, C and D obtained from the spleen of a Gaucher patient
  508. Sphingosine base and fatty acid compositions of pig brain Sphingolipids
  509. Biochemistry of the Sphingolipids. XIV. Inositol lipids of flaxseed
  510. Sphingolipid-dependent protein kinases
  511. L-cycloserine inhibition of Sphingolipid synthesis in the anaerobic bacterium Bacteroides levii
  512. Characteristics of asparagine-linked sugar chains of Sphingolipid activator protein 1 purified from normal human liver and GM1 gangliosidosis (type 1) liver
  513. Fumonisin B1 alters Sphingolipid metabolism and immune function in BALB/c mice: Immunological responses to fumonisin B1
  514. Generation of lipid polarity in intestinal epithelial (Caco-2) cells: Sphingolipid synthesis in the Golgi complex and sorting before vesicular traffic to the plasma …
  515. Sphingolipid metabolism II. The biosynthesis of 3‐keto‐dihydrosphingosine by a partially‐purified enzyme from rat brain
  516. Sphingolipids and cancer
  517. Changes in Composition of Newly Synthesized Sphingolipids of HeLa Cells During the Cell Cycle: Suppression of Sphingomyelin and Higher‐GlycoSphingolipid …
  518. Temperature-induced changes in the hydroxy and non-hydroxy fatty acid-containing Sphingolipids abundant in the surface membrane of Tetrahymena …
  519. Problems in prenatal diagnosis using Sphingolipid hydrolase assays
  520. Sphingolipids increase calcium concentration in isolated rat liver nuclei
  521. Role of Sphingolipids in the transport of prosaposin to the lysosomes
  522. Studies on the Lipids of Egg Yolk Part II. Nature of Sphingolipids
  523. Analysis of long-chain bases in Sphingolipids by positive ion fast atom bombardment or matrix-assisted secondary ion mass spectrometry
  524. Only Sphingolipid activator protein B (SAP‐B or saposin B) stimulates the degradation of globotriaosylceramide by recombinant human lysosomal α‐galactosidase in …
  525. Sphingolipid receptor signaling and function in human bladder carcinoma cells: inhibition of LPA-but enhancement of thrombin-stimulated cell motility
  526. Comparative phytotoxicity of the fumonisins, AAL-toxin and yeast Sphingolipids in Lemna minor L. (duckweed)
  527. Transport of (glyco) Sphingolipids in and between cellular membranes; multidrug transporters and lateral domains
  528. STUDIES ON THE BIOSYNTHESIS OF GLYCO‐Sphingolipids IN CULTURED MOUSE NEUROBLASTOMA CELLS: CHARACTERIZATION AND ACCEPTOR …
  529. Sphingolipids of transplantable rat nephroma-RA.
  530. A glycoSphingolipid spin label: Ca2+ effects on Sphingolipid distribution in bilayers containing phosphatidyl serine
  531. Polar lipids in bovine milk II. Long-chain bases, normal and 2-hydroxy fatty acids, and isomeric cis and trans monoenoic fatty acids in the Sphingolipids
  532. Determination of saposin proteins (Sphingolipid activator proteins) in human tissues
  533. Sphingolipids and glycolipids of fungi and higher plants. 3. Isolation of a cerebroside from A. niger.
  534. Susceptibility of myelin glycerophospholipids and Sphingolipids to oxidative attack by hydroxyl free radicals as measured by the thiobarbituric acid test
  535. STUDIES IN THE Sphingolipids SERIES. I. SYNTHESIS OF RACEMIC 2-AMINO-1, 3-DIHYDROXYOCTADECANE
  536. Synthesis of potentially caged Sphingolipids, possible precursors of cellular modulators and second messengers
  537. Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and Sphingolipid activator protein (SAP, saposin) 1 and …
  538. [34] Use of yeast as a model system for studies of Sphingolipid metabolism and signaling
  539. Studies in the Sphingolipids Series. II. Synthesis of Enantiomeric Sphingines
  540. A triple-binding-domain model explains the specificity of the interaction of a Sphingolipid activator protein (SAP-1) with sulphatide, GM1-ganglioside and …
  541. Biochemistry of the Sphingolipids. XIX. Epimerization phenomenon in the oligosaccharide of phytoglycolipid
  542. … Sphingolipids including gangliosides in two cases of juvenile amaurotic family idiocy (Spielmeyer-Vogt type) using a new analytical procedure of Sphingolipids.
  543. Studies on a Sphingolipid activator protein (SAP-2) in fibroblasts from patients with lysosomal storage diseases, including Niemann-Pick disease type C
  544. … to the study of Sphingolipid enriched membrane domains: The use of microscopic autoradiography to reveal metabolically tritium labeled Sphingolipids in cell cultures
  545. … OF POSTHEMOLYTIC RESIDUE OR STROMA OF ERYTHROCYTES VIII. THE NATURE OF HEXOSAMINE AND FATTY ACIDS OF BLOOD CELLS Sphingolipids
  546. Combined gas chromatography-chemical ionization mass spectrometry of Sphingolipids. I. Glucosyl sphingosine, ceramides and cerebrosides of the spleen in …
  547. Sphingolipid metabolic disorders in Trembler mouse peripheral nerves in vivo result from an abnormal substrate supply
  548. Transport of biosynthetic Sphingolipids from Golgi to plasma membrane in HT29 cells: involvement of different carrier vesicle populations.
  549. Activities of the initial enzymes of glycerolipid and Sphingolipid synthesis in lung microsomes from rats exposed to air or 85% oxygen
  550. 10 Sphingolipid Formation
  551. Role of inositol-containing Sphingolipids in Saccharomyces cerevisiae during inositol starvation
  552. Alteration of glycerolipid and Sphingolipid-derived second messenger kinetics in ras transformed 3T3 cells
  553. Correlation between bioeffector characteristics of Sphingolipids and the structure of their hydrophobic fragment
  554. Sphingolipid base metabolism. Concerning the origin of the oxygen atom at carbon atom 4 of phytosphingosine
  555. The molecular biology of the Sphingolipid hydrolases
  556. Functional involvement of proteins, interacting with Sphingolipids, in Sphingolipid transport to the canalicular membrane in the human hepatocytic cell line, HepG2?
  557. [52] Use of N-([1-14C] Hexanoyl)-D-erythro-Sphingolipids to assay Sphingolipid metabolism
  558. Role of Sphingolipids in regulating the phospholipase D pathway and cell division
  559. Regulation of Sphingolipid and glycoSphingolipid metabolism during neuronal growth and development
  560. The effect of fumonisin B1 on developing chick embryos: correlation between de novo Sphingolipid biosynthesis and gross morphological changes
  561. Circular dichroism spectra of aqueous dispersions of Sphingolipids
  562. Changes in Sphingolipid levels induced by epidermal growth factor in osteoblastic cells. Effects of these metabolites on cytosolic calcium levels
  563. Products of Sphingolipid catabolism block activation of the p21-activated protein kinases in neutrophils
  564. The interrelation between the biological functions of Sphingolipids and their chemical structure
  565. Biosynthesis of unsaturated Sphingolipid bases by microsomal preparations from oysters
  566. Sphingolipid base metabolism. Chemical syntheses and properties of N-acetyl derivatives of 4R-, 4S-S, 5R-, and 5S-hydroxysphinganine
  567. Ceramide, a Sphingolipid second messenger
  568. ENZYMATIC SULPHATION OF SOME GALACTOSE‐CONTAINING Sphingolipids IN DEVELOPING RAT BRAIN1
  569. Biochemistry of Shell-Fish Lipid II. Isolation of the Ethanolamine-Containing Sphingolipid from Corbicula, Corbicula sandai
  570. Structural characteristics of plant Sphingolipids in relation to chilling and freezing tolerance
  571. Studies in the Sphingolipids series. XXXV. Separation and chemical characterization of the cerebrins from the yeast Saccharomyces cerevisiae
  572. Sphingoid bases: Sphingolipid-derived modulators of signal transduction
  573. Sphingolipid bases. A revisitation of the O-methyl derivatives of sphingosine. Isolation and characterization of diacetate derivatives, with revised 13C nuclear magnetic …
  574. Energy-dependent incorporation of Sphingolipid precursors and fatty acids in Bacteriodes melaninogenicus
  575. Sphingolipid base metabolism sphinganine-1-phosphate lyase: Identification of ethanolamine 1-phosphate as product
  576. Sphingolipid metabolism in leucocytes. I. Incorporation of14C-glucose and14C-galactose into glycoSphingolipids by intact human leucocytes
  577. Sulfatides and sodium ion transport, Sphingolipid composition of the rectal gland of spiny dogfish
  578. Inhibitors of Sphingolipid synthesis modulate interferon (IFN)-γ-induced intercellular adhesion molecule (ICAM)-1 and human leukocyte antigen (HLA)-DR expression …
  579. GlycoSphingolipids and Sphingolipids closely associated with or causing apoptosis
  580. Structure and function of sphinolipids. 1. Differences in Sphingolipid long-chain base pattern between kidney cortex, medulla, and papillae
  581. An epoxide derived from D-glucose as the key intermediate for penaresidine and Sphingolipids synthesis
  582. Disorders of Sphingolipid metabolism
  583. Immunological studies on Sphingolipid activator proteins in the neuronal ceroid-lipofuscinoses
  584. Relationship between Sphingolipid and Phospholipid Metabolism
  585. Modulation of phosphorylase kinase activity by Sphingolipids.
  586. Lipase-mediated efficient preparation of both enantiomers of 2-acetoxytetracosanoic acid, the intermediate for Sphingolipid synthesis
  587. Sphingolipids of animal nervous tissue IA Comparative study of polar lipid sphingosine bases
  588. Structure of the lysosomal Sphingolipid activator protein 1 by homology with influenza virus neuraminidase
  589. Sphingolipid metabolites and the cellular phenotype
  590. Sphingolipids (Galactosylceramide and Sulfatide) in Lamellar− Hexagonal Phospholipid Phase Transitions and in Membrane Fusion
  591. Direct evidence by carbon‐13 NMR spectroscopy for the erythro configuration of the sphingoid moiety in Gaucher cerebroside and other natural Sphingolipids
  592. Immunocytochemical localization of Sphingolipid activator protein-1, the sulfatide/GM1 ganglioside activator, to lysosomes in human liver and colon
  593. Distribution of saposins (Sphingolipid activator proteins) in tissues of lysosomal storage disease patients
  594. Sphingolipids inhibit multistage carcinogenesis and protein kinase C
  595. Antenatal diagnosis of Sphingolipid and mucopolysaccharide storage diseases.
  596. Incorporation of Very‐Long‐Chain Fatty Acids into Sphingolipids of Cultured Neural Cells
  597. Studies in the Sphingolipids Series. XXI. C20-Sphingosine, a New Long-Chain Base of Animal Origin
  598. Synthesis of novel phenoxy-linked diazirine glycero-and Sphingolipid probes via trialkylaryltin intermediates
  599. Utilization of exogenously supplied sphingosine analogues for Sphingolipid biosynthesis in Chinese hamster ovary and mouse LM cell fibroblasts.
  600. Assembly of Sphingolipids into membranes of the yeast, Saccharomyces cerevisiae
  601. Analysis of the multiple forms of Gaucher spleen Sphingolipid activator protein 2
  602. Binding of GM1 ganglioside to a synthetic peptide derived from the lysosomal Sphingolipid activator protein saposin B
  603. 12 Activator Proteins for Sphingolipid Hydrolysis
  604. Structure and apoptosis-inducing activity of Sphingolipids isolated from Sphingobacterium spiritivorum
  605. Biochemistry of Sphingolipids. 14. Identification of sphingosine base degradation products originating from different acid hydrolytic conditions.
  606. Dramatic alteration of Sphingolipid bases of Hansenulaciferrii by exogenous fatty acid
  607. Removal of the Sphingolipid impurity from preparations of yeast phosphatidyl inositol.
  608. Beyond a structural component: Sphingolipids in immunology.
  609. Neutral lipid and Sphingolipid composition of the brain of a patient with membranous lipodystrophy
  610. … ON CEREBROSIDE‐β‐GALACTOSIDASE CATALYSED TRANSGALACTOSYLATION AND COMPARISON OF ASSAY METHODS FOR Sphingolipid …
  611. [30] Sphingolipid hydrolyzing enzymes in the gastrointestinal tract
  612. Effects of Sphingolipids on erythroblastic maturation in the mouse
  613. Studies in the Sphingolipids series—XXIV: Synthesis of C18-phytosphingosine
  614. Sphingolipid biosynthesis by L-PDMP after rat MCA occlusion
  615. Existence, localization and some properties of the activators of Sphingolipid hydrolases
  616. The Sphingolipid in Agaricus bisporus
  617. Synthesis and characterization of a bioactive 82-residue Sphingolipid activator protein, saposin C
  618. N-terminal amino-acid sequence of a Sphingolipid activator protein missing in a new human Gaucher disease variant
  619. Sphingolipid Antibodies. II. Specificity of Antibody in Patients with Demyelinating Diseases.
  620. Identification of a novel growth factor-like lipid, 1-O-cis-alk-1′-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) that is present in commercial Sphingolipid …
  621. Sphingolipid-saccharide complex from black gram sprouts
  622. The bile salt activation of leucocyte Sphingolipid hydrolase activity and the modifying effects of Triton X-100
  623. Composition and biosynthesis of the major hexose containing Sphingolipids of pig leucocytes
  624. Effects of Echinostoma caproni infection on the phospholipid and Sphingolipid content of the intestinal mucosa of ICR mice
  625. Studies in the Sphingolipids Series. IV.1 Determination of the Configuration of the Amino Carbon Atom in Sphingosine2
  626. Sphingolipid base metabolism. Stereospecific uptake of proton in the enzymatic conversion of sphinganine 1-phosphate to ethanolamine 1-phosphate.
  627. 3-KetoSphingolipids: application to the determination of Sphingolipids which contain 4-sphingenine
  628. Lysosomal enzymes, Sphingolipid activator proteins, and protective protein
  629. STUDIES IN THE Sphingolipids SERIES. III. PREPARATION OF SPHINGINE BY THE CATALYTIC REDUCTION OF TRIBENZOYLSPHINGOSINE1
  630. Dietary fumonisins disrupt Sphingolipid metabolism in mink and increase the free sphinganine to sphingosine ratio in urine but not in hair.
  631. … of lignoceric acid to ceramides and cerebrosides containing both alpha-hydroxy and nonhydroxy fatty acids. Effects of compounds which affect Sphingolipid …
  632. Sphingolipids as regulators of cellular growth, differentiation, and behavior
  633. Gaucher disease: Accurate identification of asymptomatic French‐Canadian carrier using nonlabeled authentic Sphingolipid substrate N‐palmitoyl …
  634. Elevated levels of Sphingolipids in type II (a+ b) hyperlipoproteinemia
  635. Distribution of sphingosine 1-phosphate, a bioactive Sphingolipid, in rat tissues
  636. Salient structural features in the chemical composition of oral anaerobes, with particular emphasis on plasmalogens and Sphingolipids
  637. Identification of a new Sphingolipid 3-O-acyl-D-erythro-sphingomyelin in newborn pig and infant plasma
  638. Effects of mepanipyrim on intracellular trafficking: a comparative study on its effects on exocytic and endocytic trafficking of proteins, Sphingolipids, and cholesterol
  639. [13] Inositol-containing Sphingolipids
  640. Chemical and hemolytic properties of Sphingolipids modified by ozonolysis and reduction
  641. Molecular basis of genetic Sphingolipid activator protein deficiencies
  642. Sphingolipids and malignant growth
  643. 11 Sphingolipid Hydrolysis
  644. Sphingolipid fatty acid composition of rat brain “membranous sacs”
  645. A new procedure for synthesis of 3-keto derivatives of Sphingolipids and its application for study of fatty acid composition of brain ceramides and cerebrosides …
  646. Correlation of subcellular localization of disease-specific inclusions and Sphingolipid activator protein-1 (SAP-1) in sulfatide sulfatase-deficient fibroblasts
  647. Characterization of a Saccharomyces cerevisiae mutant defective in inositol Sphingolipid synthesis
  648. … of mRNAs encoding proteins of the glycoSphingolipid catabolism in mouse models of GM2 gangliosidoses and Sphingolipid activator protein precursor …
  649. Studies in the Sphingolipids Series. XXIII. Synthesis and Resolution of erythro and threo”‘C20-Sphingosines
  650. Investigations on the structure of the Sphingolipids of the genus Bacteroides (author’s transl)
  651. Sphingolipid Metabolism and Cell Signaling, Part A
  652. Biochemistry of Sphingolipids. 25. Separation and identification of long-chain bases and their degradation products on silica gel layers impregnated with silver nitrate.
  653. Studies in the Sphingolipids Series. IX.* Synthesis of DL-2-Amino-1, 3, 4-trihydroxyoctadecane and of Its C4-Methyl Ether
  654. Preparative separation of Sphingolipids and of individual molecular species by high-performance liquid chromatography and their identification by gas …
  655. Studies on Sphingolipids of Barnea (Umitakea) dilatata japonica. I. Cerebroside and ceramide aminoethylphosphonate
  656. Dominant suppressor mutation bypasses the Sphingolipid requirement for growth of Saccharomyces cells at low pH: role of the CWP2 gene
  657. Sphingolipid storage diseases of the central nervous system: bases of biochemical and clinical heterogeneity
  658. Animal and cellular models of Sphingolipid storage disorders of humans
  659. Sphingolipids and monocyte/macrophage differentiation of HL-60 cells
  660. … in lipid composition of human brain during development and in Sphingolipidoses: use of two-dimensional thin layer chromatography. Inborn disorders of Sphingolipid …
  661. Structures of the 2-hydroxy unsaturated fatty acids of pig brain Sphingolipids
  662. Sphingolipid-induced enhancement of receptor-mediated uptake of low density lipoproteins in normal and receptor-deficient human skin fibroblasts
  663. Studies on Sphingolipids, I. Gas-liquid Chromatographic Analyses of Sphingosine Bases.
  664. Changes of Sphingolipids and free amino acids in surfactant induced scaly skin
  665. Localization of Sphingolipid activator protein-1 (SAP-1) in the brain of a normal human and a patient with metachromatic leukodystrophy
  666. Disorders of Sphingolipid activator proteins
  667. [32] Enzymatic N-deacylation of Sphingolipids
  668. [42] Radiolabeling of the Sphingolipid backbone
  669. Differential labelling of Sphingolipids by [3H] serine and ([3H] methyl)-methionine in fish leukocytes
  670. 424. The Sphingolipid field. Part II. An improved synthesis of racemic 2-amino-octadecane-1: 3-diols, and an X-ray examination of its derivatives
  671. 541. The Sphingolipid field. Part I. Synthesis of racemic 2-amino-octadecane-1: 3-diols
  672. Studies in the Sphingolipids Series. XI. Synthesis of l-14C-hydroxy-2-aminooctadecane (DL_l-14C-Sphingine)
  673. Hydrolases of the Simple Sphingolipids: Ceramide, Glucocerebroside, and Galactocerebroside
  674. Observations on the biosynthesis of rat brain Sphingolipids in vivo: Formation of fatty acid amides
  675. [44] Synthesis of key precursors of radiolabeled Sphingolipids
  676. A potential source of error in the enzymatic diagnosis of the neurolipidoses when radiolabelled Sphingolipids are used as substrates
  677. Studies in the Sphingolipids series—XVII: Synthesis and resolution of erythro and threo-C20-dihydrosphingosines
  678. Saposins (Sphingolipid activator proteins) in the twitcher mutant mouse
  679. Sphingolipids of Euhadra hickonis. III. Ceramides of the Viscera
  680. Δ15, 18-tetracosadienoic acid content of Sphingolipids from platel and erythrocytes of animals fed diets high in saturated or polyunsaturated fats
  681. The estimation of Sphingolipids by gas chromatography-chemical ionization mass spectrometry of their derived aldehydes with particular reference to the ceramides of …
  682. Studies in the Sphingolipids series, XXXII: Synthesis and resolution into optical antipodes of C20-phytosphingosine
  683. Studies in the Sphingolipids Series. VIII*. Synthesis of N-Benzoylsphingine Glucosides, Compounds Related to Cerebrosides
  684. Aryl-fused Sphingolipids as novel PKC inhibitors with topical antiinflammatory activity
  685. Studies in the Sphingolipids Series. XIX. Note on the Distribution of C1a and C20-Phytosphingosine in Yeast Cerebrin
  686. The use of cerebroside synthase inhibitors as probes for assessing the metabolism and function of Sphingolipids
  687. Studies on Sphingolipids, II. Sphingolipid Bases in Rat Brain, Liver and Kindney.
  688. Sphingolipid and Sterols of the Sponge Callyspongia spinosissima
  689. Sphingolipid biosynthesis by particulate fractions of normal and “Quaking” mouse brain
  690. Synthesis of 3-deoxy analogs of Sphingolipids
  691. Studies in the Sphingolipids Series. VII The Configuration of α-Hydroxy-n-hexacosanoic Acidof Yeast Cerebrin
  692. Dexamethasone and Sphingolipids inhibit concanavalin A stimulated glucose uptake in 3T3-L1 fibroblasts
  693. Influence of Sphingolipid Bases, Fatty Acids and Tween 80 on the Folate Requirement of Tetrahymena pyriformis*
  694. Functional roles of glycoSphingolipids and Sphingolipids in signal transduction
  695. Enzymatic Aspects of Sphingolipid Metabolism
  696. Sphingolipids of Hemifusus ternatanus ceramide monohexosides and ceramide aminoethylphosphonate of the viscera
  697. [48] Synthesis and characterization of metabolically stable Sphingolipids
  698. Farber bodies found in murine phagocytes after injection of ceramides and related Sphingolipids
  699. 1, 25 dihydroxyvitamin D3 activates sphingomyelin turnover in ROS17/2.8 osteosarcoma cells without Sphingolipid-induced changes in cytosolic Ca2+
  700. Sphingolipid Metabolites in Signal Transduction
  701. Membrane Sphingolipid Signaling Pathways Focusing on Functional Roles of Sphingosine in Apoptosis Induction
  702. Sphingosine, a Breakdown Product of Cellular Sphingolipids, in Cellular Proliferation and Phospholipid Metabolism
  703. Disruption of Sphingolipid Metabolism as a Potential Mechanism of Fumonisin Inhibition of Cell Growth in LLC-PK1 Cells
  704. Isolation and Characterization of Sphingolipid from Ochromonas danica
  705. Sphingolipid β-D-galactosidases in globoid cell leukodystrophy (Krabbe disease)
  706. Chemical characterization of glycerolipids, sterollipids and Sphingolipids in Leguminosae seeds
  707. Brain Sphingolipids in Experimental “Allergic” Encephalomyelitis.
  708. Role of Sphingolipid metabolites in the actions of growth factors and cytokines
  709. Sphingolipid composition and catabolism in human fetal tissues
  710. The influence of long-chain bases (Sphingolipids) on early stages of T lymphocyte activation
  711. Composition and Molecular Species of Sphingolipids in Maize Organs
  712. Sphingolipids Metabolites: A New Class of Second Messengers in the Regulation of Cell Growth
  713. Chemotherapeutic and chemopreventive roles of Sphingolipids in human breast cancer
  714. [41] Sphingolipid-dependent signaling in regulation of cytochrome P450 expression
  715. Biochemistry of Sphingolipids. 23. Paper chromatography of human brain gangliosides.
  716. Studies in the Sphingolipids Series. XVIII. Synthesis and Resolution of 1-Hydroxy-2-aminoeicosane (C20-Sphingine)
  717. Sphingolipids of Euhadra hickonis. I. Ceramide monohexosides and sphingophosphonolipids of viscera
  718. On the stereochemistry of 2, 3-dihydroxy fatty acids of fungi Sphingolipids. Resolution and configuration analysis of erythro-2, 3-dihydroxyoctadecanoic acid
  719. Fungal inhibitors of Sphingolipid biosynthesis: Tools, toxins, and therapeutic agents
  720. Sphingolipid-derived signalling modulators: interaction with phosphatidylserine
  721. Cerebral Sphingolipids in the quaking mouse
  722. GlycoSphingolipids and Sphingolipid activator proteins: Cell biology, biochemistry and molecular genetics
  723. Human keratinocytes in vitro can utilize exogenously supplied sphingosine analogues for Sphingolipid biosynthesis.
  724. The structure of Sphingolipid long chain bases from ceramides of the anaerobe genus Bacteroides
  725. Sphingolipid 430|| alie 233
  726. Incorporation in vivo and in vitro of radiolabeled Sphingolipid precursors into Paramecium tetraurelia lipids
  727. I. Microscale stereochemical analyses of Sphingolipids and brassinosteroids. II. On the structure and physiology of endogenous ouabain
  728. Expression and interactions of cytoskeletal elements and Sphingolipids in the differentiation of myelin-forming cells in the vertebrate nervous system
  729. Lipid composition and Sphingolipid fatty acids of myelin in fruit bat brain
  730. Modulation of nanotube assembly in simple Sphingolipids
  731. Intestinal Sphingolipid excretion associated with feeding of phytohemagglutinin lectin (Phaseolus vulgaris) to germ-free and conventional rats
  732. Fumonisin Inhibition of de Novo Sphingolipid Biosynthesis and Cytotoxicity Are Correlated in LLC-PK, Cells
  733. Evidence for Indirect Utilization of Glycine for Production of N-Bases of Glycerophospholipids and Sphingolipids in Mouse Neuroblastoma Cells by Using 15N …
  734. Synthesis of Sphingolipids
  735. Lysosomal storage diseases, genetic or drug-induced? Effect of glycosaminoglycan and Sphingolipid disorders on dental tissues
  736. Studies in t) le Sphingolipids Series. XII. Structure of the Cerebrin Anhydro Base of Yeast (C20-Phytosphingosine Anhydro Base)
  737. Sphingolipids in Childhood Malignancies
  738. Bioactivity of Sphingolipids
  739. Sphingolipid changes in rat cerebral cortex during focal ischemia–how does ceramide accumulate in an ischemic condition?
  740. Structural and Metabolic Studies of Sphingolipids
  741. Membrane glycerolipid and Sphingolipid headgroups
  742. The chemistry and analysis of Sphingolipids in natural products
  743. Sphingolipids and Glycerolipids. I. cerebrosides I and II from Soybean
  744. The Biochemistry of Sphingolipids
  745. Sphingolipids in the Progress of Head Injury-A Preliminary Report
  746. Function of Sphingolipid Metabolites in Cell Regulation
  747. Influence of Sphingolipids on T lymphocyte activation and differentiation in vitro
  748. Sphingolipids as regulators of neuronal growth and development
  749. Measurement of Sphingolipids in the human stratum corneum. Relations between the quantity of Sphingolipids and aging
  750. Biochemistry of Sphingolipids. 21. Separation of dinitrophenyl derivatives of long-chain bases by reaction paper chromatography.
  751. Regulation of Sphingolipid transport in mammalian cells
  752. Studies in the Sphingolipids Series. XIII. On the Ceramides and Ceramide Esters of C20-Phytosphingosine and Cio-Phytosphingosine Anhydro Base of Yeast
  753. Studies on a Sphingolipid From Beef Lung
  754. Effects of Sphingolipid extracts on the morphological structure and lipid
  755. Sphingolipids role in the eukaryotic heat stress response
  756. Oxidation of Sphingolipids by Mycobacterium leprae
  757. The biosynthesis and metabolism of inositol-containing Sphingolipids in the yeast Saccharomyces cerevisiae.
  758. Sphingolipids and glycerolipids. I. Chemical structures and ionophoretic activities of soya-cerebrosides I and II from soybean.
  759. Substrate availability for long-chain base formation as a regulator of hepatic Sphingolipid and cholesterol biosynthesis
  760. Sphingolipids of Euhadra hickonis. II. Branched Long Chain Bases in Sphingolipids of the Viscera
  761. Sphingolipid signaling in human platelets
  762. Regulation of human breast cancer cell death by Sphingolipids
  763. Function and Metabolism of Sphingolipids in Platelets
  764. THE CHEMISTRY AND METABOLISM OF Sphingolipid LONG CHAIN BASES.
  765. THE ROLE OF Sphingolipids IN STRESS RESPONSES AND APOPTOSIS IN EUKARYOTES
  766. Sphingolipids Inhibit Protein Kinase C and Multistep Transformation
  767. Sphingolipid analogue biomodulators in foods alter Sphingolipid metabolism–implications for health and disease
  768. Biosynthesis of Sphingolipids in Paramecium tetraurelia
  769. Studies on the Lipids of Egg Yolk: Part II. Nature of Sphingolipids
  770. The inhibition of Sphingolipid biosynthesis in rat primary
  771. Role of Sphingolipid signal transduction in stress response in Saccharomyces cerevisiae
  772. Sphingolipid signal transduction in Saccharomyces cerevisiae
  773. Effects of Sphingolipid inhibitors on skeletal muscle differentiation in vitro: comparative studies
  774. Synthetic strategies toward omega-functionalized Sphingolipid analogs
  775. Screening for Sphingolipid-Storage Diseases
  776. Use of Bodipy™-Labeled Sphingolipids to Study Membrane Traffic in Animal Cells
  777. STUDIES OF SERINE PALMITOYLTRANSFERASE IN NORMAL AND ATHEROSCLEROTIC AORTA (ARTERIOSCLEROSIS, Sphingolipids …
  778. The role of Sphingolipids in the development of axonal and dendritic morphology in cultured hippocampal neurons
  779. Incorporation of Serine-3-14C into Sphingolipid by Rat Liver Particulate
  780. Sphingolipids and Glycerolipids. IV. Syntheses and Ionophoretic Activities of Several Analogues of Soya-cerebroside II, a Calcium Ionophoretic Sphingoglycolipid …
  781. Topology and Regulation of Ganglioside Metabolism—Function and Pathobiochemistry of Sphingolipid Activator Proteins
  782. Identification of two suppressors of GSG2 calcium sensitivity, SCS7 and SUR2, as genes encoding hydroxylases of the Sphingolipid biosynthetic pathway of …
  783. A versatile route to Sphingolipids.
  784. Changes in Sterollipids and Sphingolipids of Adzuki Beans (Vigna angularis) during Maturation
  785. Fumonisin-induced Sphingolipid alterations, hepatotoxicity and apoptotic cell death in regenerating rat liver
  786. Compartments in HepG2 Cells: A Role for Non-Golgi–Related Intracellular Sites in the Polarized Distribution of (Glyco) Sphingolipids
  787. Enantioselective syntheses of novel analogues of Sphingolipids and glycerolipid precursors
  788. Utilization of Exogenous Ceramide for the Synthesis of Sphingolipids in Cultured SV40-Transformed Rat Schwann Cells
  789. Enzymic hydrolysis of Sphingolipids. Hydrolysis of ceramide lactoside by an enzyme from rat brain
  790. Book Review: Chemistry and Metabolism of Sphingolipids
  791. Mixing of Sphingolipids with phospholipids in lipid bilayer membranes: calorimetric and fluorescence studies
  792. Acidic glycolipids from marine annelida (Lugworm, Tylorhynchus heterochaetus): Occurrence of methylinositol phosphate-containing Sphingolipids
  793. NOVEL IMMUNOREACTIVE PHOSPHOINOSITOL CONTAINING Sphingolipids FROM THE FUNGAL PATHOGEN HISTOPLASMA CAPSULATUM …
  794. Studies on Side Chain Reactivity of Aza-Aromatic Compounds Catalyzed by Carboxylic Acids, and Synthesis of Sphingolipid Bases and Their Properties
  795. Structural determination of Sphingolipids by first field-free region collision-induced dissociations and scans at a constant ratio of B/E
  796. … (scs1-scs7) of CSG2, a Gene Required by Saccharomyces Cerevisiae for Growth in Media Containing 10 MM Ca2+, Identify Genes Required for Sphingolipid …
  797. Selective transport of Sphingolipids from the sub-apical compartment to the apical plasma membrane via rab11-positive intermediate compartments
  798. Sphingolipid metabolism and the localization and trafficking of Golgi membrane proteins
  799. Sphingolipids and Glycerolipids. Part II. Syntheses of Two Pairs of Enantiomeric C18-Sphingosines and a Palmitoyl Analogue of Gaucher Spleen Glucocerebroside.
  800. Asymmetric syntheses of amino alcohols as bioactive compounds: Chapter One. Syntheses of Sphingolipid analogues as inhibitors of the protein kinase C enzyme …
  801. TSC (Temperature Sensitive suppressors of the Calcium sensitivity of csg2Delta mutants: A tool to investigate Sphingolipid metabolism in the yeast …
  802. Sphingolipids–a new group of lipid second messengers?
  803. CHEMISTRY AND METABOLISM OF Sphingolipid BASES.
  804. Studies in the Sphingolipids Series. XV. Partial Synthesis of Anhy~ ro Cerebrin of Yeast
  805. Sphingolipids of the yeast, Saccharomyces cerevisiae.
  806. Synthesis of penaresidins and Sphingolipids from Glucose
  807. Chemistry of Succinimido Esters. XVII.* 1 The erythro/threo Separation of Sphingolipid Bases Labelled with N-Succinimidyl Benzoates by Normal Phase HPLC
  808. Inhibition of de Novo Sphingolipid Biosynthesis by Geranyllinalool in LLC-PK1, Cells
  809. Sphingolipid synthesis deficiency in a mutant of Bacteroides levii
  810. Transport and sorting of Sphingolipids in polarized cells
  811. 26 Sphingolipids: From Chemistry
  812. TSC (Temperature Sensitive Suppressors of the Calcium Sensitivity of CSG2A) Mutants; A Tool to Investigate Sphingolipid metabolism in the Yeast Saccharomyces …
  813. INBORN DISORDERS OF Sphingolipid METABOLISM
  814. Biological Substances: Chemistry of Sphingolipids. David Shapiro. Hermann, Paris, 1969. 122 pp. Paper, 30 F. Chemistry of Natural Products (Original Series), vol. 9; …
  815. Biochemical analysis of temperature-sensitive lethal Sphingolipid-defective mutants of the yeast Saccharomyces cerevisiae.
  816. GlycoSphingolipid engineering using a Sphingolipid ceramide N-deacylase (SCDase); SCDase wo mochiita sufuingo toshishitsu kogaku
  817. Carbohydrate antigens and xenotransplantationAspects of preparation, analysis and pharmaceutical administration of glyco-Sphingolipids. Mechanisms of hyperacute …
  818. Additions and Corrections-Synthetic Studies on Sphingolipids. VI. The Total Syntheses of Cerasine and Phrenosine.
  819. Phosphonosphingoglycolipid, a Novel Sphingolipid from the Viscera of Turbo cornutus
  820. TNF-a and Sphingolipid enhanced mitochondrial gene transcript levels and Superoxide production
  821. Regulation of Sphingolipid synthesis in renal cells from normal subjects and familial hypercholesterolemic subjects
  822. Apoptosis Triggered by the Absence of an Integrin Signal: Role of the Sphingolipid Ceramide
  823. Amide Exchangeable Protons of Sphingolipids as an NMR Probe for the Study of Interfaces in Lipid Bilayers
  824. Metabolic studies of N-bases of phospholipids and long chain bases of Sphingolipids in two-weeks-old mouse brain tissue in comparison with one-month-old mouse …
  825. Biochemistry of Shellfish Lipids: X. Isolation of a Sphingolipid Containing 2-Monomethylalnino-ethylphosphonic Acid from Shellfish
  826. The sites and regulation of Sphingolipid biosynthesis
  827. … MECONIUM: CHARACTERIZATION USING SPECIFIC ANTI-OLIGOSACCHARIDE ANTIBODIES (GLYCOLIPIDS, Sphingolipids, ONCOFETAL, FETAL, CANCER …
  828. Transport and sorting of Sphingolipids in polarized cells: the involvement of the sub-apical compartment
  829. Bcl-2 oncoprotein and Sphingolipids blood levels in childhood lymphoma and leukemia
  830. Expression of Sphingolipids in human glioma cell line U373-MG
  831. … (scs1-scs7) of CSG2, a gene required by Saccharomyces cerevisiae for growth in media containing 10 mM calcium ion, identify genes required for Sphingolipid …
  832. Cloning and Characterization of LCBl, a Saccharomyces Gene Required for Biosynthesis of the Long-Chain Base Component of Sphingolipids
  833. The complex life of simple Sphingolipids
  834. Sphingolipid metabolism diseases
  835. Biologically active Sphingolipids in cancer pathogenesis and treatment
  836. Role of Sphingolipids in microbial pathogenesis
  837. The ins and outs of Sphingolipid synthesis
  838. Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism
  839. Principles of bioactive lipid signalling: lessons from Sphingolipids
  840. Sphingolipids and cell death
  841. Sphingolipids in bacteria and fungi
  842. Sphingolipids in the lungs
  843. An introduction to plant Sphingolipids and a review of recent advances in understanding their metabolism and function
  844. Sphingolipids in inflammation: roles and implications
  845. Sphingolipid functions in Saccharomyces cerevisiae
  846. Sphingolipids
  847. Thematic review series: Sphingolipids. New insights into Sphingolipid metabolism and function in budding yeast
  848. De novo Sphingolipid biosynthesis: a necessary, but dangerous, pathway
  849. Separation and identification of major plant Sphingolipid classes from leaves
  850. Sphingolipids in infectious diseases
  851. Translational aspects of Sphingolipid metabolism
  852. The metabolism and function of Sphingolipids and glycoSphingolipids
  853. Sphingolipids in mammalian cell signalling
  854. Functions and metabolism of Sphingolipids in Saccharomyces cerevisiae
  855. Thematic Review Series: Sphingolipids. Biodiversity of sphingoid bases (“sphingosines”) and related amino alcohols
  856. The organizing potential of Sphingolipids in intracellular membrane transport
  857. Chemistry and biology of Sphingolipids
  858. Enzymes of Sphingolipid metabolism: from modular to integrative signaling
  859. Sphingolipid transport: rafts and translocators
  860. Sphingolipid targets in cancer therapy
  861. Thematic review series: Sphingolipids. Nuclear Sphingolipids: Metabolism and signaling
  862. Plant Sphingolipids: structural diversity, biosynthesis, first genes and functions
  863. Sphingolipids: Metabolism and cell signaling
  864. Sphingolipids and the immune system
  865. Sphingolipid metabolism in neural cells
  866. Sphingolipids in cancer: regulation of pathogenesis and therapy
  867. Inhibitors of Sphingolipid metabolism enzymes
  868. Effect of the structure of natural sterols and Sphingolipids on the formation of ordered Sphingolipid/sterol domains (rafts)
  869. Epidermal Sphingolipids: metabolism, function, and roles in skin disorders
  870. Biophysics of Sphingolipids I. Membrane properties of sphingosine, ceramides and other simple Sphingolipids
  871. Bioactive Sphingolipids in the modulation of the inflammatory response
  872. Sphingolipid mediators in cardiovascular cell biology and pathology
  873. Sphingolipid signalling in the cardiovascular system: good, bad or both?
  874. Identification and characterization of a Sphingolipid Δ4-desaturase family
  875. Sphingolipids and the regulation of the immune response
  876. Roles of bioactive Sphingolipids in cancer biology and therapeutics
  877. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in Sphingolipid metabolism
  878. Serine palmitoyltransferase, a key enzyme of Sphingolipid metabolism
  879. Sphingolipid-binding proteins
  880. Sphingolipid metabolites in neural signalling and function
  881. Analysis of phospho-and Sphingolipids in dairy products by a new HPLC method
  882. Sphingolipid signaling and redox regulation
  883. Structure and function of glycoSphingolipids and Sphingolipids: recollections and future trends
  884. Biochemical properties of mammalian neutral sphingomyelinase2 and its role in Sphingolipid metabolism
  885. Yeast Sphingolipids: metabolism and biology
  886. Protein-Sphingolipid interactions within cellular membraness⃞
  887. Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of Sphingolipids by liquid chromatography tandem mass spectrometry
  888. Sphingolipid signalling and liver diseases
  889. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins.
  890. Dynamic and structural properties of Sphingolipids as driving forces for the formation of membrane domains
  891. Sphingolipid biology
  892. Sphingolipids as therapeutics
  893. Spatial and functional heterogeneity of Sphingolipid-rich membrane domains
  894. The Sphingolipid salvage pathway in ceramide metabolism and signaling
  895. Sphingolipid Long-Chain Base Hydroxylation Is Important for Growth and Regulation of Sphingolipid Content and Composition in Arabidopsis
  896. Principles of lysosomal membrane digestion: stimulation of Sphingolipid degradation by Sphingolipid activator proteins and anionic lysosomal lipids
  897. Yeast Sphingolipids: recent developments in understanding biosynthesis, regulation, and function
  898. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
  899. Simulation and validation of modelled Sphingolipid metabolism in Saccharomyces cerevisiae
  900. Sphingolipids as modulators of cancer cell death: potential therapeutic targets
  901. Are glucocerebrosides the predominant Sphingolipids in plant plasma membranes?
  902. Effect of myriocin on plasma Sphingolipid metabolism and atherosclerosis in apoE-deficient mice
  903. Sphingolipids and the formation of sterol-enriched ordered membrane domains
  904. Host Sphingolipid biosynthesis as a target for hepatitis C virus therapy
  905. Simultaneous quantitative analysis of bioactive Sphingolipids by high-performance liquid chromatography-tandem mass spectrometry
  906. Anticancer compounds and Sphingolipid metabolism in the colon
  907. Mechanism of action of Sphingolipids and their metabolites in the toxicity of fumonisin B1
  908. Two Sphingolipid transfer proteins, CERT and FAPP2: their roles in Sphingolipid metabolism
  909. Sphingolipids, new players in plant signaling
  910. Dietary Sphingolipids in colorectal cancer prevention
  911. Sphingolipids in macroautophagy
  912. Ceramides and other bioactive Sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics …
  913. Analysis of Sphingolipid classes and their contents in meals
  914. Regulation of de novo Sphingolipid biosynthesis and the toxic consequences of its disruption
  915. A Post‐genomic Approach to Understanding Sphingolipid Metabolism in Arabidopsis thaliana
  916. Cross talk between Sphingolipids and glycerophospholipids in the establishment of plasma membrane asymmetry
  917. Sply regulation of Sphingolipid signaling molecules is essential for Drosophila development
  918. Altered adipose and plasma Sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk
  919. The structure of serine palmitoyltransferase; gateway to Sphingolipid biosynthesis
  920. Entry of muscle satellite cells into the cell cycle requires Sphingolipid signaling
  921. Chemical tools to investigate Sphingolipid metabolism and functions
  922. Intracellular trafficking of Sphingolipids: relationship to biosynthesis
  923. Sphingolipids are essential for differentiation but not growth in Leishmania
  924. Sphingolipids and the balancing of immune cell function: lessons from the mast cell
  925. Microarray analysis of altered Sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer
  926. Thematic Review Series: Sphingolipids. Role of ganglioside metabolism in the pathogenesis of Alzheimer’s disease—a review
  927. Identification of a novel role for Sphingolipid signaling in TNF α and ischemic preconditioning mediated cardioprotection
  928. Identification of a common Sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins
  929. Critical role of virion-associated cholesterol and Sphingolipid in hepatitis C virus infection
  930. Sphingolipids from marine organisms: a review
  931. Perturbation of Sphingolipid metabolism and ceramide production in HIV‐dementia
  932. Maternal disturbance in activated Sphingolipid metabolism causes pregnancy loss in mice
  933. Roles of l-serine and Sphingolipid synthesis in brain development and neuronal survival
  934. Vascular effects of Sphingolipids
  935. The involvement of Sphingolipids in multidrug resistance
  936. Sphingolipid signalling in Arabidopsis guard cells involves heterotrimeric G proteins
  937. The roles of ceramide and complex Sphingolipids in neuronal cell function
  938. Phospholipid, Sphingolipid, and fatty acid compositions of the milk fat globule membrane are modified by diet
  939. Role of Sphingolipids in the biogenesis of membrane domains
  940. The clinical potential of Sphingolipid-based therapeutics
  941. A defect of Sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis
  942. Sphingolipids in apoptosis, survival and regeneration in the nervous system
  943. Membrane dynamics and cell polarity: the role of Sphingolipids
  944. Enzymes of Sphingolipid metabolism in Drosophila melanogaster
  945. Functions of Sphingolipid metabolism in mammals—lessons from genetic defects
  946. Pleiotropic effects of Sphingolipids in skeletal muscle
  947. Metabolism and biological functions of two phosphorylated Sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate
  948. Vitamin K and Sphingolipid metabolism: evidence to date
  949. Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of Sphingolipids
  950. Modulation of Intracellular β-Catenin Localization and Intestinal Tumorigenesis in Vivo and in Vitro by Sphingolipids
  951. Modulation of entry of enveloped viruses by cholesterol and Sphingolipids
  952. Isc1 regulates Sphingolipid metabolism in yeast mitochondria
  953. Structure‐Specific, quantitative methods for analysis of Sphingolipids by liquid Chromatography–Tandem mass spectrometry:“Inside‐Out” Sphingolipidomics
  954. Ceramide and other Sphingolipids in cellular responses
  955. Sphingolipid metabolism and signaling minireview series
  956. Rapid measurement of Sphingolipids from Arabidopsis thaliana by reversed‐phase high‐performance liquid chromatography coupled to electrospray ionization …
  957. Membrane Sphingolipid-Ergosterol Interactions Are Important Determinants of Multidrug Resistance in Candida albicans
  958. Sphingolipid-mediated signalling in plants
  959. Digestion of maize Sphingolipids in rats and uptake of sphingadienine by Caco-2 cells
  960. Phospho‐and Sphingolipid distribution during processing of milk, butter and whey
  961. A role for Sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing’s syndrome
  962. Distinct mechanisms of clathrin-independent endocytosis have unique Sphingolipid requirements
  963. Lipid phosphate phosphatases regulate signal transduction through glycerolipids and Sphingolipids
  964. Modulating Sphingolipid biosynthetic pathway rescues photoreceptor degeneration
  965. The way we view cellular (glyco) Sphingolipids
  966. Quantification of Sphingolipids in soybeans
  967. Sphingolipids of the nucleus and their role in nuclear signaling
  968. The emerging role for Sphingolipids in the eukaryotic heat shock response
  969. The Essential Nature of Sphingolipids in Plants as Revealed by the Functional Identification and Characterization of the Arabidopsis LCB1 Subunit of Serine …
  970. The Sur7p Family Defines Novel Cortical Domains in Saccharomyces cerevisiae, Affects Sphingolipid Metabolism, and Is Involved in Sporulation
  971. Serine palmitoyl-CoA transferase (SPT) deficiency and Sphingolipid levels in mice
  972. Occurrence and biological properties of Sphingolipids-A review
  973. Selective substrate supply in the regulation of yeast de novo Sphingolipid synthesis
  974. Clathrin-dependent and-independent internalization of plasma membrane Sphingolipids initiates two Golgi targeting pathways
  975. Sphingolipids as bioactive regulators of thrombin generation
  976. The lysosomal trafficking of Sphingolipid activator proteins (SAPs) is mediated by sortilin
  977. Sphingolipid metabolizing enzymes as novel therapeutic targets
  978. Initial steps of Shigella infection depend on the cholesterol/Sphingolipid raft-mediated CD44–IpaB interaction
  979. Multiple roles for Sphingolipids in steroid hormone biosynthesis
  980. Changes in the lipid turnover, composition, and organization, as Sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro
  981. σ2 Receptors regulate changes in Sphingolipid levels in breast tumor cells
  982. Regulation of lipid metabolism by Sphingolipids
  983. Cell cycle progression and cell polarity require Sphingolipid biosynthesis in Aspergillus nidulans
  984. Developmentally regulated Sphingolipid synthesis in African trypanosomes
  985. Leishmania salvage and remodelling of host Sphingolipids in amastigote survival and acidocalcisome biogenesis
  986. DmAMP1, an antifungal plant defensin from dahlia (Dahlia merckii), interacts with Sphingolipids from Saccharomyces cerevisiae
  987. The role of skeletal muscle Sphingolipids in the development of insulin resistance
  988. Interactions between neural membrane glycerophospholipid and Sphingolipid mediators: a recipe for neural cell survival or suicide
  989. γ-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting Sphingolipid synthesis
  990. Membrane microdomains, caveolae, and caveolar endocytosis of Sphingolipids
  991. Mass spectrometry‐based profiling of phospholipids and Sphingolipids in extracts from Saccharomyces cerevisiae
  992. Modulation of amyloid precursor protein cleavage by cellular Sphingolipids
  993. Identification of the human Sphingolipid C4‐hydroxylase, hDES2, and its up‐regulation during keratinocyte differentiation
  994. Is autophagy the key mechanism by which the Sphingolipid rheostat controls the cell fate decision?
  995. Molecular profiling of LGL leukemia reveals role of Sphingolipid signaling in survival of cytotoxic lymphocytes
  996. Redirection of Sphingolipid metabolism toward de novo synthesis of ethanolamine in Leishmania
  997. VEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between Sphingolipid and growth factor receptors
  998. Gene expression alterations in the Sphingolipid metabolism pathways during progression of dementia and Alzheimer’s disease: a shift toward ceramide accumulation …
  999. The Sphingolipid long-chain base-Pkh1/2-Ypk1/2 signaling pathway regulates eisosome assembly and turnover
  1000. Coordinate control of Sphingolipid biosynthesis and multidrug resistance in Saccharomyces cerevisiae
  1001. Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via Sphingolipid receptors
  1002. Sphingolipid requirement for generation of a functional v1 component of the vacuolar ATPase
  1003. Diabetes alters Sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy
  1004. Human cytomegalovirus regulates bioactive Sphingolipids
  1005. Niemann-Pick C variant detection by altered Sphingolipid trafficking and correlation with mutations within a specific domain of NPC1
  1006. Sphingolipids in human lens membranes: an update on their composition and possible biological implications
  1007. Plant Sphingolipids today-are they still enigmatic?
  1008. Sphingolipid uptake by cultured cells: complex aggregates of cell Sphingolipids with serum proteins and lipoproteins are rapidly catabolized
  1009. Sphingolipids in anticancer therapy
  1010. Sphingolipid‐free Leishmania are defective in membrane trafficking, differentiation and infectivity
  1011. A minimalist approach to MALDI imaging of glycerophospholipids and Sphingolipids in rat brain sections
  1012. A genome-wide visual screen reveals a role for Sphingolipids and ergosterol in cell surface delivery in yeast
  1013. Use of Bodipy-labeled Sphingolipid and cholesterol analogs to examine membrane microdomains in cells
  1014. Dietary Soy Sphingolipids Suppress Tumorigenesis and Gene Expression in 1,2-Dimethylhydrazine-Treated CF1 Mice and ApcMin/+ Mice
  1015. Stimulation of acid sphingomyelinase activity by lysosomal lipids and Sphingolipid activator proteins
  1016. Sphingolipids in the chemoprevention of colon cancer
  1017. GPI anchoring leads to Sphingolipid-dependent retention of endocytosed proteins in the recycling endosomal compartment
  1018. Sterol-dependent regulation of Sphingolipid metabolism in Saccharomyces cerevisiae
  1019. Sphingolipids, apoptosis, cancer treatments and the ovary: investigating a crime against female fertility
  1020. Sphingolipids are required for the stable membrane association of glycosylphosphatidylinositol-anchored proteins in yeast
  1021. Loss‐of‐function mutations and inducible RNAi suppression of Arabidopsis LCB2 genes reveal the critical role of Sphingolipids in gametophytic and sporophytic cell …
  1022. Vitamin C stimulates Sphingolipid production and markers of barrier formation in submerged human keratinocyte cultures
  1023. The marine Sphingolipid-derived compound ES 285 triggers an atypical cell death pathway
  1024. Biosynthesis and Trafficking of Sphingolipids in the Yeast Saccharomyces cerevisiae
  1025. Novel Sphingolipids from Conyza canadensis
  1026. P-glycoprotein retains function when reconstituted into a Sphingolipid-and cholesterol-rich environment
  1027. Sphingolipids from Conyza canadensis
  1028. Phospho-and Sphingolipid content of selected dairy products as determined by HPLC coupled to an evaporative light scattering detector (HPLC–ELSD)
  1029. Sphingolipid metabolism enzymes as targets for anti-cancer therapy
  1030. Sphingolipid signaling pathways as potential therapeutic targets in gliomas
  1031. A Sphingolipid elicitor-inducible mitogen-activated protein kinase is regulated by the small GTPase OsRac1 and heterotrimeric G-protein in rice
  1032. Secondary Sphingolipid accumulation in a macrophage model of Gaucher disease
  1033. Sphingolipid and Other Constituents from Almond Nuts (Prunus amygdalus Batsch)
  1034. Apoptotic Sphingolipid signaling by ceramides in lung endothelial cells
  1035. Sphingolipid partitioning into ordered domains in cholesterol-free and cholesterol-containing lipid bilayers
  1036. Fumonisins disrupt Sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube …
  1037. The function of Sphingolipids in the nervous system: lessons learnt from mouse models of specific Sphingolipid activator protein deficiencies
  1038. Structural determinants of Sphingolipid recognition by commercially available anti-ceramide antibodies
  1039. Integration of kinetic information on yeast Sphingolipid metabolism in dynamical pathway models
  1040. Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in China
  1041. Ceramide as a TLR4 agonist; a putative signalling intermediate between Sphingolipid receptors for microbial ligands and TLR4
  1042. Serine palmitoyltransferase, a key enzyme for de novo synthesis of Sphingolipids, is essential for male gametophyte development in Arabidopsis
  1043. Genetic diseases of Sphingolipid metabolism: pathological mechanisms and therapeutic options
  1044. A Sphingolipid and tyrosinase inhibitors from the fruiting body ofphellinus linteus
  1045. Alveolar Sphingolipids generated in response to TNF-α modifies surfactant biophysical activity
  1046. Dietary Sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis in APOE*3Leiden mice–
  1047. Functional Analysis of CaIPT1, a Sphingolipid Biosynthetic Gene Involved in Multidrug Resistance and Morphogenesis of Candida albicans
  1048. The yeast PH domain proteins Slm1 and Slm2 are targets of Sphingolipid signaling during the response to heat stress
  1049. Depletion of acyl-coenzyme A-binding protein affects Sphingolipid synthesis and causes vesicle accumulation and membrane defects in Saccharomyces cerevisiae
  1050. Fungal Sphingolipids as targets for the development of selective antifungal therapeutics
  1051. Quantitative RT-PCR analysis of Sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes
  1052. Male germ cells require polyenoic Sphingolipids with complex glycosylation for completion of meiosis: a link to ceramide synthase-3
  1053. Paired helical filaments contain small amounts of cholesterol, phosphatidylcholine and Sphingolipids
  1054. The Sphingolipid pathway regulates Pkc1 through the formation of diacylglycerol in Cryptococcus neoformans
  1055. Functional identification of a Δ8-Sphingolipid desaturase from Borago officinalis
  1056. Sphingolipid activator proteins: proteins with complex functions in lipid degradation and skin biogenesis
  1057. Sphingolipids and membrane biology as determined from genetic models
  1058. Identification of fungal Sphingolipid C9-methyltransferases by phylogenetic profiling
  1059. … electrospray ionization (DESI) mass spectrometry and tandem mass spectrometry (MS/MS) of phospholipids and Sphingolipids: ionization, adduct formation, and …
  1060. Versatile synthetic method for Sphingolipids and functionalized sphingosine derivatives via olefin cross metathesis
  1061. The role of Sphingolipids in neuronal development: lessons from models of Sphingolipid storage diseases
  1062. Distribution and dynamic changes of Sphingolipids in blood in response to platelet activation
  1063. A fluorescent Sphingolipid binding domain peptide probe interacts with Sphingolipids and cholesterol-dependent raft domainss⃞
  1064. FTY720, an immunomodulatory Sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis
  1065. How Sphingolipids bind and shape proteins: molecular basis of lipid-protein interactions in lipid shells, rafts and related biomembrane domains
  1066. SKN1, a novel plant defensin-sensitivity gene in Saccharomyces cerevisiae, is implicated in Sphingolipid biosynthesis
  1067. … effect of advanced glycation end products on mesangial cell proliferation is mediated by neutral ceramidase regulation and endogenous Sphingolipids
  1068. Interfacial regulation of acid ceramidase activity: stimulation of ceramide degradation by lysosomal lipids and Sphingolipid activator proteins
  1069. Differential effects of modification of membrane cholesterol and Sphingolipids on the conformation, function, and trafficking of the G protein-coupled …
  1070. The protozoan inositol phosphorylceramide synthase: a novel drug target that defines a new class of Sphingolipid synthase
  1071. New Sphingolipids with a Previously Unreported 9-Methyl-C20-sphingosine Moiety from a Marine Algous Endophytic Fungus Aspergillus niger EN-13
  1072. The effect of dietary Sphingolipids on plasma sphingomyelin metabolism and atherosclerosis
  1073. Sphingolipid storage induces accumulation of intracellular cholesterol by stimulating SREBP-1 cleavage
  1074. Sphingolipids and cell signaling: involvement in apoptosis and atherogenesis
  1075. Modulation of transforming growth factor-β (TGF-β) signaling by endogenous Sphingolipid mediators
  1076. Metabolomic profiling of Sphingolipids in human glioma cell lines by liquid chromatography tandem mass spectrometry.
  1077. Disruption of the Sphingolipid Δ8-desaturase gene causes a delay in morphological changes in Candida albicans
  1078. Mitochondria as sensors of Sphingolipids
  1079. Sphingolipids: modulators of HIV-1 infection and pathogenesis
  1080. A mutation in the saposin A domain of the Sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the …
  1081. De novo ceramide accumulation due to inhibition of its conversion to complex Sphingolipids in apoptotic photosensitized cells
  1082. Thematic review series: Sphingolipids. Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling
  1083. Acute activation of de novo Sphingolipid biosynthesis upon heat shock causes an accumulation of ceramide and subsequent dephosphorylation of SR …
  1084. Altered Sphingolipid Metabolism inN-(4-Hydroxyphenyl)-retinamide-resistant A2780 Human Ovarian Carcinoma Cells
  1085. BcR-induced apoptosis involves differential regulation of C16 and C24-ceramide formation and Sphingolipid-dependent activation of the proteasome
  1086. Metabolism of Acylglycerols & Sphingolipids
  1087. ABCA2 deficiency results in abnormal Sphingolipid metabolism in mouse brain
  1088. Novel mutations that control the Sphingolipid and cholesterol dependence of the Semliki Forest virus fusion protein
  1089. Sphingolipids, cholesterol, and HIV-1: a paradigm in viral fusion
  1090. Collision‐induced dissociation pathways of yeast Sphingolipids and their molecular profiling in total lipid extracts: a study by quadrupole TOF and linear ion trap …
  1091. Sphingolipid trafficking and protein sorting in epithelial cells
  1092. Dysregulation of Sphingolipid and sterol metabolism by ApoE4 in HIV dementia
  1093. Disruption of Sphingolipid metabolism elicits apoptosis-associated reproductive defects in Drosophila
  1094. A role for the de novo Sphingolipids in apoptosis of photosensitized cells
  1095. Sphingolipids: major regulators of lipid metabolism
  1096. The mitochondria-associated endoplasmic-reticulum subcompartment (MAM fraction) of rat liver contains highly active Sphingolipid-specific glycosyltransferases
  1097. Novel role of Sphingolipid synthesis genes in regulating giardial encystation
  1098. Sphingolipid synthesis is necessary for kinetoplast segregation and cytokinesis in Trypanosoma brucei
  1099. Multidrug Transporters CaCdr1p and CaMdr1p of Candida albicans Display Different Lipid Specificities: both Ergosterol and Sphingolipids Are Essential for Targeting …
  1100. Mutagenesis of the putative sterol-sensing domain of yeast Niemann Pick C–related protein reveals a primordial role in subcellular Sphingolipid distribution
  1101. Unsaturated fatty acid-mediated decreases in sterol regulatory element-mediated gene transcription are linked to cellular Sphingolipid metabolism
  1102. … containing phosphatidylcholine, studied by spin-label ESR and IR spectroscopies. A possible stabilization of gel-phase Sphingolipid domains by cholesterol
  1103. Sphingolipid metabolism during epidermal barrier development in mice
  1104. A Higher Plant Δ8 Sphingolipid Desaturase with a Preference for (Z)-Isomer Formation Confers Aluminum Tolerance to Yeast and Plants
  1105. Altered Sphingolipid metabolism in multidrug‐resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus
  1106. Roles for Sphingolipid biosynthesis in mediation of specific programs of the heat stress response determined through gene expression profiling
  1107. Armillaramide, a new Sphingolipid from the fungus Armillaria mellea
  1108. Alkaline methanolysis of lipid extracts extends shotgun lipidomics analyses to the low-abundance regime of cellular Sphingolipids
  1109. Synthetic, non-natural Sphingolipid analogs inhibit the biosynthesis of cellular Sphingolipids, elevate ceramide and induce apoptotic cell death
  1110. Chromatographic resolution and quantitative assay of CNS tissue sphingoids and Sphingolipids
  1111. Structure and stereochemistry of a novel bioactive Sphingolipid from a Calyx sp.
  1112. Uptake of long chain fatty acids is regulated by dynamic interaction of FAT/CD36 with cholesterol/Sphingolipid enriched microdomains (lipid rafts)
  1113. Evidence for de novo Sphingolipid biosynthesis in Toxoplasma gondii
  1114. Endocytosis and sorting of glycoSphingolipids in Sphingolipid storage disease
  1115. Rafts and Sphingolipid biosynthesis in the kinetoplastid parasitic protozoa
  1116. N-terminal protein acylation confers localization to cholesterol, Sphingolipid-enriched membranes but not to lipid rafts/caveolae
  1117. Storage diseases: new insights into Sphingolipid functions
  1118. Role of biologically active Sphingolipids in tumor growth
  1119. Pharmacological modulation of Sphingolipids and role in disease and cancer cell biology
  1120. Nitric oxide and Sphingolipids: mechanisms of interaction and role in cellular pathophysiology
  1121. Novel Sphingolipid derivatives promote keratinocyte differentiation
  1122. Cryptosporidium parvum infects human cholangiocytes via Sphingolipid‐enriched membrane microdomains
  1123. Use of fluorescent Sphingolipid analogs to study lipid transport along the endocytic pathway
  1124. Biophysics of Sphingolipids II. GlycoSphingolipids: an assortment of multiple structural information transducers at the membrane surface
  1125. Sphingolipid and cholesterol dependence of alphavirus membrane fusion: lack of correlation with lipid raft formation in target liposomes
  1126. Endocytic trafficking of glycoSphingolipids in Sphingolipid storage diseases
  1127. Elicitor activity of cerebroside, a Sphingolipid elicitor, in cell suspension cultures of rice
  1128. Effects of membrane potential and Sphingolipid structures on fusion of Semliki Forest virus
  1129. Coordination of the dynamics of yeast Sphingolipid metabolism during the diauxic shift
  1130. Sphingolipid management by an orchestra of lipid transfer proteins
  1131. Signalling functions for Sphingolipid long-chain bases in Saccharomyces cerevisiae
  1132. Converging roles for Sphingolipids and cell stress in the progression of neurological dysfunction in AIDS
  1133. Sphingosine-1-phosphate phosphohydrolase in regulation of Sphingolipid metabolism and apoptosis
  1134. Sphingomyelinase cleavage of sphingomyelin in pure and mixed lipid membranes. Influence of the physical state of the Sphingolipid
  1135. Involvement of Sphingolipids in apoptin-induced cell killing
  1136. New Sphingolipids from marine sponge Iotrochota baculifera
  1137. Synthesis of New Trans Double-Bond Sphingolipid Analogues:  Δ4,6 and Δ6 Ceramides
  1138. Determination of Sphingolipids in nuts and seeds by a single quadrupole liquid chromatography–mass spectrometry method
  1139. Bioactive Sphingolipids are constituents of soy and dairy products
  1140. Sphingolipids in vascular biology
  1141. Sphingolipids are necessary for nicotinic acetylcholine receptor export in the early secretory pathway
  1142. Combination of C17 sphingoid base homologues and mass spectrometry analysis as a new approach to study Sphingolipid metabolism
  1143. Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/Sphingolipid mitogenic pathway
  1144. Level of M (IP) 2C Sphingolipid affects plant defensin sensitivity, oxidative stress resistance and chronological life-span in yeast
  1145. Effects of Chamomilla recutita flavonoids on age-related liver Sphingolipid turnover in rats
  1146. Occurrence of bioactive Sphingolipids in meat and fish products
  1147. Rvs161p and Sphingolipids are required for actin repolarization following salt stress
  1148. Fumonisin B1 exposure and its selective effect on porcine jejunal segment: Sphingolipids, glycolipids and trans-epithelial passage disturbance
  1149. Trypanosomatid and fungal glycolipids and Sphingolipids as infectivity factors and potential targets for development of new therapeutic strategies
  1150. Rhizochalins C and D from the Sponge Rhizochalina incrustata. A Rare threo-Sphingolipid and a Facile Method for Determination of the Carbonyl Position in α,ω …
  1151. Evidence for coupled biogenesis of yeast Gap1 permease and Sphingolipids: essential role in transport activity and normal control by ubiquitination
  1152. Functional characterization of Sphingolipid C4-hydroxylase genes from Arabidopsis thaliana
  1153. Yeast cells lacking the ARV1 gene harbor defects in Sphingolipid metabolism: Complementation by human ARV1
  1154. Comparative quantification of Sphingolipids and analogs in biological samples by high-performance liquid chromatography after chloroform extraction
  1155. Disturbance of Sphingolipid biosynthesis abrogates the signaling of Mss4, phosphatidylinositol-4-phosphate 5-kinase, in yeast
  1156. A neutral sphingomyelinase resides in Sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour …
  1157. Ceramide Synthase Inhibition by Fumonisin B1 Treatment Activates Sphingolipid-Metabolizing Systems in Mouse Liver
  1158. Thematic review series: Sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a
  1159. Sphingolipids with neuritogenic activity from Euphorbia sororia
  1160. Medicinal chemistry aspects of drug targets in Sphingolipid metabolism
  1161. Very long-chain fatty acid-containing lipids rather than Sphingolipids per se are required for raft association and stable surface transport of newly synthesized …
  1162. Effects of flavonoids on Sphingolipid turnover in the toxin-damaged liver and liver cells
  1163. Comparison of urinary Sphingolipids in human populations with high and low maize consumption as a possible biomarker of fumonisin dietary exposure
  1164. Evidence for a link between Sphingolipid metabolism and expression of CD1d and MHC‐class II: monocytes from Gaucher disease patients as a model
  1165. Chemical synthesis of fluorescent glycero-and Sphingolipids
  1166. Synthesis of Sphingolipids with very long chain fatty acids but not ergosterol is required for routing of newly synthesized plasma membrane ATPase to the cell …
  1167. Complex Sphingolipid synthesis in plants: characterization of inositolphosphorylceramide synthase activity in bean microsomes
  1168. Sphingolipid players in the leukemia arena
  1169. The role of cholesterol and Sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion
  1170. Sphingolipid profile in the CNS of the twitcher (globoid cell leukodystrophy) mouse: a lipidomics approach.
  1171. Yeast Sphingolipids do not need to contain very long chain fatty acids
  1172. New Sphingolipids and a sterol from a Lobophytum species of the Indian Ocean
  1173. Activity of partially inhibited serine palmitoyltransferase is sufficient for normal Sphingolipid metabolism and viability of HSN1 patient cells
  1174. Sphingolipids involved in the induction of multinuclear cell formation
  1175. Cholesterol and Sphingolipids in alcohol‐induced liver injury
  1176. LASS5 is the predominant ceramide synthase isoform involved in de novo Sphingolipid synthesis in lung epithelia
  1177. Lack of ceramide generation and altered Sphingolipid composition are associated with drug resistance in human ovarian carcinoma cells
  1178. Regulation of Sphingolipid and glycoSphingolipid metabolism in extrahepatic tissues by endotoxin
  1179. Mutation in saposin D domain of Sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of …
  1180. A triterpenoidal saponin and Sphingolipids from Pteleopsis hylodendron
  1181. Elevation of endogenous Sphingolipid long-chain base phosphates kills Saccharomyces cerevisiae cells
  1182. HPLC quantification of Sphingolipids in soybeans with modified palmitate content
  1183. Dual effects of IGFBP‐3 on endothelial cell apoptosis and survival: involvement of the Sphingolipid signaling pathways
  1184. Ceramide regulates atypical PKCζ/λ-mediated cell polarity in primitive ectoderm cells: a novel function of Sphingolipids in morphogenesis
  1185. Regulation of the Sphingolipid signaling pathways in the growing and hypoxic rat heart
  1186. Sphingolipid signalling: molecular basis and role in TNF-α-induced cell death
  1187. Effect of seed development stage on Sphingolipid and phospholipid contents in soybean seeds
  1188. Thematic review series: Sphingolipids. ISC1 (inositol phosphoSphingolipid-phospholipase C), the yeast homologue of neutral sphingomyelinases
  1189. The plant disease resistance gene Asc‐1 prevents disruption of Sphingolipid metabolism during AAL‐toxin‐induced programmed cell death
  1190. Sphingolipid signaling in epidermal homeostasis: Current knowledge and new therapeutic approaches in dermatology
  1191. A possible role of Sphingolipids in the aluminium resistance of yeast and maize
  1192. Shift in Sphingolipid metabolism leads to an accumulation of ceramide in senescence
  1193. The synthesis of internal standards for the quantitative determination of Sphingolipids by tandem mass spectrometry
  1194. A Sphingolipid rich lipid fraction isolated from attenuated Leishmania donovani promastigote induces apoptosis in mouse and human melanoma cells in vitro
  1195. Mass spectrometric analysis reveals changes in phospholipid, neutral Sphingolipid and sulfatide molecular species in progressive epilepsy with mental retardation …
  1196. The development of aggressive cancer: a possible role for Sphingolipids
  1197. Human glycolipid transfer protein—intracellular localization and effects on the Sphingolipid synthesis
  1198. Sphingolipids from Bombycis Corpus 101A and their neurotrophic effects
  1199. De novo Sphingolipid synthesis is essential for viability, but not for transport of glycosylphosphatidylinositol-anchored proteins, in African trypanosomes
  1200. … parallel mass spectrometry and 31P nuclear magnetic resonance spectroscopy for analysis of sphingomyelin and dihydrosphingomyelin: II. Bovine milk Sphingolipids
  1201. Immunoseparation of Sphingolipid‐enriched membrane domains enriched in Src family protein tyrosine kinases and in the neuronal adhesion molecule TAG‐1 by anti …
  1202. Sphingolipids influence the sensitivity of lipid bilayers to fungicide, syringomycin E
  1203. Leukotrienes, Sphingolipids, and leukocyte trafficking
  1204. Reactive oxygen species generation is independent of de novo Sphingolipids in apoptotic photosensitized cells
  1205. Sphingolipids and atherosclerosis: a mechanistic connection? A therapeutic opportunity?
  1206. Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive Sphingolipid ceramide
  1207. Sphingolipid Synthesis via Olefin Cross Metathesis:  Preparation of a Differentially Protected Building Block and Application to the Synthesis of d-erythro-Ceramide
  1208. Menaquinone-4 concentration is correlated with Sphingolipid concentrations in rat brain
  1209. Rhizochalin A, a Novel Two-Headed Sphingolipid from the Sponge Rhizochalina incrustata
  1210. A novel role for Sphingolipid intermediates in activation-induced cell death in T cells
  1211. Distinct roles for de novo versus hydrolytic pathways of Sphingolipid biosynthesis in Saccharomyces cerevisiae
  1212. Essential requirement for sphingosine kinase 2 in a Sphingolipid apoptosis pathway activated by FTY720 analogues
  1213. Increasing endogenous ceramide using inhibitors of Sphingolipid metabolism maximizes ionizing radiation‐induced mitochondrial injury and apoptotic cell killing
  1214. Sphingolipid therapy in myocardial ischemia–reperfusion injury
  1215. Interfacial behavior of glycoSphingolipids and chemically related Sphingolipids
  1216. Composition-driven surface domain structuring mediated by Sphingolipids and membrane-active proteins: above the nano-but under the micro-scale: Mesoscopic …
  1217. Mutant analysis reveals complex regulation of Sphingolipid long chain base phosphates and long chain bases during heat stress in yeast
  1218. Cholesterol and Sphingolipids as lipid organizers of the immune cells’ plasma membrane: their impact on the functions of MHC molecules, effector T-lymphocytes and …
  1219. Fungal metabolite sulfamisterin suppresses Sphingolipid synthesis through inhibition of serine palmitoyltransferase
  1220. Downstream targets of altered Sphingolipid metabolism in response to inhibition of ENOX2 by phenoxodiol
  1221. Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the Sphingolipid signaling pathways
  1222. Sphingolipids in neuroblastoma: their role in drug resistance mechanisms
  1223. Sphingolipids of the mycopathogen Sporothrix schenckii: identification of a glycosylinositol phosphorylceramide with novel core GlcNH2α1→ 2Ins motif
  1224. Rottlerin inhibits chlamydial intracellular growth and blocks chlamydial acquisition of Sphingolipids from host cells
  1225. Analysis of Sphingolipids in potatoes (Solanum tuberosum L.) and sweet potatoes (Ipomoea batatas (L.) Lam.) by reversed phase high‐performance liquid …
  1226. Partitioning of pyrene-labeled phospho-and Sphingolipids between ordered and disordered bilayer domains
  1227. Sphingolipids in tumor metastases and angiogenesis
  1228. New Sphingolipids from the root of Isatis indigotica and their cytotoxic activity
  1229. High-performance liquid chromatography analysis of molecular species of Sphingolipid-related long chain bases and long chain base phosphates in Saccharomyces …
  1230. Potential new antimalarial chemotherapeutics based on Sphingolipid metabolism
  1231. Sphingolipids as targets for microbial infections
  1232. Interactions between nitric oxide and Sphingolipids and the potential consequences in physiology and pathology
  1233. Production of nerve growth factor enhanced in cultured mouse astrocytes by glycerophospholipids, Sphingolipids, and their related compounds
  1234. Preventing the binding of pathogens to the host by controlling Sphingolipid metabolism
  1235. Steroidogenic factor-1 is a Sphingolipid binding protein
  1236. A Role for G Protein‐Coupled Lysophospholipid Receptors in Sphingolipid‐Induced Ca2+ Signaling in MC3T3‐E1 Osteoblastic Cells
  1237. Continuous and highly variable rate controlled release of model drugs from Sphingolipid-based complex high axial ratio microstructures
  1238. Maternal and embryonic control of uterine Sphingolipid-metabolizing enzymes during murine embryo implantation
  1239. SLI1 (YGR212W) is a major gene conferring resistance to the Sphingolipid biosynthesis inhibitor ISP-1, and encodes an ISP-1 N-acetyltransferase in yeast
  1240. Fumonisin B1-induced neurodegeneration in mice after intracerebroventricular infusion is concurrent with disruption of Sphingolipid metabolism and activation of …
  1241. ACTH regulates steroidogenic gene expression and cortisol biosynthesis in the human adrenal cortex via Sphingolipid metabolism
  1242. Characterization of an Arabidopsis cDNA encoding a subunit of serine palmitoyltransferase, the initial enzyme in Sphingolipid biosynthesis
  1243. Hereditary sensory neuropathy type 1 mutations confer dominant negative effects on serine palmitoyltransferase, critical for Sphingolipid synthesis
  1244. Sphingolipids synthesis, transport and cellular signaling
  1245. Using genomic and lipidomic strategies to investigate Sphingolipid function in the yeast heat-stress response
  1246. Sphingolipid metabolism inhibitors and cell function
  1247. Sphingolipids differentially regulate mitogen‐activated protein kinases and intracellular Ca2+ in vascular smooth muscle: effects on CREB activation
  1248. Functional characterization of the postulated intramolecular Sphingolipid activator protein domain of human acid sphingomyelinase
  1249. … Mutations Affecting Sterol Biosynthesis in the Yeast Saccharomyces cerevisiae Result in Synthetic Lethality That Is Suppressed by Alterations in Sphingolipid Profiles
  1250. Suppression of the biosynthesis of cellular Sphingolipids results in the inhibition of the maturation of influenza virus particles in MDCK cells
  1251. Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL‐2‐independent apoptosis in human prostatic adenocarcinoma cells
  1252. Loss of sphingosine kinase‐1 activates the intrinsic pathway of programmed cell death: modulation of Sphingolipid levels and the induction of apoptosis
  1253. IPT1-independent Sphingolipid biosynthesis and yeast inhibition by syringomycin E and plant defensin DmAMP1
  1254. SVF1 Regulates Cell Survival by Affecting Sphingolipid Metabolism in Saccharomyces cerevisiae
  1255. … extraction method for the analysis by liquid chromatography/tandem mass spectrometry of fumonisins and biomarkers of disrupted Sphingolipid metabolism in tissues …
  1256. Identification of complex mixtures of Sphingolipids in the stratum corneum by reversed-phase high-performance liquid chromatography and atmospheric pressure …
  1257. Sphingolipids and other constituents from Cordia platythyrsa
  1258. Sphingosine-1-phosphate lyase in development and disease: Sphingolipid metabolism takes flight
  1259. Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by Sphingolipids
  1260. Protein sorting in the late Golgi of Saccharomyces cerevisiae does not require mannosylated Sphingolipids
  1261. Inhibition of Sphingolipid synthesis impairs cellular activation, cytokine production and proliferation in human lymphocytes
  1262. HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to Sphingolipid-enriched, detergent-resistant, raft membrane domains
  1263. Disruption of Sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populations
  1264. Sphingolipids from the edible fungus Tuber indicum
  1265. Sphingolipid Metabolite Ceramide Causes Metabolic Perturbation Contributing to HERG K+ Channel Dysfunction
  1266. The yeast O-acyltransferase Gup1p interferes in lipid metabolism with direct consequences on the Sphingolipid-sterol-ordered domains integrity/assembly
  1267. … of plasma membrane Sphingolipids are sorted to different intracellular compartments in astrocytes: Harmful effects of chronic ethanol exposure on Sphingolipid …
  1268. Sphingolipids suppress preneoplastic rat hepatocytes in vitro and in vivo
  1269. Development and function of CD1d-restricted NKT cells: influence of Sphingolipids, SAP and sex
  1270. Evaluation of Sphingolipids changes in brain tissues of rats with pentylenetetrazol-induced kindled seizures using MALDI-TOF-MS
  1271. Proteomic characterisation of neuronal Sphingolipid-cholesterol microdomains: role in plasminogen activation
  1272. Yeast Sphingolipid bypass mutants as indicators of antifungal agents selectively targeting Sphingolipid synthesis
  1273. An Inositol-Containing Sphingolipid from the Red Alga Gracilaria verrucosa
  1274. Ineffectiveness of activated carbon in reducing the alteration of Sphingolipid metabolism in rats exposed to fumonisin-contaminated diets
  1275. Dictyostelium discoideum to human cells: pharmacogenetic studies demonstrate a role for Sphingolipids in chemoresistance
  1276. Sphingolipids: metabolism and implications for health
  1277. A Sphingolipid Inhibitor Induces a Cytokinesis Arrest and Blocks Stage Differentiation in Giardia lamblia
  1278. Application of delayed extraction–matrix-assisted laser desorption ionization time-of-flight mass spectrometry for analysis of Sphingolipids in pericardial fluid …
  1279. A new class of lipid desaturase central to Sphingolipid biosynthesis and signalling
  1280. Organization and functions of Sphingolipid biosynthesis in yeast
  1281. Human meconium contains significant amounts of alkaline sphingomyelinase, neutral ceramidase, and Sphingolipid metabolites
  1282. The induction and persistence of altered Sphingolipid biosynthesis in rats treated with fumonisin B1
  1283. Sphingolipid metabolites selectively elicit increases in nuclear calcium concentration in cell suspension cultures and in isolated nuclei of tobacco
  1284. Structure elucidation of Sphingolipids from the mycopathogen Sporothrix schenckii: identification of novel glycosylinositol phosphorylceramides with core Manα1→ …
  1285. Drug resistance-associated changes in Sphingolipids and ABC transporters occur in different regions of membrane domains
  1286. The role of TNFα and Sphingolipid signaling in cardiac hypoxia: evidence that cardiomyocytes release TNFα and sphingosine
  1287. Nematicidal Sphingolipids from the freshwater fungus Paraniesslia sp. YMF1.01400
  1288. … , a serine palmitoyltransferase inhibitor, alters regional brain neurotransmitter levels without concurrent inhibition of the brain Sphingolipid biosynthesis in mice
  1289. Molecular cloning and characterization of Sphingolipid ceramideN-deacylase from a marine bacterium, Shewanella alga G8
  1290. Ceramide causes pulmonary cell apoptosis and emphysema: a role for Sphingolipid homeostasis in the maintenance of alveolar cells
  1291. Kv11.1 (ERG1) K+ Channels Localize in Cholesterol and Sphingolipid Enriched Membranes and Are Modulated by Membrane Cholesterol
  1292. Synthetic Sphingolipids as bioactive molecules
  1293. Sphingolipids related to apoptosis from the point of view of membrane structure and topology
  1294. A cross-sectional study of human serum Sphingolipids, diet and physiologic parameters
  1295. Convergent total synthesis of khafrefungin and its inhibitory activity of fungal Sphingolipid syntheses
  1296. Absence of 2-hydroxylated Sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration
  1297. Pancreatic phospholipase A2 via its receptor regulates the expression of key enzymes of phospholipid and Sphingolipid metabolism
  1298. Antifungal activity of bifunctional Sphingolipids. intramolecular synergism within long-chain α, ω-bis-aminoalcohols
  1299. Characterization of the reversible nature of the reaction catalyzed by Sphingolipid ceramide N‐deacylase: A novel form of reverse hydrolysis reaction
  1300. Dynamic pathway modeling of Sphingolipid metabolism
  1301. Nerve growth factor‐induced protein kinase C stimulation contributes to TrkA‐dependent inhibition of p75 neurotrophin receptor Sphingolipid signaling
  1302. Activation of a p53-independent, Sphingolipid-mediated cytolytic pathway in p53-negative mouse fibroblast cells treated with N-methyl-N-nitro-N …
  1303. Sphingolipid metabolism is a crucial determinant of cellular fate in nonstimulated proliferating Madin-Darby canine kidney (MDCK) cells
  1304. The combinatorial extension method reveals a Sphingolipid binding domain on pancreatic bile salt-dependent lipase: role in secretion
  1305. Interaction of saposin D with membranes: effect of anionic phospholipids and Sphingolipids
  1306. Characterization of a Δ8‐Sphingolipid Desaturase from Higher Plants: A Stereochemical and Mechanistic Study on the Origin of E,Z Isomers
  1307. The phosphatidylinositol 4, 5-biphosphate and TORC2 binding proteins Slm1 and Slm2 function in Sphingolipid regulation
  1308. Sphingolipid-cholesterol domains (lipid rafts) in normal human and dog thyroid follicular cells are not involved in thyrotropin receptor signaling
  1309. Fumonisin-induced blockade of ceramide synthase in Sphingolipid biosynthetic pathway alters aortic input impedance spectrum of pigs
  1310. Breast cancer and Sphingolipid signalling
  1311. … , and transcriptional responses of Saccharomyces cerevisiae to the novel immunomodulator FTY720 largely mimic those of the natural Sphingolipid …
  1312. Using fluorescent Sphingolipid analogs to study intracellular lipid trafficking
  1313. Probing for preferential interactions among Sphingolipids in bilayer vesicles using the glycolipid transfer protein
  1314. Sphingolipid biosynthesis in pathogenic fungi: identification and characterization of the 3-ketosphinganine reductase activity of Candida albicans and Aspergillus …
  1315. Bioeffector Sphingolipids as stimulators of cell growth and survival
  1316. Analysis of sphingosine 1-phosphate, ceramides, and other bioactive Sphingolipids by high-performance liquid chromatography-tandem mass spectrometry
  1317. Cutaneous water loss and Sphingolipids in the stratum corneum of house sparrows, Passer domesticus L., from desert and mesic environments as determined by …
  1318. A mutation in Sphingolipid synthesis suppresses defects in yeast ergosterol metabolism
  1319. Sphingolipids are involved in N-methyl-N′-nitro-N-nitrosoguanidine-induced epidermal growth factor receptor clustering
  1320. Mannosyl-Diinositolphospho-Ceramide, the Major Yeast Plasma Membrane Sphingolipid, Governs Toxicity of Kluyveromyces lactis Zymocin
  1321. Rescue of cell growth by sphingosine with disruption of lipid microdomain formation in Saccharomyces cerevisiae deficient in Sphingolipid biosynthesis
  1322. Comparison of the interaction of dihydrocholesterol and cholesterol with Sphingolipid or phospholipid Langmuir monolayers
  1323. Isolation and Characterization of the Genes Encoding Δ8-Sphingolipid Desaturase from Saccharomyces kluyveri and Kluyveromyces lactis
  1324. MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the Sphingolipid pathway
  1325. Depletion of Sphingolipids facilitates endosome to Golgi transport of ricin
  1326. Expression and functional characterization of SCaMPER: a Sphingolipid-modulated calcium channel of cardiomyocytes
  1327. Fumonisin B1 alters Sphingolipid metabolism and tumor necrosis factor α expression in heart and lung of mice
  1328. Effect of processing on Sphingolipid content in soybean products
  1329. Differential expression of Sphingolipids in P‐glycoprotein or multidrug resistance‐related protein 1 expressing human neuroblastoma cell lines
  1330. An efficient preparation of isosteric phosphonate analogues of Sphingolipids by opening of oxirane and cyclic sulfamidate intermediates with α-lithiated …
  1331. Evaluation of Sphingolipids in Wistar Rats Treated to Prolonged and Single Oral Doses of Fumonisin B1
  1332. Sphingolipids as coenzymes in anion transfer and tumor death
  1333. Evidence for an association of prion protein and Sphingolipid‐mediated signaling
  1334. Sphingolipid metabolism and caveolin expression in gonadotropin-releasing hormone-expressing GN11 and gonadotropin-releasing hormone-secreting GT1-7 …
  1335. Long-and short-term effects of thyroxine on Sphingolipid metabolism in rat liver.
  1336. Characterizing the Sphingolipid signaling pathway that remediates defects associated with loss of the yeast amphiphysin-like orthologs, Rvs161p and …
  1337. Trans-Golgi network and subapical compartment of HepG2 cells display different properties in sorting and exiting of Sphingolipids
  1338. Rafts as missing link between multidrug resistance and Sphingolipid metabolism
  1339. Endocytosis of NBD‐Sphingolipids in neurons: exclusion from degradative compartments and transport to the Golgi complex
  1340. Isolation and characterization of a cDNA encoding a Δ8 Sphingolipid desaturase from Aquilegia vulgaris
  1341. Contribution of Sphingolipids to the pathogenesis of obesity
  1342. Is the linkage region of Sphingolipids responsible for lipid raft formation?
  1343. Phosphoinositide 3‐kinase regulates crosstalk between Trk A tyrosine kinase and p75NTR‐dependent Sphingolipid signaling pathways
  1344. Sphingolipid-mediated apoptotic signaling pathways
  1345. Membrane domains and polarized trafficking of Sphingolipids
  1346. Content and constituent properties of Sphingolipid classes in Saccharomyces kluyveri
  1347. Preparation and use of liposomes for the study of Sphingolipid segregation in membrane model systems
  1348. The echinocandin “target” identified by cross-linking is a homolog of Pil1 and Lsp1, Sphingolipid-dependent regulators of cell wall integrity signaling
  1349. Disruption of Sphingolipid biosynthesis in hepatocyte nodules: selective proliferative stimulus induced by fumonisin B1
  1350. Evaluation of Sphingolipids in vitreous bodies from a patient with Gaucher disease, using delayed extraction matrix-assisted laser desorption ionization time-of-flight …
  1351. Sphingolipid microdomains mediate CD38 internalization: topography of the endocytosis
  1352. The N-glycosylation defect of cwh8Δ yeast cells causes a distinct defect in Sphingolipid biosynthesis
  1353. A guide to biochemical systems modeling of Sphingolipids for the biochemist
  1354. Efflux of Sphingolipids metabolically labeled with [1-3H]sphingosine, L-[3-3H]serine and [9,10-3H]palmitic acid from normal cells in culture
  1355. One-step labelling of Sphingolipids via a scrambling cross-metathesis reaction
  1356. Sphingolipid-to-glycerophospholipid conversion in SPL-null cells implies the existence of an alternative isozyme
  1357. Multifaceted roles of sphingosine‐1‐phosphate: How does this bioactive Sphingolipid fit with acute neurological injury?
  1358. Smart drugs for smarter stem cells: making SENSe (Sphingolipid-enhanced neural stem cells) of ceramide
  1359. Changes of Sphingolipid species in the phenotype conversion from myofibroblasts to lipocytes in hepatic stellate cells
  1360. The adhesion protein TAG‐1 has a ganglioside environment in the Sphingolipid‐enriched membrane domains of neuronal cells in culture
  1361. Functional activity of photoreceptor cyclic nucleotide-gated channels is dependent on the integrity of cholesterol-and Sphingolipid-enriched membrane domains
  1362. Transcriptional activation of tyrosinase gene by human placental Sphingolipid
  1363. Physiological relevance of Sphingolipid activator proteins in cultured human fibroblasts
  1364. … of Ypk1 in yeast differs depending on the downstream events, including endocytosis, cell growth, and resistance to a Sphingolipid biosynthesis inhibitor, ISP-1
  1365. Studies of compounds that enhance Sphingolipid metabolism in human keratinocytes1
  1366. Cloning and molecular characterisation of a Δ8-Sphingolipid-desaturase from Nicotiana tabacum closely related to Δ6-acyl-desaturases
  1367. Implications of sphingosine kinase 1 expression level for the cellular Sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells
  1368. Endogenous Sphingolipid metabolites related to the growth inSphingomonas chungbukensis
  1369. Cellular Sphingolipids regulate macrophage apolipoprotein E secretion
  1370. Inhibition of Sphingolipid synthesis affects kinetics but not fidelity of L1/NgCAM transport along direct but not transcytotic axonal pathways
  1371. What sugar next? Dimerization of Sphingolipid glycosyltransferases
  1372. Sphingolipid C4 hydroxylation influences properties of yeast detergent-insoluble glycolipid-enriched membranes
  1373. Novel analogs of De-MAPP and B13. Part 2: signature effects on bioactive Sphingolipids
  1374. New two-headed Sphingolipid-like compounds from the marine sponge Oceanapia sp.
  1375. Sphingolipids in the gut? Which are the important issues?
  1376. Bioeffector Sphingolipids as stimulators of cell growth and survival
  1377. Quantitative evaluation of Sphingolipids using delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry with …
  1378. Altered de novo Sphingolipid biosynthesis is involved in the serum deprivation-induced cell death in LLC-PK1 cells
  1379. Sphingolipids and cellular cholesterol homeostasis. Effect of ceramide on cholesterol trafficking and HMG CoA reductase activity
  1380. Disorders of Sphingolipid metabolism
  1381. Association of major histocompatibility complex II with cholesterol-and Sphingolipid-rich membranes precedes peptide loading
  1382. Sphingolipid metabolism in systemic inflammation
  1383. Diphtheria toxin translocation across cellular membranes is regulated by Sphingolipids
  1384. The potential roles of Sphingolipids in vascular smooth-muscle function
  1385. Chemical properties of epidermal lipids, especially Sphingolipids, of the Antarctic minke whale
  1386. Highlight: Sphingolipids–signals and disease
  1387. Dietary Sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis
  1388. A new Sphingolipid from the gorgonian junceella juncea of the Indian ocean
  1389. HOR7, a multicopy suppressor of the Ca2+-induced growth defect in Sphingolipid mannosyltransferase-deficient yeast
  1390. Fine tuning therapeutic targeting of the Sphingolipid biosynthetic pathway to treat atherosclerosis
  1391. Sphingolipids in Cell Signaling: Their Function as Receptor Ligands, Second Messengers, and Raft Constituents
  1392. Stereochemistry of a bifunctional dihydroceramide Δ 4-desaturase/hydroxylase from Candida albicans; a key enzyme of Sphingolipid metabolism
  1393. Sphingolipids: mechanism-based inhibitors of carcinogenesis produced by animals, plants, and other organisms
  1394. A computational approach to the inference of Sphingolipid pathways from the genome of Aspergillus fumigatus
  1395. Synthesis of a ceramide Sphingolipid as a potential sex pheromone of the hair crab Erimacrus isenbeckii using butane-2, 3-diacetal desymmetrised glycolic acid …
  1396. The use of lipid-binding toxins to study the distribution and dynamics of Sphingolipids and cholesterol
  1397. The relationship between the structure of the headgroup of Sphingolipids and their ability to form complex high axial ratio microstructures
  1398. Inhibition of Sphingolipid biosynthesis decreases phosphorylated ERK2 in LLC-PK1 cells
  1399. Simultaneous production of Sphingolipids and ethanol byKluyveromyces thermotolerans
  1400. Sphingolipid activator proteins
  1401. Marine Bifunctional Sphingolipids from the Sponge Oceanapia ramsayi
  1402. Sphingolipids in atherosclerosis: a metabolic underpinning of vascular disease
  1403. Measurement of ceramide and Sphingolipid metabolism in tumors: potential modulation of chemotherapy
  1404. Developmental changes in the protein composition of Sphingolipid‐and cholesterol‐enriched membrane domains of rat cerebellar granule cells
  1405. Differential branching of the Sphingolipid metabolic pathways with the stage of development: Involvement of sphingosine kinase
  1406. Apoptotic effects of dietary and synthetic Sphingolipids in androgen-independent (PC-3) prostate cancer cells
  1407. … receptor-related protein-1 (LRP) adapter protein GULP mediates trafficking of the LRP ligand prosaposin, leading to Sphingolipid and free cholesterol …
  1408. … -1-phosphate formation activates phosphatidylinositol-4 kinase in basolateral membranes from kidney cells: crosstalk in cell signaling through Sphingolipids and …
  1409. Effects of inhaled CdO particles on the Sphingolipid synthesis of rat lungs
  1410. Effect of sterol carrier protein-2 expression on Sphingolipid distribution in plasma membrane lipid rafts/caveolae
  1411. 12 Baker’s Yeast: a rising foundation for eukaryotic Sphingolipid-mediated cell signaling
  1412. Attenuated Leishmanial Sphingolipid induces apoptosis in A375 human melanoma cell via both caspase-dependent and-independent pathways
  1413. A glycan shield for bacterial Sphingolipids
  1414. … phosphatidylserine labels ceramide and sphingomyelin in L929 cells: evidence for a new metabolic relationship between glycerophospholipids and Sphingolipids
  1415. Biochemical and structural information transduction at the mesoscopic level in biointerfaces containing Sphingolipids
  1416. Determination of central nervous and organ tissue in meat products through GC-MS analysis of marker fatty acids from Sphingolipids and phospholipids
  1417. Determination of the phospholipid and Sphingolipid content in the feces of uninfected BALB/c mice and those infected with Echinostoma caproni by high performance …
  1418. Regulation of tumor phenotypes by caveolin-1 and Sphingolipid-controlled membrane signaling complexes
  1419. Purification of mammalian serine palmitoyltransferase, a hetero-subunit enzyme for Sphingolipid biosynthesis, by affinity-peptide chromatography
  1420. Cutaneous water loss and Sphingolipids covalently bound to corneocytes in the stratum corneum of house sparrows Passer domesticus
  1421. Cancer progression in the kidney and prostate: vital roles of Sphingolipids in chemotherapy
  1422. Use of Rab GTPases to study lipid trafficking in normal and Sphingolipid storage disease fibroblasts
  1423. Sphingolipid derivatives modulate intracellular Ca2+ in rat synaptosomes.
  1424. Use of Formalin-Fixed Tissues to Determine Fumonisin B1-Induced Sphingolipid Alterations in Swine
  1425. Saposin C and other Sphingolipid activator proteins
  1426. Influence of the Linkage Region of Sphingolipids on Sphingolipid− Phospholipid Mixing in Cholesterol-Rich Bilayers
  1427. … induced dispersal of the Golgi and anterograde membrane flow from the endoplasmic reticulum: implication of Sphingolipid metabolism in maintenance of the Golgi …
  1428. 2n-fatty acids from phosphatidylcholine label Sphingolipids—A novel role of phospholipase A2?
  1429. Change in contents of biologically active Sphingolipids modulating cell growth and survival in hepatoma 27 compared to rat liver
  1430. Fatty acids, cholesterol, and Sphingolipids: interactive regulators and targets for SREBP processing
  1431. Sphingolipid Monolayers on the Air− Water Interface and Electrochemical Behavior of the Films Transferred onto Glassy Carbon Electrodes
  1432. 11 Plant Sphingolipids
  1433. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells
  1434. Sphingolipid metabolism and signaling in atherosclerosis
  1435. Transthyretin knockout mouse nerves have increased lipoprotein lipase and Sphingolipid content following crush
  1436. Regulatory roles of cell surface sialylation in Sphingolipid-induced cell death in human B cell lymphoma
  1437. Sphingolipids as Emerging Drug Targets: Therapeutic Applications of Ceramide Analogs
  1438. Sphingolipid and apoptosis
  1439. Lipid metabolism: Sphingolipids-from membrane constituents to signaling molecules that control cell-to-cell communications
  1440. An Obese Genotype Affects the Sphingolipid Signaling Pathway
  1441. Biologically active Sphingolipids in transplantable tumors of different histogenesis
  1442. Dietary Sphingolipids suppress a subset of preneoplastic rat liver lesions exhibiting high PTEN, low phospho-Akt and high levels of ceramide species
  1443. Sterol carrier protein-2 expression alters Sphingolipid metabolism in transfected mouse L-cell fibroblasts
  1444. Role of Sphingolipids in health and disease in the nervous system
  1445. Structural Determination of Three Sphingolipids from Two Marine-derived Mangrove Endophytic Fungal Strains.
  1446. Structure–function studies of yeast C-4 Sphingolipid long chain base hydroxylase
  1447. Sphingolipids in tree nuts
  1448. Nystatin Interferes with the Effects of N‐Methyl‐N′‐nitro‐N‐nitrosoguanidine on Sphingolipid Metabolism in Human FL Cells
  1449. Biological mass spectrometry of Sphingolipids in drug discovery and development
  1450. Metabolism and Function of Sphingolipids in Saccharomyces Cerevisiae: Relevance to Cancer Research
  1451. Sphingolipids and transient receptor potential channels: Evolutionarily ancient families now joined
  1452. Sphingolipid Trafficking
  1453. Functional Lipidomics: Lessons and Examples from the Sphingolipids
  1454. Liposome-mediated, fluorescence-based studies of Sphingolipid metabolism in intact cells
  1455. Recent anticancer agents targeting Sphingolipid pathways
  1456. Sphingolipid receptors
  1457. SphinGOMAP: Lipidomic analysis of [glyco] Sphingolipid metabolism
  1458. Suppression of growth and progression of breast cancer xenografts by orally administered complex Sphingolipids
  1459. Functional analysis of TOR complex 2 and its control of Sphingolipid biosynthesis in” Saccharomyces cerevisiae”
  1460. Highly Efficient and Regioselective Phosphorylation of Sphingolipids by Phase-Trans fer Catalysis
  1461. The biochemistry and cellular biology of Sphingolipids and glucosylceramide
  1462. Cloning and molecular characterisation of a? 8-Sphingolipid-desaturase from Nicotiana tabacum closely related to? 6-acyl-desaturases
  1463. In vitro and in vivo anti-angiogenic activities of milk Sphingolipids
  1464. 13 The Effect of Sphingolipids as a New Therapeutic Option for Acne Treatment
  1465. Structural Biology of Sphingolipid Synthesis
  1466. Sphingolipid Signaling: Implications for Vascular Biology
  1467. Functional analysis of Sphingolipids using a specific enzyme and animal cells
  1468. Bioeffector Sphingolipids devoid of 4E-double bond in the sphingoid hydrocarbon chain
  1469. Time-and dose-related changes in mouse Sphingolipid metabolism following gavage fumonisin B1 administration
  1470. Current Perspectives on Saccharomyces cerevisiae Sphingolipids
  1471. Influence of E-LDL and Ox-LDL on the metabolism of ApoE, cholesterol, Sphingolipids and glycoSphingolipids as well as on the raft-composition in human …
  1472. A comparative study of Sphingolipids in transplanted melanomas with high and low metastatic activity
  1473. Examination of the effects of a Sphingolipid-enriched lipid fraction from wheat gluten on the incidence of diabetes in BBdp rats
  1474. Sphingolipids and lung vascular barrier regulation
  1475. Investigation of chloroform-methanol soluble wheat proteins and Sphingolipids as potential dietary triggers of diabetes in BBdp rats
  1476. How do Sphingolipids and lipid rafts relate to pathology?
  1477. Novel functional association of serine palmitoyltransferase subunit 1-A peptide in Sphingolipid metabolism with cytochrome P4501A1 transactivation and proliferative …
  1478. Tandem mass of Sphingolipids and its application in diagnosis of sulphatidosis and related diseases
  1479. Sphingolipids, vehicle for pathogenic agents and cause of genetic diseases
  1480. Mechanisms of Sphingolipid functions during heat stress in” Saccharomyces cerevisiae”
  1481. Comprehensive Evaluation of Sphingolipid Gene Expression in Normal and Light-Stressed Retina and Oxidant-Stressed 661W Cells
  1482. Bioluminescent assay for Sphingolipid ceramide N-deacylase using Vibrio harveyi dark mutant M-17
  1483. Computational studies on functional molecular fragments of sphingomyelin and related Sphingolipids
  1484. Sphingolipids in rat model of transient focal cerebral ischemia: Implication for stroke injury
  1485. Ceramide-1-phosphate, a new bioactive Sphingolipid in regulating cell signaling
  1486. A primordial mover for Sphingolipids
  1487. Earthworm humoral immune system: interaction of hemolysins with lipid membranes requires Sphingolipids
  1488. Production of Sphingolipids by Submerged Culture of Ganoderma lucidum and Cutaneous Hydration Effect
  1489. Docosahexaenoic Acid Promotes Photoreceptor Survival and Differentiation by Regulating Sphingolipid Metabolism
  1490. 248 involvement of the Sphingolipid, ceramide, in heat shock-induced apoptosis in bovine oocyte
  1491. Sphingolipids in Health and
  1492. Sphingolipid and phospholipid metabolites regulate the phenotype of vascular smooth muscle cells
  1493. Chemopreventive and chemotherapeutic mechanisms of Sphingolipid metabolites in human colon cancer cells and breast stem, normal, and tumorigenic cells
  1494. Regulatory effect of Sphingolipids on secretory phospholipase A2. Comparative study using SUV and GUV
  1495. GENERAL ASPECTS OF Sphingolipid SIGNALLING
  1496. Metabolism and physiological functions of Sphingolipids
  1497. Sphingolipids in health and disease
  1498. Progress in understanding the roles of Sphingolipids in animal development
  1499. The role of Sphingolipids in pulmonary disorders
  1500. Enigmol (2-amino-3, 5-dihydroxyoctadecane [2S, 3S, 5S]) is a novel Sphingolipid analog that shows a promising effect in the treatment of prostate cancer
  1501. Sphingolipids–roads still to be taken
  1502. Characterization of genes conferring resistance against ISP-1/myriocin-induced Sphingolipid depletion in yeast
  1503. INTRODUCTION TO Sphingolipids AND RAFTS
  1504. Generation of signaling molecules by de novo Sphingolipid synthesis
  1505. Construction of Sphingolipids Libraries and their Utilities
  1506. Molecular targeting therapy for leukemia by Sphingolipid ceramide
  1507. Fusion of Semliki Forest Virus in the Absence of Sphingolipids
  1508. Sphingolipid synthesis and metabolism as a target for anti Giardial therapy
  1509. Foreword: Special issue on Sphingolipids dedicated to Professor Guido Tettamanti
  1510. A novel approach to the study of Sphingolipid metabolism mediated by sphingosine kinase, an oncogenic signaling enzyme
  1511. Characterization of Sphingolipid receptors in cardiomyocytes
  1512. Novel syntheses of Sphingolipids and their analogues
  1513. A Systems Approach Demonstrating Sphingolipid-Dependent Transcription in Stress Responses
  1514. Role of Sphingolipids in vascular smooth muscle cell function
  1515. The complexity of Sphingolipid metabolism in the modulation of neuronal development
  1516. Sphingolipids and multidrug resistance of cancer cells
  1517. Sphingolipids Metabolism Following Cerebral Ischemia
  1518. The Sphingenine/Sphinganine Ratio in Sphingolipids of Transplantable Rat Tumors Depends on a Transplantation Organ
  1519. Isolation of secondary fungal metabolites and their influence on Sphingolipid metabolism
  1520. The role of Sphingolipids in the control of apoptosis in human placental primary trophoblasts.
  1521. Computational Parameter Selection and Simulation of Complex Sphingolipid Pathway Metabolism
  1522. Syntheses of Sphingolipid analogs
  1523. Isolation and Characterization of Sphingolipids in Arabidopsis thaliana
  1524. LIPIDS: Sphingolipid metabolizing enzymes.
  1525. The role of Sphingolipids in the control of apoptosis in human placental primary trophoblasts
  1526. Modification and Purification of Sphingolipids and Gangliosides
  1527. Sphingolipids, ABC transporters and chemosensitivity in neuroblastoma
  1528. Sphingolipid metabolism and programmed cell death in tomato
  1529. Sphingolipids, rafts and multidrug resistance
  1530. A Computer Visualization Model for the De Novo Sphingolipid Biosynthetic Pathway
  1531. Sphingolipid signaling: a potential pathway for TNF-alpha induced preconditioning
  1532. Sphingolipids in mammalian lens membranes: Organization, distribution and biological implications
  1533. Sphingolipid-dependent vascular reactivity in spontaneously hypertensive rats
  1534. The effect of serine palmitoyltransferase on Sphingolipid metabolism and atherosclerosis
  1535. Systems-biology approach to Sphingolipid-storage disorders
  1536. The Role of Sphingolipids Cycle in Hydrogen Peroxide-Induced Apoptosis in HL-60 Cells
  1537. Fumonisin-induced neural tube defects: disruption of Sphingolipids and folate transport
  1538. Soybean Sphingolipid content as affected by palmitate content and by seed development stage
  1539. The role of Sphingolipids in activation-induced cell death in T-cells
  1540. Role of Sphingolipids in Microbial
  1541. Proinflammatory action of Sphingolipids in primary cultured rat intestinal smooth muscle cells
  1542. Ultra-structural organization of Sphingolipid synthesis in the mammalian Golgi
  1543. Naturally-occurring and synthetic Sphingolipids as modulators of colon carcinogenesis and roles in cell signaling
  1544. Sphingolipid Metabolism is Altered in the Diabetic Retina: Possible Implications for Diabetic Retinopathy
  1545. Identification of mechanism (s) by which the complex Sphingolipid, C2-ceramide, influences CYPIA1 induction fy 3-Methylcholanthrene
  1546. Sphingolipid signaling in denervated skeletal muscle
  1547. The modulation of Sphingolipids by human cytomegalovirus and its influence on viral protein accumulation and growth
  1548. 4-4 Sphingolipids and Multidrug Resistance of
  1549. Sphingolipids and Cancer
  1550. Sphingolipid mediated changes in cell growth in Saccharomyces cerevisiae: Effects on sterol and glucose metabolism
  1551. Studies of Saccharomyces cerevisiae Sphingolipid C4 hydroxylation and IPT1 function and their roles in syringomycin E action
  1552. 13 Sphingolipids: a New Strategy for Cancer Treatment and Prevention
  1553. Growth promoting conditions alter the role of Sphingolipids in the vasoactive effects of angiotensin II
  1554. OBESITY STUDIES: OVEREXPRESSION OF ENZYMES IN THE Sphingolipid METABOLIC PATHWAY IN DROSOPHILA MUTANTS
  1555. Up‐regulation of de novo Sphingolipid biosynthesis through serine palmitoyltransferease in RAW 264.7 cells upon Kdo2‐Lipid A treatment
  1556. The Role of Sphingolipid-and Cholesterol-Rich Membrane Domains in Pathophsiology of Cultured Human Breast Cancer
  1557. Introduction to thematic series on Sphingolipids in honor of Professor Herbert E. Carter (1910–2007)
  1558. Safingol: phosphorylation and effect on endogenous Sphingolipid formation in human ALL leukemia and neuroblastoma cell lines
  1559. The altered Sphingolipid metabolism in rats following fumonisin B1 exposure
  1560. Functional characterization of Sphingolipid C4-hydroxylase genes from Arabidopsis thaliana1
  1561. … domains (DIGs) in drug-resistant versus drug-sensitive human ovarian cancer cells differ in Sphingolipid content; Enrichment of Sphingolipids with specific fatty …
  1562. Trypanosoma brucei serine palmitoyltransferase: Roles in de novo Sphingolipid biosynthesis, life cycle, and lipid raft formation
  1563. The role of Sphingolipids in cholesterol efflux mediated by ATP-binding cassette transporter AI (ABCAI)
  1564. … A, Millimaggi D, D’Ascenzo S, Clarkson M, Bettiga A, Chigorno V et al.. Lack of ceramide generation and altered Sphingolipid composition are associated with …
  1565. Channel formation by the pro-apoptotic Sphingolipid ceramide
  1566. Sphingolipid mannosylation in yeast requires Csg2p-dependent manganese transport into the lumen of early secretory organelles
  1567. Artemisinin delays Sphingolipid biosynthesis in Plasmodium falciparum
  1568. A Higher Plant D8 Sphingolipid Desaturase with a Preference for (Z)-Isomer Formation Confers Aluminum Tolerance to Yeast and Plants [C][OA]
  1569. Profiling Analysis of Sphingolipids in HL-60 Cells by High-Performance Liquid Chromatography-Tandem Mass Spectrometry in combination with Multiple Reaction …
  1570. The Role of Sphingolipids in Cell Signalling: Studies with Synthetic Analogues
  1571. … and herbs: I. Isolation and identification of cytotoxic compounds from bay leaf (Laurus nobilis). II. Identification and quantification of Sphingolipids in nuts and …
  1572. Sphingolipid catabolism
  1573. … in decreased levels of serum sphingomyelin and apoptosis in in‐vivo cardiac tissues and aortic smooth muscle: Implications for Sphingolipids (SPH) in cardiovascular …
  1574. Prognostic relevance of alterations in Sphingolipid metabolism in breast cancer
  1575. Pathophysiology and mechanism of fumonisin B (1) induced disruption of Sphingolipid metabolism
  1576. 1-1 Sphingolipids Synthesis, Transport and Cellular Signaling
  1577. Sphingolipid Involvement in Insulin Sensitivity in C2C12 Myotubes
  1578. Sphingolipid and Glycolipid Biology
  1579. Inhibitors of Sphingolipid metabolism enzymes
  1580. The plant disease resistance gene Asc-1 prevents disruption of Sphingolipid metabolism during AAL-toxin-induced programmed cell death
  1581. The Sphingolipid Synthesis Regulator SPTLC1 is Bound by PARD3 through a Type II PDZ Protein-Protein Interaction
  1582. The Role of Sphingolipids in Cortisol Synthesis in the Adrenal Cortex
  1583. The PH domain proteins Slm1 and Slm2 are targets of Sphingolipid signaling during the response to heat stress
  1584. 12 Structural Studies of Sphingolipids, a Class of Chemopreventive Compounds in Food
  1585. Workshop 2: Approaches for Studying the Biological Roles of Sphingolipids. Probing apoptosis during neuronal development with novel ceramide analogs
  1586. Converging roles for Sphingolipids and cell stress in the progression of neuro-AIDS Norman J. Haughey, Joesph Steiner, Avindra Nath, Justin C. McArthur, Ned …
  1587. Calmodulin-Sphingolipid complex (Test project)
  1588. Suppression of growth, progression and metastasis of breast cancer xenografts by dietary complex Sphingolipids
  1589. Novel Sphingolipids from Conyza canadensis.
  1590. Two-headed Sphingolipids from Tropical Marine Sponges
  1591. DECIPHERING THE CROSS-TALK BETWEEN Sphingolipid MECHANISM AND SIGNALING PATHWAYS IN BAKER’S YEAST
  1592. 8 Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Analysis of Sphingolipids
  1593. Are Sphingolipids important in the cell death process in pancreatic cancer cells?
  1594. Fumonisin B1 induces apoptosis in sphingosine 1-phosphate lyase-null F9 cells through increase of Sphingolipids levels
  1595. Suppression of growth, progression and metastasis of breast cancer xenografts by orally administered complex Sphingolipids
  1596. 27 Sphingolipids: from Chemistry to Possible Biologic Influence on the Skin
  1597. 25 Sphingolipids as Chemopreventive Agents
  1598. Functional analysis of Sphingolipid C9-methyltransferase gene disruptants in Candida albicans.
  1599. Sphingolipid signaling in the regulation of vascular network assembly
  1600. Engineering Sphingolipid biosynthesis in non-conventional yeasts
  1601. Fractionation process to produce a new milk ingredient enriched in phospholipids and Sphingolipids
  1602. Influence of estradiol on Sphingolipid signaling pathway in uterine smooth muscle
  1603. Identification and characterization of Arabidopsis Sphingolipid genes using heterologous expression in yeast
  1604. Alterations in Sphingolipid synthesis in the model plant Arabidopsis thaliana is associated with cell polarity and developmental defects
  1605. The role of Sphingolipid signaling in muscarinic receptor‐induced rat urinary bladder contraction
  1606. Sphingolipid metabolism in vascular function
  1607. Disruption of a Sphingolipid Δ8-desaturase gene influences the morphogenesis in Candida albicans
  1608. Biologically effective Sphingolipids devoid of 4-trans-double bond in the sphingoid hydrocarbon chain
  1609. Involvement of the membrane Sphingolipid ‘rheostat’in the intrinsic effects of IGFBP-3 on cell growth and survival of human breast epithelial cells
  1610. Development of Sphingosine kinase (SPHK) inhibitors and the role of Sphingolipids in adult stem cell proliferation and differentiation
  1611. The Localization of 4-O-Methylglucuronic Acid-Containing Glyco-Sphingolipid on the Cell Surface of Bivalve Spermatozoa by Use of an Immunological Method1
  1612. Phosphatidylinositol 4, 5 bisphosphate and tyrosine phosphorylation induce actin-based movement of Sphingolipid: cholesterol raft-enriched vesicles through WASP …
  1613. Elicitor activity of cerebroside, a Sphingolipid elicitor, in cell suspention cultures of rice [Oryza sativa]
  1614. Regulation of the virulence of Cryptococcus neoformans by the Sphingolipid pathway: A novel signaling cascade mediated by diacylglycerol (DAG) and …
  1615. 1P336 Specific interaction of the fluorescent probe derived from acylated 3β-cholesteryl amine with Sphingolipid (12. Membrane dynamics, Poster Session, Abstract …
  1616. Expression and function of the Sphingolipid receptors S1P1–5 in Ewing and adult type soft tissue sarcoma cells: Examples of G protein-coupled receptors as potential …
  1617. Essential Requirement for Sphingosine Kinase 2 in a Sphingolipid Apoptosis Pathway Activated by FTY720
  1618. Sphingolipids as modulators of membrane signaling complex
  1619. Changes of Sphingolipids during the induction of the lipocyte phenotype in hepatic stellate cells
  1620. Methods for the study of Sphingolipid-protein interactions at the level of plasma membrane lipid domains
  1621. Phospholipid and Sphingolipid composition of the milk fat globule membrane (MFGM): determination by SPE and HPLG-ELSD
  1622. … for primary sclerosing cholangitis17. TLR4 translocation following oxidative stress in mouse macrophages requires Sphingolipid metabolism through the ASM …
  1623. Sphingosine kinase 1 expression is involved in leukemogenesis and modulates cellular Sphingolipid rheostat, which is a good predictive marker of daunorubicin …
  1624. Interaction of the Sigma‐1 Receptor with Endogenous Sphingolipids and Alkyl Amines
  1625. P-49 Versatile Synthesis of Sphingophospholipids toward Elucidating Sphingolipid Biological Behavior
  1626. Sphingolipidomics: methods for the comprehensive analysis of Sphingolipids
  1627. Sphingolipids in cancer
  1628. Sphingolipid metabolism and neutral sphingomyelinases
  1629. Bioactive Sphingolipids: metabolism and function
  1630. A view on Sphingolipids and disease
  1631. Plant Sphingolipids: function follows form
  1632. Sphingolipid signaling in metabolic disorders
  1633. Sphingolipidomics: a valuable tool for understanding the roles of Sphingolipids in biology and disease
  1634. An overview of Sphingolipid metabolism: from synthesis to breakdown
  1635. Sphingolipids in inflammation: pathological implications and potential therapeutic targets
  1636. Sphingolipids and plant defense/disease: the “death” connection and beyond
  1637. Plant Sphingolipids: decoding the enigma of the Sphinx
  1638. Sphingolipid and glycoSphingolipid metabolic pathways in the era of Sphingolipidomics
  1639. Deregulation of Sphingolipid metabolism in Alzheimer’s disease
  1640. Sphingolipid metabolic pathway: an overview of major roles played in human diseases
  1641. An introduction to Sphingolipid metabolism and analysis by new technologies
  1642. Orm family proteins mediate Sphingolipid homeostasis
  1643. Membranes in balance: mechanisms of Sphingolipid homeostasis
  1644. Distribution and functions of sterols and Sphingolipids
  1645. Drug targeting of Sphingolipid metabolism: sphingomyelinases and ceramidases
  1646. ELOVL1 production of C24 acyl-CoAs is linked to C24 Sphingolipid synthesis
  1647. Sphingolipids in apoptosis
  1648. Roles for Sphingolipids in Saccharomyces cerevisiae
  1649. Sphingolipids: critical players in Alzheimer’s disease
  1650. Nuclear Sphingolipid metabolism
  1651. Dysregulation of Sphingolipid metabolism in cancer
  1652. Cancer treatment strategies targeting Sphingolipid metabolism
  1653. Roles for dysfunctional Sphingolipid metabolism in Alzheimer’s disease neuropathogenesis
  1654. Sphingolipids in multiple sclerosis
  1655. Sphingolipids: regulators of crosstalk between apoptosis and autophagy
  1656. Regulation of Sphingolipid synthesis through Orm1 and Orm2 in yeast
  1657. Sphingolipids and insulin resistance: the five Ws
  1658. Sphingolipids in obesity, type 2 diabetes, and metabolic disease
  1659. Sphingolipids and expression regulation of genes in cancer
  1660. The role of Sphingolipids in respiratory disease
  1661. The complexity of Sphingolipid biosynthesis in the endoplasmic reticulum
  1662. Regulation of sphingosine kinase and Sphingolipid signaling
  1663. Control of metabolism and signaling of simple bioactive Sphingolipids: Implications in disease
  1664. Plant Sphingolipids: structure, synthesis and function
  1665. Sphingolipid biochemistry
  1666. Metabolism of Sphingolipids in the gut and its relation to inflammation and cancer development
  1667. Sphingolipid homeostasis in the endoplasmic reticulum and beyond
  1668. Sphingolipids in neurodegeneration
  1669. A rapid and quantitative LC-MS/MS method to profile Sphingolipids
  1670. Protein kinase Ypk1 phosphorylates regulatory proteins Orm1 and Orm2 to control Sphingolipid homeostasis in Saccharomyces cerevisiae
  1671. Genetic determinants of circulating Sphingolipid concentrations in European populations
  1672. Ceramide synthases at the centre of Sphingolipid metabolism and biology
  1673. Direct chemical evidence for Sphingolipid domains in the plasma membranes of fibroblasts
  1674. Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction
  1675. Circulating Sphingolipid biomarkers in models of type 1 diabetes
  1676. Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance
  1677. Sphingolipids: players in the pathology of metabolic disease
  1678. Very long chain Sphingolipids: tissue expression, function and synthesis
  1679. The Sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors
  1680. Molecular recognition of a single Sphingolipid species by a protein’s transmembrane domain
  1681. Effects of ceramide and other simple Sphingolipids on membrane lateral structure
  1682. Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure
  1683. Sphingolipids and atherosclerosis
  1684. Alterations of the Sphingolipid pathway in Alzheimer’s disease: new biomarkers and treatment targets?
  1685. My journey into the world of Sphingolipids and Sphingolipidoses
  1686. Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function
  1687. Evidence for disruption of Sphingolipid metabolism in schizophrenia
  1688. Functional interactions between Sphingolipids and sterols in biological membranes regulating cell physiology
  1689. Deregulated Sphingolipid metabolism and membrane organization in neurodegenerative disorders
  1690. Heart Sphingolipids in health and disease
  1691. The impact of cholesterol, DHA, and Sphingolipids on Alzheimer’s disease
  1692. Sphingolipid domains in the plasma membranes of fibroblasts are not enriched with cholesterol
  1693. Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis
  1694. Blood Sphingolipids in homeostasis and pathobiology
  1695. Sphingolipids as signaling and regulatory molecules
  1696. Phospholipid and Sphingolipid metabolism in Leishmania
  1697. Dihydroceramide desaturase and dihydroSphingolipids: debutant players in the Sphingolipid arena
  1698. Impaired Sphingolipid synthesis in the respiratory tract induces airway hyperreactivity
  1699. Sphingolipids and hepatic steatosis
  1700. A genome-wide screen for genes affecting eisosomes reveals Nce102 function in Sphingolipid signaling
  1701. Sphingolipid metabolism and obesity-induced inflammation
  1702. A role for Sphingolipids in the pathophysiology of obesity-induced inflammation
  1703. Hypertension is associated with marked alterations in Sphingolipid biology: a potential role for ceramide
  1704. Regulating survival and development in the retina: key roles for simple Sphingolipids
  1705. Sphingomyelin metabolism at the plasma membrane: implications for bioactive Sphingolipids
  1706. Sphingolipids and membrane environments for caveolin
  1707. ApoE4 disrupts sterol and Sphingolipid metabolism in Alzheimer’s but not normal brain
  1708. Altered Sphingolipid metabolism in human endometrial cancer
  1709. Sphingolipids function as downstream effectors of a fungal PAQR
  1710. Down-regulating Sphingolipid synthesis increases yeast lifespan
  1711. Increase in Sphingolipid catabolic enzyme activity during aging
  1712. Roles of ceramide and Sphingolipids in pancreatic β-cell function and dysfunction
  1713. Genome-wide association study identifies novel loci associated with circulating phospho-and Sphingolipid concentrations
  1714. Sphingosine kinase: Role in regulation of bioactive Sphingolipid mediators in inflammation
  1715. Molecular insights into amyloid regulation by membrane cholesterol and Sphingolipids: common mechanisms in neurodegenerative diseases
  1716. Orm proteins integrate multiple signals to maintain Sphingolipid homeostasis
  1717. A shift in Sphingolipid composition from C24 to C16 increases susceptibility to apoptosis in HeLa cells
  1718. Comprehensive quantitative analysis of bioactive Sphingolipids by high-performance liquid chromatography–tandem mass spectrometry
  1719. Sphingolipid analysis by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS)
  1720. Sphingolipid distribution changes with age in the human lens [S]
  1721. Metabolism, physiological role, and clinical implications of Sphingolipids in gastrointestinal tract
  1722. Membrane Sphingolipids as essential molecular signals for Bacteroides survival in the intestine
  1723. Viral infections and Sphingolipids
  1724. Quantitative analysis of Sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers [S]
  1725. Sphingolipid synthetic pathways are major regulators of lipid homeostasis
  1726. Regulation of autophagy by Sphingolipids
  1727. Roles of Sphingolipids in Drosophila development and disease
  1728. Antimicrobial Activity of Sphingolipids Isolated from the Stems of Cucumber (Cucumis sativus L.)
  1729. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance
  1730. Apoptotic Sphingolipid ceramide in cancer therapy
  1731. Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle
  1732. Sphingolipids in lung endothelial biology and regulation of vascular integrity
  1733. Ceramide and apoptosis: exploring the enigmatic connections between Sphingolipid metabolism and programmed cell death
  1734. Segregation of Sphingolipids and sterols during formation of secretory vesicles at the trans-Golgi network
  1735. Sphingolipids in neuroinflammation
  1736. Sphingolipids in psychiatric disorders and pain syndromes
  1737. Metabolomics implicates altered Sphingolipids in chronic pain of neuropathic origin
  1738. The interplay between bioactive Sphingolipids and steroid hormones
  1739. Serum Sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome
  1740. Connecting Hsp70, Sphingolipid metabolism and lysosomal stability
  1741. Sphingolipid Δ8 unsaturation is important for glucosylceramide biosynthesis and low‐temperature performance in Arabidopsis
  1742. Sphingolipid and ceramide homeostasis: potential therapeutic targets
  1743. Fast screening of highly glycosylated plant Sphingolipids by tandem mass spectrometry
  1744. Sphingolipids in parasitic protozoa
  1745. Sphingolipid-modulated exosome secretion promotes clearance of amyloid-β by microglia
  1746. Plasma membrane stress induces relocalization of Slm proteins and activation of TORC2 to promote Sphingolipid synthesis
  1747. Transformation-associated changes in Sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase
  1748. Microvesicles released from microglia stimulate synaptic activity via enhanced Sphingolipid metabolism
  1749. Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance
  1750. An essential function of Sphingolipids in yeast cell division
  1751. Identification of Niemann-Pick C1 disease biomarkers through Sphingolipid profiling
  1752. Analysis of mammalian Sphingolipids by liquid chromatography tandem mass spectrometry (LC-MS/MS) and tissue imaging mass spectrometry (TIMS)
  1753. Novel agents targeting bioactive Sphingolipids for the treatment of cancer
  1754. Therapeutic strategies for diabetes and complications: a role for Sphingolipids?
  1755. Gaucher’s disease and cancer: a Sphingolipid perspective
  1756. Could plasma Sphingolipids be diagnostic or prognostic biomarkers for Alzheimer’s disease?
  1757. Sphingolipid signaling mediates iron toxicity
  1758. Mass spectrometric analysis of neutral Sphingolipids: methods, applications, and limitations
  1759. The role of Sphingolipids in selected cardiovascular diseases
  1760. The sigma1 receptor interacts with N-alkyl amines and endogenous Sphingolipids
  1761. A rabidopsis mutants of Sphingolipid fatty acid α‐hydroxylases accumulate ceramides and salicylates
  1762. Sterols and Sphingolipids: dynamic duo or partners in crime?
  1763. Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy
  1764. Sphingolipids and membrane domains: recent advances
  1765. Sphingolipids in disease
  1766. Serum Sphingolipids level as a novel potential marker for early detection of human myocardial ischaemic injury
  1767. Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages
  1768. Targeting the Sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug
  1769. Altered Sphingolipid metabolism in patients with metastatic pancreatic cancer
  1770. The low intestinal and hepatic toxicity of hydrolyzed fumonisin B1 correlates with its inability to alter the metabolism of Sphingolipids
  1771. Disorders of phospholipids, Sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases
  1772. Selective knockdown of ceramide synthases reveals complex interregulation of Sphingolipid metabolism [S]
  1773. Candida albicans Sphingolipid C9-methyltransferase is involved in hyphal elongation
  1774. Reducing Sphingolipid synthesis orchestrates global changes to extend yeast lifespan
  1775. TNF-α-and tumor-induced skeletal muscle atrophy involves Sphingolipid metabolism
  1776. Sphingolipid topology and the dynamic organization and function of membrane proteins
  1777. Novel chemotherapeutic drugs in Sphingolipid cancer research
  1778. Biosynthesis of Sphingolipids in plants (and some of their functions)
  1779. Physiological functions and clinical implications of Sphingolipids in the gut
  1780. Sphingolipids and susceptibility to asthma
  1781. Orm protein phosphoregulation mediates transient Sphingolipid biosynthesis response to heat stress via the Pkh-Ypk and Cdc55-PP2A pathways
  1782. Sphingolipids in the Root Play an Important Role in Regulating the Leaf Ionome in Arabidopsis thaliana
  1783. Plasma Sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet
  1784. Sphingolipids: the nexus between Gaucher disease and insulin resistance
  1785. The Sphingolipid degradation product trans-2-hexadecenal induces cytoskeletal reorganization and apoptosis in a JNK-dependent manner
  1786. Plasma Sphingolipids and lung cancer: a population-based, nested case–control study
  1787. Lithocholic acid disrupts phospholipid and Sphingolipid homeostasis leading to cholestasis in mice
  1788. Modulators of Sphingolipid metabolism reduce lung inflammation
  1789. Sphingolipids Containing Very-Long-Chain Fatty Acids Define a Secretory Pathway for Specific Polar Plasma Membrane Protein Targeting in Arabidopsis
  1790. The potential role for Sphingolipids in neuropathogenesis of Alzheimer’s disease
  1791. Molecular facets of Sphingolipids: mediators of diseases
  1792. Interdiction of Sphingolipid metabolism to improve standard cancer therapies
  1793. Sphingolipids in acute lung injury
  1794. Self-enhancement of hepatitis C virus replication by promotion of specific Sphingolipid biosynthesis
  1795. Therapeutic applications of bioactive Sphingolipids in hematological malignancies
  1796. Sphingolipid long chain base phosphates can regulate apoptotic-like programmed cell death in plants
  1797. Computational analysis of Sphingolipid pathway systems
  1798. Targeting blood-brain barrier Sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain
  1799. CRS–MIS in Candida glabrata: Sphingolipids modulate echinocandin–Fks interaction
  1800. A novel Sphingolipid-TORC1 pathway critically promotes postembryonic development in Caenorhabditis elegans
  1801. Sphingolipids involvement in plant endomembrane differentiation: the BY2 case
  1802. Role of Sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet
  1803. Ablation of very long acyl chain Sphingolipids causes hepatic insulin resistance in mice due to altered detergent‐resistant membranes
  1804. Functional characterization of a higher plant Sphingolipid Δ4-desaturase: defining the role of sphingosine and sphingosine-1-phosphate in Arabidopsis
  1805. Sphingolipid metabolism and analysis in metabolic disease
  1806. p53 and regulation of bioactive Sphingolipids
  1807. Dietary Sphingolipids improve skin barrier functions via the upregulation of ceramide synthases in the epidermis
  1808. Metabolic Depletion of Sphingolipids Impairs Ligand Binding and Signaling of Human Serotonin1A Receptors
  1809. Sphingolipids and response to chemotherapy
  1810. Counter-regulation of opioid analgesia by glial-derived bioactive Sphingolipids
  1811. Two pathways of Sphingolipid biosynthesis are separated in the yeast Pichia pastoris
  1812. Sphingolipid storage affects autophagic metabolism of the amyloid precursor protein and promotes Aβ generation
  1813. The involvement of Sphingolipids in chronic obstructive pulmonary diseases
  1814. A new Sphingolipid and furanocoumarins with antimicrobial activity from Ficus exasperata
  1815. Altered Sphingolipid metabolism induced by tumor hypoxia–new vistas in glycolipid tumor markers
  1816. Sterols and Sphingolipids differentially function in trafficking of the A rabidopsis ABCB 19 auxin transporter
  1817. A world of Sphingolipids and glycolipids in the brain—Novel functions of simple lipids modified with glucose—
  1818. An update on sphingosine-1-phosphate and other Sphingolipid mediators
  1819. Role of sphingosine kinase localization in Sphingolipid signaling
  1820. TORC1-regulated protein kinase Npr1 phosphorylates Orm to stimulate complex Sphingolipid synthesis
  1821. Myocardial infarction differentially alters Sphingolipid levels in plasma, erythrocytes and platelets of the rat
  1822. Sphingolipids regulate the yeast high-osmolarity glycerol response pathway
  1823. Secondary alterations of Sphingolipid metabolism in lysosomal storage diseases
  1824. Gel domains in the plasma membrane of Saccharomyces cerevisiae: highly ordered, ergosterol-free, and Sphingolipid-enriched lipid rafts
  1825. A plasma-membrane E-MAP reveals links of the eisosome with Sphingolipid metabolism and endosomal trafficking
  1826. Toxoplasma gondii salvages Sphingolipids from the host Golgi through the rerouting of selected Rab vesicles to the parasitophorous vacuole
  1827. Effects of a Sphingolipid-enriched dairy formulation on postprandial lipid concentrations
  1828. Sphingolipid modulation: a strategy for cancer therapy
  1829. A lipidomic screen of palmitate-treated MIN6 β-cells links Sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking
  1830. Kdo2-lipid A, a TLR4-specific agonist, induces de novo Sphingolipid biosynthesis in RAW264. 7 macrophages, which is essential for induction of autophagy
  1831. Sphingolipid synthesis is involved in autophagy in Saccharomyces cerevisiae
  1832. Psychosine, the cytotoxic Sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture
  1833. The role of Sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis
  1834. Sphingolipid-Binding Domain in the Serotonin1A Receptor
  1835. Free-radical reactions of glycerolipids and Sphingolipids
  1836. Sphingosine kinase localization in the control of Sphingolipid metabolism
  1837. Inhibition of neutrophil apoptosis via Sphingolipid signaling in acute lung injury
  1838. Cell surface Sphingolipid glycohydrolases in neuronal differentiation and aging in culture
  1839. Regulation of autophagy and its associated cell death by “Sphingolipid rheostat”: reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian …
  1840. The compartmentalization and translocation of the sphingosine kinases: mechanisms and functions in cell signaling and Sphingolipid metabolism
  1841. Retinal Sphingolipids and their very-long-chain fatty acid–containing species
  1842. Sphingolipids and metabolic disease
  1843. PLP‐dependent enzymes as entry and exit gates of Sphingolipid metabolism
  1844. Chlamydia trachomatis Intercepts Golgi-Derived Sphingolipids through a Rab14-Mediated Transport Required for Bacterial Development and Replication
  1845. Inclusion Biogenesis and Reactivation of Persistent Chlamydia trachomatis Requires Host Cell Sphingolipid Biosynthesis
  1846. Host–virus shift of the Sphingolipid pathway along an Emiliania huxleyi bloom: survival of the fattest
  1847. A Legionella effector acquired from protozoa is involved in Sphingolipids metabolism and is targeted to the host cell mitochondria
  1848. Remodeling of Sphingolipids by plasma membrane associated enzymes
  1849. Enigmol: A Novel Sphingolipid Analogue with Anticancer Activity against Cancer Cell Lines and In vivo Models for Intestinal and Prostate Cancer
  1850. miRNA-95 mediates radioresistance in tumors by targeting the Sphingolipid phosphatase SGPP1
  1851. Sphingolipids in human ileostomy content after meals containing milk sphingomyelin
  1852. Antihypertensive treatment differentially affects vascular Sphingolipid biology in spontaneously hypertensive rats
  1853. The Sphingolipid rheostat: a potential target for improving pancreatic islet survival and function
  1854. Sphingolipids: basic science and drug development
  1855. Role of Sphingolipids in murine radiation-induced lung injury: protection by sphingosine 1-phosphate analogs
  1856. Dietary Sphingolipids ameliorate disorders of lipid metabolism in Zucker fatty rats
  1857. Sphingolipids and inflammatory diseases of the skin
  1858. Sphingolipid profiling of human plasma and FPLC-separated lipoprotein fractions by hydrophilic interaction chromatography tandem mass spectrometry
  1859. Arabidopsis Sphingolipid fatty acid 2-hydroxylases (AtFAH1 and AtFAH2) are functionally differentiated in fatty acid 2-hydroxylation and stress responses
  1860. Amelioration of hyperoxia-induced lung injury using a Sphingolipid-based intervention
  1861. Methylation of glycosylated Sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans
  1862. Specific Sphingolipid content decrease in Cerkl knockdown mouse retinas
  1863. Rapid quantitative analysis of Sphingolipids in seafood using HPLC with evaporative light-scattering detection: its application in tissue distribution of Sphingolipids in …
  1864. Sphingolipids and antimicrobial peptides: function and roles in atopic dermatitis
  1865. Modulation of Sphingolipid metabolism by the phosphatidylinositol-4-phosphate phosphatase Sac1p through regulation of phosphatidylinositol in …
  1866. Perturbation of Sphingolipid metabolism induces endoplasmic reticulum stress‐mediated mitochondrial apoptosis in budding yeast
  1867. Integration of lipidomics and transcriptomics data towards a systems biology model of Sphingolipid metabolism
  1868. Defective CFTR increases synthesis and mass of Sphingolipids that modulate membrane composition and lipid signaling
  1869. Runx regulation of Sphingolipid metabolism and survival signaling
  1870. Mass and relative elution time profiling: two-dimensional analysis of Sphingolipids in Alzheimer’s disease brains
  1871. Analysis of Sphingolipids in extracted human plasma using liquid chromatography electrospray ionization tandem mass spectrometry
  1872. Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on Sphingolipid metabolism in rat skeletal muscle
  1873. The lipid alterations in the stratum corneum of dogs with atopic dermatitis are alleviated by topical application of a Sphingolipid‐containing emulsion
  1874. Sphingolipids and brain resident macrophages in neuroinflammation: an emerging aspect of nervous system pathology
  1875. The roles of bioactive Sphingolipids in resveratrol-induced apoptosis in HL60 acute myeloid leukemia cells
  1876. Sphingolipids and ceramides in human aqueous humor
  1877. S1P lyase regulates DNA damage responses through a novel Sphingolipid feedback mechanism
  1878. An “Exacerbate-reverse” Strategy in Yeast Identifies Histone Deacetylase Inhibition as a Correction for Cholesterol and Sphingolipid Transport Defects in …
  1879. Total Synthesis of the Sphingolipid Biosynthesis Inhibitor Fumonisin B1
  1880. A new mechanism for photo-and radiation-induced decomposition of Sphingolipids
  1881. Signaling and regulatory functions of bioactive Sphingolipids as therapeutic targets in multiple sclerosis
  1882. Sphingolipid abnormalities in psychiatric disorders: a missing link in pathology?
  1883. A novel pathway of photoinduced decomposition of Sphingolipids
  1884. Evaluation of Sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin
  1885. Sphingolipids in cardiovascular and cerebrovascular systems: pathological implications and potential therapeutic targets
  1886. The Sphingolipid psychosine inhibits fast axonal transport in Krabbe disease by activation of GSK3β and deregulation of molecular motors
  1887. Sphingolipid-based drugs selectively kill cancer cells by down-regulating nutrient transporter proteins
  1888. Coordination of rapid Sphingolipid responses to heat stress in yeast
  1889. The twists and turns of Sphingolipid pathway in glucose regulation
  1890. Myriocin, a serine palmitoyltransferase inhibitor, suppresses tumor growth in a murine melanoma model by inhibiting de novo Sphingolipid synthesis
  1891. Role of Sphingolipids in digestive system
  1892. Interruption of inositol Sphingolipid synthesis triggers Stt4p-dependent protein kinase C signaling
  1893. Sphingolipids mediate formation of mRNA processing bodies during the heat-stress response of Saccharomyces cerevisiae
  1894. Gene expression profiling identifies ARSD as a new marker of disease progression and the Sphingolipid metabolism as a potential novel metabolism in chronic …
  1895. Sphingolipid signaling in yeast: potential implications for understanding disease
  1896. Thermotropic behavior and lateral distribution of very long chain Sphingolipids
  1897. Sphingolipid rheostat alterations related to transformation can be exploited for specific induction of lysosomal cell death in murine and human glioma
  1898. Inhibition of Sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and …
  1899. Effects of long-term fish oil-enriched diet on the Sphingolipid metabolism in brain of old rats
  1900. New Sphingolipids and Other Constituents of Pancovia laurentii
  1901. Cancer and Sphingolipid storage disease therapy using novel synthetic analogs of Sphingolipids
  1902. Oncogenic K-Ras regulates bioactive Sphingolipids in a sphingosine kinase 1-dependent manner
  1903. … and saposin B deficiency (activator‐deficient metachromatic leukodystrophy): report on two patients detected by analysis of urinary Sphingolipids and carrying novel …
  1904. Reproductive and Sphingolipid Metabolic Effects of Fumonisin B1 and its Alkaline Hydrolysis Product in LM/Bc Mice: Hydrolyzed Fumonisin B1 Did Not Cause …
  1905. Inhibition of Sphingolipid metabolism enhances resveratrol chemotherapy in human gastric cancer cells
  1906. Stored platelets alter glycerophospholipid and Sphingolipid species, which are differentially transferred to newly released extracellular vesicles
  1907. Endotoxin activates de novo Sphingolipid biosynthesis via nuclear factor kappa B-mediated upregulation of Sptlc2
  1908. The Sphingolipid degradation product trans-2-hexadecenal forms adducts with DNA
  1909. Myristate-derived d16: 0 Sphingolipids constitute a cardiac Sphingolipid pool with distinct synthetic routes and functional properties
  1910. Skin ceramide alterations in first-episode schizophrenia indicate abnormal Sphingolipid metabolism
  1911. Sphingolipid metabolites modulate dielectric characteristics of cells in a mouse ovarian cancer progression model
  1912. Sphingolipids cyclic derivatives: Occurrence, biological relevance and synthetic approaches
  1913. Sphingolipid depletion impairs endocytic traffic and inhibits Wingless signaling
  1914. Sphingolipid C-9 Methyltransferases Are Important for Growth and Virulence but Not for Sensitivity to Antifungal Plant Defensins in Fusarium graminearum
  1915. Sphingosine-1-phosphate: the Swiss army knife of Sphingolipid signaling
  1916. Host Sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication
  1917. Myocardial infarction changes Sphingolipid metabolism in the uninfarcted ventricular wall of the rat
  1918. Mannosylinositol phosphorylceramide is a major Sphingolipid component and is required for proper localization of plasma-membrane proteins in …
  1919. Sphingolipid signaling in fungal pathogens
  1920. Induction of cell wall thickening by the antifungal compound dihydromaltophilin disrupts fungal growth and is mediated by Sphingolipid biosynthesis
  1921. Ceramide Sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons
  1922. Role of Sphingolipids in the cytoplasmic signaling of estrogens
  1923. Endocytosis and Sphingolipid Scavenging in Leishmania mexicana Amastigotes
  1924. Involvement of the Sphingolipid ceramide in heat-shock-induced apoptosis of bovine oocytes
  1925. The Trypanosoma brucei Sphingolipid synthase, an essential enzyme and drug target
  1926. Targeting Sphingolipid metabolism in head and neck cancer: rational therapeutic potentials
  1927. Sphingolipid synthesis and scavenging in the intracellular apicomplexan parasite, Toxoplasma gondii
  1928. Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction
  1929. Triacylglycerol lipolysis is linked to Sphingolipid and phospholipid metabolism of the yeast Saccharomyces cerevisiae
  1930. … marrow-derived mesenchymal stem cells prevent the loss of Niemann-Pick type C mouse Purkinje neurons by correcting Sphingolipid metabolism and increasing …
  1931. Sphingolipids and glycoSphingolipids—their synthesis and bioactivities
  1932. Identification of Sphingolipid Metabolites That Induce Obesity via Misregulation of Appetite, Caloric Intake and Fat Storage in Drosophila
  1933. Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond
  1934. Rapid nanoscale quantitative analysis of plant Sphingolipid long-chain bases by GC-MS
  1935. Unperverted synthesis of complex Sphingolipids is essential for cell survival under nitrogen starvation
  1936. Sphingolipid metabolism and atherosclerosis
  1937. Disturbance in cerebral spinal fluid Sphingolipid content is associated with memory impairment in subjects infected with the human immunodeficiency virus
  1938. Cell-free synthesis and functional characterization of Sphingolipid synthases from parasitic trypanosomatid protozoa
  1939. Viral trans-dominant manipulation of algal Sphingolipids
  1940. Orally administered sphingomyelin in bovine milk is incorporated into skin Sphingolipids and is involved in the water-holding capacity of hairless mice
  1941. Cholesterol-and Sphingolipid-rich microdomains are essential for microtubule-based membrane protrusions induced by Clostridium difficile transferase (CDT)
  1942. Sphingolipids: the oil on the TRAFire that promotes inflammation
  1943. Keeping Sphingolipid levels nORMal
  1944. Sphingolipids as new biomarkers for assessment of delayed-type hypersensitivity and response to triptolide
  1945. SERCA2-controlled Ca2+-dependent keratinocyte adhesion and differentiation is mediated via the Sphingolipid pathway: a therapeutic target for Darier’s …
  1946. Impact of sphingomyelin synthase 1 deficiency on Sphingolipid metabolism and atherosclerosis in mice
  1947. … time of flight atmospheric pressure chemical ionization mass spectrometry for separation, detection and mass spectrometric profiling of neutral Sphingolipids and …
  1948. Localized Sphingolipid signaling at presynaptic terminals is regulated by calcium influx and promotes recruitment of priming factors
  1949. Dose-dependent effect of aspirin on the level of Sphingolipids in human blood
  1950. Serine palmitoyltransferase, the first step enzyme in Sphingolipid biosynthesis, is involved in nonhost resistance
  1951. Adaptation of neuronal cells to chronic oxidative stress is associated with altered cholesterol and Sphingolipid homeostasis and lysosomal function
  1952. Factors to consider in using [UC] palmitate for analysis of Sphingolipid biosynthesis by tandem mass spectrometry [S]
  1953. Bioactive Sphingolipid metabolites modulate ovarian cancer cell structural mechanics
  1954. Plasma membrane proteins Slm1 and Slm2 mediate activation of the AGC kinase Ypk1 by TORC2 and Sphingolipids in S. cerevisiae
  1955. Current relevance of fungal and trypanosomatid glycolipids and Sphingolipids: studies defining structures conspicuously absent in mammals
  1956. Dietary glucosylceramide is absorbed into the lymph and increases levels of epidermal Sphingolipids
  1957. Developmentally Regulated Sphingolipid Degradation in Leishmania major
  1958. A method for visualization of “omic” datasets for Sphingolipid metabolism to predict potentially interesting differences [S]
  1959. Stress-induced Sphingolipid signaling: role of type-2 neutral sphingomyelinase in murine cell apoptosis and proliferation
  1960. Modulation of the activity of cytosolic phospholipase A2α (cPLA2α) by cellular Sphingolipids and inhibition of cPLA2α by sphingomyelin [S]
  1961. Beyond LDL-C lowering: distinct molecular Sphingolipids are good indicators of proprotein convertase subtilisin/kexin type 9 (PCSK9) deficiency
  1962. Sphingolipids in lipid microdomains and obesity
  1963. Altering the Sphingolipid acyl chain composition prevents LPS/GLN-mediated hepatic failure in mice by disrupting TNFR1 internalization
  1964. Association of single nucleotide polymorphisms in the endothelial differentiation Sphingolipid G‐protein‐coupled receptor 1 gene with marbling in Japanese Black …
  1965. Fatty acid 2-Hydroxylation in mammalian Sphingolipid biology
  1966. Sphingolipid modulation of angiogenic factor expression in neuroblastoma
  1967. Metabolic depletion of Sphingolipids enhances the mobility of the human serotonin1A receptor
  1968. Characterization of secretory sphingomyelinase activity, lipoprotein Sphingolipid content and LDL aggregation in ldlr−/− mice fed on a high-fat diet
  1969. Natural products as platforms for the design of Sphingolipid-related anticancer agents
  1970. Iron, glucose and intrinsic factors alter Sphingolipid composition as yeast cells enter stationary phase
  1971. Disorders of Sphingolipid metabolism and neuronal ceroid-lipofuscinoses
  1972. Direct interaction between the inhibitor 2 and ceramide via Sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and …
  1973. The potential role of Sphingolipid-mediated cell signaling in the interaction between hyperglycemia, acute myocardial infarction and heart failure
  1974. Sphingolipid metabolism and drug resistance in hematological malignancies
  1975. 7-ketocholesterol incorporation into Sphingolipid/cholesterol-enriched (lipid raft) domains is impaired by vitamin E: A specific role for α-tocopherol with …
  1976. Large-scaled human serum Sphingolipid profiling by using reversed-phase liquid chromatography coupled with dynamic multiple reaction monitoring of mass …
  1977. Structure elucidation and chemical profile of Sphingolipids in wheat bran and their cytotoxic effects against human colon cancer cells
  1978. Sphingolipid degradation by Leishmania major is required for its resistance to acidic pH in the mammalian host
  1979. Mrp1 is essential for Sphingolipid signaling to p-glycoprotein in mouse blood–brain and blood–spinal cord barriers
  1980. Dihydroceramide desaturase knockdown impacts Sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells
  1981. Separation of fluorescently labeled phosphoinositides and Sphingolipids by capillary electrophoresis
  1982. Detection and quantification of plant Sphingolipids by LC-MS
  1983. Characteristics of the rat cardiac Sphingolipid pool in two mitochondrial subpopulations
  1984. Characterization of inositol phospho-Sphingolipid-phospholipase C 1 (Isc1) in Cryptococcus neoformans reveals unique biochemical features
  1985. Two New Sphingolipids from the Leaves of Piper betle L.
  1986. There is more to a lipid than just being a fat: Sphingolipid-guided differentiation of oligodendroglial lineage from embryonic stem cells
  1987. Structure and function of sphingosine-1-phosphate lyase, a key enzyme of Sphingolipid metabolism
  1988. A new, long-wavelength borondipyrromethene sphingosine for studying Sphingolipid dynamics in live cells [S]
  1989. Relationships between calcium and Sphingolipid-dependent signalling pathways during the early steps of plant–pathogen interactions
  1990. Inhibition of neutral sphingomyelinase‐2 perturbs brain Sphingolipid balance and spatial memory in mice
  1991. Absolute Configuration of the α,ω-Bifunctionalized Sphingolipid Leucettamol A from Leucetta microrhaphis by Deconvoluted Exciton Coupled CD
  1992. Requirement of a specific group of Sphingolipid‐metabolizing enzyme for growth of yeast Saccharomyces cerevisiae under impaired metabolism of …
  1993. … immunity in trafficking of hematopoietic stem cells—an emerging link between activation of complement cascade and chemotactic gradients of bioactive Sphingolipids
  1994. The synthetic amphipathic peptidomimetic LTX109 is a potent fungicide that disturbs plasma membrane integrity in a Sphingolipid dependent manner
  1995. Identification of a Sphingolipid‐specific phospholipase D activity associated with the generation of phytoceramide‐1‐phosphate in cabbage leaves
  1996. Evaluation of bioactive Sphingolipids in 4-HPR-resistant leukemia cells
  1997. Sphingolipid biosynthesis is required for polar growth in the dimorphic phytopathogen Ustilago maydis
  1998. FTY720 inhibits tumor growth and enhances the tumor‐suppressive effect of topotecan in neuroblastoma by interfering with the Sphingolipid signaling pathway
  1999. Does cytokine signaling link Sphingolipid metabolism to host defense and immunity against virus infections?
  2000. Imaging MALDI mass spectrometry of Sphingolipids using an oscillating capillary nebulizer matrix application system
  2001. Inactivation of ceramide synthase 6 in mice results in an altered Sphingolipid metabolism and behavioral abnormalities
  2002. Disruption of Sphingolipid biosynthesis in Nicotiana benthamiana activates salicylic acid-dependent responses and compromises resistance to Alternaria alternata f …
  2003. Marine Two-Headed Sphingolipid-Like Compound Rhizochalin Inhibits EGF-Induced Transformation of JB6 P+ Cl41 Cells
  2004. Age-Dependent Changes in the Sphingolipid Composition of Mouse CD4+ T Cell Membranes and Immune Synapses Implicate Glucosylceramides in Age …
  2005. The Sphingolipid biosynthetic pathway is a potential target for chemotherapy against Chagas disease
  2006. Sphingolipids as determinants of apoptosis and chemoresistance in the MCF-7 cell model system
  2007. Involvement of complex Sphingolipids and phosphatidylserine in endosomal trafficking in yeast Saccharomyces cerevisiae
  2008. Combining chemical genomics screens in yeast to reveal spectrum of effects of chemical inhibition of Sphingolipid biosynthesis
  2009. Transcription factor Ctip2 controls epidermal lipid metabolism and regulates expression of genes involved in Sphingolipid biosynthesis during skin …
  2010. A Genome-Wide Enhancer Screen Implicates Sphingolipid Composition in Vacuolar ATPase Function in Saccharomyces cerevisiae
  2011. Involvement of Sphingolipids in ethanol neurotoxicity in the developing brain
  2012. The therapeutic potential of nanoscale Sphingolipid technologies
  2013. The yeast oxysterol binding protein Kes1 maintains Sphingolipid levels
  2014. Human glycolipid transfer protein gene (GLTP) expression is regulated by Sp1 and Sp3: involvement of the bioactive Sphingolipid ceramide
  2015. Study of Sphingolipids oxidation by ESI tandem MS
  2016. Alterations of myelin‐specific proteins and Sphingolipids characterize the brains of acid sphingomyelinase‐deficient mice, an animal model of Niemann–Pick disease …
  2017. Vitamin E prevents the age-dependent and palmitate-induced disturbances of Sphingolipid turnover in liver cells
  2018. Animal source food intake and association with blood cholesterol, glycerophospholipids and Sphingolipids in a northern Swedish population
  2019. IKK NBD peptide inhibits LPS induced pulmonary inflammation and alters Sphingolipid metabolism in a murine model
  2020. Hereditary Sensory Neuropathy Type 1 Is Caused by the Accumulation of Two Neurotoxic Sphingolipids*♦
  2021. Preeclampsia-associated alterations in Sphingolipid composition of the umbilical cord artery
  2022. Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing Sphingolipid signaling at the outer plasma membrane
  2023. A mutation in the saposin C domain of the Sphingolipid activator protein (Prosaposin) gene causes neurodegenerative disease in mice
  2024. Comparative effects of fumonisins on Sphingolipid metabolism and toxicity in ducks and turkeys
  2025. Changes of Sphingolipids profiles after ischemia-reperfusion injury in the rat liver
  2026. … quantification of glucosylceramide and galactosylceramide by normal-phase HPLC using O-phtalaldehyde derivatives prepared with Sphingolipid ceramide N …
  2027. Characterization of Sphingolipids from sunflower seeds with altered fatty acid composition
  2028. Sphingolipid‐mediated restoration of Mitf expression and repigmentation in vivo in a mouse model of hair graying
  2029. Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific Sphingolipid production and permeability barrier formation
  2030. The selective COX-2 inhibitor celecoxib modulates Sphingolipid synthesis s⃞
  2031. A matter of fat: interaction between nitric oxide and Sphingolipid signaling in plant cold response
  2032. Sphingolipids, Sphingolipidoses and Allied Disorders: Proceedings of the Symposium on Sphingolipidoses and Allied Disorders Held in Brooklyn, New York …
  2033. Multiplex analysis of Sphingolipids using amine-reactive tags (iTRAQ)
  2034. Arabidopsis 56–Amino Acid Serine Palmitoyltransferase-Interacting Proteins Stimulate Sphingolipid Synthesis, Are Essential, and Affect Mycotoxin Sensitivity
  2035. Suppl 1: Sphingolipid Regulation of Tissue Fibrosis
  2036. 14-3-3-regulated Ca2+-dependent protein kinase CPK3 is required for Sphingolipid-induced cell death in Arabidopsis
  2037. The Equilibria of Sphingolipid-Cholesterol and Sphingolipid–Sphingolipid in Monolayers at the Air–Water Interface
  2038. Antibacterial Sphingolipid and steroids from the black coral Antipathes dichotoma
  2039. Lack of nitric oxide synthases increases lipoprotein immune complex deposition in the aorta and elevates plasma Sphingolipid levels in lupus
  2040. Disruption of Sphingolipid biosynthetic gene IPT1 reduces Candida albicans adhesion and prevents activation of human gingival epithelial cell innate immune …
  2041. Sphingolipid analogues inhibit development of malaria parasites
  2042. Methods of staining and visualization of Sphingolipid enriched and non-enriched plasma membrane regions of Arabidopsis thaliana with fluorescent dyes and …
  2043. Bioactive Sphingolipids in docetaxel-induced apoptosis in human prostate cancer cells
  2044. Evaluation of the role of secretory sphingomyelinase and bioactive Sphingolipids as biomarkers in hemophagocytic lymphohistiocytosis
  2045. Nfasc155H and MAG are specifically susceptible to detergent extraction in the absence of the myelin Sphingolipid sulfatide
  2046. Sphingolipid Degradation in Leishmania (Leishmania) amazonensis
  2047. Sphingolipid storage impairs autophagic clearance of Alzheimer-associated proteins
  2048. Roles of bioactive Sphingolipid metabolites in ovarian cancer cell biomechanics
  2049. The regulatory mechanism of melanogenesis by FTY720, a Sphingolipid analogue
  2050. Differential induction of apoptosis of leukemic cells by rhizochalin, two headed Sphingolipids from sponge and its derivatives
  2051. Glycomics meets lipidomics—associations of N-glycans with classical lipids, glycerophospholipids, and Sphingolipids in three European populations
  2052. Myocardium of type 2 diabetic and obese patients is characterized by alterations in Sphingolipid metabolic enzymes but not by accumulation of ceramide [S]
  2053. Sphingolipid activator protein B deficiency: report of 9 Saudi patients and review of the literature
  2054. A combined fluorescence spectroscopy, confocal and 2-photon microscopy approach to re-evaluate the properties of Sphingolipid domains
  2055. Nitric oxide and Sphingolipids control apoptosis and autophagy with a significant impact on Alzheimer’s disease.
  2056. Formal synthesis of fumonisin B1, a potent Sphingolipid biosynthesis inhibitor
  2057. Biochemical studies on Sphingolipids of Artemia franciscana: complex neutral glycoSphingolipids
  2058. Acid ceramidase (AC)—a key enzyme of Sphingolipid metabolism—correlates with better prognosis in epithelial ovarian cancer
  2059. Insights into Sphingolipid miscibility: separate observation of sphingomyelin and ceramide N-acyl chain melting
  2060. Evidence that Sphingolipid signaling is involved in responding to low temperature
  2061. Neurosporaside, a Tetraglycosylated Sphingolipid from Neurospora crassa
  2062. Unraveling the roles of Sphingolipids in plant innate immunity
  2063. Hydroxylation state of fatty acid and long-chain base moieties of Sphingolipid determine the sensitivity to growth inhibition due to AUR1 repression in Saccharomyces …
  2064. Arabidopsis 3-ketoacyl-coenzyme a synthase9 is involved in the synthesis of tetracosanoic acids as precursors of cuticular waxes, suberins, Sphingolipids, and …
  2065. Spiraeamide, new Sphingolipid from Spiraea brahuica
  2066. Lipoxygenase inhibitory Sphingolipids from Launaea nudicaulis
  2067. Drug target identification in Sphingolipid metabolism by computational systems biology tools: metabolic control analysis and metabolic pathway analysis
  2068. Isorhizochalin: a Minor Unprecedented Bipolar Sphingolipid of Stereodivergent Biogenesis from the Rhizochalina incrustata
  2069. Knockdown of core binding factorβ alters Sphingolipid metabolism
  2070. … after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for Sphingolipids as biomarkers of …
  2071. Lead genetic studies in Dictyostelium discoideum and translational studies in human cells demonstrate that Sphingolipids are key regulators of sensitivity to cisplatin …
  2072. Sphingolipid metabolism and leukemia: a potential for novel therapeutic approaches
  2073. Bioactive Sphingolipids in response to chemotherapy: A scope on leukemias
  2074. Nitric oxide-Sphingolipid interplays in plant signalling: a new enigma from the Sphinx?
  2075. Searching for the role of membrane Sphingolipids in selectivity of antitumor ether lipid–edelfosine
  2076. Role for the SRC family kinase Fyn in Sphingolipid acquisition by chlamydiae
  2077. Complex modulation of peptidolytic activity of cathepsin D by Sphingolipids
  2078. The effect of high-fat diet on the Sphingolipid pathway of signal transduction in regenerating rat liver
  2079. Extrusion cooking with glucose supplementation of fumonisin‐contaminated corn grits protects against nephrotoxicity and disrupted Sphingolipid metabolism in rats
  2080. Analysis of Sphingolipid and prostaglandin synthesis during zymosan-induced inflammation
  2081. Cellular Morphogenesis Under Stress Is Influenced by the Sphingolipid Pathway Gene ISC1 and DNA Integrity Checkpoint Genes in Saccharomyces cerevisiae
  2082. Improving intracellular doxorubicin delivery through nanoliposomes equipped with selective tumor cell membrane permeabilizing short-chain Sphingolipids
  2083. Reciprocal Relationship Between Cytosolic NADH and ENOX2 Inhibition Triggers Sphingolipid‐Induced Apoptosis in HeLa Cells
  2084. Altered Sphingolipid composition in Wharton’s jelly of pre-eclamptic newborns
  2085. A flexible approach to construct three contiguous chiral centers of Sphingolipids, and asymmetric synthesis of d-ribo-phytosphingosine and its derivatives
  2086. Sphingolipids‘ role in radiotherapy for prostate cancer
  2087. Sphingolipids: a potential molecular approach to treat allergic inflammation
  2088. Suppression of breast xenograft growth and progression in nude mice: implications for the use of orally administered Sphingolipids as chemopreventive agents …
  2089. Alterations in the composition of membrane glycero-and Sphingolipids in the course of Flammulina velutipes surface culture development
  2090. Plant Sphingolipid fatty acid 2-hydroxylases have unique characters unlike their animal and fungus counterparts
  2091. Evaluation of synthetic Sphingolipid analogs as ligands for peroxisome proliferator-activated receptors
  2092. Effects of Sphingolipid synthesis inhibition on cholesterol gallstone formation in C57BL/6J mice
  2093. Inhibitors of enzymes of phospholipid and Sphingolipid metabolism
  2094. Bioactive Sphingolipids and complement cascade as new emerging regulators of stem cell mobilization and homing
  2095. The yeast magmas ortholog pam16 has an essential function in fermentative growth that involves Sphingolipid metabolism
  2096. Sphingosine 1-phosphate (S1P) lyase deficiency increases Sphingolipid formation via recycling at the expense of de novo biosynthesis in neurons
  2097. Sphingolipids and the orchestration of endothelium-derived vasoactive factors: when endothelial function demands greasing
  2098. Sphingolipids and their medical impact
  2099. Yeast cells lacking all known ceramide synthases continue to make complex Sphingolipids and to incorporate ceramides into glycosylphosphatidylinositol …
  2100. The influences of Sphingolipid metabolites on gentamicin-induced hair cell loss of the rat cochlea
  2101. Asymmetric synthesis of ceramide Sphingolipid based on (2S, 3S, 4S)-3, 4-dihydroxy-5-(hydroxymethyl) pyrrolidine lactam
  2102. The role of Sphingolipids in drug metabolism and transport
  2103. Activation of PPARα by bezafibrate negatively affects de novo synthesis of Sphingolipids in regenerating rat liver
  2104. Membrane lipids, where they are and how they behave: Sphingolipids on the move
  2105. Quantitation of Multiple Sphingolipid Classes Using Normal and Reversed‐Phase LC–ESI–MS/MS: Comparative Profiling of Two Cell Lines
  2106. Membrane microdomain Sphingolipids are required for anti-CD20-induced death of chronic lymphocytic leukemia B cells
  2107. Combining anticancer agents photodynamic therapy and LCL85 leads to distinct changes in the Sphingolipid profile, autophagy, caspase-3 activation in the absence …
  2108. Binding of sterols affects membrane functioning and Sphingolipid composition in wheat roots
  2109. Ceramide and Related-Sphingolipid Levels Are Not Altered in Disease-Associated Brain Regions of APPSL and APPSL/PS1M146L Mouse Models of …
  2110. Novel drugs targeting Sphingolipid metabolism
  2111. Ophiamides AB, new potent urease inhibitory Sphingolipids from Heliotropium ophioglossum
  2112. Genetic disorders of simple Sphingolipid metabolism
  2113. Isolation and functional characterisation of the genes encoding Δ8-Sphingolipid desaturase from Brassica rapa
  2114. New Sphingolipid psychotramide A–D from the stem of Psychotria sp.
  2115. Synthesis of the Sphingolipid activator protein, saposin C, using an azido-protected O-acyl isopeptide as an aggregation-disrupting element
  2116. Sphingolipids regulate [Mg2+] o uptake and [Mg2+] i content in vascular smooth muscle cells: potential mechanisms and importance to membrane transport of Mg2+
  2117. The Sphingolipids from the spleen of a case of lipidosis
  2118. TORC2 and Sphingolipid biosynthesis and signaling: lessons from budding yeast
  2119. Tandem mass spectrometry of Sphingolipids: application in metabolic studies and diagnosis of inherited disorders of Sphingolipid metabolism
  2120. Semisynthesis of C17: 0 isoforms of sulphatide and glucosylceramide using immobilised Sphingolipid ceramide N‐deacylase for application in analytical mass …
  2121. Alternate raft pathways cooperate to mediate slow diffusion and efficient uptake of a Sphingolipid tracer to degradative and recycling compartments
  2122. Mild testicular hyperthermia transiently increases lipid droplet accumulation and modifies Sphingolipid and glycerophospholipid acyl chains in the rat testis
  2123. Fluorescence correlation methods for imaging cellular behavior of Sphingolipid-interacting probes
  2124. The gut-to-breast connection-interdependence of sterols and Sphingolipids in multidrug resistance and breast cancer therapy
  2125. Activation of H+-ATPase of the Plasma Membrane of Saccharomyces cerevisiae by Glucose: The Role of Sphingolipid and Lateral Enzyme Mobility
  2126. Effect of expression of genes in the Sphingolipid synthesis pathway on the biosynthesis of ceramide in Saccharomyces cerevisiae
  2127. Newly identified essential amino acid residues affecting Δ8-Sphingolipid desaturase activity revealed by site-directed mutagenesis
  2128. Extensive Sphingolipid depletion does not affect lipid raft integrity or lipid raft localization and efflux function of the ABC transporter MRP1
  2129. Relevance of Sphingolipids in the pleiotropic protective effects of high-density lipoproteins
  2130. Quantification of sphingosine-1-phosphate and related Sphingolipids by liquid chromatography coupled to tandem mass spectrometry
  2131. Arabidopsis 3-hydroxy-3-methylglutaryl-CoA reductase is regulated at the post-translational level in response to alterations of the Sphingolipid and the sterol …
  2132. Anti‐ageing effects of a new synthetic Sphingolipid (K6EAA‐L12) on aged murine skin
  2133. Biological activity of ceramides and other Sphingolipids
  2134. Fiber specific changes in Sphingolipid metabolism in skeletal muscles of hyperthyroid rats
  2135. Sphingolipids of human umbilical cord vein and their alteration in preeclampsia
  2136. Sphingolipid Trafficking and Purification in Chlamydia trachomatis–Infected Cells
  2137. Structure and mechanism of calmodulin binding to a signaling Sphingolipid reveal new aspects of lipid-protein interactions
  2138. A phase I dose-escalating study of ES-285, a marine Sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors
  2139. Saccharomyces cerevisiae Na+/H+ Antiporter Nha1p Associates with Lipid Rafts and Requires Sphingolipid for Stable Localization to the Plasma Membrane
  2140. A novel role for Sphingolipid metabolism in oxidant-mediated skeletal muscle fatigue. Focus on “Sphingomyelinase stimulates oxidant signaling to weaken …
  2141. Pharmacogenetics of resistance to Cisplatin and other anticancer drugs and the role of Sphingolipid metabolism
  2142. Biochemical studies on Sphingolipids of Artemia franciscana: novel neutral glycoSphingolipids [S]
  2143. Sphingolipid metabolism and signaling as a target for cancer treatment
  2144. Mutual recognition of Sphingolipid molecular species in membranes
  2145. The effect of phloretin on Sphingolipid-containing membranes modified by syringomycin E
  2146. Sphingolipid Turnover in the Hippocampus and Cognitive Dysfunction in Alcoholized Rats: Correction with the Help of Alimentary n-3 Fatty Acids
  2147. Bioactive Sphingolipids in neuroblastoma
  2148. Long N-acyl fatty acids on Sphingolipids are responsible for miscibility with phospholipids to form liquid-ordered phase
  2149. Effects of Mycoplasma pneumoniae infection on Sphingolipid metabolism in human lung carcinoma A549 cells
  2150. Peroxisome proliferator‐activated receptor gamma‐coactivator‐1 alpha coordinates Sphingolipid metabolism, lipid raft composition and myelin protein synthesis
  2151. Identification of plant Sphingolipid desaturases using chromatography and mass spectrometry
  2152. Cholesterol regulation of rab-mediated Sphingolipid endocytosis
  2153. Alteration of Sphingolipid metabolism and pSTAT3 expression by dietary cholesterol in the gallbladder of hamsters
  2154. Highly Regioselective Oxirane Ring‐Opening of a Versatile Epoxypyrrolidine Precursor of New Imino‐Sugar‐Based Sphingolipid Mimics
  2155. The role of Sphingolipids in cancer development and therapy
  2156. Characterization of bifunctional Sphingolipid Δ4-desaturases/C4-hydroxylases of trypanosomatids by liquid chromatography–electrospray tandem mass spectrometry
  2157. Entamoeba invadens: Sphingolipids metabolic regulation is the main component of a PKC signaling pathway in controlling cell growth and proliferation
  2158. … in the trans-2-enoyl-CoA reductase TER gene involved in fatty acid elongation impairs the enzyme activity and stability, leading to change in Sphingolipid …
  2159. Sphingolipid signaling in plants
  2160. 3-Deoxy-3, 4-dehydro analogs of XM462. Preparation and activity on Sphingolipid metabolism and cell fate
  2161. Correction of age-related disorders of Sphingolipid content in rat tissues by acid sphingomyelinase inhibition
  2162. Structure, metabolic pathway and function of Sphingolipids in plants
  2163. Identification of a cytochrome b5-fusion desaturase responsible for the synthesis of triunsaturated Sphingolipid long chain bases in the marine diatom Thalassiosira …
  2164. Synthesis of Sphingolipids with an ω-esterified long acyl chain, ceramide components of the human epidermis
  2165. Targeting the Sphingolipid signaling pathway in stroke
  2166. Aberrant Sphingolipid metabolism in the human fallopian tube with ectopic pregnancy
  2167. Anticancer therapeutic self-aggregates of Sphingolipid metabolite-grafted poly (amino acid)-derivative and their enhanced intracellular delivery
  2168. Effect of HFE variants on Sphingolipid expression by SH-SY5Y human neuroblastoma cells
  2169. The weak rate of Sphingolipid biosynthesis shown by basal keratinocytes isolated from aged vs. young donors is fully rejuvenated after treatment with peptides of a …
  2170. Regulation by Sphingolipids of the fate of FRTL-5 cells
  2171. Biochemical methods for quantifying Sphingolipids: ceramide, sphingosine, sphingosine kinase-1 activity, and sphingosine-1-phosphate
  2172. Sphingolipid base modifying enzymes in sunflower (Helianthus annuus): cloning and characterization of a C4-hydroxylase gene and a new paralogous Δ8 …
  2173. Regulation of phosphatidic acid metabolism by Sphingolipids in the central nervous system
  2174. Alteration of fatty acid molecular species in ceramide and glucosylceramide under heat stress and expression of Sphingolipid-related genes
  2175. Biosynthesis of 2‐Hydroxy and iso‐Even Fatty Acids is Connected to Sphingolipid Formation in Myxobacteria
  2176. Assessment of crosstalks between the Snf1 kinase complex and Sphingolipid metabolism in S. cerevisiae via systems biology approaches
  2177. Biochemical Studies on Sphingolipid of Artemia franciscana (I) Isolation and Characterization of Sphingomyelin
  2178. Evaluating Sphingolipid biochemistry in the consensus reconstruction of yeast metabolism
  2179. Conformational Studies on the Δ8(E,Z)-Sphingolipid Desaturase from Helianthus annuus with Chiral Fluoropalmitic Acids As Mechanistic Probes
  2180. Sphingolipids, possible biomarkers for atherosclerotic disorders
  2181. The Sphingolipid‐rich rafts of ALK+ lymphomas downregulate the Lyn‐Cbp/PAG signalosome
  2182. Polar lipid derangements in type 2 diabetes mellitus: potential pathological relevance of fatty acyl heterogeneity in Sphingolipids
  2183. Synthesis and Evaluation of Sphingolipid Analogues: Modification of the Hydroxy Group at C (1) of 7‐Oxasphingosine, and of the Hydroxy Group at C (1) and the …
  2184. Depressing Sphingolipids
  2185. Regulation of β‐catenin and connexin‐43 expression: Targets for Sphingolipids in colon cancer prevention
  2186. Editorial [hot topic: therapeutic targeting of the Sphingolipid “biostat” in hematologic malignancies (guest editors: Thomas p. Loughran and Hong-gang wang)]
  2187. Sphingolipids of the murine hair
  2188. Ceramides: Branched alkyl chains in the Sphingolipid siblings of diacylglycerol improve biological potency
  2189. Isolation and structure determination of the biologically active Sphingolipids from marine sponge Haliclona species
  2190. Rottlerin-Mediated Inhibition of Chlamydia trachomatis Growth and Uptake of Sphingolipids Is Independent of p38-Regulated/Activated Protein Kinase …
  2191. Terpene alcohols inhibit de novo Sphingolipid biosynthesis
  2192. Regulation of deoxy-Sphingolipids and their role in disease
  2193. The role of Sphingolipids in modulating pluripotency of stem cells
  2194. Altering Sphingolipid Metabolism in Saccharomyces cerevisiae Cells Lacking the Amphiphysin Ortholog Rvs161 Reinitiates Sugar Transporter Endocytosis
  2195. Cellular pathogenesis in Sphingolipid storage disorders: the quest for new therapeutic approaches
  2196. Amino Acid Determinants of Substrate Selectivity in the Trypanosoma brucei Sphingolipid Synthase Family
  2197. New Sphingolipids from Abutilon pakistanicum
  2198. Gene expression profile of MAP kinase PTC1 mutant exposed to Aflatoxin B1: Dysfunctions of gene expression in glucose utilization and Sphingolipid metabolism
  2199. Effects of fat-enriched diet on the content of Sphingolipids in the brain and on cognitive functions in old rats
  2200. Pharmacological modulators of Sphingolipid metabolism for the treatment of cystic fibrosis lung inflammation
  2201. Digestion and absorption of Sphingolipids as functional food components
  2202. Effect of Di-(2-ethylhexyl)-phthalate on Sphingolipid metabolic enzymes in rat liver
  2203. Sphingolipids as signaling molecules: their involvement in health and disease.
  2204. Drug sensitivity and Sphingolipid metabolism in CLL
  2205. Synthesis of Enantiopure Fluorinated Ceramides; Analogues of Natural Sphingolipids
  2206. Synaptobrevin, Sphingolipids, and secretion: lube ‘n’go at the synapse
  2207. Atypical Sphingolipids as biomarkers and therapeutic targets in cardio-metabolic diseases
  2208. Stimulation of GLUT4 (glucose transporter isoform 4) storage vesicle formation by Sphingolipid depletion
  2209. Detection and semi-quantitative analysis of Sphingolipids contained in shochu distillery waste.
  2210. Mild acid hydrolysis of Sphingolipids yields lysoSphingolipids: a matrix-assisted laser desorption and ionization time-of-flight mass spectrometry study
  2211. N-cholesteryl sphingomyelin—A synthetic Sphingolipid with unique membrane properties
  2212. Hyperphosphorylation of tau by GSK-3β in Alzheimer’s disease: The interaction of Aβ and Sphingolipid mediators as a therapeutic target
  2213. Stoichiometric network reconstruction and analysis of yeast Sphingolipid metabolism incorporating different states of hydroxylation
  2214. Novel 3-hydroxy vinylboronates influence Sphingolipid metabolism, cause apoptosis in Jurkat cells and prevent tumor development in nude mice
  2215. New 4,4-difluoro-3a,4a-diaza-s-indacene (BODIPY)-labeled Sphingolipids for membrane studies
  2216. New Sphingolipid probes for metabolism and trafficking studies
  2217. Lipidomic analysis of Sphingolipids (and precursor fatty acyl-CoA’s)
  2218. Sphingolipid signaling in retinal cell death
  2219. 6 Chemistry, Tissue and Cellular Distribution, and Developmental Profiles of Neural Sphingolipids
  2220. MRP-and BCL-2-mediated drug resistance in human SCLC: effects of apoptotic Sphingolipids in vitro
  2221. Use of Fluorescent Sphingolipid Precursors for Biophysical Studies of Sphingolipids
  2222. Nutrition and metabolism-Sphingolipids and branched chain amino acids: indicators and effectors of adipose tissue function and diabetes risk
  2223. Sphingolipid topology and membrane protein nanoclusters
  2224. Sphingolipid content in the human uterus and pair-matched uterine leiomyomas remains constant
  2225. Role of mature Sphingolipids in yeast: new tools
  2226. Sphingolipid metabolism in trans-golgi/endosomal membranes and the regulation of intracellular homeostatic processes in eukaryotic cells
  2227. Synthesis of self‐assembled Sphingolipid conjugates and their morphology effect on anticancer therapeutic potency
  2228. Interplay Among Glycerophospholipid, Sphingolipid, and Cholesterol-Derived Lipid Mediators in Brain: A Matter of Life and Death
  2229. COUP-TF-interacting protein-2 (Ctip2): driving the coupé of Sphingolipid biosynthesis in the epidermis
  2230. Role of Sphingolipid Metabolites in Metabolic Disease
  2231. Sphingolipids as a Novel Target For The Treatment Of Multiple Myeloma
  2232. Alteration in the Sphingolipid metabolism leads to activation of the apoptotic cascade in the MPTP induced mouse model of Parkinson’s disease
  2233. Bioactive Sphingolipids as mediators of ocular inflammation: observations in an animal model
  2234. Sphingolipid-Inherited Diseases of the Central Nervous System
  2235. Natural C18: 0-ceramide induces cellular Sphingolipid accumulation and apoptosis
  2236. The dietary effect of royal jelly supplementation for the pre and post-menopaused period on Sphingolipid contents and the related enzyme expression in the epidermis …
  2237. Changes in Sphingolipid metabolism in the Vitreous from Diabetic Patients
  2238. Obesity-associated steatotic liver exhibits aberrant or altered Sphingolipid composition and preferentially accumulates ceramide species containing long chain …
  2239. Sphingolipids in Toxoplasma gondii; synthesis and scavenging
  2240. Application of liquid chromatography tandem mass spectrometry for the separation and quantitative analysis of Sphingolipids
  2241. Identification of Sphingolipids as novel noninvasive biomarkers of liver damage caused by chronic hepatitis B
  2242. Contribution of Phospholipid, Sphingolipids, and Cholesterol‐Derived Lipid Mediators in the Pathogenesis of Metabolic Syndrome and Neurological Disorders
  2243. Identifying enzymes involved in Sphingolipid biosynthesis in the environmentally useful bacterium Sphingomonas wittichii
  2244. Study of serine palmitoyltransferase and de novo synthesis of Sphingolipids
  2245. Computational prediction of protein-protein interactions in Sphingolipid signaling network
  2246. Role of CFTR and Sphingolipids in hypoxic pulmonary vasoconstriction
  2247. ESSENTIAL HYPERTENSION IS ASSOCIATED WITH ALTERED Sphingolipid BIOLOGY WHICH CAN BE NORMALISED BY ANTI-HYPERTENSIVE TREATMENT …
  2248. Translational metabolomics and genomics for Chronic Obstructive Pulmonary Disease (COPD): discovering a promising role for Sphingolipids
  2249. Interactions between caveolin-1 and Sphingolipids, and their functional relevance
  2250. New lipoxygenase inhibitory Sphingolipids from Chrozophora plicata
  2251. Characterization of Phosphoinositide and Sphingolipid Domain Formation in Model Membranes
  2252. 15 Bioactive Sphingolipids: An Overview on Ceramide, Ceramide 1-Phosphate Dihydroceramide, Sphingosine, Sphingosine 1-Phosphate
  2253. CBF regulates cell senescence and autophagy through Sphingolipid metabolism.
  2254. Effect of glucosyl Sphingolipids derived from rice on human skin condition
  2255. … 2+, Mg2+-dependent DNase Involvement in Apoptotic Effects in Spermatozoa of Sea Urchin Strongylocentrotus intermedius Induced by Two-Headed Sphingolipid …
  2256. Sphingolipid involvement in the cigarette-smoke-induced endothelial barrier dysfunction
  2257. Sphingolipid signaling in mammalian photoreceptor cells
  2258. Age‐dependent changes in the Sphingolipid composition of CD4+ T cell membranes and immune synapses: impact on T cell proliferation
  2259. Defining the role of reactive oxygen species, nitric oxide, and Sphingolipid signaling in tumor necrosis factor-induced skeletal muscle weakness
  2260. Metabolic labeling of yeast Sphingolipids with radioactive D-erythro-[4, 5-3H] dihydrosphingosine
  2261. The role of Sphingolipids in gliomagenesis/submitted by Sabine Damm
  2262. Emerging Technology-Sphingolipid and its Application
  2263. Serum Sphingolipids level as a novel potential indicator for early detection of cardiac ischemia
  2264. Ceramide and related-Sphingolipid levels are not altered in disease-associated brain regions of [APP. sup. SL] and [APP. sup. SL]/[PS1. sup. M146L] mouse models of …
  2265. Mouse Models with Gene Deletions of Enzymes and Cofactors Involved in Sphingolipid Synthesis and Degradation
  2266. Kainic Acid-Mediated Neural Cell Death in Brain: Interplay Among Glycero-phospholipid-, Sphingolipid-, and Cholesterol-Derived Lipid Mediators
  2267. … using liquid chromatography-electrospray ionization-tandem mass spectrometry and its application to stable isotope-labeling and quantitation of Sphingolipid …
  2268. Effect of milk Sphingolipids on human health.
  2269. Bioactive Sphingolipid Metabolites Are Novel Markers Of Vascular Dysfunction In Sickle Cell Disease
  2270. of the Sphingolipid Club held in Leiden, The Netherlands, 14.-16.11. 2008
  2271. Warfarin‐induced vitamin K deficiency is associated with alterations in Sphingolipid status in rats
  2272. Sphingolipids and plant defense/disease: the” death” connection and beyond
  2273. Studies on the Chemostructural and Functional Properties of Sphingolipids as Food Components
  2274. Investigation of the relationship between Sphingolipid and insulin signaling pathways
  2275. Exploring the roles of Sphingolipid metabolites on breast cancer
  2276. Correction of age-related changes in Sphingolipid content in rat tissues by acid sphingomyelinase inhibition
  2277. An MBoC Favorite: Functional interactions between Sphingolipids and sterols in biological membranes regulating cell physiology
  2278. Investigating Sphingolipid Metabolism in Glioblastoma
  2279. Application of bioinformatics in studies of Sphingolipid biosynthesis
  2280. Genetic Disorders of Simple Sphingolipid Metabolism
  2281. Antiviral Activity of Bioactive Sphingolipids
  2282. Genetic Determinants of Circulating Sphingolipid Concentrations in European
  2283. Sphingolipid imbalance can take out an eye
  2284. Sphingolipids Containing Very-Long-Chain Fatty Acids Define a Secretory Pathway for Specific
  2285. Role of Sphingolipids and oxidative stress in the antineoplasic activity of 4-hpr: study in a leukemia model
  2286. The potential of Sphingolipid depletion for the treatment of atherosclerosis
  2287. The Dynamic Role of Sphingolipids and their Regulatory Enzymes in Preeclampsia
  2288. Sphingolipids in the Pathobiology of Acute Lung Injury
  2289. Sphingolipids in intestine and liver: How to analyze?
  2290. Analysis of Sphingolipid-signaling at the plasma membrane of Saccharomyces cerevisiae
  2291. Evaluation of bioactive Sphingolipids in 4-HPR-resistant leukemia cells
  2292. Sphingolipid Metabolism: A Novel Link Between Obesity and Cardiomyopathy
  2293. Tumor PDT-associated immune response: relevance of Sphingolipids
  2294. Sphingolipid synthases of toxoplasma gondii and other organisms
  2295. Short-chain Sphingolipids for enhanced cellular uptake of liposome-encapsulated amphiphilic anti-cancer drugs
  2296. Developing new ceramide analogs and identifying novel Sphingolipid
  2297. Orm2 protein level regulates Sphingolipid synthesis in response to environmental stress in yeast
  2298. Perspective and Directions for Future Developments on Glycerophospholipid-, Sphingolipid-, and Cholesterol-Derived Lipid Mediators
  2299. Plasma membrane associated enzymes for Sphingolipid structural changes and neuronal development
  2300. Do Sphingolipids Control Viral Membrane Protein Activity?
  2301. Lipidomics of Influenza Virus: Implications of Host Cell Choline-and Sphingolipid Metabolism
  2302. Sphingolipids Lower the Death Threshold
  2303. Membrane Remodeling and Sphingolipid Metabolism in Endocytosis
  2304. Possible roles of Sphingolipids in clathrin-mediated endocytosis-Vesicle formation by a glycerophospholipid cycle-a hypothesis
  2305. Alteration of Sphingolipid biostat in experimental model of oxidative stress evoked by 1-methyl-4-phenylpyridinium (MPPplus)
  2306. Sphingolipid Synthases of Toxoplasma gondii and other organisms
  2307. Sphingolipids and the orchestration of endothelium-derived vasoactive factors
  2308. Sphingolipid Asymmetry and Transmembrane Translocation in Mammalian Cells
  2309. A Novel Mechanism of Nilotinib-Induced Apoptosis; Sphingolipids.
  2310. Host Sphingolipids and fungal infection.
  2311. A modular approach to Sphingolipid analogs mediated by aziridines: Synthesis and biological studies
  2312. Novel lipidomic approaches to analyse glycerophospholipids and Sphingolipids in complex mixtures using mass spectrometry
  2313. Participation of de novo Sphingolipid biosynthesis in the regulation of autophagy in response to diverse agents
  2314. The role of Sphingolipid metabolism in diabetes-induced retinal VEGF secretion
  2315. The protein kinase Sch9 is a key regulator of Sphingolipid metabolism in Saccharomyces cerevisiae. Erwin Swinnena, Tobias Wilmsa, Jolanta Idkowiak-Baldysd, Bart …
  2316. Characterization of Glycerophospholipids and a Sphingolipid in the Cerebrospinal Fluid of Patients with Different Illnesses by LC-ESI-MS
  2317. Bioorganic chemistry of Sphingolipids: Pore formation and anion transport
  2318. Prognostic value of cell Sphingolipid profile and plasma membrane sialidase Neu3 expression in melanoma
  2319. The Role of Neutral Sphingolipids in the Pathogenesis of Parkinson Disease and Dementia with Lewy Bodies
  2320. Role of Sphingolipid signaling in pathogenesis of large granular lymphocyte leukemia
  2321. Altering Sphingolipid Metabolism in
  2322. Apoptosis and Necrosis in Brain: Contribution of Glycerophospholipid, Sphingolipid, and Cholesterol-Derived Lipid Mediators
  2323. Characterization of Influenza: Streptococcus pneumoniae synergistic disease and potential for disease alleviation via Sphingolipid therapy
  2324. Sphingolipid biosynthesis, metabolism and actions in placental trophoblast differentiation
  2325. Regulation of ceramide and its metabolites: Biosynthesis & in situ Sphingolipid analysis
  2326. Utilization of Pathway Modeling to Predict Changes in Sphingolipid Content During Granulocytic Differentiation of Retinoic Acid-induced HL60 cells
  2327. Sphingolipids Modulate the Inflammatory and Functional Response in mdx Mice
  2328. Increasing Chemosensitivity of Chronic Myeloid Leukemia Cells to Dasatinib by Targeting Bioactive Sphingolipids
  2329. Effect of fumonisins on Sphingolipid metabolism in duck and turkey.
  2330. Age‐dependent changes in the Sphingolipid composition of CD4+ T cell membranes and immune synapses
  2331. Targeting Sphingolipid Metabolism in Natural Killer Cell Large Granular Lymphocyte Leukemia
  2332. Nitric oxide and Sphingolipids as modulators of apoptosis and autophagy: functional implications in neurodegenerative chronic brain disorders
  2333. Transport of GPI‐Anchored Proteins: Connections to Sphingolipid and Sterol Transport
  2334. Fenofibrate but not Niacin Lowers Atypical Sphingolipids in Plasma of Dyslipidemic Patients
  2335. Insights into the Modulation of Ceramide Metabolism by Naturally Occurring and Synthetic Sphingolipid Analogs as Monitored by Electrospray Tandem Mass …
  2336. Sphingolipid regulation by sphingosine kinase anchoring protein (SKAP) and its implication in cancer
  2337. Elevated acid sphingomyelinase activity and concentration variations of serum Sphingolipid metabolites as putative biomarkers in chronic hepatitis C virus infection …
  2338. Improving the anti-AML efficacy of liposomal ceramide by targeting Sphingolipid metabolism.
  2339. Effects of Sphingolipids on intestinal functions and intracellular oxidative stress in CACO2-BBE and CACO2-BBE/HT29-MTX co-cultured cells
  2340. Sphingolipid METABOLISM’S ALTERATIONS CORRELATED WITH TUMOR CELL INVASIVITY AND FENRETINIDE RESISTANCE IN A HUMAN OVARIAN …
  2341. Role of Cystic Fibrosis Transmembrane Conductance Regulator and Sphingolipids in Hypoxic Pulmonary Vasoconstriction
  2342. Bioactive Sphingolipids Mediate Apoptosis and Senescence in Human Pancreatic Cancer Cells
  2343. Sphingolipid-INDUCED ACTIVATION OF THE VOLUME-SENSITIVE Cl− CURRENT IS MEDIATED BY MITOCHONDRIAL REACTIVE OXYGEN SPECIES
  2344. Inhibition Of Sphingolipid De Novo Biosynthesis Ameliorates Radiation-Induced Lung Inflammation And Fibrosis
  2345. Comparative Effects of Fumonisins on Sphingolipids Metabolism and Toxicity in Ducks and Turkeys
  2346. The Role Of Sphingolipid Metabolism In Disruption Of Circadian VEGF Production By Retinal Cells Under Hyperglycemic And Pro-inflammatory Conditions
  2347. Ceramide in beta cells apoptosis induced by gluco-lipotoxicity: possible role of cer flow for the biosynthesis of complex Sphingolipids
  2348. Reduced migration and enhanced killing of glioblastoma multiforme by mefloquine via alteration of Sphingolipid levels
  2349. The role of core binding factor in cancer cell survival, gene expression and Sphingolipid metabolism; implications for treatment of ovarian and androgen …
  2350. Inkt Cell Proliferation To Food-derived Sphingolipids In Food Allergic Vs Non-food Allergic Children
  2351. Contribution of the Adenine Nucleotide Carrier, Porin, and Sphingolipid Metabolism to Mitochondria Membrane Permeabilization in Saccharomyces cerevisiae
  2352. Ceramide-mediated regulation of cell polarity in primitive ectoderm cells: A novel role for Sphingolipids in morphogenesis
  2353. Sterol Affinity for GlycoSphingolipid Containing Bilayer Membranes-effect of Sphingolipid Structure
  2354. Normalization of Fatty Acid Elongase ELOVL4 In Diabetic Retina Prevents Vascular Degeneration and Inflammation Through Modification of Sphingolipid Metabolism
  2355. Sphingolipid-Enriched Microdomains in the Plasma Membrane of Saccharomyces Cerevisiae: Ergosterol-Free «Lipid Rafts» in the Gel Phase
  2356. Sphingolipids for Ubiquitination
  2357. Influence of ionizing radiation and antitumor drug etoposid on Sphingolipid amount and acid Zn2+-dependent sphingomyelinase activity in the blood serum of …
  2358. Modulation of Sphingolipid Metabolism in Human Cardiac Microvascular Endothelial Cells by Long‐Chain Bipolar Natural Sphingolipids
  2359. A Highlights from MBoC Selection: Orm protein phosphoregulation mediates transient Sphingolipid biosynthesis response to heat stress via the Pkh-Ypk and …
  2360. Altered Expression of Genes and microRNA Modulators of Sphingolipid Metabolism and Gdf1/Nodal Signaling in Fumonisin and FTY720-treated Exencephalic …
  2361. Extensive Sphingolipid depletion does not affect lipid raft integrity or lipid raft localization and efflux function of the ABC transporter MRP1
  2362. Sphingolipid α‐Hydroxylase (Scs7p)
  2363. Ca, Mg-dependent DNase Involvement in Apoptotic Effects in Spermatozoa of Sea Urchin Strongylocentrotus intermedius Induced by Two-Headed Sphingolipid …
  2364. Control of the Sphingolipid rheostat by the protein kinase Sch9 in Saccharomyces cerevisiae
  2365. Characterization of diffusion behavior of a novel extra-cellular Sphingolipid associated peptide probe by fluorescence correlation spectroscopy and imaging …
  2366. A Plasma Membrane E-MAP Reveals Links Between the Eisosome, Sphingolipid Metabolism and Endosomal Trafficking
  2367. Cytosolic NADH as an intracellular modulator of Sphingolipid-mediated apoptosis by inhibitors of a cell-surface tumor-associated NADH oxidase
  2368. 13′‐Carboxychromanol, a long‐chain metabolite of delta‐tocopherol, has potent anti‐cancer effects by interrupting de novo Sphingolipid synthesis in human cancer …
  2369. Circulatory and Intragraft Sphingolipid Profiles after Liver Transplantation.: Abstract# P-364
  2370. Sphingolipid cofactors
  2371. Bioactive Sphingolipids in inflammation and cancer
  2372. 1438 THE CANCER DRUG ENIGMOL ALTERS Sphingolipid METABOLISM AND REDUCES MACROPHAGE PRESENCE IN PROSTATE TUMORS
  2373. Sphingolipids as a novel target for the treatment of multiple myeloma.
  2374. The Ireland-Claisen rearrangement of 3-alkoxypropenol amino esters as an entry to Sphingolipid amino acid natural products
  2375. Sphingolipids and Retinal Degeneration
  2376. 2607-Plat Affinity of a Sphingolipid Binding Domain Peptide to GlycoSphingolipid Receptors
  2377. Vitamin E forms and 13′-carboxychromanol, a long-chain metabolite of α-tocopherol, induce cell death by interrupting de novo Sphingolipid synthesis in human …
  2378. Metabolites of Sphingolipids as targets for cancer therapy
  2379. Sphingolipid biosynthesis and inflammatory signaling in asthma
  2380. Role of Sphingolipids in fibrinogen‐induced cerebrovascular permeability
  2381. Transport and trafficking of fluorescent sphingosine, Sphingolipids, and their metabolites
  2382. Mechanisms of non‐random Sphingolipid organization in the plasma membranes of fibroblast cells
  2383. Effect of the Sphingolipid synthesis inhibitor, myriocin, in a murine pulmonary inflammation model (94.19)
  2384. The involvement of Sphingolipids in apoptosis induced by acetic acid in yeast
  2385. Effect of a Sphingolipid Enriched Diet on Serum Lipid Profile and Cholesterol Metabolism in humans
  2386. Abstract P222: Signaling Sphingolipids in Regulation of Cardiomyocyte Ischemia/Reperfusion-Induced Injury
  2387. Downregulation of the autophagy protein ATG-7 correlates with distinct Sphingolipid profile in MCF-7 cells sensitized to photodamage
  2388. Studies of interactions of Sphingolipid-interacting peptides and liposomes with surface plasmon resonance.
  2389. 2009 MBoC PAPER OF THE YEAR Functional Interactions between Sphingolipids and Sterols in Biological Membranes Regulating Cell Physiology
  2390. Sphingolipid metabolism modulates motor neuron degeneration in Drosophila
  2391. 6. METHOD DEVELOPMENT FOR Sphingolipid AND PHOSPHOLIPID PROFILING USING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY AND …
  2392. Correlation of acid ceramidase (AC), a key enzyme of the Sphingolipid metabolism, with prognosis in epithelial ovarian cancer.
  2393. 12 Sphingolipids in Airway
  2394. Sphingolipid metabolism as a therapeutic target in chemotherapy resistant and hormone therapy resistant breast cancer
  2395. Role Of Sphingolipid Signaling In Sepsis Mediated Acute Lung Injury
  2396. Targeting the Sphingolipid pathway in NK large granular lymphocyte leukemia
  2397. Development of a High-Resolution Growth Assay for Yeast Functional Genomics and Identification of Orm Family Proteins as Key Mediators of Sphingolipid …
  2398. Regulation of CaV1. 2 Channels by Sphingolipids and Cholesterol. Specific Role of the Gamma Subunit
  2399. Kinetic modeling of the yeast Sphingolipid metabolism identifies prevalent mutant strains through integration of lipidomic data profiles
  2400. Sphingolipids signal rapid loss of P‐glycoprotein transport activity at the blood‐brain barrier
  2401. The role of Sphingolipid metabolism genes in the response of Saccharomyces cerevisiae cells to starvation for essential nutrients.
  2402. Dietary Fat Composition Modifies Cell Sphingolipid Biosynthesis to Mediate the consequences of obesity.
  2403. Investigating an unusual bacterial acyl carrier protein: a direct link between fatty acid and Sphingolipid biosynthesis?
  2404. Time‐dependent changes in long range Sphingolipid organization revealed by high‐resolution secondary ion mass spectrometry
  2405. REGULATION OF PLASMA MEMBRANE‐LOCALIZED STRESS RESPONSE SIGNALING BY INOSITOL‐CONTAINING Sphingolipids
  2406. Expression of muscular and renal ganglioside GM3 and its Sphingolipid precursors in rat models of diabetes type 1 and 2
  2407. Alteration of Sphingolipid metabolism during 4‐HPR induced cell death in the ARPE‐19 human retinal pigment epithelial cell line
  2408. E012 Smooth muscle cell proliferation elicited by hydrogen peroxide involves the metalloprotease/Sphingolipid pathway
  2409. Chemical Imaging of Cholesterol and Sphingolipid Distribution in the Plasma Membranes of Fibroblast Cells
  2410. Effect of inhibitor of Sphingolipid synthesis on Leishmania (Viannia) braziliensis cytokinesis
  2411. Sphingolipid puts the squeeze on apoptotic cells
  2412. Amelioration of hyperoxia-induced lung injury in newborn mice using a Sphingolipid-based intervention
  2413. Mass spectrometry methods for the analysis of bioactive Sphingolipids: A high-performance liquid chromatography/tandem mass spectrometry approach
  2414. Participation of de novo Sphingolipid biosynthesis in the regulation of autophagy in Kdo2‐Lipid A stimulated RAW264.7 macrophages
  2415. Role Of Sphingolipids In Murine Lung Development: Relevance To Bronchopulmonary Dysplasia
  2416. Deficiency in Sphingolipids Has No Effect on Self-antigen Presentation to Invariant NKT Cells (134.17)
  2417. Critical Role Of Sphingolipid Pathway Components In Murine Radiation-Induced Lung Injury: Protection By Sphingosine 1 Phosphate Analogues
  2418. Sphingolipid Ratios in Marine Mammal Skeletal Muscle Cell Membranes: Protection from Oxidative Stress?
  2419. Combination photodynamic therapy+ Sphingolipid analog LCL85 leads to autophagy, defective apoptosis and long‐term sensitization
  2420. Mechanistic investigation of cell death and Sphingolipid alteration induced by vitamin E forms in human colon cancer cells
  2421. Vitamin E forms induce apoptosis, necrosis, and autophagy and caused accumulation of Sphingolipid intermediates in human colon cancer cells
  2422. Designing and testing fluorescent Sphingolipid-interacting peptides as probes of cell membrane organization.
  2423. The low intestinal and hepatic toxicity of hydrolyzed fumonisin B1 correlateswith its inability to alter the metabolism of Sphingolipids
  2424. Optically invisible properties of membrane organization are revealed by TIRF‐FCS on Sphingolipid‐interacting probes
  2425. Co-administration of the short-chain Sphingolipid N-octanoyl-glucosylceramide improves doxorubicin therapy by enhancing intracellular drug accumulation in vivo
  2426. Combining chemical genomics screens in yeast to reveal spectrum of effects of chemical inhibition of Sphingolipid biosynthesis
  2427. Sphingolipid metabolism in Xenopus laevis oocyte maturation and apoptotic death
  2428. Modulation of Sphingolipids, cholesterol and saturated fatty acids interact with the neurodegeneration in the Drosophila blue cheese mutant.
  2429. Myristate‐derived d16: 0‐Sphingolipids constitute an abundant cardiac Sphingolipid pool with distinct synthetic routes and functional properties
  2430. Abstract LB-165: The role of Sphingolipid metabolism in the treatment of acute myeloid leukemia
  2431. Intracellular carriers based on poly (amino acid)-derivatives and their application as anticancer drug and Sphingolipid carriers
  2432. Sphingolipid Dependent Integration of TNF Receptor Signaling in Endothelial Cell Lipid Microdomains.
  2433. Apoptosis sensitization of hepatocytes by acyl-CoA synthetase 5 involves deregulation of Sphingolipid metabolism and alterations in mitochondrial signalling
  2434. Influence of ionizing radiation and antitumor drug etoposide on Sphingolipid amount and acid Zn {sup 2+}-dependent sphingomyelinase activity in the blood serum of …
  2435. Acyl-CoA synthetase 5 induces apoptosis sensitisation in human hepatocytes by channelling Acyl-CoAs into Sphingolipid metabolism
  2436. New mechanisms of radiation-induced transformations of Sphingolipids
  2437. Orm protein phosphoregulation mediates transient Sphingolipid biosynthesis response to heat stress via the Pkh-Ypk and Cdc55-PP2A pathways
  2438. Effect of omega 3 fatty acids in Jurkat cell intracellular signaling and the involvement of Sphingolipids
  2439. Abstract# 23: Regulation of\# 946;-catenin transcriptional activity by exogenous Sphingolipids
  2440. [OM4-3]: Deficiency in Sphingolipid de novo synthesis impairs cell polarity
  2441. Sphingolipid metabolites in inflammatory disease
  2442. Sphingolipids in cardiovascular diseases and metabolic disorders
  2443. Plant Sphingolipids: Their importance in cellular organization and adaption
  2444. Ceramidases, roles in Sphingolipid metabolism and in health and disease
  2445. Sphingolipids in mitochondria
  2446. Revisiting the Sphingolipid rheostat: Evolving concepts in cancer therapy
  2447. Sphingolipids and lipoproteins in health and metabolic disorders
  2448. Sphingolipids in colon cancer
  2449. Sphingolipid metabolism and interorganellar transport: localization of Sphingolipid enzymes and lipid transfer proteins
  2450. Sphingolipids in viral infection
  2451. The role of Sphingolipid metabolism in cutaneous permeabilitybarrier formation
  2452. Sphingolipid homeostasis in the web of metabolic routes
  2453. Sphingolipids and lifespan regulation
  2454. Sphingolipid lysosomal storage disorders
  2455. Relevance of dietary glycerophospholipids and Sphingolipids to human health
  2456. Sphingolipids and mitochondrial apoptosis
  2457. Sphingolipids and glycerophospholipids–the “ying and yang” of lipotoxicity in metabolic diseases
  2458. High levels of Sphingolipids in human breast cancer
  2459. Dietary and endogenous Sphingolipid metabolism in chronic inflammation
  2460. Ceramide: a simple Sphingolipid with unique biophysical properties
  2461. The role of epidermal Sphingolipids in dermatologic diseases
  2462. Plant Sphingolipid metabolism and function
  2463. Sphingolipid organization in the plasma membrane and the mechanisms that influence it
  2464. Sphingolipids and lysosomal pathologies
  2465. Sphingolipids contribute to human atherosclerotic plaque inflammation
  2466. Sphingolipids and phospholipids in insulin resistance and related metabolic disorders
  2467. Sphingolipids in high fat diet and obesity-related diseases
  2468. Sphingolipids: important players in multiple sclerosis
  2469. Glycerophospholipid and Sphingolipid species and mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
  2470. Autophagy in the light of Sphingolipid metabolism
  2471. Plasma Sphingolipids associated with chronic obstructive pulmonary disease phenotypes
  2472. Sphingolipids in obesity and related complications
  2473. Sphingolipids as targets for treatment of fungal infections
  2474. Sphingolipids: membrane microdomains in brain development, function and neurological diseases
  2475. Role of Sphingolipids in the pathobiology of lung inflammation
  2476. Fostering inflammatory bowel disease: Sphingolipid strategies to join forces
  2477. The yeast Sphingolipid signaling landscape
  2478. Sphingolipids in human synovial fluid-a lipidomic study
  2479. Eudicot plant-specific Sphingolipids determine host selectivity of microbial NLP cytolysins
  2480. Serum Sphingolipids: relationships to insulin sensitivity and changes with exercise in humans
  2481. Evolving concepts in cancer therapy through targeting Sphingolipid metabolism
  2482. Taming the sphinx: Mechanisms of cellular Sphingolipid homeostasis
  2483. The role of Sphingolipid signalling in diabetes‑associated pathologies
  2484. Revisiting plant plasma membrane lipids in tobacco: a focus on Sphingolipids
  2485. Identification of a new class of antifungals targeting the synthesis of fungal Sphingolipids
  2486. A Sphingolipid mechanism for behavioral extinction
  2487. Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance
  2488. Sphingolipids in pulmonary fibrosis
  2489. Sphingolipids in the DNA damage response
  2490. Application of stable isotopes to investigate the metabolism of fatty acids, glycerophospholipid and Sphingolipid species
  2491. Sphingolipid metabolism and its role in the skeletal tissues
  2492. Muscle Sphingolipids during rest and exercise: a C18: 0 signature for insulin resistance in humans
  2493. The Sphingolipid receptor S1PR2 is a receptor for Nogo-a repressing synaptic plasticity
  2494. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells
  2495. Role of Sphingolipids and metabolizing enzymes in hematological malignancies
  2496. Role of Sphingolipids in infant gut health and immunity
  2497. The expanding role of Sphingolipids in lipid droplet biogenesis
  2498. On ceramides, other Sphingolipids and impaired glucose homeostasis
  2499. Tamoxifen regulation of Sphingolipid metabolism—therapeutic implications
  2500. The protein kinase Sch9 is a key regulator of Sphingolipid metabolism in Saccharomyces cerevisiae
  2501. Untargeted lipidomic analysis in chronic obstructive pulmonary disease. Uncovering Sphingolipids
  2502. Dysregulated Sphingolipid metabolism in endometriosis
  2503. Making sense of the yeast Sphingolipid pathway
  2504. The GARP complex is required for cellular Sphingolipid homeostasis
  2505. The role of Sphingolipids in arachidonic acid metabolism
  2506. Sphingolipids: Promising lipid-class molecules with potential applications for industry. A review
  2507. Sphingolipids, ORMDL3 and asthma: what is the evidence?
  2508. Serum Sphingolipid variations associate with hepatic decompensation and survival in patients with cirrhosis
  2509. Podocyte pathology and nephropathy–Sphingolipids in glomerular diseases
  2510. Re-configuration of Sphingolipid metabolism by oncogenic transformation
  2511. Computational modeling of Sphingolipid metabolism
  2512. Sphingolipids as a new factor in the pathomechanism of preeclampsia–mass spectrometry analysis
  2513. Aneuploid cell survival relies upon Sphingolipid homeostasis
  2514. Sphingolipids in the function of G protein-coupled receptors
  2515. Critical role of the Sphingolipid pathway in stroke: a review of current utility and potential therapeutic targets
  2516. The role of Sphingolipids in endothelial barrier function
  2517. Cholesterol, Sphingolipids, and glycolipids: what do we know about their role in raft-like membranes?
  2518. Biophysical properties of sphingosine, ceramides and other simple Sphingolipids
  2519. Regulation of PP2A by Sphingolipid metabolism and signaling
  2520. Sphingolipid de novo biosynthesis: a rheostat of cardiovascular homeostasis
  2521. A Sphingolipid-dependent diffusion barrier confines ER stress to the yeast mother cell
  2522. Levels of blood organophosphorus flame retardants and association with changes in human Sphingolipid homeostasis
  2523. Sphingolipid metabolism regulates development and lifespan in Caenorhabditis elegans
  2524. Sphingolipids in lung growth and repair
  2525. CFTR and Sphingolipids mediate hypoxic pulmonary vasoconstriction
  2526. Translational aspects of Sphingolipid metabolism in renal disorders
  2527. Exploring the role of Sphingolipid machinery during the epithelial to mesenchymal transition program using an integrative approach
  2528. Sepsis-associated encephalopathy: the blood–brain barrier and the Sphingolipid rheostat
  2529. Establishment of HeLa cell mutants deficient in Sphingolipid-related genes using TALENs
  2530. Sphingolipids in liver injury, repair and regeneration
  2531. Tackling the biophysical properties of Sphingolipids to decipher their biological roles
  2532. Sphingolipids in spinal cord injury
  2533. Autophagy regulates Sphingolipid levels in the liver [S]
  2534. The yeast model system as a tool towards the understanding of apoptosis regulation by Sphingolipids
  2535. Dietary Sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease
  2536. The pleiotropic roles of Sphingolipid signaling in autophagy
  2537. Unraveling the role of the Target of Rapamycin signaling in Sphingolipid metabolism
  2538. Analysis of glycerophospho‐and Sphingolipids by CE
  2539. Hemagglutinin clusters in the plasma membrane are not enriched with cholesterol and Sphingolipids
  2540. Identification of novel Sphingolipid-binding motifs in mammalian membrane proteins
  2541. Serine-dependent Sphingolipid synthesis is a metabolic liability of aneuploid cells
  2542. Biological effects of naturally occurring Sphingolipids, uncommon variants, and their analogs
  2543. Bifunctional sphingosine for cell-based analysis of protein-Sphingolipid interactions
  2544. Sphingolipids are dual specific drug targets for the management of pulmonary infections: perspective
  2545. Autophagic flux and autophagosome morphogenesis require the participation of Sphingolipids
  2546. Sphingolipids as modulators of membrane proteins
  2547. Sphingolipids as cell fate regulators in lung development and disease
  2548. Targeting Sphingolipid metabolism in the treatment of obesity/type 2 diabetes
  2549. Role of Sphingolipids in oestrogen signalling in breast cancer cells: an update
  2550. Sphingolipids in major depression
  2551. A comprehensive high-resolution targeted workflow for the deep profiling of Sphingolipids
  2552. Sphingolipid-enriched extracellular vesicles and Alzheimer’s disease: a decade of research
  2553. Legionella pneumophila S1P-lyase targets host Sphingolipid metabolism and restrains autophagy
  2554. Detailed structural characterization of Sphingolipids via 193 nm ultraviolet photodissociation and ultra high resolution tandem mass spectrometry
  2555. The composition of West Nile virus lipid envelope unveils a role of Sphingolipid metabolism in flavivirus biogenesis
  2556. TORC2-dependent protein kinase Ypk1 phosphorylates ceramide synthase to stimulate synthesis of complex Sphingolipids
  2557. Paradoxical antidepressant effects of alcohol are related to acid sphingomyelinase and its control of Sphingolipid homeostasis
  2558. Comprehensive identification of Sphingolipid species by in silico retention time and tandem mass spectral library
  2559. Modulation of neuroinflammation in the central nervous system: role of chemokines and Sphingolipids
  2560. Nogo-B regulates endothelial Sphingolipid homeostasis to control vascular function and blood pressure
  2561. Serum profiling of healthy aging identifies phospho-and Sphingolipid species as markers of human longevity
  2562. From molecules to the clinic: linking schizophrenia and metabolic syndrome through Sphingolipids metabolism
  2563. The effect of altered Sphingolipid acyl chain length on various disease models
  2564. The role of ORMDL proteins, guardians of cellular Sphingolipids, in asthma
  2565. Sphingolipids modulate the function of human serotonin1A receptors: insights from Sphingolipid-deficient cells
  2566. Therapeutic implications of bioactive Sphingolipids: A focus on colorectal cancer
  2567. The role of Sphingolipids in neuronal plasticity of the brain.
  2568. Sphingolipid accumulation causes mitochondrial dysregulation and cell death
  2569. The importance of Sphingolipids and reactive oxygen species in cardiovascular development
  2570. Multiple Sphingolipid abnormalities following cerebral microendothelial hypoxia
  2571. A rapid LC–MS/MS method for quantitative profiling of fatty acids, sterols, glycerolipids, glycerophospholipids and Sphingolipids in grapes
  2572. Deciphering the link between salicylic acid signaling and Sphingolipid metabolism
  2573. Sphingolipids contribute to acetic acid resistance in Zygosaccharomyces bailii
  2574. Disruption of Sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia
  2575. Sphingolipid metabolic flow controls phosphoinositide turnover at the trans‐Golgi network
  2576. De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington’s Disease
  2577. ORMDL/serine palmitoyltransferase stoichiometry determines effects of ORMDL3 expression on Sphingolipid biosynthesis
  2578. Plasma Sphingolipids in acute pancreatitis
  2579. Differential regulation of specific Sphingolipids in colon cancer cells during staurosporine-induced apoptosis
  2580. Plasma phospholipid and Sphingolipid alterations in presenilin1 mutation carriers: A pilot study
  2581. Binding of the Sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation
  2582. Identification of a Sphingolipid α-Glucuronosyltransferase That Is Essential for Pollen Function in Arabidopsis
  2583. Opinion article on lipidomics: Inherent challenges of lipidomic analysis of Sphingolipids
  2584. Airway reactivity and Sphingolipids—implications for childhood asthma
  2585. Sphingolipid regulation of ezrin, radixin, and moesin proteins family: implications for cell dynamics
  2586. Amyotrophic lateral sclerosis and denervation alter Sphingolipids and up-regulate glucosylceramide synthase
  2587. Disruption of Sphingolipid Biosynthesis Blocks Phagocytosis of Candida albicans
  2588. Unravelling the role of Sphingolipids in cystic fibrosis lung disease
  2589. Novel mechanisms of action of classical chemotherapeutic agents on Sphingolipid pathways
  2590. Preclinical development of a C6-ceramide NanoLiposome, a novel Sphingolipid therapeutic
  2591. Human genetic disorders of Sphingolipid biosynthesis
  2592. Trafficking and functions of bioactive Sphingolipids: lessons from cells and model membranes
  2593. Beyond the cherry-red spot: Ocular manifestations of Sphingolipid-mediated neurodegenerative and inflammatory disorders
  2594. Bioactive Sphingolipids in cancer biology and therapy
  2595. Cerebrospinal fluid Sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer’s disease
  2596. Changes in membrane Sphingolipid composition modulate dynamics and adhesion of integrin nanoclusters
  2597. Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?
  2598. Plasma lipidomics reveal profound perturbation of glycerophospholipids, fatty acids, and Sphingolipids in diet-induced hyperlipidemia
  2599. Plasma and ovarian tissue Sphingolipids profiling in patients with advanced ovarian cancer
  2600. Monogenic neurological disorders of Sphingolipid metabolism
  2601. Temporal changes in Sphingolipids and systemic insulin sensitivity during the transition from gestation to lactation
  2602. Plasma Sphingolipids and depressive symptoms in coronary artery disease
  2603. Sphingolipids in inflammation: from bench to bedside
  2604. Potential health benefits of Sphingolipids in milk and dairy products
  2605. Synthesis of Sphingolipids Impacts Survival of Porphyromonas gingivalis and the Presentation of Surface Polysaccharides
  2606. Switching the Sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage
  2607. GIPC: Glycosyl Inositol Phospho Ceramides, the major Sphingolipids on earth
  2608. Sphingolipids as mediators in the crosstalk between microbiota and intestinal cells: implications for inflammatory bowel disease
  2609. De novo Sphingolipid biosynthesis is required for adipocyte survival and metabolic homeostasis
  2610. Anti‐adherence and bactericidal activity of Sphingolipids against Streptococcus mutans
  2611. Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer’s disease
  2612. Free-radical destruction of Sphingolipids resulting in 2-hexadecenal formation
  2613. On-tissue localization of ceramides and other Sphingolipids by MALDI mass spectrometry imaging
  2614. Expression of the ORMDLS, modulators of serine palmitoyltransferase, is regulated by Sphingolipids in mammalian cells
  2615. Efficient replacement of plasma membrane outer leaflet phospholipids and Sphingolipids in cells with exogenous lipids
  2616. Dysregulations in circulating Sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study
  2617. Neuronal Sphingolipidoses: membrane lipids and Sphingolipid activator proteins regulate lysosomal Sphingolipid catabolism
  2618. Sphingolipids in neutrophil function and inflammatory responses: mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis
  2619. Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered Sphingolipid metabolism
  2620. Plasma Sphingolipid changes with autopsy-confirmed Lewy body or Alzheimer’s pathology
  2621. Ethylene Modulates Sphingolipid Synthesis in Arabidopsis
  2622. … plasma metabolomic analyses of atherosclerotic progression reveal alterations in glycerophospholipid and Sphingolipid metabolism in apolipoprotein E …
  2623. Structure and nanomechanics of model membranes by atomic force microscopy and spectroscopy: insights into the role of cholesterol and Sphingolipids
  2624. Sphingolipids, lipid rafts, and giardial encystation: the show must go on
  2625. Sphingolipid levels crucially modulate lateral microdomain organization of plasma membrane in living yeast
  2626. Evaluation of aegerolysins as novel tools to detect and visualize ceramide phosphoethanolamine, a major Sphingolipid in invertebrates
  2627. Analysis of Sphingolipids, sterols, and phospholipids in human pathogenic Cryptococcus strains [S]
  2628. Changes in membrane biophysical properties induced by sphingomyelinase depend on the Sphingolipid N-acyl chain
  2629. Modifications of Sphingolipid content affect tolerance to hemibiotrophic and necrotrophic pathogens by modulating plant defense responses in Arabidopsis
  2630. Loss of inositol phosphorylceramide Sphingolipid mannosylation induces plant immune responses and reduces cellulose content in Arabidopsis
  2631. Lipid bilayers containing sphingomyelins and ceramides of varying N-acyl lengths: a glimpse into Sphingolipid complexity
  2632. Sphingolipid Biosynthetic Pathway Genes FEN1 and SUR4 Modulate Amphotericin B Resistance
  2633. Roles of Sphingolipid metabolism in pancreatic β cell dysfunction induced by lipotoxicity
  2634. Altered Sphingolipid balance in capillary cerebral amyloid angiopathy
  2635. DNA damage response and Sphingolipid signaling in liver diseases
  2636. Glycosylation of inositol phosphorylceramide Sphingolipids is required for normal growth and reproduction in Arabidopsis
  2637. Plasma phospholipids and Sphingolipids identify stent restenosis after percutaneous coronary intervention
  2638. The ganglioside GM1 interacts with the serotonin1A receptor via the Sphingolipid binding domain
  2639. Comparative analysis of biological Sphingolipids with glycerophospholipids and diacylglycerol by LC-MS/MS
  2640. Sphingolipids as regulators of the phagocytic response to fungal infections
  2641. Effects of plant Sphingolipids on inflammatory stress in differentiated Caco-2 cells
  2642. Sphingolipid metabolism is strikingly different between pollen and leaf in Arabidopsis as revealed by compositional and gene expression profiling
  2643. Sphingolipids in Alzheimer’s disease and related disorders
  2644. Changes in the metabolism of Sphingolipids after subarachnoid hemorrhage
  2645. Sphingolipid transfer proteins defined by the GLTP-fold
  2646. Vascular Sphingolipids in physiological and pathological adaptation
  2647. Hepatic fatty acid uptake is regulated by the Sphingolipid acyl chain length
  2648. Description of the Sphingolipid content and subspecies in the diabetic cornea
  2649. Viral serine palmitoyltransferase induces metabolic switch in Sphingolipid biosynthesis and is required for infection of a marine alga
  2650. Symbiont-derived Sphingolipids modulate mucosal homeostasis and B cells in teleost fish
  2651. Sphingolipid pathway enzymes modulate cell fate and immune responses
  2652. Profiling of plasma metabolites suggests altered mitochondrial fuel usage and remodeling of Sphingolipid metabolism in individuals with type 2 diabetes and …
  2653. Age-dependent changes in nervonic acid-containing Sphingolipids in mouse hippocampus
  2654. Enrichment of hydroxylated C24- and C26-acyl-chain Sphingolipids mediates PIN2 apical sorting at trans-Golgi network subdomains
  2655. Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: A beneficial role for very long-chain Sphingolipid species
  2656. Adipocyte-specific deficiency of de novo Sphingolipid biosynthesis leads to lipodystrophy and insulin resistance
  2657. Gene expression of Sphingolipid metabolism pathways is altered in hidradenitis suppurativa
  2658. Labeled chemical biology tools for investigating Sphingolipid metabolism, trafficking and interaction with lipids and proteins
  2659. Sphingolipids inhibit vimentin-dependent cell migration
  2660. Alterations of plasma glycerophospholipid and Sphingolipid species in male alcohol-dependent patients
  2661. A functionalized Sphingolipid analogue for studying redistribution during activation in living T cells
  2662. The Sphingolipid biosynthetic enzyme Sphingolipid delta8 desaturase is important for chilling resistance of tomato
  2663. Network-based analysis of the Sphingolipid metabolism in hypertension
  2664. Ischemia/reperfusion injury alters Sphingolipid metabolism in the gut
  2665. ORM Expression Alters Sphingolipid Homeostasis and Differentially Affects Ceramide Synthase Activity
  2666. The effect of the bioactive Sphingolipids S1P and C1P on multipotent stromal cells–new opportunities in regenerative medicine
  2667. Introduction to Thematic Minireview Series: Novel Bioactive Sphingolipids*: MINIREVIEW: Novel Bioactive Sphingolipids
  2668. Loss of Frataxin activates the iron/Sphingolipid/PDK1/Mef2 pathway in mammals
  2669. Regulation of de novo Sphingolipid biosynthesis by the ORMDL proteins and sphingosine kinase-1
  2670. Legionella pneumophila restrains autophagy by modulating the host’s Sphingolipid metabolism
  2671. Long-term food restriction prevents aging-associated Sphingolipid turnover dysregulation in the brain
  2672. … E γ-tocotrienol inhibits cytokine-stimulated NF-κB activation by induction of anti-inflammatory A20 via stress adaptive response due to modulation of Sphingolipids
  2673. Influenza viral manipulation of Sphingolipid metabolism and signaling to modulate host defense system
  2674. Delineating amyloid plaque associated neuronal Sphingolipids in transgenic Alzheimer’s disease mice (tgArcSwe) using MALDI imaging mass spectrometry
  2675. Fenofibrate lowers atypical Sphingolipids in plasma of dyslipidemic patients: A novel approach for treating diabetic neuropathy?
  2676. Loss of Frataxin induces iron toxicity, Sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration
  2677. A profile of Sphingolipids and related compounds tentatively identified in yak milk
  2678. … serum samples associated with exposure levels of Persistent organic pollutants indicate important perturbations in Sphingolipids and Glycerophospholipids levels
  2679. Aberrant TGFβ signalling contributes to dysregulation of Sphingolipid metabolism in intrauterine growth restriction
  2680. A systematic simulation of the effect of salicylic acid on Sphingolipid metabolism
  2681. Sng1 associates with Nce102 to regulate the yeast Pkh–Ypk signalling module in response to Sphingolipid status
  2682. Interference with distinct steps of Sphingolipid synthesis and signaling attenuates proliferation of U87MG glioma cells
  2683. Three-dimensional imaging of cholesterol and Sphingolipids within a Madin-Darby canine kidney cell
  2684. Sphingolipid pathway regulates innate immune responses at the fetomaternal interface during pregnancy
  2685. Sphingolipids from the human fungal pathogen Aspergillus fumigatus
  2686. Orosomucoid proteins interact with the small subunit of serine palmitoyltransferase and contribute to Sphingolipid homeostasis and stress responses in Arabidopsis
  2687. Overexpression of Arabidopsis ceramide synthases differentially affects growth, Sphingolipid metabolism, programmed cell death, and mycotoxin resistance
  2688. Endothelial Nogo-B regulates Sphingolipid biosynthesis to promote pathological cardiac hypertrophy during chronic pressure overload
  2689. Low serum Sphingolipids in children with attention deficit-hyperactivity disorder
  2690. Lipopolysaccharide disrupts mitochondrial physiology in skeletal muscle via disparate effects on Sphingolipid metabolism
  2691. Structure–Function Relationship of Complex Sphingolipids in Yeast
  2692. Simultaneous quantification of Sphingolipids in small quantities of liver by LC-MS/MS
  2693. … for analysis and design of metabolism using metabolomics data and kinetic models: Application on lipidomics using a novel kinetic model of Sphingolipid …
  2694. Metabolic modifications in human biofluids suggest the involvement of Sphingolipid, antioxidant, and glutamate metabolism in Alzheimer’s disease pathogenesis
  2695. Sphingolipid biosynthesis upregulation by TOR complex 2–Ypk1 signaling during yeast adaptive response to acetic acid stress
  2696. Gamma-tocotrienol profoundly alters Sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of Sphingolipid hydrolysis …
  2697. Gastrointestinal Degradation of Fumonisin B1 by Carboxylesterase FumD Prevents Fumonisin Induced Alteration of Sphingolipid Metabolism in Turkey and Swine
  2698. Sphingolipids and mitochondrial function in budding yeast
  2699. Rice ORMDL Controls Sphingolipid Homeostasis Affecting Fertility Resulting from Abnormal Pollen Development
  2700. Sphingolipids and mitochondrial function, lessons learned from yeast
  2701. Variations in serum Sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection
  2702. Muscle-specificity of age-related changes in markers of autophagy and Sphingolipid metabolism
  2703. Sphingolipids, Transcription Factors, and Conserved Toolkit Genes: Developmental Plasticity in the Ant Cardiocondyla obscurior
  2704. Unexpected profile of Sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia
  2705. Sphingolipids in genetic and acquired forms of chronic kidney diseases
  2706. Peripheral Sphingolipids are associated with variation in white matter microstructure in older adults
  2707. Regulation of Sphingolipid biosynthesis by the morphogenesis checkpoint kinase Swe1
  2708. Membrane engineering of S. cerevisiae targeting Sphingolipid metabolism
  2709. Quantitative profiling of Sphingolipids in wild Cordyceps and its mycelia by using UHPLC-MS
  2710. Development of a mass-spectrometry-based lipidomics platform for the profiling of phospholipids and Sphingolipids in brain tissues
  2711. Plasma Sphingolipids: potential biomarkers for severe hepatic fibrosis in chronic hepatitis C
  2712. Sphingolipid symmetry governs membrane lipid raft structure
  2713. Diverse biological functions of Sphingolipids in the CNS: ceramide and sphingosine regulate myelination in developing brain but stimulate demyelination …
  2714. FTY720 induces apoptosis of M2 subtype acute myeloid leukemia cells by targeting Sphingolipid metabolism and increasing endogenous ceramide levels
  2715. The effects of graded levels of calorie restriction: IX. Global metabolomic screen reveals modulation of carnitines, Sphingolipids and bile acids in the liver of C57 BL/6 …
  2716. Innate immune responses in the brain of Sphingolipid lysosomal storage diseases
  2717. In-depth lipidomic analysis of molecular species of triacylglycerides, diacylglycerides, glycerophospholipids, and Sphingolipids of buttermilk by GC-MS/FID, HPLC …
  2718. Azide‐Tagged Sphingolipids: New Tools for Metabolic Flux Analysis
  2719. Long-chain bases of Sphingolipids are transported into cells via the acyl-CoA synthetases
  2720. Pakistamide C, a new Sphingolipid from Abutilon pakistanicum
  2721. Modification of Sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia—impact on enzyme activity and response to …
  2722. Serum Sphingolipids reflect the severity of chronic HBV infection and predict the mortality of HBV-acute-on-chronic liver failure
  2723. Sphingosine 1-phosphate is a key metabolite linking Sphingolipids to glycerophospholipids
  2724. Qualitative and quantitative measurements of Sphingolipids by mass spectrometry
  2725. Characterization of AnNce102 and its role in eisosome stability and Sphingolipid biosynthesis
  2726. The role of the trans double bond in skin barrier Sphingolipids: permeability and infrared spectroscopic study of model ceramide and dihydroceramide membranes
  2727. FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and Sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts
  2728. Integrated targeted Sphingolipidomics and transcriptomics reveal abnormal Sphingolipid metabolism as a novel mechanism of the hepatotoxicity and nephrotoxicity of …
  2729. Sphingolipids modulate the epithelial–mesenchymal transition in cancer
  2730. HCV 3a core protein increases lipid droplet cholesteryl ester content via a mechanism dependent on Sphingolipid biosynthesis
  2731. Sphingolipids facilitate age asymmetry of membrane proteins in dividing yeast cells
  2732. Sphingolipid profile alters in retinal dystrophic P23H-1 rats and systemic FTY720 can delay retinal degeneration [S]
  2733. Alterations of calcium homoeostasis in cultured rat astrocytes evoked by bioactive Sphingolipids
  2734. Dietary fish oil improves endothelial function and lowers blood pressure via suppression of Sphingolipid-mediated contractions in spontaneously hypertensive …
  2735. The Role of Sphingolipids on Innate Immunity to Intestinal Salmonella Infection
  2736. TOR complex 2-Ypk1 signaling maintains Sphingolipid homeostasis by sensing and regulating ROS accumulation
  2737. … liquid chromatography electrospray ionization tandem mass spectrometry for accurate analysis of glycerophospholipids and Sphingolipids in drug resistance tumor …
  2738. The role of Sphingolipids and lipid rafts in determining cell fate
  2739. The cellular ceramide transport protein CERT promotes Chlamydia psittaci infection and controls bacterial Sphingolipid uptake
  2740. Systems biology approaches for studying Sphingolipid signaling
  2741. Exploration of the Sphingolipid metabolite, sphingosine-1-phosphate and sphingosine, as novel biomarkers for aspirin-exacerbated respiratory disease
  2742. Aziridine ring opening for the synthesis of Sphingolipid analogues: inhibitors of Sphingolipid-metabolizing enzymes
  2743. Modulation of the Sphingolipid rheostat is involved in paclitaxel resistance of the human prostate cancer cell line PC3-PR
  2744. DHA-mediated enhancement of TRAIL-induced apoptosis in colon cancer cells is associated with engagement of mitochondria and specific alterations in Sphingolipid …
  2745. Sphingolipid signalling mediates mitochondrial dysfunctions and reduced chronological lifespan in the yeast model of N iemann‐P ick type C 1
  2746. Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and Sphingolipids independent of differences in weight …
  2747. Metabolomics approach reveals altered plasma amino acid and Sphingolipid profiles associated with patholological state in transition dairy cows
  2748. Plasma Sphingolipids as potential indicators of hepatic necroinflammation in patients with chronic hepatitis C and normal alanine aminotransferase level
  2749. Associations of systemic Sphingolipids with measures of hepatic function in liver cirrhosis are related to cholesterol
  2750. Resveratrol and its oligomers: modulation of Sphingolipid metabolism and signaling in disease
  2751. Polymer resonators sensors for detection of Sphingolipid gel/fluid phase transition and melting temperature measurement
  2752. A hyphenated technique based on high-performance thin layer chromatography for determining neutral Sphingolipids: a proof of concept
  2753. An anti-mycobacterial bisfunctionalized Sphingolipid and new bromopyrrole alkaloid from the Indonesian marine sponge Agelas sp.
  2754. New insights into Sphingolipid metabolism and functions by using chemical tools
  2755. Port‐to‐port delivery: mobilization of toxic Sphingolipids via extracellular vesicles
  2756. Analysis of Sphingolipids in human corneal fibroblasts from normal and keratoconus patients
  2757. Inhibition of very long acyl chain Sphingolipid synthesis modifies membrane dynamics during plant cytokinesis
  2758. Maternal plasma and amniotic fluid Sphingolipids profiling in fetal Down syndrome
  2759. Interictal, circulating Sphingolipids in women with episodic migraine: a case-control study
  2760. Altered levels of α-synuclein and Sphingolipids in Batten disease lymphoblast cells
  2761. Differential regulation of Sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered Sphingolipid modulating agents
  2762. Sphingolipid metabolism potential in fecal microbiome and bronchiolitis in infants: a case–control study
  2763. Alteration of complex Sphingolipid composition and its physiological significance in yeast Saccharomyces cerevisiae lacking vacuolar ATPase
  2764. Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography
  2765. Critical role for very-long chain Sphingolipids in invariant natural killer T cell development and homeostasis
  2766. Sphingolipids in marine microalgae: Development and application of a mass spectrometric method for global structural characterization of ceramides and …
  2767. How membrane dysfunction influences neuronal survival pathways in Sphingolipid storage disorders
  2768. … upregulates protein kinase C isoforms in cardiovascular tissues and cells; relation to NF-kB, cytokines, ceramide salvage Sphingolipid pathway and PKC-zeta …
  2769. Proteomic and phosphoproteomic analyses of yeast reveal the global cellular response to Sphingolipid depletion
  2770. … of ultra-high pressure liquid chromatography–tandem mass spectrometry determination in plasma and red blood cells of four Sphingolipids and their evaluation as …
  2771. Separation and sensitive determination of Sphingolipids at low femtomole level by using HPLC-PIESI-MS/MS
  2772. Plasma Sphingolipids in HIV-associated chronic obstructive pulmonary disease
  2773. Sphingolipid metabolism via sphingosine 1-phosphate and its role in physiology, pathology, and nutrition
  2774. Metabolomics and lipidomics reveal perturbation of Sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
  2775. Complex effects of 24: 1 Sphingolipids in membranes containing dioleoylphosphatidylcholine and cholesterol
  2776. Sphingolipids affect fibrinogen-induced caveolar transcytosis and cerebrovascular permeability
  2777. Imaging mass spectrometry reveals acyl-chain-and region-specific Sphingolipid metabolism in the kidneys of sphingomyelin synthase 2-deficient mice
  2778. Effects of dietary glucocerebrosides from sea cucumber on the brain Sphingolipid profiles of mouse models of Alzheimer’s disease
  2779. Distinct serum Sphingolipid profiles among school-aged children with exercise-induced wheeze and asthma persistence
  2780. Impact of insulin deprivation and treatment on Sphingolipid distribution in different muscle subcellular compartments of streptozotocin-diabetic C57Bl/6 mice
  2781. Neurochemical metabolomics reveals disruption to Sphingolipid metabolism following chronic haloperidol administration
  2782. Sphingolipids and HDL Metabolism
  2783. Sphingolipid metabolic pathway impacts thiazide diuretics blood pressure response: Insights from genomics, metabolomics, and lipidomics
  2784. Expression of the bacterial type III effector DspA/E in Saccharomyces cerevisiae down-regulates the Sphingolipid biosynthetic pathway leading to growth …
  2785. ARAP2 promotes GLUT1-mediated basal glucose uptake through regulation of Sphingolipid metabolism
  2786. The consequences of genetic and pharmacologic reduction in Sphingolipid synthesis
  2787. Basics of Sphingolipid metabolism and signalling
  2788. Unravelling the interplay of Sphingolipids and TGF-β signaling in the human corneal stroma
  2789. The interaction of dipole modifiers with amphotericin-ergosterol complexes. Effects of phospholipid and Sphingolipid membrane composition
  2790. Differential Sphingolipid and phospholipid profiles in alcohol and nicotine‐derived nitrosamine ketone‐associated white matter degeneration
  2791. A lipidomics approach to assess the association between plasma Sphingolipids and verbal memory performance in coronary artery disease patients undertaking …
  2792. Altering Sphingolipid composition with aging induces contractile dysfunction of gastric smooth muscle via KCa1.1 upregulation
  2793. Membrane phosphoproteomics of yeast early response to acetic acid: role of Hrk1 kinase and lipid biosynthetic pathways, in particular Sphingolipids
  2794. Characterisation of Sphingolipids in the human lens by thin layer chromatography–desorption electrospray ionisation mass spectrometry
  2795. A blood spot method for detecting fumonisin-induced changes in putative Sphingolipid biomarkers in LM/Bc mice and humans
  2796. An LC/MS/MS method for the simultaneous determination of individual Sphingolipid species in B cells
  2797. Effects of Sphingolipid extracts on the morphological structure and lipid profile in an in vitro model of canine skin
  2798. Structure of Sphingolipids From Sea Cucumber Cucumaria frondosa and Structure‐Specific Cytotoxicity Against Human HepG2 Cells
  2799. Switching head group selectivity in mammalian Sphingolipid biosynthesis by active-site-engineering of sphingomyelin synthases
  2800. Activities of genes controlling Sphingolipid metabolism in human fibroblasts treated with flavonoids
  2801. Sphingolipid in lung cancer pathogenesis and therapy
  2802. Sphingolipid metabolism of a sea anemone is altered by the presence of dinoflagellate symbionts
  2803. Sphingolipids and ceramides of mouse aqueous humor: Comparative profiles from normotensive and hypertensive DBA/2J mice
  2804. Krabbe disease: involvement of connexin43 in the apoptotic effects of Sphingolipid psychosine on mouse oligodendrocyte precursors
  2805. Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in Pseudomonas aeruginosa Infection of Cystic Fibrosis …
  2806. Sphingolipid signaling reduces basal P-glycoprotein activity in renal proximal tubule
  2807. Sphingolipids metabolism in the salivary glands of rats with obesity and streptozotocin induced diabetes
  2808. A conserved signaling network monitors delivery of Sphingolipids to the plasma membrane in budding yeast
  2809. Differential changes in Sphingolipids between TNF-induced necroptosis and apoptosis in U937 cells and necroptosis-resistant sublines
  2810. … lipidomic screen of pancreatic β-cells using mass spectroscopy defines novel features of glucose-stimulated turnover of neutral lipids, Sphingolipids and …
  2811. HPTLC‐MALDI MS for (glyco) Sphingolipid multiplexing in tissues and blood: A promising strategy for biomarker discovery and clinical applications
  2812. Misexpression of the Niemann-Pick disease type C1 (NPC1)-like protein in Arabidopsis causes Sphingolipid accumulation and reproductive defects
  2813. Sphingolipid metabolism affects the anticancer effect of cisplatin
  2814. Arabidopsis Bax inhibitor-1 promotes Sphingolipid synthesis during cold stress by interacting with ceramide-modifying enzymes
  2815. Fam20C is under the control of Sphingolipid signaling in human cell lines
  2816. Evaluation of the change in Sphingolipids in the human multiple myeloma cell line U266 and gastric cancer cell line MGC-803 treated with arsenic trioxide
  2817. Molecular evolution of the enzymes involved in the Sphingolipid metabolism of Leishmania: selection pressure in relation to functional divergence and …
  2818. Sphingolipids in skeletal muscles of C57B1/6 mice after short-term simulated microgravity
  2819. Cholesterol–ceramide interactions in phospholipid and Sphingolipid bilayers as observed by positron annihilation lifetime spectroscopy and molecular dynamics …
  2820. Feeding a modified fish diet to bottlenose dolphins leads to an increase in serum adiponectin and Sphingolipids
  2821. New norterpenoids and a Sphingolipid from Carissa opaca
  2822. Combining deep sequencing, proteomics, phosphoproteomics, and functional screens to discover novel regulators of Sphingolipid homeostasis
  2823. The role of cholesterol and Sphingolipids in the dopamine D1 receptor and G protein distribution in the plasma membrane
  2824. Inborn Disorders of Sphingolipid Metabolism: Proceedings of the Third International Symposium on the Cerebral Sphingolipidoses
  2825. An endoplasmic reticulum stress-initiated Sphingolipid metabolite, ceramide-1-phosphate, regulates epithelial innate immunity by stimulating β-defensin production
  2826. Sphingolipids mediate differential echinocandin susceptibility in Candida albicans and Aspergillus nidulans
  2827. Yeast lacking the amphiphysin family protein Rvs167 is sensitive to disruptions in Sphingolipid levels
  2828. Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of Sphingolipids metabolism
  2829. Functional and phylogenetic evidence of a bacterial origin for the first enzyme in Sphingolipid biosynthesis in a phylum of eukaryotic protozoan parasites
  2830. Mitochondrial protein alterations in a familial peripheral neuropathy caused by the V144D amino acid mutation in the Sphingolipid protein, SPTLC1
  2831. Sphingolipids and epoxidized lipid metabolites in the control of gut immunosurveillance and allergy
  2832. Following the flux of long-chain bases through the Sphingolipid pathway in vivo using mass spectrometry [S]
  2833. The Chemistry and Biology of 6‐Hydroxyceramide, the Youngest Member of the Human Sphingolipid Family
  2834. Modulation of Sphingolipid metabolism with calorie restriction enhances insulin action in skeletal muscle
  2835. Sphingolipid profiles are altered in prefrontal cortex of rats under acute hyperglycemia
  2836. Influence of intracellular membrane pH on Sphingolipid organization and membrane biophysical properties
  2837. Non-target analysis of phospholipid and Sphingolipid species in egg yolk using liquid chromatography/triple quadrupole tandem mass spectrometry
  2838. Δ10(E)-Sphingolipid Desaturase Involved in Fusaruside Mycosynthesis and Stress Adaptation in Fusarium graminearum
  2839. Visualization of Sphingolipids and phospholipids in the fundic gland mucosa of human stomach using imaging mass spectrometry
  2840. Activation of Sphingolipid Pathway in the Livers of Lipodystrophic Agpat2−/− Mice
  2841. De Novo Sphingolipid synthesis is essential for Salmonella-induced autophagy and human beta-defensin 2 expression in intestinal epithelial cells
  2842. Crosstalk between Sphingolipids and vitamin D3: potential role in the nervous system
  2843. Human trabecular meshwork Sphingolipid and ceramide profiles and potential latent fungal commensalism
  2844. Characterization of Drosophila Saposin-related mutants as a model for lysosomal Sphingolipid storage diseases
  2845. Effects of Cholesterol and Saturated Sphingolipids on Acyl Chain Order in 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine BilayersA Comparative Study with …
  2846. Effects of stereochemistry, saturation, and hydrocarbon chain length on the ability of synthetic constrained azacyclic Sphingolipids to trigger nutrient transporter down …
  2847. Effects of inhibitors of key enzymes of Sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats
  2848. Sphingolipids regulate telomere clustering by affecting the transcription of genes involved in telomere homeostasis
  2849. Non-dioxin-like organic toxicant PCB153 modulates Sphingolipid metabolism in liver progenitor cells: its role in Cx43-formed gap junction impairment
  2850. A non-target chemometric strategy applied to UPLC-MS Sphingolipid analysis of a cell line exposed to chlorpyrifos pesticide: a feasibility study
  2851. Effect of atrial pacing on the level of bioactive Sphingolipids in the heart ventricles of the rat
  2852. Inhibition of GM3 synthase attenuates neuropathology of Niemann-Pick disease Type C by affecting Sphingolipid metabolism
  2853. Sphingolipid metabolism in colorectal adenomas varies depending on histological architecture of polyps and grade of nuclear dysplasia
  2854. Tools for the analysis of metabolic flux through the Sphingolipid pathway
  2855. Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview
  2856. Recent advances in study of Sphingolipids on liver diseases
  2857. A lipidomic study of Sphingolipid species in human synovial fluid
  2858. The role and function of Sphingolipids in glioblastoma multiforme
  2859. Fabry disease: renal Sphingolipid distribution in the α-Gal A knockout mouse model by mass spectrometric and immunohistochemical imaging
  2860. Age-related increase in LDL-cholesterol is associated with enhanced oxidative stress and disturbed Sphingolipid metabolism
  2861. Ganglioside and related-Sphingolipid profiles are altered in a cellular model of Alzheimer’s disease
  2862. Elevation of plasma 1‐deoxy‐Sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
  2863. Rice Stripe Virus Infection Alters mRNA Levels of Sphingolipid-Metabolizing Enzymes and Sphingolipids Content in Laodelphax striatellus
  2864. Fumonisin B1 (FB1) Induces Lamellar Separation and Alters Sphingolipid Metabolism of In Vitro Cultured Hoof Explants
  2865. Hepatocyte nuclear factor 1A deficiency causes hemolytic anemia in mice by altering erythrocyte Sphingolipid homeostasis
  2866. Effects of orally administered fumonisin B1 (FB1), partially hydrolysed FB1, hydrolysed FB1 and N-(1-deoxy-D-fructos-1-yl) FB1 on the Sphingolipid metabolism in rats
  2867. A rabidopsis dynamin‐related protein 1 E in Sphingolipid‐enriched plasma membrane domains is associated with the development of freezing tolerance
  2868. The histone deacetylase-6 inhibitor tubacin directly inhibits de novo Sphingolipid biosynthesis as an off-target effect
  2869. … 13′-carboxychromanols inhibit pro-inflammatory enzymes, induce apoptosis and autophagy in human cancer cells by modulating Sphingolipids and suppress colon …
  2870. Plasma membrane targeting by short chain Sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma …
  2871. A novel combined approach of short-chain Sphingolipids and thermosensitive liposomes for improved drug delivery to tumor cells
  2872. Arabidopsis mutants in Sphingolipid synthesis as tools to understand the structure and function of membrane microdomains in plasmodesmata
  2873. Oroscomucoid like protein 3 (ORMDL3) transgenic mice have reduced levels of Sphingolipids including sphingosine-1-phosphate and ceramide
  2874. … -dependent kinase 1 (PDK1) and serum-and glucocorticoid-induced protein kinase 1 (SGK1) by short-chain Sphingolipid C4-ceramide rescues the trafficking …
  2875. Reduction of ceramide de novo synthesis in solid tissues changes Sphingolipid levels in rat plasma, erythrocytes and platelets
  2876. … polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle Sphingolipid synthesis in offspring …
  2877. Male meiotic cytokinesis requires ceramide synthase 3-dependent Sphingolipids with unique membrane anchors
  2878. Transient receptor potential canonical 1 (TRPC1) channels as regulators of Sphingolipid and VEGF receptor expression: Implications for thyroid cancer cell …
  2879. A facile method for controlling the reaction equilibrium of Sphingolipid ceramide N-deacylase for lyso-glycoSphingolipid production [S]
  2880. Alkaline ceramidase 3 deficiency results in Purkinje cell degeneration and cerebellar ataxia due to dyshomeostasis of Sphingolipids in the brain
  2881. Rapid evaluation of 25 key Sphingolipids and phosphoSphingolipids in human plasma by LC-MS/MS
  2882. C24 Sphingolipids play a surprising and central role in governing cholesterol and lateral organization of the live cell plasma membrane
  2883. UPLC-HRMS based metabolomics reveals the Sphingolipids with long fatty chains and olefinic bonds up-regulated in metabolic pathway for hypoxia preconditioning
  2884. Sphingolipids in Inflammation: From Bench to Bedside
  2885. Comprehensive characterization of Sphingolipid ceramide N-deacylase for the synthesis and fatty acid remodeling of glycoSphingolipids
  2886. Tandem Mass Spectrometry of Sphingolipids: Applications for Diagnosis of Sphingolipidoses
  2887. Dietary Sphingolipids in colon cancer prevention
  2888. Leishmanial Sphingolipid induces apoptosis in Sarcoma 180 cancer cells through regulation of tumour growth via angiogenic switchover
  2889. Localization of Sphingolipid enriched plasma membrane regions and long-chain base composition during mature-fruit abscission in olive
  2890. Synthesis of nontoxic fluorous Sphingolipids as molecular probes of exogenous metabolic studies for rapid enrichment by fluorous solid phase extraction
  2891. Targeting Cell Membrane Lipid Rafts by Stoichiometric Functionalization of Gold Nanoparticles with a Sphingolipid‐Binding Domain Peptide
  2892. Insights into abnormal Sphingolipid metabolism in multiple sclerosis: targeting ceramide biosynthesis as a unique therapeutic strategy
  2893. Defective ceramide synthases in mice cause reduced amplitudes in electroretinograms and altered Sphingolipid composition in retina and cornea
  2894. Comparison of four enzymes from brain which hydrolyze Sphingolipids
  2895. The genetics of Sphingolipid hydrolases and Sphingolipid storage diseases
  2896. Liquid Chromatography–High Resolution Mass Spectrometry Method to Study Sphingolipid Metabolism Changes in Response to CD95L
  2897. Stress-activated degradation of Sphingolipids regulates mitochondrial function and cell death in yeast
  2898. CSF Sphingolipids and phospholipids characterization in dementia patients
  2899. Enhanced apoptotic cancer cell killing after Foscan photodynamic therapy combined with fenretinide via de novo Sphingolipid biosynthesis pathway
  2900. Low level of the plasma Sphingolipid, glucosylceramide, is associated with thrombotic diseases
  2901. The ATP-binding cassette transporter-2 (ABCA2) regulates esterification of plasma membrane cholesterol by modulation of Sphingolipid metabolism
  2902. Brain, fish oil-enriched diet, and Sphingolipids
  2903. Annexin II-dependent actin remodelling evoked by hydrogen peroxide requires the metalloproteinase/Sphingolipid pathway
  2904. Runx1 orchestrates Sphingolipid metabolism and glucocorticoid resistance in lymphomagenesis
  2905. 4-Hydroxynonenal contributes to angiogenesis through a redox-dependent Sphingolipid pathway: prevention by hydralazine derivatives
  2906. Disorders of Sphingolipid synthesis, Sphingolipidoses, niemann-pick disease type C and neuronal Ceroid lipofuscinoses
  2907. Altered leukocyte Sphingolipid pathway in breast cancer
  2908. Lipoprotein-mediated delivery of BODIPY-labeled sterol and Sphingolipid analogs reveals lipid transport mechanisms in mammalian cells
  2909. Psychosine-triggered endomitosis is modulated by membrane Sphingolipids through regulation of phosphoinositide 4, 5-bisphosphate production at the cleavage …
  2910. Antineoplastic impact of leishmanial Sphingolipid in tumour growth with regulation of angiogenic event and inflammatory response
  2911. Rapid externalization of 27-kDa heat shock protein (HSP27) and atypical cell death in neutrophils treated with the Sphingolipid analog drug FTY720
  2912. Sphingolipids–who’s controlling who in disease?
  2913. Dysregulation of Sphingolipid metabolism in melanoma: Roles in pigmentation, cell survival and tumor progression
  2914. Chemical probes of Sphingolipid metabolizing enzymes
  2915. Harnessing the power of yeast to elucidate the role of Sphingolipids in metabolic and signaling processes pertinent to psychiatric disorders
  2916. Chemical tools to investigate the role of Sphingolipids in disease
  2917. … human head and neck squamous cell carcinoma cells after photodynamic therapy plus fenretinide via the de novo Sphingolipid biosynthesis pathway and …
  2918. Sphingolipids in congenital diaphragmatic hernia; results from an international multicenter study
  2919. Role of Sphingolipids in non-melanoma skin cancer
  2920. Sphingolipid activity in oxidative stress response and tumor immunity
  2921. Co-option of the Sphingolipid metabolism for the production of nitroalkene defensive chemicals in termite soldiers
  2922. Characterization of heterogeneous response to chemotherapy by perturbation-based modeling of fluorescent Sphingolipid metabolism in cancer cell subpopulations
  2923. Gangliosides in dairy products: Milk Sphingolipids
  2924. A comparison of trabecular meshwork Sphingolipids and ceramides of ocular normotensive and hypertensive states of DBA/2J mice
  2925. Caenorhabditis elegans as a model to study Sphingolipid signaling
  2926. Synthesis of a panel of carbon‐13‐labelled (glyco) Sphingolipids
  2927. Antagonism and synergy of single chain Sphingolipids sphingosine and sphingosine-1-phosphate toward lipid bilayer properties. Consequences for their role as cell …
  2928. Digestion of Ceramide 2-Aminoethylphosphonate, a Sphingolipid from the Jumbo Flying Squid Dosidicus gigas, in Mice
  2929. Sphingolipids in ocular inflammation
  2930. Sphingolipids in intestinal inflammation and tumorigenesis
  2931. Sphingolipids as Mediators of Breast Cancer Progression, Metastasis, Response and Resistance to Chemotherapy
  2932. Palmitate induces COX-2 expression via the Sphingolipid pathway-mediated activation of NF-κB, p38, and ERK in human dermal fibroblasts
  2933. Role of Sphingolipids in hematological malignancies: lymphoproliferative disorders
  2934. Sphingolipids are required for efficient triacylglycerol loss in conjugated linoleic Acid treated adipocytes
  2935. Proinflammatory role of Sphingolipids and glycoSphingolipids in the human atherosclerotic plaque
  2936. Overexpression of patatin-related phospholipase AIIIβ altered the content and composition of Sphingolipids in Arabidopsis
  2937. Role of Sphingolipids in hematological malignancies: myeloproliferative disorders
  2938. Sphingolipids, new kids on the block, promoting glomerular fibrosis in the diabetic kidney
  2939. Sphingolipid biology and its role in cancer development and therapy
  2940. Nuclear translocation of SGPP-1 and decrease of SGPL-1 activity contribute to Sphingolipid rheostat regulation of inflammatory dendritic cells
  2941. A Novel Jaspine B Ceramide Hybrid Modulates Sphingolipid Metabolism
  2942. Research advances in the role of Sphingolipids in HCV and HBV life cycles
  2943. Identification of the substrate recognition region in the Δ6-fatty acid and Δ8-Sphingolipid desaturase by fusion mutagenesis
  2944. Role of Sphingolipids signaling in pathogenesis of pulmonary fibrosis
  2945. Genes encoding Δ8-Sphingolipid desaturase from various plants: identification, biochemical functions, and evolution
  2946. Elevation of ceramide in senescence: role of Sphingolipid metabolism
  2947. Sphingolipids in gonococcal infection
  2948. Specific skeletal muscle Sphingolipid compounds in energy expenditure regulation and weight gain in Native Americans of Southwestern heritage
  2949. Membrane organization determines barrier properties of endothelial cells and short-chain Sphingolipid-facilitated doxorubicin influx
  2950. Morphogenetic Sphingolipids in stem cell differentiation and embryo development
  2951. Inhibition of GSK3β by pharmacological modulation of Sphingolipid metabolism occurs independently of ganglioside disturbance in a cellular model of Alzheimer’s …
  2952. Investigation of the Sphingolipid pathway in the early stages of Alzheimer’s disease
  2953. Identification of cancer chemosensitivity by ODE and GMM modeling of heterogeneous cellular response to perturbations in fluorescent Sphingolipid metabolism
  2954. Effect of atrial pacing on the level of bioactive Sphingolipids in the heart ventricles of the rat
  2955. Sphingolipids transfer proteins (GLTP and CPTP) regulate the neoplastic progression of colon and breast cancer cells
  2956. Detection and distribution of Sphingolipids in tissue by FTICR MALDI-imaging mass spectrometry
  2957. Computational model of Sphingolipids metabolism: a case study of Alzheimer’s disease
  2958. Ex vivo study of the importance of Sphingolipid in Leishmania amastigote
  2959. Warfarin-induced vitamin K deficiency is associated with cognitive and behavioral perturbations, and alterations in brain Sphingolipids in rats
  2960. Highlight: molecular medicine of Sphingolipids
  2961. The role of the Sphingolipid metabolism pathway in healthy aging
  2962. PODOCYTE PATHOLOGY AND NEPHROPATHY-Sphingolipids IN GLOMERULAR DISEASES
  2963. Sphingolipid SIGNALING AND DISEASE: THE KEY ROLE OF CERAMIDE TRAFFIC IN CELL FATE REGULATION
  2964. Solving the Riddle of the Role of Sphingolipids in Cell Signaling
  2965. Role of Sphingolipids in Liver Cancer
  2966. Is the Site of Influenza Virus Assembly and Budding Enriched with Cholesterol and Sphingolipids?
  2967. Sphingolipids: de novo synthesis and signaling in blood pressure homeostasis
  2968. Determination of Sphingolipids by LC-MS/MS
  2969. Pancreatic Cancer and Sphingolipids
  2970. Approaches to polyunsaturated Sphingolipids: new conformationally restrained analogs with minimal structural modifications
  2971. Sphingolipids as mediators in the crosstalk between microbiota and intestinal cells: Implications for inflammatory bowel disease
  2972. Tuning of membrane electrostatic properties by single chain Sphingolipids sphingosine and sphingosine-1-phosphate: The effect on bilayer dipole potential
  2973. On the possible structural role of single chain Sphingolipids Sphingosine and Sphingosine 1-phosphate in the amyloid-β peptide interactions with membranes …
  2974. Serum and hepatic Sphingolipids relate to insulin resistance, hepatic mitochondrial capacity and oxidative stress in non-alcoholic fatty liver disease
  2975. Sphingoproteomics: Proteomic Strategies to Examine Sphingolipid Biology
  2976. Aβ1-25-derived Sphingolipid-domain tracer peptide sbd interacts with membrane ganglioside clusters via a coil-helix-coil motif
  2977. Analysis of Sphingolipid Synthesis and Transport by Metabolic Labeling of Cultured Cells with [3H]Serine
  2978. The mechanism of Sphingolipid processing revealed by a GALC-SapA complex structure
  2979. Three homologous genes encoding functional ∆8-Sphingolipid desaturase in Populus tomentosa
  2980. Stereoselective total synthesis of Sphingolipids
  2981. Overview of methods used for determination of selected Sphingolipids in different biological materials
  2982. Odorasides A and B, new Sphingolipid glucosides from Klienia odora
  2983. LATE-BREAKING ABSTRACT: Sphingolipids in tracheal aspirates of prematurely born infants with and without BPD
  2984. Ingestion of Sphingolipids restores the skin permeability barrier after damage caused by repeated ultraviolet B irradiation in mice
  2985. Neoglycoconjugates Derived from Deoxynojirimycin as Possible Therapeutic Agents for Cystic Fibrosis Lung Disease, by Modulation of the Sphingolipid Metabolism
  2986. Design, synthesis and their application of effective probes for dynamic analysis of Sphingolipids and their related biomolecules [an abstract of dissertation and a …
  2987. Role of Macroautophagy in Anti‐Cancer Effects of the Novel Sphingolipid, Enigmol
  2988. The emerging role of Sphingolipids in cancer stem cell biology
  2989. Doxorubicin: comparison between 3-h continuous and bolus intravenous administration paradigms on cardio-renal axis, mitochondrial Sphingolipids and pathology
  2990. New lipoxygenase and cholinesterase inhibitory Sphingolipids from Carthamus oxyacantha
  2991. Colon cancer: the role of Sphingolipid metabolic enzymes
  2992. Characterization of Volvocine Sphingolipid Metabolism
  2993. A Pilot Study of Age-Related Changes in the Sphingolipid Composition of the Rat Sarcoplasmic Reticulum.
  2994. Biphasic regulation of type II phosphatidylinositol-4 kinase by sphingosine: Cross talk between glycero-and Sphingolipids in the kidney
  2995. … Vein Occlusion, Vision Loss, Myocardial Infarction, Stroke and Mortality: Potential Roles of Hypomagnesaemia, Release of Sphingolipids, and Platelet-Activating …
  2996. The role of bioactive Sphingolipids in vascular calcification
  2997. Sphingolipids in Ventilator-Induced Lung Injury
  2998. Disruption of Sphingolipid homeostasis affects murine placental development
  2999. Sphingolipids in the Pathogenesis of Head and Neck and Lung Cancers: Translational Aspects for Therapy and Biomarker Development
  3000. The Synthesis of Chemical Tools for Studying Sphingolipid Metabolism
  3001. Changes in the Sphingolipid content in tissues and behavioral modifications of rats subjected to neurogenic stress: role of sphingomyelinases
  3002. The pro-inflammatory role of Sphingolipids and glycoSphingolipids in the human atherosclerotic plaque
  3003. Interactions between antitumor alkylphosphocholines and membrane Sphingolipids in Langmuir monolayers
  3004. Spatial Distribution of Sphingolipids in The Mouse Retina by MALDI Imaging Mass Spectrometry
  3005. Sphingolipids profiling of plasma in patients with diabetes mellitus associated with atherosclerosis by a novel normal-phase UPLC-QToF MS method
  3006. Effects of chronic neurogenic stress on behavior of rats and contents of Sphingolipids in their brain and peripheral tissues
  3007. Sphingolipids Regulate Myeloid-Erythroid Fate Determination in Human Hematopoiesis
  3008. Anticancer Effects of Vitamin E Forms and Their Long-Chain Metabolites Via Modulation of Sphingolipid Metabolism
  3009. Comment: Altered Sphingolipid metabolism—A marker for episodic migraine?
  3010. Polyene Sphingolipids with latent fluorescence: new tools to study the biophysical properties of cellular membranes
  3011. Plasma Sphingolipid profiling reveals novel distinct biomarkers for predicting cardiovascular disease and type 2 diabetes mellitus
  3012. Sphingolipids and deoxySphingolipids in diabetes
  3013. Correction: The Sphingolipid Receptor S1PR2 Is a Receptor for Nogo-A Repressing Synaptic Plasticity
  3014. Sphingolipid transfer by GLTP-fold proteins is differentially regulated by phosphatidylinositol derivatives
  3015. Endogenous Sphingolipid Signaling Pathway Implicated in the Action of Croton membranaceus on the Prostate Gland in BPH Patients
  3016. Sphingolipids in viral infection
  3017. Research progress in aberrant Sphingolipid metabolism and obesity and obesity-mediated insulin resistance
  3018. Long acyl chain Sphingolipids govern visible microdomains and cholesterol in both model and plasma membranes
  3019. The diverse roles of the\textit {Pseudomonas aeruginosa} phospholipase PlcH and the\textit {Toxoplasma gondii} serine palmitoyltransferase in Sphingolipid …
  3020. Chemical approaches to Sphingolipid research
  3021. Sphingolipid biosynthesis and inflammatory signaling in asthma (605.21)
  3022. Global Sphingolipid profile of Giardia lamblia during stage differentiation: The influence of sphingomyelin abundance on cyst viability
  3023. A3. 28 Screening of Sphingolipids in SLE-before and after treatment
  3024. Unexpected profile of Sphingolipid
  3025. Liposomal circular dichroism (L-Cd) of arenoyl derivatives of Sphingolipids. Amplification of cotton effects in ordered lipid bilayers
  3026. Sphingolipids in the Human Cornea, to boldly go where no one has gone before
  3027. Effect of immunomodulator, fingolimod, on ischemia reperfusion testicular injury in rats: Targeting the role of Sphingolipid rheostat (fingolimod on I/R induced …
  3028. Sphingolipid zyxwvutsrqponmlkjih
  3029. Resveratrol and pterostilbene inhibit TNF‐α stimulated activation of NF‐kB and its upstream TAK1 in macrophages via modulation of Sphingolipids
  3030. Chemotherapy and Sphingolipid Metabolism
  3031. Decreased Sphingolipid Synthesis Enhances Rhinovirus-Triggered Airway Hyperreactivity
  3032. Sphingolipid VARIETY, BIOSYNTHESIS AND REGULATION
  3033. Repurposing P‐glycoprotein Inhibitors as Modifiers of Sphingolipid Metabolism—Therapeutic Implications in Cancer
  3034. 1. Chemical approaches to Sphingolipid research
  3035. Regulation of mitochondrial fun Sphingolipids
  3036. Chemical approaches to Sphingolipid research (Seminaris de Recerca 2014)
  3037. 172 The Role of Bioactive Sphingolipids in Vascular Calcification
  3038. Manipulation of the Sphingolipid rheostat alters the mediator of flow-induced dilation in the human microcirculation
  3039. Role and Regulation of Sphingolipids in Neuropathy
  3040. Effect of hypoxia on the cardiovascular Sphingolipid system
  3041. Hybrid mathematical modeling decodes the complexity of Sphingolipid pathway to predict chemosensitivity
  3042. THU0240 Dysregulations in The Sphingolipid Pathway in SLE Patients
  3043. Sphingolipids and the Control of Fatty Acid Synthesis
  3044. Atypical peripheral manifestation of abnormal Sphingolipid metabolism
  3045. Study on the function of Sphingolipids during the starvation
  3046. Vitamin D and Sphingolipids: Role in Bone and Neural System
  3047. Role of Sphingolipids in Death Receptor Signalling
  3048. Investigating Sphingolipid behavior and function using metabolic labeling
  3049. On the Role of Bioactive Sphingolipids and Their Metabolizing Enzymes in Cancer
  3050. Sphingolipid Metabolism and Insulin Resistance in Dairy Cattle
  3051. Sphingolipid Metabolism and Insulin Resistance in Dairy Cattle
  3052. Sphingolipids in Breast Cancer Progression and Inflammatory Responses
  3053. Synthesis and optimization of new Sphingolipid sensors for metabolism and trafficking studies
  3054. Abstract A04: Differential dependence on Sphingolipid metabolism in the normal and leukemic human hematopoietic hierarchy
  3055. Aging‐induced impairments in diaphragm isotonic contractile properties and modifications of proteomic and Sphingolipid profile
  3056. Lipid oversupply to cardiomyocytes induces Sphingolipid-dependent oxidative stress and induction of mitophagy through ceramide synthase 2
  3057. A6. 14 Dysregulations in the Sphingolipid pathway in sle patients
  3058. Synthetic Sphingolipid analogues: biophysical properties and subcellular localization
  3059. Serum Sphingolipids–relationships to insulin sensitivity 3 and changes with exercise in humans 4
  3060. Crosstalk between Sphingolipids and HDACs in the Development of Ischemic Retinal Injury
  3061. Simultaneously inhibiting multiple nutrient acquisition pathways using synthetic Sphingolipid compounds
  3062. Mini-Review: Enhancement of Maldi-MS Imaging on Sphingolipids
  3063. The utility of Sphingolipid pathway inhibitors in the treatment of aspergillosis
  3064. Sphingolipid, Neurodegeneration & Stem Cell Niches
  3065. A hyphenated technique based on high-performance thin layer chromatography for determining neutral Sphingolipids: A proof of concept
  3066. INVOLVEMENT OF THE Sphingolipid METABOLISM IN PROSTATE AND BLADDER CANCER MALIGNANCY
  3067. Sphingolipid Turnover Inhibitors as Modulators of Cellular Metabolism and Obesity
  3068. Investigation of Pathways for Complex Sphingolipid Biosynthesis in Arabidopsis thaliana (L.) Heynh
  3069. Gamma‐tocotrienol inhibits cytokine‐stimulated NF‐kB activation by inducing A20 and modulating Sphingolipids
  3070. The Role of Transforming Growth Factor? Signalling in Regulating the Sphingolipid Rheostat in Intrauterine Growth Restriction
  3071. Hexokinase 2; Tangled between Sphingolipid and sugar metabolism
  3072. Investigating the Mechanisms of Non-Random Sphingolipid Organization in the Plasma Membranes of Fibroblast Cells
  3073. Defining the Roles of Serine Palmitoyltransferase-Interacting Proteins in the Regulation of Sphingolipid Homeostasis
  3074. Low Serum Sphingolipids in Attention Deficit Hyperactivity Disorder (ADHD)
  3075. The Role of Sphingolipids in the Maintenance of the Neural Retina and Pathological Neovascularization.
  3076. Unravelling how the biosynthesis of Sphingolipids impacts stress responses in Aspergillus nidulans
  3077. Human Sphingolipid Biomarkers of Single Dose Radiotherapy: A Clinical trial
  3078. STUDY OF THE ROLE OF PLASMA MEMBRANE Sphingolipids IN CYSTIC FIBROSIS AIRWAYS INFECTION
  3079. Targeting Sphingolipid metabolism in large granular lymphocyte leukemia
  3080. The Role of Transforming Growth Factor Beta Signalling in Regulating the Sphingolipid Rheostat in Intrauterine Growth Restriction
  3081. Sphingolipids in mitochondria
  3082. The role of cholesterol and Sphingolipids in glomerular disease
  3083. Macrophage Activation in Sickle Cell Disease: The Role of Sphingolipid Metabolism in the Disease State
  3084. Starving cancer: the molecular mechanisms of nutrient transporter loss induced by anti-neoplastic Sphingolipids
  3085. Cell Damage Induced by Lysosomal Impairment: Study of the Role of Plasma Membrane Sphingolipids
  3086. Binding mechanisms and dynamic properities of Sphingolipid binding peptides on lipid rafts: molecular dynamics simulation studies
  3087. A reflection of the lasting contributions from Dr. Robert Bittman to sterol trafficking, Sphingolipid and phospholipid research
  3088. Genome Wide Analysis Identifies Sphingolipid Metabolism As A New Target Of Valproic Acid
  3089. The protein kinase Sch9 as modulator of ageing in yeast-a connection with Sphingolipid metabolism and the V-ATPase
  3090. Activation of Liver X receptors (LXRs) increases Sphingolipid biosynthesis in hepatic cells
  3091. Role of” Sphingolipid rheostat” in mediating the apoptotic effect of luteolin in colon cancer cells
  3092. Is the site of influenza virus assembly and budding enriched with cholesterol and Sphingolipids?
  3093. Serum lipidomic analysis showed a dysregulation of Sphingolipids in AMD patients, which may reflect the response of cells to lipid peroxidation products
  3094. Building a metabolic bridge between glycolysis and Sphingolipid biosynthesis: implications in cancer.
  3095. Sphingolipids AS TARGETS FOR RECOVERY FROM SPINAL CORD INJURIES: DECIPHERING THE ROLE OF SPHINGOSINE-1-PHOSPHATE
  3096. Sphingolipid Targeting Agent MIPS247 Attenuates Collagen Synthesis by Cardiac and Kidney Cells via Stabilisation of PPM1A
  3097. Loss of ABCB5 leads to progressive visual loss due to Sphingolipid accumulation in Retinal Pigment Epithelium
  3098. The natural flavonoid Luteolin induces apoptosis in colon cancer cells by dysregulating the Sphingolipid rheostat
  3099. Identification of a Sphingolipid a-Glucuronosyltransferase That Is Essential for Pollen Function in ArabidopsisC W OPEN
  3100. Feeling the burn: Sphingolipids and infection risk after thermal injury
  3101. Plasma Sphingolipid changes with autopsy-confirmed Lewy body or Alzheimer’s pathology
  3102. Cannabinoids derivatives modify the pattern of Sphingolipids in acute myeloid leukemia cells and produce a potent anti-leukemic effect
  3103. Effect of Green House Condition on Development of Soybean Seed Saponins, Sphingolipids, and Phytosterols Concentrations and Compositions
  3104. Cannabinoids Derivatives Exert a Potent Antileukemic Effect By Modifying the Pattern of Membrane Sphingolipids
  3105. Homeostatic regulation of Sphingolipid synthesis by the ORMDL proteins: Molecular mechanisms
  3106. Abstract B18: Role of Sphingolipids and ER stress in curcumin mediated cytotoxicity In human neuroblastoma cells
  3107. ORIGINAL RESEARCH ARTICLE Sphingolipids METABOLISM IN THE SALIVARY GLANDS OF RATS WITH OBESITY AND STREPTOZOTOCIN INDUCED …
  3108. Novel cancer-related regulatory targets for the signalling Sphingolipids sphingosine-1-phosphate and sphingosylphosphorylcholine
  3109. DETERMINATION OF THE Sphingolipid BIOSYNTHESIS INHIBITOR MYRIOCIN BY LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC-MS/MS) …
  3110. Sphingolipid Metabolism, Sit4p and TORC1 in the Yeast Model of Niemann-Pick Type C1 Disease
  3111. Sphingolipid signaling as a target in photoreceptor degeneration: an in vitro model for therapeutic strategies in Retinitis Pigmentosa
  3112. A36 HOST DEFENSE AGAINST VIRAL INFECTION: Decreased Sphingolipid Synthesis Enhances Rhinovirus-Triggered Airway Hyperreactivity
  3113. Therapeutic potential of fingolimod against prostate cancer cells is partly attributed to interrupting the cross talk between estrogen and Sphingolipid metabolisms
  3114. Oxidized graphene nanoparticles as a delivery system for the bioactive Sphingolipid ceramide
  3115. Concluding Step in Cell Restitution Cycle: ER Transport Vesicles with Sphingolipids in the Outer Leaflet of the Membrane Restore Lysosomes
  3116. Expression levels of bioactive Sphingolipid genes in newly diagnosed and drug-resistant chronic myeloid leukemia patients and their impact on the clinical progress
  3117. Crosstalk between Three Coordinated Stress Responses: Cell Wall Integrity Signaling, Endoplasmic Reticulum Stress, and Sphingolipid Biosynthesis
  3118. Intermediate product and inhibitor determination in Sphingolipid biosynthesis pathway based on OPA-HPLC-UV.
  3119. The DNA Damage Response: p53 Regulation of the CHK1-Suppressed Pathway and Sphingolipid Metabolism
  3120. Deciphering the link between genetic variants and Sphingolipid metabolites in fumonisin B1-and FTY720-induced neural tube defects
  3121. Paradoxical antidepressant effects of alcohol are related to acid sphingomyelinase and its control of Sphingolipid homeostasis
  3122. Proteasome inhibition decreases triglycerides in hepatic and adipose tissues via Sphingolipid modulation
  3123. Sphingolipid Synthesis And Composition Are Altered In Children With Asthma
  3124. Identification of Sphingolipid Metabolism Perturbations in Endothelial Cells Induced by the Acid Sphingomyelinase Inhibitor Imipramine Using Stable Isotope Labeling …
  3125. Analysis of Glycerophospholipids and Sphingolipids in Murine Brain Using Liquid Chromatography–Electrospray Ionization-Tandem Mass Spectrometry and Matrix …
  3126. Changes of Sphingolipid profiles in serum of patients with diabetes
  3127. Biomedicine of Sphingolipids
  3128. Development of novel antimicrobial agents through inhibition of cytokinetic protein FtsZ in Mycobacterium tuberculosis and Sphingolipid GlcCer in fungi
  3129. Kinetic reconstruction and analysis of Sphingolipid metabolism
  3130. Metformin suppresses synthesis of pro-survival Sphingolipid, sphingosine-1-phosphate, by inhibition of sphingosine kinase-1, in MCF-7 and SK-BR-3 breast cancer …
  3131. Development of novel antimicrobial agents through inhibition of cytokinetic protein FtsZ in Mycobacterium tuberculosis and Sphingolipid GlcCer in fungi
  3132. How do Cholesterol and Saturated Sphingolipids Affect Acyl Chain Order in the Fluid Phase of Binary POPC Bilayers-a Study with 1-oleoyl-2-propionyl-DPH-sn …
  3133. Front Cover: Synthesis of Nontoxic Fluorous Sphingolipids as Molecular Probes of Exogenous Metabolic Studies for Rapid Enrichment by Fluorous Solid Phase …
  3134. Sphingolipids modulate the function of human serotonin (1A) receptors: Insights from Sphingolipid-deficient cells
  3135. Plasma membrane targeting by short chain Sphingolipids inserted in nanoliposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast …
  3136. FTY720 (Fingolimod) Targets the Sphingolipid Pathway and Induces Autophagy-Related Apoptosis in Human Natural Killer Large Granular Lymphocyte …
  3137. Curcumin mediated apoptosis in human neuroblastoma cells via ROS and Sphingolipid generation
  3138. UV-induced free radical transformations of Sphingolipids
  3139. … -pyridinium ceramide enhances killing of SCC17B human head and neck squamous cell carcinoma cells via the de novo Sphingolipid biosynthesis and mitochondrial …
  3140. To Grow or Die: Regulation of Plant Sphingolipid Metabolism
  3141. Sphingolipids and TGF-β signaling in the human cornea
  3142. Novel Mechanisms of Regulation of Bioactive Sphingolipids in Cancer Biology
  3143. Sphingolipid Metabolism In Retinal Ischemic Preconditioning
  3144. Analysis of Sphingolipid Composition of Human Vitreous from Control and Diabetic Individuals
  3145. Prevalence of the Sphingolipid storage diseases M. Gaucher and M. Niemann-Pick type B: results in a nation-wide screening project in 224 patients
  3146. Stereoselective preparation of quaternary 2-vinyl sphingosines and ceramides and their effect on basal Sphingolipid metabolism
  3147. PRESUMABLE ROLE OF Sphingolipid MECHANISMS IN DISUSE ATROPHY OF SKELETAL MUSCLE
  3148. Expression of enzymes of Sphingolipid metabolism in the blood vessel.(LB697)
  3149. 2298: Allergic asthma is associated with elevated Sphingolipid levels in children
  3150. Abstract A108: Targeting Sphingolipid metabolism and metastasis with motuporamine derivatives
  3151. Stereoselective preparation of quaternary 2-vinyl sphingosines and ceramides and their effect on basal Sphingolipid metabolism
  3152. Disruption of Prolyl hydroxylase domain protein-2 (PHD2) activity impairs TGFβ-dependent Sphingolipid metabolism in murine placenta
  3153. Sphingolipid biology, lipid rafts and their roles in neurodegeneration and neuroprotection
  3154. Palmitic Acid Stimulates a Delayed but Extremely High Expression of IL-6 and Also Enhances LPS Signaling via Sphingolipid Metabolism in Human Aortic Endothelial …
  3155. Metabolism of Sphingolipids in experimental obesity and insulin resistance
  3156. COMPREHENSIVE METABOLOMIC ANALYSES REVEAL ALTERATIONS IN GLYCEROPHOSPHOLIPID AND Sphingolipid METABOLISM DURING THE …
  3157. The unexpected Sphingolipid and cholesterol distribution in the plasma membrane (107.1)
  3158. Deciphering the link between salicylic acid signaling and Sphingolipid metabolism
  3159. Importance of the Sphingolipid Metabolism in the Acquisition of Final MDCK Differentiation
  3160. Regulation of Sphingolipid Biosynthesis by Endoplasmic Reticulum Stress
  3161. Sphingolipid signaling in corneal neovascularization.
  3162. The yeast proteolipid Pmp3p affects plasma membrane Sphingolipid abundance
  3163. Research Article 4-Hydroxynonenal Contributes to Angiogenesis through a Redox-Dependent Sphingolipid Pathway: Prevention by Hydralazine Derivatives
  3164. Novel Role for Sphingolipid Metabolism in Radiation Nephropathy
  3165. To be a medicine or a toxin? this is a question–a Sphingolipid story
  3166. Sphingolipid regulates pro-inflammatory cytokines to subdue the neoplastic lesions in hepatocellular carcinoma
  3167. D27 MITOCHONDRIA: LIVE AND LET DIE: Involvement Of Sphingolipids In Cigarette Smoke Induced Lung Epithelial Cell Mitophagy And Necroptosis
  3168. Deregulation of Mitochondrial Sphingolipid Metabolism in Diabetes
  3169. Effects of Blood Cholesterol Levels and Dietary Fatty Acids on Sphingolipid Profiles in Plasma, Liver and Adipose Tissue
  3170. Characterization of Sphingolipid-based stress responses in the yeast Saccharomyces cerevisiae through reverse engineering
  3171. Abstract P212: Sphingolipid De Novo Pathway is a Novel Regulator of Blood Pressure Homeostasis
  3172. Analyzing roles of Sphingolipid in neurodegenerative blue cheese mutants in drosophila
  3173. Bioactive Sphingolipid mediators promote corneal epithelial homeostasis and wound healing
  3174. Metabolomic signature in COPD. Plasma and lung tissue comparison identify Sphingolipids as potential biomakers
  3175. ORM: A Central Regulator of Sphingolipid Homeostasis and Composition in Arabidopsis
  3176. Additional Mode of Action? Fingolimod Inhibits the IL-33 Induced IFN-γ Formation in CD8+ and Affects the Formation of Bioactive Sphingolipids in Patients with …
  3177. Endothelial-derived Sphingolipids Preserve Systemic Vascular Function And Blood Pressure
  3178. Advanced Glycation End Products Inhibition Restores Sphingolipid Rheostat in Mice Liver and Prevents Diet-Induced Insulin Resistance
  3179. 220 Regulation of Vascular Calcification by Bioactive Sphingolipids
  3180. Roles of Sphingolipid metabolism in non‐alcoholic fatty liver disease (96.1)
  3181. 12 Sphingolipids in Airway Inflammation
  3182. Sphingolipids mediate the signals for all the essential functions of Target Of Rapamycin Complex 2
  3183. HPTLC-ESI-MS/MS for identifying neutral lipids, Sphingolipids and phospholipids in complex samples
  3184. Sphingolipids of Commensals Modulate Host Immunity through Regulation of iNKT Cells
  3185. Liposomal Nanomedicine with Short Chain Sphingolipids Modulate Tumor Cell Membrane Permeability Modulate Tumor Cell Membrane Permeability and Improve …
  3186. Synthesis of 2-Vinyl Sphingolipids as S1PL inhibitors
  3187. New fluorescence microscopy approaches to explore the influence of Sphingolipids on lateral organization of biomembranes: From artificial systems to cellular …
  3188. Role of Trpm2 in Sphingolipid-Mediated Radiation-Induced Lung Injury
  3189. HyperpHospHorylAtion of tAu by GsK-3β in AlzHeimer’s diseAse: tHe interAction of Aβ And Sphingolipid mediAtors As A tHerApeutic tArGet
  3190. Sphingolipid chaperone proteins modulate signal transduction and pathophysiology
  3191. Deterring breast cancer progression. The critical role of a lipid-Sphingolipid epigenetic mechanism of cell fate
  3192. Inhibitory effects of Leishmanial Sphingolipid on Endotoxin induced macrophage activation and sepsis associated inflammatory injury
  3193. Cystic fibrosis transmembrane conductance regulator and Sphingolipids regulate hypoxic pulmonary vasoconstriction
  3194. Two specific ESCRT components rescue the Sphingolipid-mediated intracellular accumulation of ergosterol
  3195. Identification of the Microbial Lyso-Sphingolipid Sphingosylphosphorylcholine as a Defense Inducer in Arabidopsis thaliana-a computational and molecular biological …
  3196. Optimizing Vascular Invasion into Hydrogel Scaffolds Using Bioactive Sphingolipids
  3197. Arabidopsis mutants in Sphingolipid synthesis as tools to understand the structure and function of membrane microdomains in plasmodesmata
  3198. Does the Influenza Virus Bud from Cholesterol-and Sphingolipid-Enriched Plasma membrane domains?
  3199. Endothelial Nogo-B Controls Sphingolipid de novo Biosynthesis to Impact Coronary Artery Atherosclerosis
  3200. Cerebrospinal fluid Sphingolipids and acid sphingomyelinase change with beta amyloid levels in Alzheimer’s disease (576.5)
  3201. Cholesterolâ Ceramide Interactions in Phospholipid and Sphingolipid Bilayers As Observed by Positron Annihilation Lifetime Spectroscopy and Molecular Dynamics …
  3202. Endothelial Nogo-B Regulates Sphingolipid Biosynthesis to Promote the Onset of Pathological Hypertrophy During Chronic Pressure Overload
  3203. Copper-64 Labelled Fingolimod for PET Imaging of the Sphingolipid-1-Phosphate Axis in Prostate Cancer
  3204. Erratum to: Activities of genes controlling Sphingolipid metabolism in human fibroblasts treated with flavonoids
  3205. MacKay, Simon P. and Pyne, Susan and Pyne, Nigel J.(2014) Resveratrol and its oligomers: modulation of Sphingolipid metabolism and signaling in disease …
  3206. C34 NEW BASIC SCIENCE IN ASTHMA: ALLERGIC INFLAMMATION I: Depletion Of Sphingolipids In A Murine Model Of Allergic Asthma Exacerbates Airway Hyper …
  3207. Th2 Cytokines and IL-17 Have Distinct Effects on Sphingolipid Metabolism in Differentiated Primary Human Keratinocytes
  3208. … BETWEEN INFECTION, INJURY, AND REPAIR: Aged Allogeneic Platelets Trigger Antibody-Independent Transfusion Related Acute Lung Injury Via A Sphingolipid …
  3209. Corrigendum to “Hepatic fatty acid uptake is regulated by the Sphingolipid acyl chain length”[Mol. Cell Biol. Lipids 1841 (12)(2014) 1754–1766]
  3210. Orm proteins integrate multiple signals to maintain Sphingolipid homeostasis.
  3211. Reducing Sphingolipid Synthesis Orchestrates Global Changes to Extend Yeast Lifespan Jun Liu, Xinhe Huang, Bradley R. Withers, Eric Blalock, Ke Liu and Robert C …
  3212. Sphingolipids and their metabolism in physiology and disease
  3213. A comprehensive review: Sphingolipid metabolism and implications of disruption in Sphingolipid homeostasis
  3214. Role of bioactive Sphingolipids in physiology and pathology
  3215. Sphingolipids and lipid rafts: Novel concepts and methods of analysis
  3216. Exploring Sphingolipid implications in neurodegeneration
  3217. Sphingolipids in metabolic disease: The good, the bad, and the unknown
  3218. Sphingolipids in host–microbial interactions
  3219. On the role of Sphingolipids in cell survival and death
  3220. Sphingolipids and mitochondrial dynamic
  3221. Role of ceramidases in Sphingolipid metabolism and human diseases
  3222. Sphingolipid biosynthesis in man and microbes
  3223. Neurodegenerative disorders: Spotlight on Sphingolipids
  3224. Sphingolipid metabolism in cancer signalling and therapy
  3225. Sphingolipids in the heart: from cradle to grave
  3226. Sphingolipids in Alzheimer’s disease, how can we target them?
  3227. Targeting Sphingolipids for cancer therapy
  3228. Sphingolipids: towards an integrated view of metabolism during the plant stress response
  3229. Role of Sphingolipid metabolism in neurodegeneration
  3230. THE IMPORTANCE OF Sphingolipids IN HUMAN DISEASES
  3231. Role of cholesterol and Sphingolipids in brain development and neurological diseases
  3232. Functions of Sphingolipids in pathogenesis during host–pathogen interactions
  3233. The role of Sphingolipids in allergic disorders
  3234. Sphingolipid metabolism, transport, and functions in plants: Recent progress and future perspectives
  3235. Sphingolipids in food and their critical roles in human health
  3236. Sphingolipids in obesity and correlated co-morbidities: the contribution of gender, age and environment
  3237. Ceramides and other Sphingolipids as drivers of cardiovascular disease
  3238. Alteration of Sphingolipids in biofluids: Implications for neurodegenerative diseases
  3239. The manifold roles of Sphingolipids in viral infections
  3240. Novelty of Sphingolipids in the central nervous system physiology and disease: Focusing on the Sphingolipid hypothesis of neuroinflammation and neurodegeneration
  3241. Sphingolipids as biomarkers of disease
  3242. The role of Sphingolipids metabolism in cancer drug resistance
  3243. A reference map of Sphingolipids in murine tissues
  3244. Sphingolipids in foodstuff: Compositions, distribution, digestion, metabolism and health effects–A comprehensive review
  3245. Role of Sphingolipids in the biogenesis and biological activity of extracellular vesicles
  3246. Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy
  3247. Sphingolipids as critical players in retinal physiology and pathology
  3248. Circulating ceramides-are origins important for Sphingolipid biomarkers and treatments?
  3249. Decreased Sphingolipid synthesis in children with 17q21 asthma–risk genotypes
  3250. Sphingolipid hydroxylation in mammals, yeast and plants–An integrated view
  3251. Role of Sphingolipids in senescence: implication in aging and age-related diseases
  3252. Sphingolipid analysis in clinical research
  3253. Sphingolipids in neurodegeneration (with focus on ceramide and S1P)
  3254. Childhood amyotrophic lateral sclerosis caused by excess Sphingolipid synthesis
  3255. Characteristics and mechanisms of a Sphingolipid-associated childhood asthma endotype
  3256. Approaches for probing and evaluating mammalian Sphingolipid metabolism
  3257. Sphingolipid metabolism in non-alcoholic fatty liver diseases
  3258. Sphingolipids in inflammation
  3259. Novel Sphingolipid-based cancer therapeutics in the personalized medicine era
  3260. Physiological and pathological functions of Sphingolipids in pregnancy
  3261. A Comprehensive Review on the Interplay between Neisseria spp. and Host Sphingolipid Metabolites
  3262. Colon cancer and perturbations of the Sphingolipid metabolism
  3263. Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease
  3264. The role of Sphingolipids in endoplasmic reticulum stress
  3265. Machine learning reveals serum Sphingolipids as cholesterol-independent biomarkers of coronary artery disease
  3266. CerS6-derived Sphingolipids interact with Mff and promote mitochondrial fragmentation in obesity
  3267. Bacteroides-derived Sphingolipids are critical for maintaining intestinal homeostasis and symbiosis
  3268. Plant cell-surface GIPC Sphingolipids sense salt to trigger Ca2+ influx
  3269. The impact of dietary Sphingolipids on intestinal microbiota and gastrointestinal immune homeostasis
  3270. Serine restriction alters Sphingolipid diversity to constrain tumour growth
  3271. Emergence of membrane Sphingolipids as a potential therapeutic target
  3272. The dynamics and role of Sphingolipids in eukaryotic organisms upon thermal adaptation
  3273. The lipid status in patients with ulcerative colitis: Sphingolipids are disease-dependent regulated
  3274. Alterations of endogenous Sphingolipid metabolism in cardiometabolic diseases: Towards novel therapeutic approaches
  3275. Bioactive Sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid
  3276. Roles of ceramides and other Sphingolipids in immune cell function and inflammation
  3277. The role of the ‘sphingoid motif’in shaping the molecular interactions of Sphingolipids in biomembranes
  3278. Sphingolipids: effectors and Achilles heals in viral infections?
  3279. Dietary Sphingolipids contribute to health via intestinal maintenance
  3280. Sphingolipid metabolism: a new therapeutic opportunity for brain degenerative disorders
  3281. Bioactive Sphingolipids as major regulators of coronary artery disease
  3282. Sphingolipids in the Pathogenesis of Parkinson’s Disease and Parkinsonism
  3283. Diverse facets of Sphingolipid involvement in bacterial infections
  3284. Sphingolipids in lung pathology in the coronavirus disease era: A review of Sphingolipid involvement in the pathogenesis of lung damage
  3285. Sphingolipids in plants: a guidebook on their function in membrane architecture, cellular processes, and environmental or developmental responses
  3286. Sphingolipids and their enigmatic role in asthma
  3287. Sphingolipids in COPD
  3288. Sphingolipids in non-alcoholic fatty liver disease and hepatocellular carcinoma: ceramide turnover
  3289. Ceramide phosphoethanolamine, an enigmatic cellular membrane Sphingolipid
  3290. Sphingolipid lysosomal storage diseases: from bench to bedside
  3291. Emerging roles of Sphingolipid signaling in plant response to biotic and abiotic stresses
  3292. Specific hepatic Sphingolipids relate to insulin resistance, oxidative stress, and inflammation in nonalcoholic steatohepatitis
  3293. Sphingolipid metabolism during Toll‐like receptor 4 (TLR4)‐mediated macrophage activation
  3294. Sphingolipids and neuronal degeneration in lysosomal storage disorders
  3295. Sphingolipid metabolism in type 2 diabetes and associated cardiovascular complications
  3296. Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation …
  3297. Sphingolipid‐enriched domains in fungi
  3298. Sphingolipid metabolism: new insight into ceramide-induced lipotoxicity in muscle cells
  3299. A perilous path: the inborn errors of Sphingolipid metabolism
  3300. Who moves the sphinx? An overview of intracellular Sphingolipid transport
  3301. Updates on Sphingolipids: Spotlight on retinopathy
  3302. The role of Sphingolipids in cardiovascular pathologies
  3303. Invited review: Sphingolipid biology in the dairy cow: The emerging role of ceramide
  3304. Sphingolipids as modulators of SARS-CoV-2 infection
  3305. A comprehensive review on the manipulation of the Sphingolipid pathway by pathogenic bacteria
  3306. Altering Sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction
  3307. Targeting Sphingolipid metabolism as an approach for combination therapies in haematological malignancies
  3308. Sphingolipids and the link between alcohol and cancer
  3309. Intracellular localization of diacylglycerols and Sphingolipids influences insulin sensitivity and mitochondrial function in human skeletal muscle
  3310. The role of Sphingolipids in cancer immunotherapy
  3311. Overview of concepts of the Sphingolipid metabolism
  3312. Sphingolipid metabolism in the development and progression of cancer: one cancer’s help is another’s hindrance
  3313. The role of Sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders
  3314. Sphingolipid analysis indicate lactosylceramide as a potential biomarker of inflammatory bowel disease in children
  3315. Potential therapeutic targets for atherosclerosis in Sphingolipid metabolism
  3316. Sphingolipid metabolism and signaling in skeletal muscle: from physiology to physiopathology
  3317. Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels
  3318. Sphingolipids as emerging mediators in retina degeneration
  3319. Large-scale lipidomics identifies associations between plasma Sphingolipids and T2DM incidence
  3320. Abnormal islet Sphingolipid metabolism in type 1 diabetes
  3321. Sphingolipids as a culprit of mitochondrial dysfunction in insulin resistance and type 2 diabetes
  3322. The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PDGBA
  3323. Cholesterol and Sphingolipid enriched lipid rafts as therapeutic targets in cancer
  3324. Antineoplastic agents targeting Sphingolipid pathways
  3325. Biophysical analysis of the plant-specific GIPC Sphingolipids reveals multiple modes of membrane regulation
  3326. Plasma Sphingolipids and risk of cardiovascular diseases: a large-scale lipidomic analysis
  3327. Sphingolipid composition of circulating extracellular vesicles after myocardial ischemia
  3328. Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosis [S]
  3329. Visualizing Sphingolipid biosynthesis in cells
  3330. Conserved functions of ether lipids and Sphingolipids in the early secretory pathway
  3331. Cancer prevention and therapy with polyphenols: Sphingolipid-mediated mechanisms
  3332. Convergence of Sphingolipid desaturation across over 500 million years of plant evolution
  3333. Candida albicans gains azole resistance by altering Sphingolipid composition
  3334. Click chemistry in Sphingolipid research
  3335. Serum Sphingolipid profile in asthma
  3336. Targeting the Sphingolipid system as a therapeutic direction for glioblastoma
  3337. Dietary fat and protein intake in relation to plasma Sphingolipids as determined by a large-scale lipidomic analysis
  3338. Synthetic probes and chemical tools in Sphingolipid research
  3339. Sphingolipids in HDL–Potential markers for adaptation to pregnancy?
  3340. New insights into the role of Sphingolipid metabolism in melanoma
  3341. Sphingolipid signaling in renal fibrosis
  3342. Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases
  3343. Sphingolipids and membrane targets for therapeutics
  3344. Biosynthesis of long chain base in Sphingolipids in animals, plants and fungi
  3345. Ceramide synthase inhibition by fumonisins: a perfect storm of perturbed Sphingolipid metabolism, signaling, and disease [S]
  3346. Interrelations of Sphingolipid and lysophosphatidate signaling with immune system in ovarian cancer
  3347. Sphingolipids as potential therapeutic targets against enveloped human RNA viruses
  3348. The role of Sphingolipid metabolism in bone remodeling
  3349. Sphingolipids and acid ceramidase as therapeutic targets in cancer therapy
  3350. Circulating Sphingolipids, insulin, HOMA-IR, and HOMA-B: the strong heart family study
  3351. Sphingolipid-mediated calcium signaling and its pathological effects
  3352. Sphingolipids in hematopoiesis: Exploring their role in lineage commitment
  3353. Fumonisin B1: A tool for exploring the multiple functions of Sphingolipids in plants
  3354. Mapping Sphingolipid metabolism pathways during phagosomal maturation
  3355. The cross-talk between Sphingolipids and insulin-like growth factor signaling: significance for aging and neurodegeneration
  3356. Alteration of Sphingolipid metabolism as a putative mechanism underlying LPS‐induced BBB disruption
  3357. Dysregulation of Sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
  3358. Particular CSF Sphingolipid patterns identify iNPH and AD patients
  3359. Fingolimod interrupts the cross talk between estrogen metabolism and Sphingolipid metabolism within prostate cancer cells
  3360. Sphingolipids and the unfolded protein response
  3361. De novo synthesis of Sphingolipids is essential for decidualization in mice
  3362. Comprehensive characterization of bovine milk lipids: Phospholipids, Sphingolipids, glycolipids, and ceramides
  3363. Follicular dynamics of glycerophospholipid and Sphingolipid metabolisms in polycystic ovary syndrome patients
  3364. Imaging with mass spectrometry, the next frontier in Sphingolipid research? A discussion on where we stand and the possibilities ahead
  3365. Interdiction of Sphingolipid metabolism revisited: focus on prostate cancer
  3366. A circular network of coregulated Sphingolipids dictates lung cancer growth and progression
  3367. C24 Sphingolipids govern the transbilayer asymmetry of cholesterol and lateral organization of model and live-cell plasma membranes
  3368. Sphingolipids as targets for inhalation treatment of cystic fibrosis
  3369. Nanoscale imaging of bacterial infections by Sphingolipid expansion microscopy
  3370. Sphingolipids in type 1 diabetes: focus on beta-cells
  3371. Sphingolipids and diagnosis, prognosis, and organ damage in systemic lupus erythematosus
  3372. The Ormdl genes regulate the Sphingolipid synthesis pathway to ensure proper myelination and neurologic function in mice
  3373. DEGS1-associated aberrant Sphingolipid metabolism impairs nervous system function in humans
  3374. The role of Sphingolipids and specialized pro-resolving mediators in Alzheimer’s disease
  3375. ORMDL3 and asthma: linking Sphingolipid regulation to altered T cell function
  3376. Optical Control of Glycerolipids and Sphingolipids
  3377. Sphingolipid metabolism–an ambiguous regulator of autophagy in the brain
  3378. Age-dependent changes to Sphingolipid balance in the human hippocampus are gender-specific and may sensitize to neurodegeneration
  3379. Sphingolipid metabolism in glioblastoma and metastatic brain tumors: a review of sphingomyelinases and sphingosine-1-phosphate
  3380. Sphingolipids controlling ciliary and microvillar function
  3381. Sphingolipid-transporting proteins as cancer therapeutic targets
  3382. Sphingolipid biosynthesis modulates plasmodesmal ultrastructure and phloem unloading
  3383. Ether lipids, Sphingolipids and toxic 1‐deoxyceramides as hallmarks for lean and obese type 2 diabetic patients
  3384. Author Correction: Sphingolipids and their metabolism in physiology and disease.
  3385. Reduced Sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
  3386. Unbalanced Sphingolipid metabolism and its implications for the pathogenesis of psoriasis
  3387. Automated Annotation of Sphingolipids Including Accurate Identification of Hydroxylation Sites Using MSn Data
  3388. Role of bioactive Sphingolipids in inflammation and eye diseases
  3389. De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer
  3390. Monitoring the Sphingolipid de novo Synthesis by Stable-Isotope Labeling and Liquid Chromatography-Mass Spectrometry
  3391. The many facets of Sphingolipids in the specific phases of acute inflammatory response
  3392. Alterations of Sphingolipid metabolism in different types of polycystic ovary syndrome
  3393. Sphingolipid modulation activates proteostasis programs to govern human hematopoietic stem cell self-renewal
  3394. Biological roles played by Sphingolipids in dimorphic and filamentous fungi
  3395. Increasing Sphingolipid synthesis alleviates airway hyperreactivity
  3396. Associations among circulating Sphingolipids, β-cell function, and risk of developing type 2 diabetes: A population-based cohort study in China
  3397. Sphingolipids activate the endoplasmic reticulum stress surveillance pathway
  3398. Multi-technique comparison of atherogenic and MCD NASH models highlights changes in Sphingolipid metabolism
  3399. Sphingolipids role in the regulation of inflammatory response: From leukocyte biology to bacterial infection
  3400. Sphingolipids of Asteroidea and Holothuroidea: Structures and biological activities
  3401. Analysis of Sphingolipid composition in human vitreous from control and diabetic individuals
  3402. Synthesis and function of complex Sphingolipid glycosylation
  3403. Antifungal drug development: targeting the fungal Sphingolipid pathway
  3404. Enhancement of Sphingolipid synthesis improves osmotic tolerance of Saccharomyces cerevisiae
  3405. Fungal Sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies
  3406. Bioactive Sphingolipids as biomarkers predictive of disease severity and treatment response in cancer: current status and translational challenges
  3407. Sphingolipid signature of human feto-placental vasculature in preeclampsia
  3408. The role of Sphingolipids in psychoactive drug use and addiction
  3409. Resolving Sphingolipid isomers using cryogenic infrared spectroscopy
  3410. Circulating Sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study
  3411. The noncanonical chronicles: Emerging roles of Sphingolipid structural variants
  3412. Platelet extracellular vesicles mediate transfusion-related acute lung injury by imbalancing the Sphingolipid rheostat
  3413. Identification of lysophosphatidylcholines and Sphingolipids as potential biomarkers for acute aortic dissection via serum metabolomics
  3414. Sphingolipids at the crossroads of NAFLD and senescence
  3415. Bicelles rich in both Sphingolipids and cholesterol and their use in studies of membrane proteins
  3416. Sphingolipids in early viral replication and innate immune activation
  3417. Distinctive Sphingolipid patterns in chronic multiple sclerosis lesions
  3418. Sphingolipid mediators of myocardial pathology
  3419. A review of the role of Sphingolipids in apoptosis phenomenon
  3420. Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia
  3421. Sphingolipid dysregulation due to lack of functional KDSR impairs proplatelet formation causing thrombocytopenia
  3422. Sphingolipids and redox signaling in renal regulation and chronic kidney diseases
  3423. Sphingolipids as regulators of autophagy and endocytic trafficking
  3424. Acylhydrazones as antifungal agents targeting the synthesis of fungal Sphingolipids
  3425. Analysis of urinary Sphingolipids using liquid chromatography‐tandem mass spectrometry in diabetic nephropathy
  3426. Anxiety and depression are related to higher activity of Sphingolipid metabolizing enzymes in the rat brain
  3427. Inflammatory ocular diseases and Sphingolipid signaling
  3428. Neuroprotective role of Sphingolipid rheostat in excitotoxic retinal ganglion cell death
  3429. Glycosylated Sphingolipids and progression to kidney dysfunction in type 1 diabetes
  3430. The role of the Sphingolipid pathway in liver fibrosis: An emerging new potential target for novel therapies
  3431. Bioactive Sphingolipids in the pathogenesis of chronic obstructive pulmonary disease
  3432. Manipulation of the Sphingolipid rheostat influences the mediator of flow‐induced dilation in the human microvasculature
  3433. Iron and Sphingolipids as common players of (Mal) adaptation to hypoxia in pulmonary diseases
  3434. Porphyromonas gingivalis Sphingolipid Synthesis Limits the Host Inflammatory Response
  3435. Association between serum Sphingolipids and eudaimonic well-being in white US adults
  3436. DeoxySphingolipid precursors indicate abnormal Sphingolipid metabolism in individuals with primary and secondary disturbances of serine availability
  3437. LC-HRMS based approach to identify novel Sphingolipid biomarkers in breast cancer patients
  3438. Mutations in Sphingolipid metabolism genes are associated with ADHD
  3439. Click reactions with functional Sphingolipids
  3440. Everybody needs Sphingolipids, right! Mining for new drug targets in protozoan Sphingolipid biosynthesis
  3441. Altered Sphingolipids metabolism damaged mitochondrial functions: lessons learned from Gaucher and Fabry diseases
  3442. Sphingolipid de novo biosynthesis is essential for intestine cell survival and barrier function
  3443. Circulating extracellular vesicles carrying Sphingolipid cargo for the diagnosis and dynamic risk profiling of alcoholic hepatitis
  3444. Gut Sphingolipid composition as a prelude to necrotizing enterocolitis
  3445. A localized chimeric hydrogel therapy combats tumor progression through alteration of Sphingolipid metabolism
  3446. The role of acid sphingomyelinase and modulation of Sphingolipid metabolism in bacterial infection
  3447. Biophysical and biological properties of atypical Sphingolipids: implications to physiology and pathophysiology
  3448. Diminished Sphingolipid metabolism, a hallmark of future type 2 diabetes pathogenesis, is linked to pancreatic β cell dysfunction
  3449. Small molecule inhibitors targeting biosynthesis of ceramide, the central hub of the Sphingolipid network
  3450. Absolute quantitative imaging of Sphingolipids in brain tissue by exhaustive liquid microjunction surface sampling–liquid chromatography–mass spectrometry
  3451. Altered Sphingolipid metabolism is associated with asthma phenotype in house dust mite-allergic patients
  3452. Sphingolipid metabolism is dysregulated at transcriptomic and metabolic levels in the spinal cord of an animal model of amyotrophic lateral sclerosis
  3453. Uptake of exogenous serine is important to maintain Sphingolipid homeostasis in Saccharomyces cerevisiae
  3454. Intestinal microbial-derived Sphingolipids are inversely associated with childhood food allergy
  3455. Druggable Sphingolipid pathways: experimental models and clinical opportunities
  3456. Sphingolipids: regulators of azole drug resistance and fungal pathogenicity
  3457. Inhibition of Sphingolipid synthesis improves outcomes and survival in GARP mutant wobbler mice, a model of motor neuron degeneration
  3458. The onus of Sphingolipid enzymes in cancer drug resistance
  3459. The role of Sphingolipids in acute kidney injury
  3460. Endothelial Sphingolipid de novo synthesis controls blood pressure by regulating signal transduction and NO via ceramide
  3461. Sphingolipids mediate polar sorting of PIN2 through phosphoinositide consumption at the trans-Golgi network
  3462. Regulation of necroptosis by phospholipids and Sphingolipids
  3463. Profile of Sphingolipid-related genes and its association with prognosis highlights Sphingolipid metabolism in oral cancer
  3464. Host Sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease
  3465. Endosome and Golgi‐associated degradation (EGAD) of membrane proteins regulates Sphingolipid metabolism
  3466. Human breast milk as source of Sphingolipids for newborns: Comparison with infant formulas and commercial cow’s milk
  3467. CPTP: A Sphingolipid transfer protein that regulates autophagy and inflammasome activation
  3468. Association between Sphingolipids and cardiopulmonary fitness in coronary artery disease patients undertaking cardiac rehabilitation
  3469. Inhibition of Sphingolipid synthesis as a phenotype-modifying therapy in cystic fibrosis.
  3470. SIRT1 regulates Sphingolipid metabolism and neural differentiation of mouse embryonic stem cells through c-Myc-SMPDL3B
  3471. Kicking off Sphingolipid biosynthesis: structures of the serine palmitoyltransferase complex
  3472. Probing de novo Sphingolipid metabolism in mammalian cells utilizing mass spectrometry [S]
  3473. Quantitative profiling of glycerides, glycerophosphatides and Sphingolipids in Chinese human milk with ultra-performance liquid chromatography/quadrupole-time-of …
  3474. Genetic defects in the Sphingolipid degradation pathway and their effects on microglia in neurodegenerative disease
  3475. Sphingolipids and microRNA changes in blood following blast traumatic brain injury: an exploratory study
  3476. Abnormal Sphingolipid world in inflammation specific for lysosomal storage diseases and skin disorders
  3477. Are glucosylceramide-related Sphingolipids involved in the increased risk for cancer in gaucher disease patients? Review and hypotheses
  3478. Strong alterations in the Sphingolipid profile of chickens fed a dose of fumonisins considered safe
  3479. Seipin negatively regulates Sphingolipid production at the ER–LD contact site
  3480. Sphingolipid metabolism and drug resistance in ovarian cancer
  3481. Sphingolipids and innate immunity: a new approach to infection in the post-antibiotic era?
  3482. Optical manipulation of Sphingolipid biosynthesis using photoswitchable ceramides
  3483. Proteomic analysis uncovers the modulation of ergosterol, Sphingolipid and oxidative stress pathway by myristic acid impeding biofilm and virulence in Candida …
  3484. Are Sphingolipids and serine dipeptide lipids underestimated virulence factors of Porphyromonas gingivalis?
  3485. Sphingosine phosphate lyase insufficiency syndrome (SPLIS): a novel inborn error of Sphingolipid metabolism
  3486. Drug‐like Sphingolipid SH‐BC‐893 opposes ceramide‐induced mitochondrial fission and corrects diet‐induced obesity
  3487. CRISPR/Cas9 deletion of ORMDLs reveals complexity in Sphingolipid metabolism
  3488. Azidosphinganine enables metabolic labeling and detection of Sphingolipid de novo synthesis
  3489. Polar lipid composition of bioactive dairy co-products buttermilk and butterserum: Emphasis on Sphingolipid and ceramide isoforms
  3490. Recent advances in the formulation of Sphingolipid anticancer therapeutics
  3491. Loss of the Sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy
  3492. Plasma Sphingolipid profile associated with subclinical atherosclerosis and clinical disease markers of systemic lupus erythematosus: Potential predictive …
  3493. Mouse liver compensates loss of Sgpl1 by secretion of Sphingolipids into blood and bile
  3494. Distinct phospholipid and Sphingolipid species are linked to altered HDL function in apolipoprotein AI deficiency
  3495. Sphingolipid metabolism as a marker of hepatotoxicity in drug-induced liver injury
  3496. Ellagic acid protects from myelin-associated Sphingolipid loss in experimental autoimmune encephalomyelitis
  3497. Nuclear lipid mediators: Role of nuclear Sphingolipids and sphingosine‐1‐phosphate signaling in epigenetic regulation of inflammation and gene expression
  3498. Adiponectin and related C1q/TNF-related proteins bind selectively to anionic phospholipids and Sphingolipids
  3499. Sphingolipid profiling reveals different extent of ceramide accumulation in bovine retroperitoneal and subcutaneous adipose tissues
  3500. Analysis of the plasma metabolome after trauma, novel circulating Sphingolipid signatures, and in-hospital outcomes
  3501. Sex differences in the association of Sphingolipids with age in Dutch and South-Asian Surinamese living in Amsterdam, the Netherlands
  3502. Loss of E-cadherin leads to druggable vulnerabilities in Sphingolipid metabolism and vesicle trafficking
  3503. Sphingolipid biosynthesis induces a conformational change in the murine norovirus receptor and facilitates viral infection
  3504. Side effects in cancer therapy: are Sphingolipids to blame?
  3505. … and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and Sphingolipid …
  3506. Polyunsaturated fatty acid and Sphingolipid measurements by tandem mass spectrometry
  3507. Identification and distribution of gene clusters required for synthesis of Sphingolipid metabolism inhibitors in diverse species of the filamentous fungus …
  3508. Time-dependent changes in hepatic Sphingolipid accumulation and PI3K/Akt/mTOR signaling pathway in a rat model of NAFLD
  3509. Preanalytical biases in the measurement of human blood Sphingolipids
  3510. The influence of coumestrol on Sphingolipid signaling pathway and insulin resistance development in primary rat hepatocytes
  3511. Altered hepatic Sphingolipid metabolism in insulin resistant mice: Role of advanced glycation endproducts
  3512. Metformin induces lipid changes on Sphingolipid species and oxidized lipids in polycystic ovary syndrome women
  3513. Regulation of serum Sphingolipids in Andean children born and living at high altitude (3775 m)
  3514. Biodistribution of 68/67Ga-Radiolabeled Sphingolipid Nanoemulsions by PET and SPECT Imaging
  3515. Oligosaccharides, polyamines and Sphingolipids in ruminant milk
  3516. Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem …
  3517. Inflammatory role of extracellular Sphingolipids in Cystic Fibrosis
  3518. Sphingolipid regulation of lung epithelial cell mitophagy and necroptosis during cigarette smoke exposure
  3519. Topical treatment with Sphingolipids and GLYCOSAMINOGLYCANS for canine atopic dermatitis
  3520. Altered Sphingolipid function in Alzheimer’s disease; a gene regulatory network approach
  3521. Emerging roles for Sphingolipids in cellular aging
  3522. Lipid rafts, Sphingolipids, and ergosterol in yeast vacuole fusion and maturation
  3523. … tools and current statistical methods used in ultra-high-performance liquid chromatography-mass spectrometry of glycero-, glycerophospho-and Sphingolipids
  3524. Intra-and intercellular trafficking in Sphingolipid metabolism in myelination
  3525. Sphingolipids in ventilator induced lung injury: role of sphingosine-1-phosphate lyase
  3526. Establishment of a measurement system for Sphingolipids in the cerebrospinal fluid based on liquid chromatography-tandem mass spectrometry, and its application in …
  3527. Sphingolipid/ceramide pathways and autophagy in the onset and progression of melanoma: Novel therapeutic targets and opportunities
  3528. TIMELESS regulates Sphingolipid metabolism and tumor cell growth through Sp1/ACER2/S1P axis in ER-positive breast cancer
  3529. Serum Sphingolipids predict de novo hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virologic response
  3530. Cell metabolism regulates integrin mechanosensing via an SLC3A2-dependent Sphingolipid biosynthesis pathway
  3531. Clinical signs of meibomian gland dysfunction (MGD) are associated with changes in meibum Sphingolipid composition
  3532. Plasma Sphingolipids are associated with gait parameters in the Mayo Clinic Study of Aging
  3533. Effects of Sphingolipids overload on red blood cell properties in Gaucher disease
  3534. Unregulated Sphingolipid Biosynthesis in Gene-Edited Arabidopsis ORM Mutants Results in Nonviable Seeds with Strongly Reduced Oil Content
  3535. Untargeted metabolomics identifies a plasma Sphingolipid-related signature associated with lifestyle intervention in prepubertal children with obesity
  3536. Sphingolipid control of fibroblast heterogeneity revealed by single-cell lipidomics
  3537. Platelet autophagic machinery involved in thrombosis through a novel linkage of AMPK-MTOR to Sphingolipid metabolism
  3538. Sphingolipids as multifaceted mediators in ovarian cancer
  3539. Jasmonates modulate Sphingolipid metabolism and accelerate cell death in the ceramide kinase mutant acd5
  3540. Sphingolipids as regulators of neuro-inflammation and NADPH oxidase 2
  3541. Interaction between nitric oxide and storage temperature on Sphingolipid metabolism of postharvest peach fruit
  3542. Serum Sphingolipids and incident diabetes in a US population with high diabetes burden: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
  3543. FRET probes for measuring Sphingolipid metabolizing enzyme activity
  3544. Cannabidiol–A phytocannabinoid that widely affects Sphingolipid metabolism under conditions of brain insulin resistance
  3545. Sphingolipid and endocannabinoid profiles in adult attention deficit hyperactivity disorder
  3546. Unique roles of Sphingolipids in selected malignant and nonmalignant lesions of female reproductive system
  3547. Dynamics of Sphingolipids and the serine palmitoyltransferase complex in rat oligodendrocytes during myelination [S]
  3548. Serum Sphingolipid level in psoriatic patients with obesity
  3549. … in Sphingolipid profile of benzo [a] pyrene-transformed human bronchial epithelial cells are reflected in the altered composition of Sphingolipids in their exosomes
  3550. Chemotherapy selection pressure alters Sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cells
  3551. Identification of Sphingolipid-binding motif in G protein-coupled receptors
  3552. Protection mechanisms against aberrant metabolism of Sphingolipids in budding yeast
  3553. Sphingolipid Pathway as a Source of Vulnerability in IDH1mut Glioma
  3554. Plasma lipidomic analysis of Sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease
  3555. Sphingolipids in inflammatory hypoxia
  3556. Regulation of Sphingolipid synthesis by the G1/S transcription factor Swi4
  3557. Vitamin K deficiency induced by warfarin is associated with cognitive and behavioral perturbations, and alterations in brain Sphingolipids in rats
  3558. Multiple actions of doxorubicin on the Sphingolipid network revealed by flux analysis [S]
  3559. Impact of Sphingolipids on osteoblast and osteoclast activity in Gaucher disease
  3560. Ether lipid and Sphingolipid expression patterns are estrogen receptor-dependently altered in breast cancer cells
  3561. Associations of plasma Sphingolipid profiles with insulin response during oral glucose testing in Icelandic horses
  3562. Metabolic Depletion of Sphingolipids Reduces Cell Surface Population of the Human Serotonin1A Receptor due to Impaired Trafficking
  3563. Recent insights into the interplay of alpha-synuclein and Sphingolipid signaling in Parkinson’s disease
  3564. Rab39a and Rab39b display different intracellular distribution and function in Sphingolipids and phospholipids transport
  3565. Role of Sphingolipid signaling in glomerular diseases: focus on DKD and FSGS
  3566. Quantitative systems pharmacology model for Alzheimer disease indicates targeting Sphingolipid dysregulation as potential treatment option
  3567. A Sphingolipid synthesis‐related protein OrmA in Aspergillus fumigatus is responsible for azole susceptibility and virulence
  3568. Validation of urinary Sphingolipid metabolites as biomarker of effect for fumonisins exposure in Kenyan children
  3569. Disrupted Sphingolipid metabolism following acute clozapine and olanzapine administration
  3570. Sphingolipids in Infection Control
  3571. Membrane contact sites in yeast: control hubs of Sphingolipid homeostasis
  3572. Adjustments of both phospholipids and Sphingolipids contribute to cold tolerance in stony hard peach fruit by continuous ethylene
  3573. Effect of ER stress on Sphingolipid levels and apoptotic pathways in retinal pigment epithelial cells
  3574. Sphingolipid-containing outer membrane vesicles serve as a delivery vehicle to limit macrophage immune response to Porphyromonas gingivalis
  3575. Membrane Sphingolipids Regulate the Fitness and Antifungal Protein Susceptibility of Neurospora crassa
  3576. Autoimmunity in multiple sclerosis: role of Sphingolipids, invariant NKT cells and other immune elements in control of inflammation and neurodegeneration
  3577. Dysregulation of Sphingolipid metabolic enzymes leads to high levels of sphingosine‐1‐phosphate and ceramide in human hepatocellular carcinoma
  3578. Modulatory effects of fingolimod (FTY720) on the expression of Sphingolipid metabolism-related genes in an animal model of Alzheimer’s disease
  3579. Sphingolipids signaling in lamellipodia formation and enhancement of endothelial barrier function
  3580. Sphingolipids regulate neuromuscular synapse structure and function in Drosophila
  3581. Reduced chain length in myelin Sphingolipids and poorer motor coordination in mice deficient in the fatty acid elongase Elovl1
  3582. Sphingolipid effects on the plasma membrane produced by addition of fumonisin B1 to maize embryos
  3583. Participation of Sphingolipids in the pathogenesis of atherosclerosis
  3584. The effect of enterolactone on Sphingolipid pathway and hepatic insulin resistance development in HepG2 cells
  3585. A lipidomics atlas of selected Sphingolipids in multiple mouse nervous system regions
  3586. Bioactive phytochemicals of tree nuts. Determination of the melatonin and Sphingolipid content in almonds and pistachios
  3587. Complex interplay between Sphingolipid and sterol metabolism revealed by perturbations to the Leishmania metabolome caused by miltefosine
  3588. Gene pair correlation coefficients in Sphingolipid metabolic pathway as a potential prognostic biomarker for breast cancer
  3589. Sphingolipid-induced cell death in Arabidopsis is negatively regulated by the papain-like cysteine protease RD21
  3590. A simple method for Sphingolipid analysis of tissues embedded in optimal cutting temperature compound [S]
  3591. Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of Sphingolipid metabolism
  3592. Effect of antidepressant drugs on the brain Sphingolipid system
  3593. A genome-wide CRISPR/Cas9 screen reveals that the aryl hydrocarbon receptor stimulates Sphingolipid levels
  3594. Ceramide Analogue SACLAC Modulates Sphingolipid Levels and MCL-1 Splicing to Induce Apoptosis in Acute Myeloid Leukemia
  3595. Sphingolipid serum profiling in vitamin D deficient and dyslipidemic obese dimorphic adults
  3596. Diurnal regulation of Sphingolipids in blood
  3597. Hexosaminidase A (HEXA) regulates hepatic Sphingolipid and lipoprotein metabolism in mice
  3598. Introduction to the special issue on Sphingolipid signaling in chronic disease
  3599. A lysosome–plasma membrane–Sphingolipid axis linking lysosomal storage to cell growth arrest
  3600. Sphingolipids and kidney disease: Possible role of preeclampsia and intrauterine growth restriction (IUGR)
  3601. Sphingolipid metabolism at the ER-golgi contact zone and its impact on membrane trafficking
  3602. Probing compartment-specific Sphingolipids with targeted bacterial sphingomyelinases and ceramidases
  3603. Screening of chemical libraries for new antifungal drugs against Aspergillus fumigatus reveals Sphingolipids are involved in the mechanism of action of miltefosine
  3604. Reprogramming Sphingolipid glycosylation is required for endosymbiont persistence in Medicago truncatula
  3605. Sphingolipid synthesis inhibition by myriocin administration enhances lipid consumption and ameliorates lipid response to myocardial ischemia reperfusion …
  3606. Plant Sphingolipids promote extracellular vesicle release and alleviate amyloid-β pathologies in a mouse model of Alzheimer’s disease
  3607. Sphingolipids as a novel therapeutic target in radiation-induced lung injury
  3608. The Effect of Fusarium verticillioides Fumonisins on Fatty Acids, Sphingolipids, and Oxylipins in Maize Germlings
  3609. Podocyte Sphingolipid signaling in nephrotic syndrome
  3610. Evaluation of serum Sphingolipids and the influence of genetic risk factors in age-related macular degeneration
  3611. Sphingolipidomics of drug resistant Candida auris clinical isolates reveal distinct Sphingolipid species signatures
  3612. Lithium Hydroxide Hydrolysis Combined with MALDI TOF Mass Spectrometry for Rapid Sphingolipid Detection
  3613. LAPTM4B controls the Sphingolipid and ether lipid signature of small extracellular vesicles
  3614. Acid ceramidase protects against hepatic ischemia/reperfusion injury by modulating Sphingolipid metabolism and reducing inflammation and oxidative stress
  3615. Defective Sphingolipids metabolism and tumor associated macrophages as the possible links between gaucher disease and blood cancer development
  3616. The complex tail of circulating Sphingolipids in atherosclerosis and cardiovascular disease
  3617. iTrEnDi: In situ trimethylation enhancement using diazomethane: improved and expanded glycerophospholipid and Sphingolipid analyses via a microscale …
  3618. Organ function, Sphingolipid levels and inflammation in tunicamycin induced endoplasmic reticulum stress in male rats
  3619. ECHS1, an interacting protein of LASP1, induces Sphingolipid-metabolism imbalance to promote colorectal cancer progression by regulating ceramide …
  3620. Altered mRNA expression levels of the major components of Sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer
  3621. Severity of COVID-19 patients predicted by serum Sphingolipids signature
  3622. Tracheal aspirate VEGF and Sphingolipid metabolites in the preterm infant with later development of bronchopulmonary dysplasia
  3623. Macrophage Sphingolipids are essential for the entry of mycobacteria
  3624. An integrated method for direct interrogation of Sphingolipid homeostasis in the heart and brain tissues of mice through postnatal development up to reproductive …
  3625. Sphingolipids modulate secretion of glycosylphosphatidylinositol-anchored plasmodesmata proteins and callose deposition
  3626. Sphingolipids: Functional and Biological Aspects in Mammals, Plants, and Fungi
  3627. Dynamic Phosphoproteomics Uncovers Signaling Pathways Modulated by Anti-oncogenic Sphingolipid Analogs*[S]
  3628. Dissecting the regulatory roles of ORM proteins in the Sphingolipid pathway of plants
  3629. The role of Sphingolipids in cardiovascular pathologies
  3630. Sphingolipid long‐chain base hydroxylation influences plant growth and callose deposition in Physcomitrium patens
  3631. Disarranged Sphingolipid metabolism from sphingosine-1-phosphate lyase deficiency leads to congenital nephrotic syndrome
  3632. The role of Sphingolipid metabolism disruption on lipopolysaccharide-induced lung injury in mice
  3633. Sphingolipid/Pkh1/2-TORC1/Sch9 signaling regulates ribosome biogenesis in tunicamycin-induced stress response in yeast
  3634. Introduction: enigmas of Sphingolipids
  3635. Mycotoxin Fumonisin B1 Interferes Sphingolipid Metabolisms and Neural Tube Closure during Early Embryogenesis in Brown Tsaiya Ducks
  3636. Accumulation of Cerebrospinal fluid glycerophospholipids and Sphingolipids in cognitively healthy participants with Alzheimer’s biomarkers precedes lipolysis …
  3637. SAR studies on aromatic acylhydrazone-based inhibitors of fungal Sphingolipid synthesis as next-generation antifungal agents
  3638. Vitamin E δ-tocotrienol inhibits TNF-α-stimulated NF-κB activation by up-regulation of anti-inflammatory A20 via modulation of Sphingolipid including elevation of …
  3639. Plasma Sphingolipid profile in association with incident metabolic syndrome in a Chinese population-based cohort study
  3640. Protective role of the HOG pathway against the growth defect caused by impaired biosynthesis of complex Sphingolipids in yeast Saccharomyces cerevisiae
  3641. Contributions of amino acid, acylcarnitine and Sphingolipid profiles to type 2 diabetes risk among South-Asian Surinamese and Dutch adults
  3642. Lipidomics revealed alteration of Sphingolipid metabolism during the reparative phase after myocardial infarction injury
  3643. Sphingoid bases of dietary ceramide 2-aminoethylphosphonate, a marine Sphingolipid, absorb into lymph in rats
  3644. Sphingolipid extracts enhance gene delivery of cationic lipid vesicles into retina and brain
  3645. Sphingolipids inhibit endosomal recycling of nutrient transporters by inactivating ARF6
  3646. Epidermal permeability barrier function and Sphingolipid content in the skin of sphingomyelin synthase 2 deficient mice
  3647. Lipidomic analysis of human corneal epithelial cells exposed to ocular irritants highlights the role of phospholipid and Sphingolipid metabolisms in detergent toxicity …
  3648. Influence of resveratrol on Sphingolipid metabolism in hepatocellular carcinoma cells in lipid overload state
  3649. Placental production of eicosanoids and Sphingolipids in women who developed preeclampsia on low-dose aspirin
  3650. Sphingomyelin synthase 1 (SMS1) downregulation is associated with Sphingolipid reprogramming and a worse prognosis in melanoma
  3651. Aortic gene expression profiles show how ApoA-I levels modulate inflammation, lysosomal activity, and Sphingolipid metabolism in murine atherosclerosis
  3652. Fuse your mitochondria, lose appetite: an anorexic, anti‐obesity Sphingolipid
  3653. Drosophila DNA/RNA methyltransferase contributes to robust host defense in aging animals by regulating Sphingolipid metabolism
  3654. High-fat, high-protein, and high-carbohydrate diets affect Sphingolipid profile in pancreatic steatosis in Wistar rats
  3655. Sphingolipid biosynthesis in Physcomitrella patens
  3656. Sphingolipid inhibitors as an alternative to treat candidiasis caused by fluconazole-resistant strains
  3657. Regulation of Sphingolipid metabolism by microRNAs: a potential approach to alleviate atherosclerosis
  3658. Solving the riddle: targeting the imbalance of Sphingolipids in asthma to oppose airway hyperresponsiveness
  3659. Long-term use of fluoxetine accelerates bone loss through the disruption of Sphingolipids metabolism in bone marrow adipose tissue
  3660. Identification of TRAMs as Sphingolipid-binding proteins using a photoactivatable and clickable short-chain ceramide analog
  3661. Metabolomics analysis identifies Sphingolipids as key signaling moieties in appressorium morphogenesis and function in Magnaporthe oryzae
  3662. Sphingolipid Metabolism and Transport in Chlamydia trachomatis and Chlamydia psittaci Infections
  3663. Sphingolipids and cell signaling: Relationship between health and disease in the central nervous system
  3664. Sphingolipid dyshomeostasis in the brain of the mouse model of mucopolysaccharidosis type IIIA
  3665. Sphingolipid metabolism perturbations in Rett syndrome
  3666. A Golgi UDP-GlcNAc transporter delivers substrates for N-linked glycans and Sphingolipids
  3667. … of Triterpenoids From Ganoderma lucidum Mitigates Age-Associated Brain Physiological Decline via Regulating Sphingolipid Metabolism and Enhancing …
  3668. Sphingolipids and plasma membrane hydrolases in human primary bronchial cells during differentiation and their altered patterns in cystic fibrosis
  3669. Self-Protection against the Sphingolipid Biosynthesis Inhibitor Fumonisin B1 Is Conferred by a FUM Cluster-Encoded Ceramide Synthase
  3670. Overexpression of PDR16 confers resistance to complex Sphingolipid biosynthesis inhibitor aureobasidin A in yeast Saccharomyces cerevisiae
  3671. Sphingolipid profile during cotton fiber growth revealed that a phytoceramide containing hydroxylated and saturated VLCFA is important for fiber cell elongation
  3672. The metabolic pathway of Sphingolipids biosynthesis and signaling in Entamoeba histolytica
  3673. Disruption of Arabidopsis neutral ceramidases 1 and 2 results in specific Sphingolipid imbalances triggering different phytohormone‐dependent plant cell death …
  3674. Perinatal origins of chronic lung disease: mechanisms–prevention–therapy—Sphingolipid metabolism and the genetic and perinatal origins of childhood …
  3675. Modulation of DNA damage response by Sphingolipid signaling: An interplay that shapes cell fate
  3676. SERUM Sphingolipids AS CANDIDATE BIOMARKERS IN RHEUMATOID ARTHRITIS.
  3677. Spinal mechanisms contributing to the development of pain hypersensitivity induced by Sphingolipids in the rat
  3678. Peeking inside the Sphingolipid network in lung cancer
  3679. Interaction of palmitate and LPS regulates cytokine expression and apoptosis through Sphingolipids in human retinal microvascular endothelial cells
  3680. BiP-overexpressing soybean plants display accelerated hypersensitivity response (HR) affecting the SA-dependent Sphingolipid and flavonoid pathways
  3681. Profiling of Sphingolipids in Caenorhabditis elegans by two-dimensional multiple heart-cut liquid chromatography–mass spectrometry
  3682. Akt/AS160 signaling pathway inhibition impairs infection by decreasing Rab14-controlled Sphingolipids delivery to chlamydial inclusions
  3683. Superresolution microscopy of Sphingolipids
  3684. Sphingolipid-dependent Dscam sorting regulates axon segregation
  3685. Cholesterol is enriched in the Sphingolipid patches on the substrate near nonpolarized MDCK cells, but not in the Sphingolipid domains in their plasma …
  3686. Sphingolipid biosynthetic pathway is crucial for growth, biofilm formation and membrane integrity of Scedosporium boydii
  3687. The AGC Kinase YpkA Regulates Sphingolipids Biosynthesis and Physically Interacts With SakA MAP Kinase in Aspergillus fumigatus
  3688. Deregulation of signalling in genetic conditions affecting the lysosomal metabolism of cholesterol and galactosyl-Sphingolipids
  3689. Plasma levels of the bioactive Sphingolipid metabolite S1P in adult cystic fibrosis patients: potential target for immunonutrition?
  3690. Large granular lymphocyte leukemia serum and corresponding hematological parameters reveal unique cytokine and Sphingolipid biomarkers and associations with …
  3691. De novo synthesis of Sphingolipids plays an important role during in vitro encystment of Entamoeba invadens
  3692. … matrix overcoming the ion suppression of phosphatidylcholine for MALDI MS comprehensive imaging of glycerophospholipids and Sphingolipids in impact-induced …
  3693. Is there a role for therapeutic Sphingolipids in inflammatory bowel disease?
  3694. γ-Tocotrienol induces apoptosis in pancreatic cancer cells by upregulation of ceramide synthesis and modulation of Sphingolipid transport
  3695. Comparative metabolomics analysis reveals sterols and Sphingolipids play a role in cotton fiber cell initiation
  3696. Fenofibrate increases very-long-chain Sphingolipids and improves blood glucose homeostasis in NOD mice
  3697. Solving the enigma: Mass spectrometry and small molecule probes to study Sphingolipid function
  3698. CHO/LY-B cell growth under limiting Sphingolipid supply: correlation between lipid composition and biophysical properties of Sphingolipid-restricted cell membranes+
  3699. Exome sequencing and metabolomic analysis of a chronic kidney disease and hearing loss patient family revealed RMND1 mutation induced Sphingolipid …
  3700. The role of plasmalogens, Forssman lipids, and Sphingolipid hydroxylation in modulating the biophysical properties of the epithelial plasma membrane
  3701. Lipidomic Profiling Reveals Distinct Differences in Sphingolipids Metabolic Pathway between Healthy Apis cerana cerana larvae and Chinese Sacbrood Disease
  3702. CD40 enhances Sphingolipids in orbital fibroblasts: Potential role of sphingosine-1-Phosphate in inflammatory T-cell migration in graves’ orbitopathy
  3703. Deletion of specific Sphingolipids in distinct neurons improves spatial memory in a mouse model of Alzheimer’s Disease
  3704. C24: 0 and C24: 1 Sphingolipids in cholesterol-containing, five-and six-component lipid membranes
  3705. Wnt-controlled Sphingolipids modulate Anthrax Toxin Receptor palmitoylation to regulate oriented mitosis in zebrafish
  3706. Protective effect of picroside I against hepatic fibrosis in mice via Sphingolipid metabolism, bile acid biosynthesis, and PPAR signaling pathway
  3707. … metabolomics reveal that Astragalus polysaccharide alleviates doxorubicin-induced cardiomyopathy by regulating Sphingolipid and glycerophospholipid homeostasis
  3708. Characterisation of Protein-Very Long Chain Fatty Acid-Containing Sphingolipid Interactions
  3709. Sphingolipid identification and skin barrier recovery capacity of a milk Sphingolipid‐enriched fraction (MSEF) from buttermilk powder
  3710. The role of distinctive Sphingolipids in the inflammatory and apoptotic effects of electronegative LDL on monocytes
  3711. Sphingolipids are biomarkers of coronary disease
  3712. Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition
  3713. CERKL is upregulated in cutaneous squamous cell carcinoma and maintains cellular Sphingolipids and resistance to oxidative stress
  3714. … thin-layer chromatography coupled with electrospray ionization tandem mass spectrometry for identifying neutral lipids and Sphingolipids in complex samples
  3715. Differential Expression of Sphingolipid Metabolizing Enzymes in Spontaneously Hypertensive Rats: A Possible Substrate for Susceptibility to Brain and Kidney …
  3716. Sphingolipids associated with flesh browning onset and development in ‘Cripps Pink’apples (Malus domestica Borkh.)
  3717. Spirulina liquid extract prevents metabolic disturbances and improves liver Sphingolipids profile in hamster fed a high-fat diet
  3718. Repeated low-dose exposures to sarin disrupted the homeostasis of phospholipid and Sphingolipid metabolism in guinea pig hippocampus
  3719. Click-correlative light and electron microscopy (click-AT-CLEM) for imaging and tracking azido-functionalized Sphingolipids in bacteria
  3720. Chasing the major Sphingolipids on earth: automated annotation of plant Glycosyl inositol Phospho ceramides by Glycolipidomics
  3721. Separation of Glycolipids/Sphingolipids from Glycerophospholipids on TiO2 Coating in Aprotic Solvent for Rapid Comprehensive Lipidomic Analysis with Liquid …
  3722. Sphingolipid, fatty acid and phospholipid metabolites are associated with disease severity and mTOR inhibition in lymphangioleiomyomatosis
  3723. Sphingolipid distribution, content and gene expression during olive-fruit development and ripening
  3724. The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit Sphingolipid biosynthesis
  3725. Sphingolipids in adipose tissue: What’s tipping the scale?
  3726. Elovl4 and Fa2h expression during rat spermatogenesis: a link to the very-long-chain PUFAs typical of germ cell Sphingolipids [S]
  3727. Bi-and trifunctional lipids for visualization of Sphingolipid dynamics within the cell
  3728. Purification, characterization and influence on membrane properties of the plant-specific Sphingolipids GIPC
  3729. Sphingolipid composition and metabolism differ in three auchenorrhynchous pests of rice
  3730. Different rates of flux through the biosynthetic pathway for long-chain versus very-long-chain Sphingolipids
  3731. A Novel Function of Sphingolipid Signaling via S1PR3 in Hematopoietic and Leukemic Stem Cells
  3732. More Evidence for Inborn Dysregulation of Sphingolipid Metabolism in Children with Asthma?
  3733. Evaluation of Sphingolipid metabolism on diabetic retinopathy
  3734. Bioinformatic exploration for prognostic significance of Sphingolipid metabolism-related genes in invasive ductal carcinoma using the cancer genome atlas cohort
  3735. Sphingolipid properties in sake rice cultivars and changes during polishing and brewing
  3736. Alterations in β-Cell Sphingolipid Profile Associated with ER Stress and iPLA2β: Another Contributor to β-Cell Apoptosis in Type 1 Diabetes
  3737. Neutrophil elastase correlates with increased Sphingolipid content in cystic fibrosis sputum
  3738. Reduced serum Sphingolipids constitute a molecular signature of malnutrition in hospitalized patients with decompensated cirrhosis
  3739. At last—linking ORMDL3 polymorphisms, decreased Sphingolipid synthesis, and asthma susceptibility
  3740. Myeloperoxidase and septic conditions disrupt Sphingolipid homeostasis in murine brain capillaries in vivo and immortalized human brain endothelial cells in vitro
  3741. Decreased caveolae in AGPAT2 lacking adipocytes is independent of changes in cholesterol or Sphingolipid levels: a whole cell and plasma membrane …
  3742. Caveolin-1-mediated Sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer
  3743. Sake (rice wine) brewing hydrolyzes highly polar Sphingolipids to ceramides and increases free sphingoid bases
  3744. Sphingolipid synthesis and role in uterine epithelia proliferation
  3745. Lipidomic analysis reveals disturbances in glycerophospholipid and Sphingolipid metabolic pathways in benzene-exposed mice
  3746. Sphingolipids involved in T1DM
  3747. Polychlorinated environmental toxicants affect Sphingolipid metabolism during neurogenesis in vitro
  3748. Specific alterations of Sphingolipid metabolism identified in EpCAM-positive cells isolated from human colon tumors
  3749. The kidney in Fabry disease: more than mere Sphingolipids overload
  3750. The enigma of Sphingolipids in health and disease
  3751. Disruption of long‐chain base hydroxylation alters growth and impacts Sphingolipid synthesis in Physcomitrella patens
  3752. Role of Sphingolipids in the pathogenesis of intrahepatic cholestasis
  3753. Circulating fatty acylcarnitines are elevated in overweight periparturient dairy cows in association with Sphingolipid biomarkers of insulin resistance
  3754. Sphingolipid changes do not underlie fatty acid-evoked GLUT4 insulin resistance nor inflammation signals in muscle cells [S]
  3755. Tsc3 regulates SPT amino acid choice in Saccharomyces cerevisiae by promoting alanine in the Sphingolipid pathway
  3756. Cardioprotective effects of Taurisolo® in cardiomyoblast H9c2 cells under high-glucose and trimethylamine N-oxide treatment via de novo Sphingolipid …
  3757. Saccharomyces cerevisiae as a platform for assessing Sphingolipid lipid kinase inhibitors
  3758. The regulatory proteins Rtg1/3 govern Sphingolipid homeostasis in the human-associated yeast Candida albicans
  3759. Defective Sphingolipids metabolism and tumor associated macrophages as the possible links between gaucher disease and blood cancer development
  3760. Antibacterial and cytotoxic activities of new Sphingolipids and other constituents isolated from Cissus incisa leaves
  3761. Hydroxylated Sphingolipid biosynthesis regulates photoreceptor apical domain morphogenesis
  3762. Role of local CpG DNA methylation in mediating the 17q21 asthma susceptibility gasdermin B (GSDMB)/ORMDL Sphingolipid biosynthesis regulator 3 (ORMDL3) …
  3763. Developing new ceramide analogs and identifying novel Sphingolipid-controlled genes against a virus-associated lymphoma
  3764. HPLC-MS/MS methods for diacylglycerol and Sphingolipid molecular species in skeletal muscle
  3765. Small angle X-ray scattering sensing membrane composition: the role of Sphingolipids in membrane-amyloid β-peptide interaction
  3766. Facile determination of Sphingolipids under alkali condition using metal-free column by LC-MS/MS
  3767. “Fix and assay”: separating in-cellulo Sphingolipid reactions from analytical assay in time and space using an aldehyde-based fixative
  3768. Sphingolipids modulate docking, Ca2+ sensitivity and membrane fusion of native cortical vesicles
  3769. Epigenetics and Sphingolipid metabolism in health and disease
  3770. Tamoxifen acts on Trypanosoma cruzi Sphingolipid pathway triggering an apoptotic death process
  3771. Acid ceramidase depletion impairs neuronal survival and induces morphological defects in neurites associated with altered gene transcription and Sphingolipid …
  3772. Protocol for measuring Sphingolipid metabolism in budding yeast
  3773. Modulation of Sphingolipid long-chain base composition and gene expression during early olive-fruit development, and putative role of brassinosteroid
  3774. Yeast Sphingolipid-enriched domains and membrane compartments in the absence of mannosyldiinositolphosphorylceramide
  3775. Mass SpectrometrySpectrometry-Based Profiling of Plant SphingolipidsSphingolipids from Typical and Aberrant Metabolism
  3776. Aspergillus fumigatus Afssn3-Afssn8 Pair Reverse Regulates Azole Resistance by Conferring Extracellular Polysaccharide, Sphingolipid Pathway Intermediates, and …
  3777. Effects of Sphingolipid fractions from golden oyster mushroom (Pleurotus citrinopileatus) on apoptosis induced by inflammatory stress in an intestinal tract in vitro …
  3778. Synthetic Sphingolipids with 1, 2-pyridazine appendages improve antiproliferative activity in human cancer cell lines
  3779. The features of Sphingolipids‘ profile in patients with the family history of atherosclerosis
  3780. Lipid profiling of Alzheimer’s disease brain highlights enrichment in glycerol (phospho) lipid, and Sphingolipid metabolism
  3781. The microbiome affects liver Sphingolipids and plasma fatty acids in a murine model of the Western diet based on soybean oil
  3782. A hybrid mathematical modeling approach of the metabolic fate of a fluorescent Sphingolipid analogue to predict cancer chemosensitivity
  3783. Glycerophospholipids and Sphingolipids correlate with poor prognostic genotypes of human papillomavirus in cervical cancer: global lipidomics analysis
  3784. Effect of bariatric surgery on urinary Sphingolipids in adolescents with severe obesity
  3785. Mass spectrometric analysis of bioactive Sphingolipids in fungi
  3786. Targeted lipidomics reveals associations between serum Sphingolipids and insulin sensitivity measured by the hyperinsulinemic-euglycemic clamp
  3787. Characterization of Sphingolipid biosynthesis and modification in plants
  3788. Role of Sphingolipids in inflammatory respiratory diseases
  3789. Qualitative distribution of endogenous Sphingolipids in plasma of human and rodent species by UPLC-Q-Exactive-MS
  3790. Design, synthesis and anticancer activity of constrained Sphingolipid-phenoxazine/phenothiazine hybrid constructs targeting protein phosphatase 2A
  3791. The Study of Sphingolipids Metabolism and Its Effect on Brain Disorders
  3792. Sphingolipids and inositol phosphates regulate the tau protein phosphorylation status in humanized yeast
  3793. Transcriptional regulation of Sphingolipid metabolism in budding yeast
  3794. Role of SPTSSB-regulated de Novo Sphingolipid synthesis in prostate cancer depends on androgen receptor signaling
  3795. Dihydrosphingosine driven enrichment of Sphingolipids attenuates TGFβ induced collagen synthesis in cardiac fibroblasts
  3796. Oxidized graphene nanoparticles as a delivery system for the pro‐apoptotic Sphingolipid C6 ceramide
  3797. Sphingolipids of plant pathogenic fungi
  3798. Brain cancer-activated microglia: a potential role for Sphingolipids
  3799. Sphingolipids are required for exocyst polarity and exocytic secretion in Saccharomyces cerevisiae
  3800. Effect of tamoxifen on the Sphingolipid biosynthetic pathway in the different intraerythrocytic stages of the apicomplexa Plasmodium falciparum
  3801. The ceramide activated protein phosphatase Sit4 impairs Sphingolipid dynamics, mitochondrial function and lifespan in a yeast model of Niemann-Pick type …
  3802. Bedside stereomicroscopy of Fabry kidney biopsies: An easily available method for diagnosis and assessment of Sphingolipid deposits
  3803. Plasma Sphingolipids mediate a relationship between type 2 diabetes and memory outcomes in patients with coronary artery disease undertaking exercise
  3804. Role of Sphingolipids in Bacterial Infections
  3805. Sensitization of drug resistant sarcoma tumors by membrane modulation via short chain Sphingolipid-containing nanoparticles
  3806. The link between Gaucher disease and Parkinson’s disease sheds light on old and novel disorders of Sphingolipid metabolism
  3807. Sorafenib treatment and modulation of the Sphingolipid pathway affect proliferation and viability of hepatocellular carcinoma in vitro
  3808. In Vitro Photodynamic Activity of N‐Methylated and N‐Oxidised Tripyridyl Porphyrins with Long Alkyl Chains and Their Inhibitory Activity in Sphingolipid Metabolism
  3809. Sphingolipid Δ4-desaturation is an important metabolic step for glycosylceramide formation in Physcomitrium patens
  3810. Metabolism of HSAN1-and T2DM-associated 1-deoxy-Sphingolipids inhibits the migration of fibroblasts
  3811. Inflammatory response and its relation to Sphingolipid metabolism proteins: Chaperones as potential indirect anti-inflammatory agents
  3812. Understanding phosphatidylserine and Sphingolipid metabolism in macrophages
  3813. Neuronal membrane dynamics as fine regulator of Sphingolipid composition
  3814. Quantitation of Sphingolipids in Mammalian Cell Lines by Liquid Chromatography–Mass Spectrometry
  3815. S1P controls endothelial Sphingolipid homeostasis via ORMDL
  3816. Disturbed Sphingolipid metabolism with elevated 1-deoxySphingolipids in glycogen storage disease type I–A link to metabolic control
  3817. Vaticanol C, a phytoalexin, induces apoptosis of leukemia and cancer cells by modulating expression of multiple Sphingolipid metabolic enzymes
  3818. Erratum for Mor et al.,“Identification of a new class of antifungals targeting the synthesis of fungal Sphingolipids”
  3819. Biophysical properties of Sphingolipid-deficient cell membranes
  3820. Discovery of unexpected Sphingolipids in almonds and pistachios with an innovative use of triple quadrupole tandem mass spectrometry
  3821. Serum Sphingolipid levels associate with upcoming virologic events and HBV genotype D in a cohort of patients with HBeAg-negative HBV infection
  3822. Cerebrospinal fluid levels of Sphingolipids associate with disease severity in first episode psychosis patients
  3823. Metabolomics-driven identification of perturbations in amino acid and Sphingolipid metabolism as therapeutic targets in a rat model of anorexia nervosa …
  3824. Special Issue on “Sphingolipids: From Pathology to Therapeutic Perspectives”
  3825. Structure-inspired design of a Sphingolipid mimic sphingosine-1-phosphate receptor agonist from a naturally occurring sphingomyelin synthase inhibitor
  3826. Yeast Sphingolipid Phospholipase Gene ISC1 Regulates the Spindle Checkpoint by a CDC55-Dependent Mechanism
  3827. Biosynthesis of Sphingolipids with very-long-chain pufa a hallmark of differentiating male germ cells
  3828. Sphingolipid production by gut Bacteroidetes regulates glucose homeostasis
  3829. Bioactive Sphingolipids, complement cascade, and free hemoglobin levels in stable coronary artery disease and acute myocardial infarction
  3830. Serum lipidomics of bovine paratuberculosis: Disruption of choline-containing glycerophospholipids and Sphingolipids
  3831. Oceanapiside, a Marine Natural Product, Targets the Sphingolipid Pathway of Fluconazole-Resistant Candida glabrata
  3832. Sphingolipid metabolism governs Purkinje cell patterned degeneration in Atxn1[82Q]/+ mice
  3833. Combining Sphingolipidomics and Computational Systems Biology to Study Red Blood Cell Sphingolipid Metabolism in Health and Disease
  3834. Role of Sphingolipids in the immune response against tumor after local radiation
  3835. A targeted mass spectrometric analysis reveals the presence of a reduced but dynamic Sphingolipid metabolic pathway in an ancient protozoan, Giardia …
  3836. Jaspine B Hydrochloride-induced Apoptosis in HeLa Cells Is Associated With Disrupted Sphingolipid Metabolism and Ceramide Overload
  3837. Dose dependent actions of LCL521 on acid ceramidase and key Sphingolipid metabolites
  3838. The Extraction and Analytical Profiling of Bioactive Phospho-and Sphingolipids from Commercial Whey Protein Phospholipid Concentrate
  3839. Sphingolipid metabolism in the pathophysiology and treatment of Alzheimer’s disease
  3840. Function of ceramide synthases on growth, ganoderic acid biosynthesis and Sphingolipid homeostasis in Ganoderma lucidum
  3841. Human remyelination promoting antibody stimulates astrocytes proliferation through modulation of the Sphingolipid rheostat in primary rat mixed glial cultures
  3842. Exploring the structure and function of key enzymes involved in microbial Sphingolipid biosynthesis
  3843. Functional characterization of anti-cancer Sphingolipids from the marine crab Dromia dehanni
  3844. Omega 3 improves both apoB100-containing lipoprotein turnover and their Sphingolipid profile in hypertriglyceridemia
  3845. Characterization of the effect of Sphingolipid accumulation on membrane compactness, dipole potential, and mobility of membrane components
  3846. Monitoring Sphingolipid trafficking in cells using fluorescence microscopy
  3847. Very long-chain acyl-CoA synthetase 3 mediates onco-Sphingolipid metabolism in malignant glioma
  3848. Sphingolipids are involved in Pieris brassicae egg-induced cell death in Arabidopsis thaliana
  3849. Sphingolipids: Effectors and Achilles Heals in Viral Infections? Cells 2021, 10, 2175
  3850. How the replacement of cholesterol by 25-hydroxycholesterol affects the interactions with Sphingolipids: The Langmuir Monolayer Study complemented with …
  3851. Implication of Sphingolipid metabolism gene dysregulation and cardiac sphingosine-1-phosphate accumulation in heart failure
  3852. Abiraterone and ionizing radiation alter the Sphingolipid homeostasis in prostate cancer cells
  3853. Altered Sphingolipid metabolism and its interaction with the intestinal microbiome is another key to the pathogenesis of inflammatory bowel disease
  3854. Ceramide analog [18F]F-HPA-12 detects Sphingolipid disbalance in the brain of Alzheimer’s disease transgenic mice by functioning as a metabolic probe
  3855. Ex vivo assay to evaluate the efficacy of drugs targeting Sphingolipids in preventing SARS-CoV-2 infection of nasal epithelial cells
  3856. Dissecting the Regulatory Network of Sphingolipid Biosynthesis in Plants
  3857. Sphingolipids in Cancer
  3858. Intestinal Availability and Metabolic Effects of Dietary Camelina Sphingolipids during the Metabolic Syndrome Onset in Mice
  3859. Structure Elucidation of Calyxoside B, a Bipolar Sphingolipid from a Marine Sponge Cladocroce sp. through the Use of Beckmann Rearrangement
  3860. GONST2 transports GDP-Mannose for Sphingolipid glycosylation in the Golgi apparatus of Arabidopsis
  3861. Gene cloning of a neutral ceramidase from the Sphingolipid metabolic pathway based on transcriptome analysis of Amorphophallus muelleri
  3862. Lipid phosphate phosphatase 3 regulates adipocyte Sphingolipid synthesis, but not developmental adipogenesis or diet-induced obesity in mice
  3863. Getting to the heart of the Sphingolipid riddle
  3864. Sphingolipid profiles and their relationship with inflammatory factors in asthmatic patients of different sexes
  3865. Azide-tagged Sphingolipids for the proteome-wide identification of C16-ceramide-binding proteins
  3866. Sphingolipid Flux: a New Flow to Static Ideas
  3867. Sphingolipids and physical function in the Atherosclerosis Risk in Communities (ARIC) study
  3868. In vitro measurement of Sphingolipid intermembrane transport illustrated by GLTP superfamily members
  3869. Sphingosine kinase and sphingosine-1-phosphate regulate epithelial cell architecture by the modulation of de novo Sphingolipid synthesis
  3870. ROS-mediated synthetic growth defect caused by impaired metabolism of Sphingolipids and phosphatidylserine in budding yeast
  3871. Sphingolipids in Physcomitrella patens
  3872. Widespread tissue distribution and synthetic pathway of polyunsaturated C24: 2 Sphingolipids in mammals
  3873. Host-microbiome synergistic control on Sphingolipid metabolism by mechanotransduction in model arthritis
  3874. The revelation of selective Sphingolipid pathway inhibition mechanism on fumonisin toxin binding to ceramide synthases in susceptible organisms and survival …
  3875. Modulation of plasma and milk Sphingolipids in dairy cows fed high-starch diets
  3876. The impact of Sphingolipids on\(Neisseria\)\(meningitidis\) and their role in meningococcal pathogenicity
  3877. In Silico Analysis for Sphingolipid Metabolism-Related Genes in Human Kidney Clear Cell Carcinoma Using The Cancer Genome Atlas.
  3878. The concept of Sphingolipid rheostat in skin: a driving force for new active ingredients in cosmetic applications
  3879. Two new Sphingolipids from the stem bark of Synsepalum msolo (Sapotaceae)
  3880. Dysregulation in Sphingolipid signaling pathways is associated with symptoms and functional connectivity of pain processing brain regions in provoked …
  3881. Large‐scale whole‐exome sequencing association study identifies FOXH1 gene and Sphingolipid metabolism pathway influencing major depressive disorder
  3882. GDF1 Is a Regulator of Sphingolipid Metabolism in Acute Myeloid Leukemia
  3883. Codon optimization of the synthetic 3-ketosphinganine reductase (3KSR) protein for enhancing Sphingolipid biosynthetic enzyme expression
  3884. The long chain base unsaturation has a stronger impact on 1-deoxy (methyl)-Sphingolipids biophysical properties than the structure of its C1 functional group
  3885. Crosstalk between ORMDL3, serine palmitoyltransferase, and 5-lipoxygenase in the Sphingolipid and eicosanoid metabolic pathways
  3886. Sphingolipid signaling modulates trans-endothelial cell permeability in dengue virus infected HMEC-1 cells
  3887. Structural analyses of 4-phosphate adaptor protein 2 yield mechanistic insights into Sphingolipid recognition by the glycolipid transfer protein family
  3888. Genome analysis of Sphingolipid metabolism‐related genes in Tetrahymena thermophila and identification of a fatty acid 2‐hydroxylase involved in the sexual stage …
  3889. Impact of acute pancreatic injury on Sphingolipid metabolism in the salivary glands
  3890. CHAPTER EIGHT Sphingolipids AND CANCER GÖKSENİN ÜNLÜGÜZEL ÜSTÜN
  3891. Tianma Formula Alleviates Dementia via ACER2-Mediated Sphingolipid Signaling Pathway Involving Aβ
  3892. Endotoxemia rocks Sphingolipid metabolism at the blood–brain barrier: An Editorial Highlight for ‘Alteration of Sphingolipid metabolism as a putative mechanism …
  3893. Isolation of sphingoid bases from starfish Asterias amurensis glucosylceramides and their effects on Sphingolipid production in cultured keratinocytes
  3894. Glycans meet Sphingolipids: Structure-based design of glycan containing analogues of a sphingosine kinase inhibitor
  3895. Impact of Sphingolipid mediators on the determination of cochlear survival in ototoxicity
  3896. Shotgun Sphingolipid analysis of human aqueous humor
  3897. Development of a new doubly-labeled fluorescent ceramide probe for monitoring the metabolism of Sphingolipids in living cells
  3898. Predicting cancer chemosensitivity based on intensity/distribution profiles of cells loaded with a fluorescent Sphingolipid analogue
  3899. … compartmental dysregulation of PI3K and PTEN molecules in lipid rafts of tongue squamous carcinoma cells by attenuating Rac1-Akt-GLUT-1-mediated Sphingolipid …
  3900. Imbalanced Sphingolipid signaling is maintained as a core proponent of a cancerous phenotype in spite of metabolic pressure and epigenetic drift
  3901. Symbiont-derived Sphingolipids regulate inflammatory responses in rainbow trout (Oncorhynchus mykiss)
  3902. Therapeutic implications and role of serum Sphingolipids on psoriasis severity after narrow band ultraviolet B treatment: A cross sectional controlled study
  3903. … between isoenzymes of glyceraldehyde‐3‐phosphate dehydrogenase regulates its aggregation state, the glycolytic activity and Sphingolipid status in Saccharomyces …
  3904. Differential expression of the Sphingolipid pathway is associated with sensitivity to the PP2A activator FTY720 in colorectal cancer cell lines
  3905. OH radical reactions with the hydrophilic component of Sphingolipids
  3906. Interaction of a Sphingolipid with human serum albumin in the native, thermally denatured and chemically denatured states: Emission wavelength-dependent …
  3907. APOL1 polymorphism modulates Sphingolipid profile of human podocytes
  3908. Functional analyses of Sphingolipid biosynthesis in an apicomplexan parasite
  3909. Mutations in Sphingolipid metabolism genes are associated with ADHD
  3910. Changes in the Content of Sphingolipids in the Nigrostriatal Dopaminergic System in the Brain of Mice with a Neurotoxic Model of Parkinson’s Disease
  3911. Role of ceramide-1 phosphate in regulation of Sphingolipid and eicosanoid metabolism in lung epithelial cells
  3912. Inhibitory effect of several Sphingolipid metabolites on calcineurin
  3913. Serum Sphingolipids Aiding the Diagnosis of Adult HIV-Negative Patients with Talaromyces marneffei Infection
  3914. Mechanistic dissection of Sphingolipid binding to the ER stress transducer ATF6-insights into the coordination of Sphingolipid and protein production
  3915. ROLE OF BIOACTIVE Sphingolipids IN INNER EAR AND SKELETAL MUSCLE BIOLOGY
  3916. Treatment of Allergic Asthma with Fenretinide Formulation (LAU-7b) Downregulates ORMDL Sphingolipid Biosynthesis Regulator 3 (Ormdl3) Expression and …
  3917. Sphingolipids with very long-chain fatty acids regulate vacuole fusion during tethering and docking
  3918. Advances in molecular regulation of Sphingolipids in plant-fungus interactions
  3919. Sphingolipid Biosynthesis Inhibition As A Host Strategy Against Diverse Pathogens
  3920. Effect of a Sphingolipid‐mimetic compound on the promotion of hair growth: A randomized, double‐blind, placebo‐controlled clinical trial
  3921. Sphingolipid mediators of cell signaling and metabolism
  3922. Erratum for Mor et al.,“Identification of a new class of antifungals targeting the synthesis of fungal Sphingolipids”. mBio 9: e00188-18
  3923. Association of 1-deoxy-Sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease
  3924. Chemical preparation of sphingosine and Sphingolipids: a review of enantioselective syntheses
  3925. Dietary fat and protein intakes in relation to plasma Sphingolipids as determined by a large-scale lipidomic analysis
  3926. Mutations in the Sphingolipid Pathway Gene SPTLC1 are a Cause of Amyotrophic Lateral Sclerosis
  3927. Sphingolipid metabolism products: potential new players in the pathogenesis of bortezomib-induced neuropathic pain
  3928. Integrated systems approach reveals Sphingolipid metabolism pathway dysregulation in association with late-onset Alzheimer’s Disease
  3929. Role of UCHL1 in radiation-induced lung injury mediated by Sphingolipids
  3930. Report of the 12th Sphingolipid Club Meeting, Trabia, Italy (Sept. 7–10, 2017)
  3931. Blood bioactive Sphingolipids in patients with advanced serous epithelial ovarian cancer–mass spectrometry analysis
  3932. Stereoselective synthesis of unnatural (2 S, 3 S)-6-hydroxy-4-sphingenine-containing Sphingolipids
  3933. Altered Sphingolipid function in Alzheimer’s disease; a gene regulatory network approach
  3934. CHO/LY-B cell growth under limiting Sphingolipid supply: Correlation between lipid composition and biophysical properties of Sphingolipid-restricted cell membranes
  3935. 19q13. 12 microdeletion syndrome fibroblasts display abnormal storage of cholesterol and Sphingolipids in the endo-lysosomal system
  3936. RETRACTED: Physcion 8-O-β-glucopyranoside exhibits anti-leukemic activity through targeting Sphingolipid rheostat
  3937. Dissecting the Regulatory Network of Sphingolipid Biosynthesis in Plants
  3938. Automated untargeted stable isotope assisted lipidomics of liver cells on high glucose shows alteration of Sphingolipid kinetics
  3939. FAM57B is a modulator of ceramide synthesis that regulates Sphingolipid homeostasis and synaptic composition in the developing brain
  3940. Drug triggered pruritus, rash, papules, and blisters–is AGEP a clash of an altered Sphingolipid-metabolism and lysosomotropism of drugs accumulating in the …
  3941. Structural diversity of photoswitchable Sphingolipids for optodynamic control of lipid raft microdomains
  3942. The Role of Sphingolipids Metabolism in Cancer Drug Resistance
  3943. Author Correction: Candida albicans gains azole resistance by altering Sphingolipid composition
  3944. Central role of Sphingolipids on the intracellular survival of\(Neisseria\)\(gonorrhoeae\) in epithelial cells
  3945. Targeted Metabonomics of Sphingolipids in Liver Tissue from Early Stage Hyperlipidemia Hamsters Using Liquid Chromatography-tandem Mass Spectrometry
  3946. … of erythro-B13 enantiomers and stereospecific action of full set of B13-isomers in MCF7 breast carcinoma cells: Cellular metabolism and effects on Sphingolipids
  3947. Study on Sphingolipids in tissues of animals with the diet-induced obesity
  3948. Bioactive Sphingolipid profile in a xenograft mouse model of head and neck squamous cell carcinoma
  3949. Purification of plant derived molecules that modulate Sphingolipid enzymes in cancer and inflammation
  3950. Sortilin evokes endothelial dysfunction and arterial hypertension through the dysregulation of Sphingolipid metabolism and oxidative stress
  3951. Transcriptomics, metabolomics, lipidomics, metabolic flux and mGWAS analyses of Sphingolipid pathway highlights novel drugs for Alzheimer’s disease
  3952. Meeting Report–The 2019 FEBS special meeting on Sphingolipid biology: Sphingolipids in physiology and pathology
  3953. Correction to: Reduced Sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
  3954. Regulatory role of Sphingolipid metabolites, sphingosine-1-phosphate and C16: 0 ceramide, in immunogenic cell death of colon cancer cells induced by Bak/Bax …
  3955. Lipidomic analysis of human serum reveals elevated phospho-and Sphingolipid species levels during osteoarthritis
  3956. The role of Sphingolipids in AKI and the progression to CKD: potential therapuetic targets.
  3957. The features of Sphingolipids‘ profile in young patients with atherothrombotic stroke
  3958. GLUT1 is associated with Sphingolipid-organized, cholesterol-independent domains in L929 mouse fibroblast cells
  3959. Bioactive Sphingolipids and Wound Healing
  3960. Sphingolipid-Enriched Domains in Yeast: Biophysical Properties and Antifungal Interaction
  3961. Investigating the Functional Consequences of a Common Human Single Nucleotide Polymorphism on Sphingolipid Acylation and Cardiometabolic Health
  3962. CHANGES IN PLASMA Sphingolipid LEVELS AGAINST THE BACKGROUND OF LIPID-LOWERING THERAPY IN PATIENTS WITH PREMATURE …
  3963. Impact of Sphingolipid Profile in Yeast Gel Domains and Membrane Compartments
  3964. Sphingolipids: From Pathology to Therapeutic Perspectives—A Themed Honorary Issue to Prof. Lina Obeid
  3965. EPR study on radicals derived from Sphingolipids and model compounds
  3966. Relevance of Circulating Extracellular Vesicles Carrying Sphingolipid Cargo in Alcoholic Hepatitis: Need for More Validation!
  3967. Impact of Targeting Glycosylated Ceramides on Tumorigenic Properties, and Characterization of Sphingolipids in Head and Neck Tumors
  3968. Design and Synthesis of Novel Probes for the Monitoring of Potential Drug Targets in Sphingolipid Metabolism
  3969. Ether lipid and Sphingolipid expression patterns are G-protein coupled estrogen receptor 1-dependently altered in breast cancer cells
  3970. Imbalance of Sphingolipids synthesis/degradation pathway in preeclamptic mouse placenta and kidney of intrauterine growth restricted mouse fetus
  3971. Evaluation of Xie et al.: Sphingolipid Modulation Activates Proteostasis Programs to Govern Human Hematopoietic Stem Cell Self-Renewal
  3972. The synthesis and in vitro evaluation of short interfering RNA containing triazole functionalized Sphingolipid-based derivatives
  3973. α1-COP delivers Sphingolipid modifiers and controls plasmodesmal callose deposition in Arabidopsis
  3974. Flow infusion electrospray ionization high-resolution mass spectrometry of the chloride adducts of Sphingolipids, glycerophospholipids, glycerols, hydroxy fatty acids …
  3975. Analysis of the Sphingolipid Profile in Regenerating Skeletal Muscle of a Murine Model of Type 1 Diabetes Mellitus
  3976. Research Article Impact of Acute Pancreatic Injury on Sphingolipid Metabolism in the Salivary Glands
  3977. Sphingolipid Containing Outer Membrane Vesicles Serve as a Delivery Vehicle to Limit Host Immune Response to Porphyromonas gingivalis
  3978. Synthesis of (2S,3R,5R)-2-Azido-3,5-dihydroxynonadecane Sphingolipid Analogue
  3979. The effect of human glucosylceramidase on Sphingolipid level in cells
  3980. Detection of Functionalized Sphingolipid Analogs in Detergent-Resistant Membranes of Immune Cells
  3981. Effect of sterols and Sphingolipids deprivation on pollen tube growth in Nicotiana tabacum (L.).
  3982. … we Dispense with Sphingolipids? Correlation between Membrane Lipid Composition and Biophysical Properties in Sphingolipid-Restricted Mammalian Cells
  3983. Associations of mediterranean-style diet adherence with circulating Sphingolipid patterns (P18-004-19)
  3984. Extraction and Quantification of Sphingolipids from Hemiptera Insects by Ultra-Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry
  3985. Protein-Sphingolipid interactions and their role in immunity and disease
  3986. Effect of antidepressant drugs on the brain Sphingolipid system
  3987. A novel class of Sphingolipids mediate autophagy and apoptosis in models of ischemia
  3988. Abstract P492: circulating Sphingolipids and risk of mortality: the cardiovascular health study
  3989. Biomimetic Synthesis of Complex Natural Products—and—The Synthesis and Evaluation of Photoswitchable Sphingolipids
  3990. … to respiratory tract infection are characterised by reduced circulating memory T regulatory cells, upper airway microbial dysbiosis and dysregulation of Sphingolipid …
  3991. Plasma Sphingolipids and subclinical atherosclerosis–novel associations uncovered by a large-scale lipidomic analysis (P18-129-19)
  3992. Virus interactions with the Sphingolipid network: sphingosine kinase 2 in immunosuppression, immunopathology, and viral propagation
  3993. Synthetic Sphingolipid analogs and anti-cancer drugs synergistically induced human colon and pancreatic cancer cell death through inhibiting ceramide metabolism
  3994. Plant Sphingolipids
  3995. Modification of redox processes in C6 glioma cells by 2-hexadeсenal, the product of Sphingolipid destruction
  3996. Alterations in Sphingolipid Composition and Mitochondrial Complex I Deficiency Represent Synergistic Therapeutic Vulnerabilities Linked to Vincristine …
  3997. Sphingolipids in Cellular Signaling
  3998. Disorders of Purine, Sphingolipid, and Amino Acid Metabolism
  3999. Yeast Sphingolipid-Enriched Domains and Membrane Compartments in the Absence of Mannosyldiinositolphosphorylceramide
  4000. Structure-dependent absorption of Sphingolipid long-chain bases from the digestive tract into lymph
  4001. Expression profiles of Sphingolipids in peripheral serum in patients with hepatitis B/C cirrhosis
  4002. … Functions: Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of Sphingolipid …
  4003. Engineering of membrane complex Sphingolipids improves osmotic tolerance of Saccharomyces cerevisiae
  4004. Characterization and Exploration of the Rationale for Sphingolipid Metabolism in Host-Associated Bacteroides
  4005. Plasma concentration of selected Sphingolipids correlates with lung function parameters in house dust mite allergic patients
  4006. Environmental Risks and Sphingolipid Signatures in Adult Asthma and Its Phenotypic Clusters: A Multi-Center Exploratory Study
  4007. Metabolism of Sphingolipids in Saccharomyces cerevisiae
  4008. Synthesis of phytosphingosine and phytoceramide probes to study the Sphingolipid metabolism in non-alcoholic fatty liver disease
  4009. Phosphorylation of LCB1 subunit of serine palmitoyltransferase stimulates its activity and modulates Sphingolipid biosynthesis in Arabidopsis
  4010. STUDY OF Sphingolipids ROLE ON THE INTERACTION OF B. vulgatus AND B.
  4011. Dysregulation of Sphingolipid Metabolism and Actions in Tuberous Sclerosis Complex
  4012. Study of Sphingolipid-mediated signaling and metabolism during aging
  4013. Sphingolipid metabolism
  4014. Super-Resolution Microscopy of Sphingolipids and Protein Nanodomains
  4015. Target lipidomics reveals associations between serum Sphingolipids and insulin sensitivity by the glucose clamp
  4016. DDRE-20. TARGETING Sphingolipid PATHWAY REVEALS VULNERABILITY IN IDH1MUT GLIOMA
  4017. Corticosteroids Effect Sphingolipid De Novo Synthesis in Lung Epithelial Cells
  4018. Sphingolipid profile analysis method based on ultra high performance liquid chromatography-orbitrap mass spectrometry and its application in vegetable oil and oil …
  4019. Correction: alkaline ceramidase 3 deficiency results in purkinje cell degeneration and cerebellar ataxia due to dyshomeostasis of Sphingolipids in the brain
  4020. Dysregulation in Sphingolipid Signaling Pathways is Associated With Symptoms and Functional Connectivity of Pain Processing Brain Regions in Provoked …
  4021. Sphingolipid profiles differ between adipose tissue depots in Holstein bulls
  4022. MOTOR NEURON DISORDERS AND NEUROPATHIES: EP. 245 Characterization of a novel form of ALS associated with changes in the Sphingolipid metabolism
  4023. Corrigendum: A Comprehensive Review on the Manipulation of the Sphingolipid Pathway by Pathogenic Bacteria
  4024. Bioinformatic Analysis of Sphingolipid Metabolism-related Genes for Prognostic Significance in Patients with Hepatocellular Carcinoma using The Cancer Genome …
  4025. Sphingolipid Biosynthesis Inhibition As A Host Strategy Against Diverse Pathogens (preprint)
  4026. NEW GENES, NEW TECHNIQUES IN NEUROMUSCULAR DISORDERS: O. 9 Childhood amyotrophic lateral sclerosis caused by excess Sphingolipid synthesis
  4027. Inside Cover: Resolving Sphingolipid Isomers Using Cryogenic Infrared Spectroscopy (Angew. Chem. Int. Ed. 32/2020)
  4028. Over-expression of ORMDL Sphingolipid biosynthesis regulator 2 in human endometrial cancer.
  4029. Metformin induces lipid changes on Sphingolipid species and oxidized lipids in polycystic ovary syndrome women
  4030. The role of Sphingolipid metabolism in lifespan and healthspan extension in C. elegans
  4031. Erratum: Multiple actions of doxorubicin on the Sphingolipid network revealed by flux analysis
  4032. PLACENTAL UNTARGETED LIPIDOMICS UNVEILS Sphingolipid AND CARNITNE CHANGES IMPLICATED IN ER AND MITOCHONDRIAL DYSFUNCTION IN …
  4033. Investigating Sphingolipid metabolism in budding yeast using stable isotope-labeled and caged vacuole-specific probes
  4034. When Polyphenols Meet Sphingolipids: Cancer Prevention and Therapy
  4035. Synthesis of chiral Sphingolipids and their stereochemical effects on induction of neurite outgrowth and sphingomyelin synthase activity
  4036. Sphingolipid Modulators as Retinitis Pigmentosa Therapeutics
  4037. Abiraterone and Ionizing Radiation Alter the Sphingolipid Homeostasis
  4038. Exploring the Association of rs708272 of the CETP Gene Variant with Features of Sphingolipids‘ Profile in the Patients with Premature Atherosclerosis
  4039. 194 VCP979 Treatment Attenuates Cardiac Fibroblasts Collagen Synthesis and Sphingolipid Metabolism Regulated by TGFβ
  4040. Novel biomarkers for tyrosine kinase inhibitor resistance in chronic myeloid leukemia patients: Bioactive Sphingolipids
  4041. Sphingolipid-Induced Programmed Cell Death Is a Salicylic Acid and EDS1-Dependent Phenotype in Arabidopsis
  4042. Sphingolipids during olive fruit ripening
  4043. Recruiting Sphingolipids to promote migration of retinal pigment epithelium cells
  4044. Reticulons Bind Sphingolipids to Activate the ER Stress Surveillance (ERSU) Pathway
  4045. Distribution of Sphingolipids in the Human Lens by Mass Spectrometry Imaging
  4046. Mutations in Sphingolipid metabolism genes are associated with ADHD
  4047. The role of Sphingolipids in pathogenesis of amyotrophic lateral sclerosis
  4048. Sphingolipids and TGF-β: Seeking out novel treatments for corneal fibrosis
  4049. Review on the relationship between Sphingolipid metabolism and cardiovascular diseases
  4050. PS930 SENSITIZATION OF PH+ ALL RESISTANT TO IMATINIB BY TARGETING Sphingolipid METABOLISM
  4051. Diet Quality and Circulating Sphingolipids: The Strong Heart Family Study
  4052. Highlight: Sphingolipids in infectious biology and immunology
  4053. Sphingolipid Synthesis Inhibition Modulates Transcriptional Phenotype and Promotes the Defense against Aspergillus Fumigatus Infection in Cystic Fibrosis
  4054. Metabolism of long-chain bases of Sphingolipids and fatty acid α-oxidation
  4055. Sphingolipid Turnover Turns Over the Fate of Aneuploid Cells
  4056. Fatty acids and Sphingolipids profile in the blood plasma of experienced divers in response to hyperbaric exposure.
  4057. Caveolin-Assisted Sphingolipid Transport to the Plasma Membrane
  4058. Sphingolipids and TGF-β signaling in corneal fibrosis: the continuing mission
  4059. Plasma 1-deoxy-Sphingolipid Levels and (Para) clinical Correlations in 100 Idiopathic Small Fiber Neuropathy Patients (4883)
  4060. Intestinal Microbial-Derived Sphingolipids Are Associated with Childhood Food Allergy
  4061. Sphingolipid Gel/Fluid Phase Transition Measurement by Integrated Resonance Probe Light
  4062. Lipid-lipid interactions in bilayers containing polar Sphingolipids, ceramide and cholesterol
  4063. Sphingolipid METABOLISM CONTRIBUTES TO MITOCHONDRIAL DYSFUNCTON INDUCED BY DIABETOGENIC CONDITION IN RETINAL EPITHELIAL CELLS
  4064. Abstract MP03: Plasma Sphingolipids and Risks of Heart Failure and Atrial Fibrillation in Older Adults: The Cardiovascular Health Study
  4065. Role of the most abundant plant Sphingolipids, Glycosyl Inositol Phosphoryl Ceramides GIPCs, in membrane structure and host/pathogen interactions
  4066. Aberrant DEGS1 Sphingolipid metabolism impairs central and peripheral nervous system function in humans
  4067. Sphingolipid alterations in the cross-talk between primed microglia-and dopaminergic neurons
  4068. Empagliflozin Lowers Mitochondrial Respiration and Skeletal Muscle Sphingolipid Content in Female Mice Fed Western Diet
  4069. Glycans Meet Sphingolipids: Rational Structure-Based Design of a New Generation of Sphingosine Kinase Inhibitors
  4070. Lipid-lipid interactions in bilayers containing polar Sphingolipids, ceramide and cholesterol.
  4071. The regulation of yeast homotypic vacuole fusion and membrane trafficking events by Sphingolipids, ergosterol, and lipid rafts
  4072. Chromosome 1 trisomy overcomes the block of Sphingolipid biosynthesis caused by aureobasidin A and confers pleiotropic effects on susceptibility to antifungals in …
  4073. Complex Effects of 24: 1 Sphingolipids in Membranes Containing Dioleoylphosphatidylcholine and Cholesterol
  4074. Proteomics of trans-Golgi Network subdomains revealed lipid crosstalk between Sphingolipids and phosphoinositides in plants.
  4075. Sphingolipid Perturbation Activates Proteostasis Programs to Govern Human Hematopoietic Stem Cell Self-Renewal
  4076. Sphingolipid Deficiency Alters Rhinovirus Infection of Airway Epithelial Cells and Macrophages
  4077. Tuning of Membrane Sphingolipid Content Influences the Links of Outer-Leaflet Membrane Lipid Dynamics to Cholesterol and Cytoskeleton
  4078. Publisher Correction: Sphingolipid biosynthesis modulates plasmodesmal ultrastructure and phloem unloading
  4079. Sphingolipid Response to High Fat Diet in Mouse Liver and Plasma
  4080. Expression of Concern: Stress-Induced Sphingolipid Signaling: Role of Type-2 Neutral Sphingomyelinase in Murine Cell Apoptosis and Proliferation
  4081. Direct Imaging of the Cholesterol and Sphingolipid Abundance at the Site of Influenza Virus Assembly with High‐Resolution SIMS
  4082. Sphingolipid and sterol accumulation during olive fruit abscission
  4083. Allergic Asthma Is Associated with Altered Sphingolipid Composition in Children
  4084. Separation of Glycolipids/Sphingolipids from Glycerophospholipids on TiO₂ Coating in Aprotic Solvent for Rapid Comprehensive Lipidomic Analysis with Liquid …
  4085. Fumonisin B1 (FB1) and Fingolimod (FTY720): Tortilla Toxin and Oral Therapeutic Target Sphingolipid Pathways During Neural Tube Closure
  4086. Alterations in Sphingolipid Synthesis Affect Small Airway Reactivity in Mice
  4087. Functional Analysis of Sphingolipid Metabolism-Related Cell Apoptosis in Pancreatic Cancer Cells
  4088. Metabolism and Effects of Skeletal Muscle Sphingolipids in Functional Unloading
  4089. Analysis of the Sphingolipid Profile in Regenerating Skeletal Muscle of a Murine Model of Type 1 Diabetes Mellitus
  4090. TARGETING ENZYMES OF Sphingolipid METABOLISM IN TREATMENT OF COLORECTAL CANCER
  4091. Inhibition of Sphingolipid Metabolism Has Ceramide-Induced Anti-Tumor Effect on Pancreatic Cancer Cells
  4092. Supplementary Material: Sphingolipid Pathway As a Source of Vulnerability in IDH1mut Glioma
  4093. Author Correction: Particular CSF Sphingolipid patterns identify iNPH and AD patients
  4094. Natural Sphingolipids are necessary for the correct morphogenesis of the chicken inner ear
  4095. Role of Sphingolipids in the inflammatory and apoptotic effects of LDL (-) on monocytes
  4096. AGEs induce alterations of Sphingolipids metabolism in the liver of genetically-and diet-induced diabetic mice
  4097. Association of TREM2 variants and Sphingolipid levels with AD in blood and brain: Biomarkers (non‐neuroimaging)/novel biomarkers
  4098. Sphingolipid MECHANISMS OF MUSCLE ATROPHY IN HYPOGRAVITATIONAL UNLOADING
  4099. Modulation of Sphingolipid metabolites in Type 2 Diabetic Retinopathy
  4100. The concept of Sphingolipid rheostat in skin: a driving force for new active ingredients in cosmetic applications
  4101. The role of Sphingolipid metabolism in sickle bone disease and bone stem cells
  4102. Targeting Mitochondrial Sphingolipids to Improve Brain Function in Gulf War Illness
  4103. Sphingolipids are involved in short-term muscle disuse: effects of the inhibitor of acid sphingomyelinase clomipramine
  4104. 2062-P: Improvement in Sphingolipids after Combined Weight Loss and Exercise Training in Adults with Obesity and Prediabetes
  4105. Sphingolipids in cancer health disparities and as prospective targets for cancer therapy
  4106. Associations between meibum quality and Sphingolipid quantity and composition
  4107. Neutrophil Elastase Regulates Sphingolipid Profile and Inflammatory Response in CF Mice
  4108. Biphasic Responses of Sphingolipids in Airway Inflammation and Airway Hyperreactivity
  4109. Subcellular Distribution of Cholesterol and Sphingolipids in Rat Hepatocytes
  4110. Effects of Porphyromonas gingivalis derived Sphingolipids on osteoclastogenesis
  4111. Single-cell lipidomics reveals a role for cell-to-cell Sphingolipid heterogeneity in fibroblast activation
  4112. Sphingolipid-induced cell death in Arabidopsis is negatively regulated by the papain-like cysteine protease RD21
  4113. Sphingolipid Metabolites Profiling in Hair Growth
  4114. Sphingolipid metabolism determines the efficacy of nanoliposomal ceramide in acute myeloid leukemia
  4115. Comment on: effect of bariatric surgery on urinary Sphingolipids in adolescents with severe obesity
  4116. Enzymes involved in the biosynthesis of Sphingolipids with very-long-chain PUFA concur with male germ cell differentiation
  4117. Placental Eicosanoids and Sphingolipids in Preeclampsia
  4118. Dysregulation of Sphingolipid Metabolism in Pulmonary Lymphangioleiomyomatosis (LAM)
  4119. Resveratrol Targets Sphingolipid Metabolism to Induce Growth Inhibition in FLT3 ITD Acute Myeloid Leukemia
  4120. Author Correction: Targeting Sphingolipid metabolism as an approach for combination therapies in haematological malignancies
  4121. Abstract TP388: Targeted Sphingolipid Profiling Identifies Novel Biomarkers of Cerebral Microvascular Disease
  4122. Resveratrol Targets Sphingolipid Metabolism and BCR-ABL in Ph+ Acute Lymphoblastic Leukemia to Induce Growth Inhibiton
  4123. Crosstalk of Sphingolipids and inflammasomes modulates tumor microenvironment and promotes cancer progression
  4124. Single Cell RNA Sequencing Identifies Aberrant Sphingolipid Metabolism and Actions in Pulmonary Lymphangioleiomyomatosis
  4125. … Deletion of Cardiac miR-17-92 Cluster Exacerbates Ischemic Myocardial Injury in Diabetic Mice Through Induction of Sphingolipid Biosynthesis and Cardiomyocyte …
  4126. Phospho-and Sphingolipid metabolism is altered in hereditary hemochromatosis independent of iron content and PNPLA3 polymorphism
  4127. Endosome and Golgi-associated degradation (EGAD) of membrane proteins regulates Sphingolipid metabolism
  4128. Sphingolipid Profiling Identifies Large Vessel Occlusions at Early Time Points: Results of the ASPIRE-Stroke Study
  4129. Fingolimod modulates genes’ expressions of Sphingolipids metabolism enzymes and mitochondrial respiratory chain proteins in hippocampus of Alzheimer’s …
  4130. Reply to Letter to the Editor of Dr. Sitkin et al., Regarding “Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome is Another Key to the …
  4131. A novel role of Sphingolipids and mitochondria in glutamate‐induced programmed necrosis in oligodendrocytes
  4132. A Novel Hypomyelinating Leukodystrophy Caused by Loss of the Sphingolipid Desaturase DEGS1 with Potential Therapy
  4133. The synthesis of chemical tools for studying Sphingolipid metabolism
  4134. 2177-P: Role of De Novo Sphingolipid Metabolites in Oleate-Induced Pancreatic ß-Cell Proliferation in Rats
  4135. Drosophila DNA/RNA methyltransferase contributes to robust host defense in ageing animals by regulating Sphingolipid metabolism
  4136. Publisher Correction: Sphingolipid serum profiling in vitamin D deficient and dyslipidemic obese dimorphic adults
  4137. 633: Changes in Sphingolipids and Glycerophosphotidylcholine in Multiorgan Dysfunction Syndrome Patients
  4138. 5893 Adipose tissue secreted ceramides and related Sphingolipids-potential modulators of vascular redox signalling in cardiovascular disease
  4139. 609-P: Effect of Rosuvastatin on Lipoprotein Sphingolipids in Patients with Type 2 Diabetes
  4140. F24. OMEGA-6 PUFA METABOLISM DISTURBED IN PHOSPHO-AND Sphingolipids IN NEUROLEPTIC-NAïVE FIRST-EPISODE SCHIZOPHRENIA PATIENTS–A …
  4141. Sphingolipid control of cognitive functions in health and disease
  4142. Compartmentation and functions of Sphingolipids
  4143. Sphingolipids and their role in health and disease in the central nervous system
  4144. Phospholipids and Sphingolipids in nutrition, metabolism, and health
  4145. Sphingolipid metabolism and signaling in cardiovascular diseases
  4146. Role and interaction of bacterial Sphingolipids in human health
  4147. The Sphingolipid anteome: implications for evolution of the Sphingolipid metabolic pathway
  4148. Targeting Sphingolipid metabolism as a therapeutic strategy in cancer treatment
  4149. Diversity in Sphingolipid metabolism across land plants
  4150. Circulating Sphingolipids and glucose homeostasis: an update
  4151. Circulating Sphingolipids in insulin resistance, diabetes and associated complications
  4152. Implications of Sphingolipid metabolites in kidney diseases
  4153. Sphingolipids in neurodegenerative diseases
  4154. Dynamic modulations of Sphingolipids and glycerophospholipids in COVID‐19
  4155. The Implication of Sphingolipids in Viral Infections
  4156. Sphingolipids in atherosclerosis: chimeras in structure and function
  4157. The role of obesity, inflammation and Sphingolipids in the development of an abdominal aortic aneurysm
  4158. Sphingolipids and their carriers
  4159. Analysis of Sphingolipids in Pediatric Patients with Cholelithiasis—A Preliminary Study
  4160. Regulation of the lysosome by Sphingolipids: Potential role in aging
  4161. Sphingolipids as functional food components: Benefits in skin improvement and disease prevention
  4162. SPTLC1 variants associated with ALS produce distinct Sphingolipid signatures through impaired interaction with ORMDL proteins
  4163. Plasma Sphingolipid abnormalities in neurodegenerative diseases
  4164. Sphingolipids: from structural components to signaling hubs
  4165. Diverse Sphingolipid profiles in rectal and colon cancer
  4166. Exploring the role of Sphingolipid-related genes in clinical outcomes of breast cancer
  4167. Sphingolipid players in multiple sclerosis: Their influence on the initiation and course of the disease
  4168. Evaluation of plasma Sphingolipids as mediators of the relationship between kidney disease and cardiovascular events
  4169. Host hepatic metabolism is modulated by gut microbiota-derived Sphingolipids
  4170. The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers
  4171. Sphingolipids and Lymphomas: A Double-Edged Sword
  4172. Functional roles of Sphingolipids in immunity and their implication in disease
  4173. Sphingolipid metabolism and cancer
  4174. Ciliogenesis requires Sphingolipid-dependent membrane and axoneme interaction
  4175. Sphingolipids in plant immunity
  4176. Sphingolipids control dermal fibroblast heterogeneity
  4177. Inhibition of Sphingolipid de novo synthesis counteracts muscular dystrophy
  4178. Role of circulating Sphingolipids in lipid metabolism: Why dietary lipids matter
  4179. Compartmentalization of Sphingolipid metabolism: Implications for signaling and therapy
  4180. Role of ceramides and Sphingolipids in Parkinson’s disease
  4181. Effects of Sphingolipid metabolism disorders on endothelial cells
  4182. Effects of Pregnancy on Plasma Sphingolipids Using a Metabolomic and Quantitative Analysis Approach
  4183. Cvm1 is a component of multiple vacuolar contact sites required for Sphingolipid homeostasis
  4184. Targeting the Sphingolipid rheostat in gliomas
  4185. Recognition of pathogen-derived Sphingolipids in Arabidopsis
  4186. Ambient air pollution and atherosclerosis: a potential mediating role of Sphingolipids
  4187. Impact of Sphingolipids on protein membrane trafficking
  4188. The role of Sphingolipids in the pathogenesis of psoriasis
  4189. The therapeutic potential of Sphingolipids for cardiovascular diseases
  4190. Sphingolipid metabolism and signaling in endothelial cell functions
  4191. The function of Sphingolipids in different pathogenesis of Alzheimer’s disease: A comprehensive review
  4192. Gene Therapy of Sphingolipid Metabolic Disorders
  4193. SPTSSA variants alter Sphingolipid synthesis and cause a complex hereditary spastic paraplegia
  4194. Sphingolipids and cholesterol
  4195. De novo Sphingolipid biosynthesis necessitates detoxification in cancer cells
  4196. The key role of Sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance
  4197. The Critical Impact of Sphingolipid Metabolism in Breast Cancer Progression and Drug Response
  4198. From Bacteria to Host: Deciphering the Impact of Sphingolipid Metabolism on Food Allergic Reactions
  4199. Machine learning to construct Sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal …
  4200. An intestinal Sphingolipid confers intergenerational neuroprotection
  4201. Sphingolipid subtypes differentially control proinsulin processing and systemic glucose homeostasis
  4202. Sphingolipids accumulate in aged muscle, and their reduction counteracts sarcopenia
  4203. Sphingolipids signature in plasma and tissue as diagnostic and prognostic tools in oral squamous cell carcinoma
  4204. Prognostic signatures of Sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular …
  4205. Endoplasmic reticulum stress and mitochondrial dysfunction during aging: role of Sphingolipids
  4206. Harnessing the power of Sphingolipids: Prospects for acute myeloid leukemia
  4207. Environmental exposures: another effect on Sphingolipids in asthma?
  4208. Elevation in Sphingolipid upon SARS-CoV-2 infection: possible implications for COVID-19 pathology
  4209. Low Sphingolipid levels predict poor survival in patients with alcohol-related liver disease
  4210. Interplay between Vitamin D and Sphingolipids in Cardiometabolic Diseases
  4211. Integration of systematic review, lipidomics with experiment verification reveals abnormal Sphingolipids facilitate diabetes retinopathy by inducing oxidative stress on …
  4212. Abnormalities of Sphingolipids Metabolic Pathways in the Pathogenesis of Psoriasis
  4213. Function of ceramide transfer protein for biogenesis and Sphingolipid composition of extracellular vesicles
  4214. An update on Sphingolipidomics: Is something still missing? Some considerations on the analysis of complex Sphingolipids and free-sphingoid bases in …
  4215. Role of Sphingolipids in the host-pathogen interaction
  4216. Cardiomyocytes, Sphingolipids and cardio myotoxicity
  4217. Sphingolipid metabolism plays a key role in diabetic peripheral neuropathy
  4218. Sphingolipids with 2-hydroxy fatty acids aid in plasma membrane nanodomain organization and oxidative burst
  4219. CERT1 mutations perturb human development by disrupting Sphingolipid homeostasis
  4220. Sphingolipids and acylcarnitines are altered in placentas from women with gestational diabetes mellitus
  4221. Resveratrol affects Sphingolipid metabolism in A549 lung adenocarcinoma cells
  4222. Diagnostic value of serum Sphingolipids in patients with colorectal cancer
  4223. Erythrocyte Sphingolipid species as biomarkers of Alzheimer’s disease
  4224. Sphingolipid profiling: a promising tool for stratifying the metabolic syndrome-associated risk
  4225. Identification and validation of a prognostic risk-scoring model based on Sphingolipid metabolism-associated cluster in colon adenocarcinoma
  4226. Sphingolipid metabolism and signaling in lung cancer: a potential therapeutic target
  4227. Mechanism of Sphingolipid homeostasis revealed by structural analysis of Arabidopsis SPT-ORM1 complex
  4228. Cholesterol-dependent homeostatic regulation of very long chain Sphingolipid synthesis
  4229. Novel Insight into the Serum Sphingolipid Fingerprint Characterizing Longevity
  4230. Sphingolipids at Plasmodesmata: Structural Components and Functional Modulators
  4231. Genetic Tools for Studying the Roles of Sphingolipids in Viral Infections
  4232. Microdomain protein Nce102 is a local sensor of plasma membrane Sphingolipid balance
  4233. Unique Sphingolipid signature identifies luminal and triple‐negative breast cancer subtypes
  4234. The biological functions of Sphingolipids in plant pathogenic fungi
  4235. Grade‐dependent changes in Sphingolipid metabolism in clear cell renal cell carcinoma
  4236. Comparative assessment of erythrocyte Sphingolipid levels as potential cardiovascular health markers in women from Libya and Serbia: a small-scale study
  4237. Dynamic modulations of urinary Sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries
  4238. Lipid signatures of West Nile virus infection unveil alterations of Sphingolipid metabolism providing novel biomarkers
  4239. Structure and function of mammalian Sphingolipids in health and disease
  4240. Sphingolipid metabolism in brain insulin resistance and neurological diseases
  4241. Implications of Sphingolipids on aging and age-related diseases
  4242. Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy
  4243. Ceramide sensing by human SPT-ORMDL complex for establishing Sphingolipid homeostasis
  4244. Clinical Sphingolipids pathway in parkinson’s disease: from GCase to integrated-biomarker discovery
  4245. Epigenetic Regulation Mediated by Sphingolipids in Cancer
  4246. Sphingolipid classes and the interrelationship with pediatric asthma and asthma risk factors
  4247. Molecular Advances in MAFLD—A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis
  4248. System level modeling and analysis of TNF-α mediated Sphingolipid signaling pathway in neurological disorders for the prediction of therapeutic targets
  4249. An ERAD‐independent role for rhomboid pseudoprotease Dfm1 in mediating Sphingolipid homeostasis
  4250. Bile acids and Sphingolipids in non-alcoholic fatty liver disease
  4251. Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation
  4252. Sphingolipids are involved in insect egg-induced cell death in Arabidopsis
  4253. Serum Sphingolipid profiling as a novel biomarker for metabolic syndrome characterization
  4254. Hypoxia induced deregulation of Sphingolipids in colon cancer is a prognostic marker for patient outcome
  4255. CFTR modulator therapy alters plasma Sphingolipid profiles in people with cystic fibrosis
  4256. Loss of tolerance to multiple environmental stresses due to limitation of structural diversity of complex Sphingolipids
  4257. Advancements on the Multifaceted Roles of Sphingolipids in Hematological Malignancies
  4258. Yeast Svf1 binds ceramides and contributes to Sphingolipid metabolism at the ER cis-Golgi interface
  4259. The ER calcium channel Csg2 integrates Sphingolipid metabolism with autophagy
  4260. Detailed Sphingolipid profile responded to salt stress in cotton root and the GhIPCS1 is involved in the regulation of plant salt tolerance
  4261. Systematic Metabolic Profiling Identifies De Novo Sphingolipid Synthesis as Hypha Associated and Essential for Candida albicans Filamentation
  4262. Prevotella copri variants among a single host diverge in Sphingolipid production
  4263. Glial control of Sphingolipid levels sculpts diurnal remodeling in a circadian circuit
  4264. Diverse Sphingolipid species harbor different effects on ire1 clustering
  4265. Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation
  4266. Pharmacological inhibition of Sphingolipid synthesis reduces ferroptosis by stimulating the HIF-1 pathway
  4267. Meibum Sphingolipid composition is altered in individuals with meibomian gland dysfunction-a side by side comparison of Meibum and Tear Sphingolipids
  4268. Investigating Sphingolipids as biomarkers for the outcomes of acute ischemic stroke patients receiving endovascular treatment
  4269. A simple and rapid method for extraction and measurement of circulating Sphingolipids using LC–MS/MS: a targeted lipidomic analysis
  4270. The link between the Sphingolipid rheostat and obstructive sleep apnea
  4271. Very-long-chain fatty acids are crucial to neuronal polarity by providing Sphingolipids to lipid rafts
  4272. Targeted Sphingolipid analysis in chickens suggests different mechanisms of fumonisin toxicity in kidney, lung, and brain
  4273. The role of Sphingolipid signaling in oxidative lung injury and pathogenesis of bronchopulmonary dysplasia
  4274. By integrating single-cell RNA-seq and bulk RNA-seq in Sphingolipid metabolism, CACYBP was identified as a potential therapeutic target in lung …
  4275. Sphingolipids in mitochondria—from function to disease
  4276. Circulating Sphingolipids in Obesity, Insulin Resistance, Diabetes and Associated Complications
  4277. Sphingolipid Catabolism and Glycerophospholipid Levels Are Altered in Erythrocytes and Plasma from Multiple Sclerosis Patients
  4278. Mysterious Sphingolipids: metabolic interrelationships at the center of pathophysiology
  4279. Lysosomal proteomics links disturbances in lipid homeostasis and Sphingolipid metabolism to CLN5 disease
  4280. Metabolic depletion of Sphingolipids inhibits agonist‐induced endocytosis of the serotonin1A receptor
  4281. Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets
  4282. Targeted analysis of Sphingolipids in turkeys fed Fusariotoxins: first evidence of key changes that could help explain their relative resistance to Fumonisin …
  4283. A Sphingolipid Fatty Acid Constituent Made by Alkyne trans‐Hydrogenation: Total Synthesis of Symbioramide
  4284. Residue of thiram in food, suppresses immune system stress signals and disturbs Sphingolipid metabolism in chickens
  4285. Structural characterization of phospholipids and Sphingolipids by in-source fragmentation MALDI/TOF mass spectrometry
  4286. Sortilin drives hypertension by modulating Sphingolipid/ceramide homeostasis and by triggering oxidative stress
  4287. Circulating Lipoprotein Sphingolipids in Chronic Kidney Disease with and without Diabetes
  4288. Sphingolipid-Based Synergistic Interactions to Enhance Chemosensitivity in Lung Cancer Cells
  4289. Dissecting the effect of Sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature
  4290. Sphingolipids in thyroid eye disease
  4291. New paradigms in brassinosteroids, strigolactones, Sphingolipids, and nitric oxide interaction in the control of lateral and adventitious root formation
  4292. Cross-Regulation of the Cellular Redox System, Oxygen, and Sphingolipid Signalling
  4293. Accurate Sphingolipid Quantification Reducing Fragmentation Bias by Nonlinear Models
  4294. Tribulus terrestris L. induces cell apoptosis of breast cancer by regulating Sphingolipid metabolism signaling pathways
  4295. Interplay of Sphingolipid Metabolism in Predicting Prognosis of GBM Patients: Towards Precision Immunotherapy
  4296. Caulobacter lipid A is conditionally dispensable in the absence of fur and in the presence of anionic Sphingolipids
  4297. Sphingolipids and impaired hypoxic stress responses in Huntington disease
  4298. Autophagy is regulated by endoplasmic reticulum calcium homeostasis and Sphingolipid metabolism
  4299. Dysregulated Sphingolipid metabolism and autophagy in granulosa cells of women with endometriosis
  4300. How do Sphingolipids play a role in epigenetic mechanisms and gene expression?
  4301. Oncosuppressive and oncogenic activity of the Sphingolipid-metabolizing enzyme β-galactosylceramidase
  4302. KLF5 governs Sphingolipid metabolism and barrier function of the skin
  4303. GOLM1 depletion modifies cellular Sphingolipid metabolism and adversely affects cell growth
  4304. Alterations of Sphingolipid and phospholipid pathways and ornithine level in the plasma as biomarkers of Parkinson’s disease
  4305. From Molecules to Medicine: Sphingolipids in Health and Disease
  4306. Effect of Quercetin and Fingolimod, Alone or in Combination, on the Sphingolipid Metabolism in HepG2 Cells
  4307. Inhibition of inflammasome activation via Sphingolipid pathway in acute lung injury by Huanglian Jiedu decoction: An integrative pharmacology approach
  4308. Sphingolipid synthesis inhibitor fumonisin B1 causes verticillium wilt in cotton
  4309. Ceramide kinase confers tamoxifen resistance in estrogen receptor-positive breast cancer by altering Sphingolipid metabolism
  4310. Human CPTP promotes growth and metastasis via Sphingolipid metabolite ceramide and PI4KA/AKT signaling in pancreatic cancer cells
  4311. The major plant Sphingolipid long chain base phytosphingosine inhibits growth of bacterial and fungal plant pathogens
  4312. Effect of empagliflozin on Sphingolipid catabolism in diabetic and hypertensive rats
  4313. “Fix and Click” for Assay of Sphingolipid Signaling in Single Primary Human Intestinal Epithelial Cells
  4314. Topical Collection: New Insights on Sphingolipids in Health and Disease
  4315. Toward Understanding the Subcellular Distributions of Cholesterol and Sphingolipids Using High-Resolution NanoSIMS Imaging
  4316. Quantitative Analyses and Validation of Phospholipids and Sphingolipids in Ischemic Rat Brains
  4317. Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease
  4318. Sphingolipids as Biomarkers and Molecular Drivers of Cardiometabolic Disease
  4319. Essential Role of Endothelial Sphingolipid Biosynthesis in Cerebrovascular Homeostasis
  4320. Preparation of the Sphingolipid fraction from mycelia of Cordyceps sinensis and its immunosuppressive activity
  4321. … Hypoperfusion Aggravates Parkinson’s Disease Dementia-Like Symptoms and Pathology in 6-OHDA-Lesioned Rat through Interfering with Sphingolipid …
  4322. Sphingolipids in Childhood Asthma and Obesity (SOAP Study): A Protocol of a Cross-Sectional Study
  4323. Elevated levels of Sphingolipid MIPC in the plasma membrane disrupt the coordination of cell growth with cell wall formation in fission yeast
  4324. Nanosecond pulsed electric field ablation‐induced modulation of Sphingolipid metabolism is associated with Ly6c2+ mononuclear phagocyte differentiation in liver …
  4325. Lipidomic Analysis Reveals Differences in Bacteroides Species Driven Largely by Plasmalogens, Glycerophosphoinositols and Certain Sphingolipids
  4326. Sphingolipid Long-Chain Base Signaling in Compatible and Non-Compatible Plant–Pathogen Interactions in Arabidopsis
  4327. Cross‐talk between CFTR and Sphingolipids in cystic fibrosis
  4328. Crosstalk between Serum and Skin Sphingolipids in Psoriasis
  4329. Biosynthesis of the Sphingolipid inhibitors sphingofungins in filamentous fungi requires aminomalonate as a metabolic precursor
  4330. How Sphingolipids affect T cells in the resolution of inflammation
  4331. Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate
  4332. Lipidomics profiling reveals distinct patterns of plasma Sphingolipid alterations in Alzheimer’s disease and vascular dementia
  4333. Selective Capture-Based Single-Cell Mass Spectrometry for Enhancing Sphingolipid Profiling of Neurons with Differentiation of Cell Body from Synapse
  4334. Specialized acyl carrier protein used by serine palmitoyltransferase to synthesize Sphingolipids in Rhodobacteria
  4335. Intestinal aberrant Sphingolipid metabolism shaped‐gut microbiome and bile acids metabolome in the development of hepatic steatosis
  4336. m6A modification-tuned Sphingolipid metabolism regulates postnatal liver development in male mice
  4337. Beyond Membrane Components: Uncovering the Intriguing World of Fungal Sphingolipid Synthesis and Regulation
  4338. Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity
  4339. Targeted Sphingolipid Analysis in Heart, Gizzard, and Breast Muscle in Chickens Reveals Possible New Target Organs of Fumonisins
  4340. Sphingolipids mediate lipotoxicity in muscular dystrophies
  4341. Characterizing human mesenchymal stromal cells’ immune-modulatory potency using targeted lipidomic profiling of Sphingolipids
  4342. The contribution of polar Sphingolipids to total Sphingolipid content in food sources determined using a facile method for quantitation of long-chain bases
  4343. Lipidome of the Bacteroides Genus Containing New Peptidolipid and Sphingolipid Families Revealed by Multiple-Stage Mass Spectrometry
  4344. Sphingolipids: Friends or Foes?
  4345. Recurrent de novo SPTLC2 variant causes childhood-onset amyotrophic lateral sclerosis (ALS) by excess Sphingolipid synthesis
  4346. … -omics analysis reveals the positive leverage of citrus flavonoids on hindgut microbiota and host homeostasis by modulating Sphingolipid metabolism in mid …
  4347. Fecal Sphingolipids predict parenteral nutrition–associated cholestasis in the neonatal intensive care unit
  4348. Transcriptional suppression of Sphingolipid catabolism controls pathogen resistance in C. elegans
  4349. Single-cell sequencing analysis related to Sphingolipid metabolism guides immunotherapy and prognosis of skin cutaneous melanoma
  4350. Circulating Sphingolipids in heart failure
  4351. Crosstalk between protein kinase A and the HOG pathway under impaired biosynthesis of complex Sphingolipids in budding yeast
  4352. Involvement of Sphingolipid metabolism enzymes in resveratrol-mediated cytotoxicity in philadelphia-positive acute lymphoblastic leukemia
  4353. Chaihu-Shugan-San ameliorates tumor growth in prostate cancer promoted by depression via modulating Sphingolipid and glycerinphospholipid metabolism
  4354. Decreased plasma levels of Sphingolipids and total cholesterol in adult cystic fibrosis patients
  4355. Characterisation of Unique Eukaryotic Sphingolipids with Temperature-Dependent Δ8-Unsaturation from the Picoalga Ostreococcus Tauri
  4356. Sphingosine‐1‐phosphate controls endothelial Sphingolipid homeostasis via ORMDL
  4357. Sphingolipid metabolism is associated with osteosarcoma metastasis and prognosis: Evidence from interaction analysis
  4358. Deoxy-Sphingolipids, oxidative stress, and vitamin C correlate with qualitative and quantitative patterns of small fiber dysfunction and degeneration
  4359. Relationship between Sphingolipids-mediated neuroinflammation and alcohol use disorder
  4360. The Role of Ergosterol and Sphingolipids in the Localization and Activity of Candida albicans’ Multidrug Transporter Cdr1p and Plasma Membrane ATPase Pma1p
  4361. A Sphingolipid-mTORC1 nutrient-sensing pathway regulates animal development by an intestinal peroxisome relocation-based gut-brain crosstalk
  4362. Environmental risks and Sphingolipid signatures in adult asthma and its phenotypic clusters: a multicentre study
  4363. mTORC2 Facilitates Liver Regeneration Through Sphingolipid-Induced PPAR-α-Fatty Acid Oxidation
  4364. Sphingolipids and Asthma
  4365. Emerging roles and therapeutic potentials of Sphingolipids in pathophysiology–emphasis on fatty acyl heterogeneity
  4366. Chronic treatment with serelaxin mitigates adverse remodeling in a murine model of ischemic heart failure and modulates bioactive Sphingolipid signaling
  4367. Hepatoviruses promote very-long-chain fatty acid and Sphingolipid synthesis for viral RNA replication and quasi-enveloped virus release
  4368. Sphingolipid pathway as a biosensor of cancer chemosensitivity: a proof of principle
  4369. Sphingolipid Metabolism in Tumor Cells
  4370. Insights into the role of Sphingolipids in antifungal drug resistance
  4371. Early secretory pathway-resident Zn transporter proteins contribute to cellular Sphingolipid metabolism through activation of sphingomyelin phosphodiesterase 1
  4372. Sphingolipids, mycobacteria and host: Unraveling the tug of war
  4373. Hydroxychloroquine Causes Early Inner Retinal Toxicity and Affects Autophagosome–Lysosomal Pathway and Sphingolipid Metabolism in the Retina
  4374. Involvement of Huanglian Jiedu decoction on microglia with abnormal Sphingolipid metabolism in Alzheimer’s disease
  4375. Chronic cadmium exposure induces Parkinson-like syndrome by eliciting Sphingolipid disturbance and neuroinflammation in the midbrain of C57BL/6J mice
  4376. Regulation of Sphingolipid biosynthesis in the endoplasmic reticulum via signals from the plasma membrane in budding yeast
  4377. Role of Sphingolipid Metabolism Played in Neurodegenerative Disease: A Descriptive Review
  4378. Structural diversity of photoswitchable Sphingolipids for optodynamic control of lipid microdomains
  4379. Pro-inflammation and pro-atherosclerotic responses to short-term air pollution exposure associated with alterations in Sphingolipid ceramides and neutrophil …
  4380. Sphingolipid depletion suppresses UPR activation and promotes galactose hypersensitivity in yeast models of classic galactosemia
  4381. The Niemann-Pick type diseases–A synopsis of inborn errors in Sphingolipid and cholesterol metabolism
  4382. Washed microbiota transplantation improves patients with overweight by the gut microbiota and Sphingolipid metabolism
  4383. The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
  4384. Untargeted metabolomics identifies metabolic dysregulation of Sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival
  4385. Development of a novel Sphingolipid signaling pathway-related risk assessment model to predict prognosis in kidney renal clear cell carcinoma
  4386. Dependence of ABCB1 transporter expression and function on distinct Sphingolipids generated by ceramide synthases-2 and-6 in chemoresistant renal …
  4387. Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis
  4388. Down-regulating a fiber-specific KCR like gene GhKCRL1 suppressed fiber elongation through blocking the synthesis of Sphingolipids in fiber cell
  4389. Untargeted lipidomics of propionic patients vs Targeted lipidomics of Sphingolipids
  4390. Decoding systems immunological model of Sphingolipids with IL-6/IL-17/IL-23 axes in L. major infection
  4391. A pilot study assessing Sphingolipids and glycolipids dysmetabolism in idiopathic normal pressure hydrocephalus
  4392. Sphingolipid paracrine signaling impairs keratinocyte adhesion to promote melanoma invasion
  4393. Alterations in Sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in …
  4394. Very-long-chain unsaturated Sphingolipids mediate oleate-induced rat β-cell proliferation
  4395. Aft1 Nuclear Localization and Transcriptional Response to Iron Starvation Rely upon TORC2/Ypk1 Signaling and Sphingolipid Biosynthesis
  4396. Development of Comorbid Depression after Social Fear Conditioning in Mice and Its Effects on Brain Sphingolipid Metabolism
  4397. The role of Sphingolipids in meibomian gland dysfunction and ocular surface inflammation
  4398. Phase behaviour of C18-N-acyl Sphingolipids, the prevalent species in human brain
  4399. Triterpenoid saponins from Ilex pubescens promote blood circulation in blood stasis syndrome by regulating Sphingolipid metabolism and the PI3K/AKT/eNOS …
  4400. Divergent amino acid and Sphingolipid metabolism in patients with inherited neuro-retinal disease
  4401. Reticulons bind Sphingolipids to activate the endoplasmic reticulum cell cycle checkpoint, the ER surveillance pathway
  4402. Sphingolipids: drivers of cardiac fibrosis and atrial fibrillation
  4403. Nervonic acid and its Sphingolipids: Biological functions and potential food applications
  4404. Abnormal expression of Sphingolipid-metabolizing enzymes in the heart of spontaneously hypertensive rat models
  4405. Reduced urine volume and changed renal Sphingolipid metabolism in P2ry14-deficient mice
  4406. Human rhinovirus infection of the respiratory tract affects Sphingolipid synthesis
  4407. Determination of endogenous Sphingolipid content in stroke rats and HT22 cells subjected to oxygen-glucose deprivation by LC‒MS/MS
  4408. Metabolomics Reveals Dysregulated Sphingolipid and Amino Acid Metabolism Associated with Chronic Obstructive Pulmonary Disease
  4409. Impaired Sphingolipid hydrolase activities in dementia with lewy bodies and multiple system atrophy
  4410. Metabonomic analysis of abnormal Sphingolipid metabolism in rheumatoid arthritis synovial fibroblasts in hypoxia microenvironment and intervention of …
  4411. Comparison of glycerophospholipid and Sphingolipid in mature milk from different sampled regions in the Chinese human milk project (CHMP) study
  4412. Development of an LC-MS/MS method to measure Sphingolipids in CSF from patients with multiple sclerosis
  4413. Sphingolipids in embryonic development, cell cycle regulation, and stemness–Implications for polyploidy in tumors
  4414. How Does CBG Administration Affect Sphingolipid Deposition in the Liver of Insulin-Resistant Rats?
  4415. Signaling Sphingolipids are biomarkers for atopic dermatitis prone to disseminated viral infections
  4416. Lipidomic Analysis of Cervicovaginal Fluid for Elucidating Prognostic Biomarkers and Relevant Phospholipid and Sphingolipid Pathways in Preterm Birth
  4417. Role of Sphingolipid metabolites in the homeostasis of steroid hormones and the maintenance of testicular functions
  4418. Plasma Sphingolipid profile of healthy black and white adults differs based on their parental history of type 2 diabetes
  4419. Sphingolipid-induced programmed cell death is a salicylic acid and EDS1-dependent phenotype in Arabidopsis fatty acid hydroxylase (Fah1, Fah2) and ceramide …
  4420. Enhancing Genome-Scale Model by Integrative Exometabolome and Transcriptome: Unveiling Carbon Assimilation towards Sphingolipid Biosynthetic Capability of …
  4421. Distinct effects of cannabidiol on Sphingolipid metabolism in subcutaneous and visceral adipose tissues derived from high-fat-diet-fed male wistar rats
  4422. Suppression of de novo Sphingolipid biosynthesis mitigates sarcopenia
  4423. Regulation of tumor immune microenvironment by Sphingolipids and lysophosphatidic acid
  4424. Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma through Regulation of Sphingolipid Rheostat
  4425. Ramadan intermittent fasting is associated with ameliorated inflammatory markers and improved plasma Sphingolipids/ceramides in subjects with obesity …
  4426. Emerging Role of Sphingolipids in Amphotericin B Drug Resistance
  4427. Association between serum Sphingolipids and necroinflammation of liver tissue pathology in chronic hepatitis B
  4428. miR-495–3p regulates Sphingolipid metabolic reprogramming to induce Sphk1/ceramide mediated mitophagy and apoptosis in NSCLC
  4429. Dietary long-chain omega 3 fatty acids modify Sphingolipid metabolism to facilitate airway hyperreactivity
  4430. Stereochemistry of Sphingolipids in Ganglioside GM3 Enhances Recovery of Nervous Functionality
  4431. The expanding boundaries of Sphingolipid lysosomal storage diseases; insights from Niemann–Pick disease type C
  4432. HILIC/MS quantitation of low-abundant phospholipids and Sphingolipids in human plasma and serum: Dysregulation in pancreatic cancer
  4433. Development of a new online SPE-HPLC-MS/MS method for the profiling and quantification of Sphingolipids and phospholipids in red blood cells–Application to the …
  4434. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a “Biochemical” Diagnosis of …
  4435. Sphingolipids: A new piece in the puzzle of insect egg-triggered plant immunity
  4436. The Role of Sphingolipids in Regulating Vascular Permeability in Idiopathic Pulmonary Fibrosis
  4437. The Pathogenic Sphingolipid Psychosine is Secreted in Extracellular Vesicles in the Brain of a Mouse Model of Krabbe Disease
  4438. Antileishmanial activity of tamoxifen by targeting Sphingolipid metabolism: a review
  4439. Urinary Sphingolipids in adolescents and young adults with youth-onset diabetes
  4440. Altered Sphingolipid pathway in SARS-CoV-2 infected human lung tissue
  4441. Sphingolipid and Phospholipid Levels Are Altered in Human Brain in Chorea‐Acanthocytosis
  4442. Sphingolipid metabolism as a new predictive target correlated with aging and ad: a transcriptomic analysis
  4443. Ceramides and other Sphingolipids as predictors of incident dysglycemia (CASPID): Design, methods, and baseline characteristics
  4444. A Comprehensive Profiling of Cellular Sphingolipids in Mammalian Endothelial and Microglial Cells Cultured in Normal and High-Glucose Conditions
  4445. The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity
  4446. The Sphingolipid Asset Is Altered in the Nigrostriatal System of Mice Models of Parkinson’s Disease
  4447. A meal rich in palm oil or butter modifies the Sphingolipid profile of postprandial triglyceride-rich lipoproteins from type 2 diabetic women
  4448. The Interplay between Bioactive Sphingolipids in the Psoriatic Skin and the Severity of the Disease
  4449. Murine endothelial serine palmitoyltransferase 1 (SPTLC1) is required for vascular development and systemic Sphingolipid homeostasis
  4450. The role of serum Sphingolipids as potential biomarkers of non‐response to direct acting antiviral therapy in chronic hepatitis C virus infection
  4451. Unveiling the Mechanism of Photodamage to Sphingolipid Molecules via Laser Flash Photolysis and EPR
  4452. Emerging role for Sphingolipids in the genetics of amyotrophic lateral sclerosis
  4453. Cord blood Sphingolipids are associated with atopic dermatitis and wheeze in the first year of life
  4454. Relationships between ocular surface sphingomyelinases, Meibum and Tear Sphingolipids, and clinical parameters of meibomian gland dysfunction
  4455. … Analysis of TRPC1 Ca2+-Permeable Channel-Knock Out Mouse Demonstrates a Vital Role in Placental Tissue Sphingolipid and Triacylglycerol Homeostasis …
  4456. Circular network of coregulated Sphingolipids dictates chronic hypoxia damage in patients with tetralogy of fallot
  4457. Temporal Alterations of Sphingolipids in Optic Nerves after Indirect Traumatic Optic Neuropathy
  4458. The regulatory effect of Angelicae Sinensis Radix on neuroendocrine-immune network and Sphingolipid metabolism in CUMS-induced model of depression
  4459. Mouse Model of Nitrogen Mustard Ocular Surface Injury Characterization and Sphingolipid Signaling
  4460. The potential serum Sphingolipid biomarkers for distinguishing Wilson disease
  4461. Mechanosensing and Sphingolipid-Docking Mediate Lipopeptide-Induced Immunity in Arabidopsis
  4462. Potentiation of Sphingolipids and TGF-β in the human corneal stroma reveals intricate signaling pathway crosstalks
  4463. … -Based Imprint Mass Spectrometry Imaging with an Ambient Liquid Extraction Technique for Enhancing Coverage of Glycerolipids and Sphingolipids in Brain Tissue
  4464. Tick-borne encephalitis virus modulates Sphingolipid and phospholipid metabolism in infected human neuronal cells
  4465. The Sphingolipids ceramide and inositol phosphorylceramide protect the Leishmania major membrane from sterol-specific toxins
  4466. Multi-omics reveals Bifidobacterium longum CECT7894 alleviate food allergy by regulating the Sphingolipid metabolism pathway
  4467. Intracellular Sphingolipid sorting drives membrane phase separation in the yeast vacuole
  4468. A key Sphingolipid pathway gene, MoDES1, regulates conidiation, virulence and plasma membrane tension in Magnaporthe oryzae
  4469. The identification of novel stroke-related Sphingolipid biomarkers using UPLC-MS/MS
  4470. Hepatocyte ABCA1 deficiency is associated with reduced HDL Sphingolipids
  4471. Ceramides and Sphingolipids are more than simple building blocks
  4472. Identification of dysregulation of Sphingolipids in retinoblastoma using liquid chromatography-mass spectrometry
  4473. Bone marrow mesenchymal stem cells therapy regulates Sphingolipid and glycerophospholipid metabolism to promote neurological recovery in stroke rats: A …
  4474. The Presence of Periodontitis Exacerbates Non-Alcoholic Fatty Liver Disease via Sphingolipid Metabolism-Associated Insulin Resistance and Hepatic …
  4475. Lipid peroxidation and Sphingolipid alterations in the cerebral cortex and hypothalamus of rats fed a high-protein diet
  4476. Lipidomics revealed alteration of the Sphingolipid metabolism in the liver of nonalcoholic steatohepatitis mice treated with scoparone
  4477. Associations between genetic variants in Sphingolipid metabolism pathway genes and hepatitis B virus-related hepatocellular carcinoma survival
  4478. A comprehensive multiomics approach reveals that high levels of Sphingolipids in cardiac cachexia adipose tissue are associated with inflammatory and …
  4479. SLC3A2, as an indirect target gene of ALDH2, exacerbates alcohol-associated liver cancer via the Sphingolipid biosynthesis pathway
  4480. Septins coordinate cell wall integrity and lipid metabolism in a Sphingolipid-dependent process
  4481. Reduced Sphingolipid biosynthesis modulates proteostasis networks to enhance longevity
  4482. Immunolocalization of Sphingolipid Catabolism Enzymes along the Nephron: Novel Early Urinary Biomarkers of Renal Damage
  4483. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and Sphingolipid species in plasma high-density …
  4484. Circulating Sphingolipids and relationship to cardiac remodelling before and following a low-energy diet in asymptomatic Type 2 Diabetes
  4485. The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF (V600E)-Mutated Human …
  4486. De Novo Sphingolipid Biosynthesis in Atherosclerosis
  4487. Implications of Sphingolipid Metabolites in Kidney Diseases.
  4488. The atypical Sphingolipid SPB 18: 1 (14Z); O2 is a biomarker for DEGS1 related hypomyelinating leukodystrophy
  4489. Suppressing inflammatory signals and apoptosis-linked Sphingolipid metabolism underlies therapeutic potential of Qing-Jin-Hua-Tan decoction against chronic …
  4490. Altered Sphingolipid hydrolase activities and alpha-synuclein level in late-onset schizophrenia
  4491. Zymosan-Induced Murine Peritonitis Is Associated with an Increased Sphingolipid Synthesis without Changing the Long to Very Long Chain Ceramide Ratio
  4492. New Therapeutic Options in Pulmonal Diseases: Sphingolipids and Modulation of Sphingolipid Metabolism
  4493. Three kingdoms and one ceramide to rule them all. A comparison of the structural basis of ceramide-dependent regulation of Sphingolipid biosynthesis in animals …
  4494. … -CoA carboxylase 1 activity through localization: functional genomics reveals a role for the lysine acetyltransferase NuA4 and Sphingolipid metabolism in regulating …
  4495. Fumonisin B1 as a Tool to Explore Sphingolipid Roles in Arabidopsis Primary Root Development
  4496. MicroRNA‐520c‐3p impacts Sphingolipid metabolism mediating PI3K/AKT signaling in NSCLC: Systems perspective
  4497. Molecular Mechanisms of Sphingolipid Transport on Plasma Lipoproteins
  4498. Sphingolipid Signaling Takes Center Stage in Regulation of Lymphatic–Immune Crosstalk in Lymphedema
  4499. Implication of Sphingolipid metabolism gene dysregulation and cardiac sphingosine-1-phosphate accumulation in heart failure
  4500. Sphingolipids: A Roadmap from Biomarker Identification to Clinical Application
  4501. Plasma membrane effects of Sphingolipid-synthesis inhibition by myriocin in CHO cells: a biophysical and lipidomic study
  4502. Lipidomics approach in alcoholic liver disease mice with Sphingolipid metabolism disorder: Alleviation using sea cucumber phospholipids
  4503. Lamiophlomis rotata attenuates rheumatoid arthritis by regulating Sphingolipid and steroid hormone metabolism
  4504. Machine learning-enhanced insights into Sphingolipid-based prognostication: revealing the immunological landscape and predictive proficiency for …
  4505. A Brief Review of FT-IR Spectroscopy Studies of Sphingolipids in Human Cells
  4506. Sphingolipids in viral skin superinfection: Friend or foe?
  4507. Associations of plasma Sphingolipids with measures of insulin sensitivity, β-cell function, and incident diabetes in Japanese Americans
  4508. Sterols and Sphingolipids as New Players in Cell Wall Building and Apical Growth of Nicotiana tabacum L. Pollen Tubes
  4509. Neuroinflammation, Energy and Sphingolipid Metabolism Biomarkers Are Revealed by Metabolic Modeling of Autistic Brains
  4510. Plasma Sphingolipids, lung function and COPD: the Cardiovascular Health Study
  4511. Sphingolipid abnormalities in encephalomyeloradiculoneuropathy (EMRN) are associated with an anti‐neutral glycolipid antibody
  4512. Sphingolipids in Cerebrospinal Fluid and Plasma Lipoproteins of APOE4 Homozygotes and Non-APOE4 Carriers with Mild Cognitive Impairment versus …
  4513. GhSMO2-2 is regulated by brassinosteroid signal and involved in cotton fiber elongation via influencing phytosterol and Sphingolipid biosynthesis
  4514. Lipid-lowering drugs affect lung cancer risk via Sphingolipid metabolism: a drug-target Mendelian randomization study
  4515. The long and the short of Huntington’s disease: How the Sphingolipid profile is shifted in the caudate of advanced clinical cases
  4516. Surfactin and Capric Acid Affect the Posaconazole Susceptibility of Candida albicans Strains with Altered Sterols and Sphingolipids Biosynthesis
  4517. A novel Sphingolipid metabolism-related long noncoding RNA signature predicts the prognosis, immune landscape and therapeutic response in pancreatic …
  4518. Sphingolipids as Oxygen Sensors and Major Orchestrators of Cellular Responses to Hypoxia
  4519. Shotgun lipidomics combined targeted MRM reveals Sphingolipid signatures of coronary artery disease
  4520. OROSOMUCOID PROTEIN 1 regulation of Sphingolipid synthesis is required for nodulation in Aeschynomene evenia
  4521. Targeting chronic inflammation of the Digestive system in cancer prevention: Modulators of the bioactive Sphingolipid sphingosine-1-phosphate pathway
  4522. Understanding Sphingolipids Metabolism in Colorectal Cancer
  4523. Sphingolipid and acylcarnitine analysis in locally advanced rectal cancer
  4524. The Sphingolipid-Signaling Pathway as a Modulator of Infection by SARS-CoV-2
  4525. Unique symbiont-derived Sphingolipids: Dietary amino acids source branch formation
  4526. Nonalcoholic steatohepatitis critically rewires the ischemia/reperfusion-induced dysregulation of cardiolipins and Sphingolipids in mice
  4527. Intracellular Sphingolipid sorting drives membrane phase separation in the yeast vacuole.
  4528. Bioactive Sphingolipids in health and disease
  4529. Screening of Sphingolipid metabolism-related genes associated with immune cells in myocardial infarction: a bioinformatics analysis
  4530. … -Chain Fatty Acids Attenuate 5-Fluorouracil-Induced THP-1 Cell Inflammation through Inhibiting NF-κB/NLRP3 Signaling via Glycerolphospholipid and Sphingolipid …
  4531. Comprehensive Glycan Analysis of Sphingolipids in Human Serum/Plasma
  4532. Disruption of CerS6-mediated Sphingolipid metabolism by FTO deficiency aggravates ulcerative colitis
  4533. The sphingosine 1-phosphate receptor 2/4 antagonist JTE-013 elicits off-target effects on Sphingolipid metabolism
  4534. Crosstalk between pro-survival Sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis
  4535. Characterization of the Sphingolipid profiling of Emiliania huxleyi against virus infection
  4536. Reverse genetic screening during L1 arrest reveals a role of the diacylglycerol kinase 1 gene dgk-1 and Sphingolipid metabolism genes in sleep regulation
  4537. The biosynthesis of Sphingolipids with very-long-chain PUFA is enhanced by testoterone in spermatogenic cells
  4538. Machine learning and biological validation identify Sphingolipids as key mediators of paclitaxel-induced neuropathy in cancer patients
  4539. Speculation of Sphingolipids in Capsanthin by Ultra-Performance Liquid Chromatography Coupled with Electrospray Ionization-Quadrupole—Time-of-Flight …
  4540. Sphingolipids and metabolic disease: Will the real killer please stand up?
  4541. Cyanidin-3-glucoside protects the photooxidative damage of retinal pigment epithelium cells by regulating Sphingolipid signaling and inhibiting MAPK …
  4542. Bacterial Sphingolipids Exacerbate Colitis by Inhibiting ILC3-derived IL-22 Production.
  4543. Asiatic acid ameliorates rifampicin‐and isoniazid‐induced liver injury in vivo by regulating Sphingolipid metabolism and mitogen‐activated protein kinase signalling …
  4544. Irradiation accelerates SARS‐CoV‐2 infection by enhancing Sphingolipid metabolism
  4545. Skeletal muscle and COVID-19: the potential involvement of bioactive Sphingolipids
  4546. Diabetes and kidney dysfunction markedly alter the content of Sphingolipids carried by circulating lipoproteins
  4547. Effects of Omega-3 and Antioxidant Cocktail Supplement on Prolonged Bed Rest: Results from Serum Proteome and Sphingolipids Analysis
  4548. Untargeted Plasma Lipidomics Reveal Perturbed Metabolites of Glycerophospholipids, and Sphingolipids in Moderate-to-Severe Acne
  4549. COVID-19 and its clinical severity are associated with alterations of plasma Sphingolipids and enzyme activities of sphingomyelinase and ceramidase
  4550. Genetic and lipidomic analyses suggest that Nostoc punctiforme, a plant-symbiotic cyanobacterium, does not produce Sphingolipids
  4551. Sphingolipids Are Depleted in Alcohol-related Liver Fibrosis
  4552. High Fat Diet Mediated Alterations in Serum Sphingolipid Profiles in An Experimental Mouse Model Measured by Matrix-Assisted Laser Desorption/Ionization …
  4553. Sphingolipids in cardiovascular diseases: from pathogenesis to therapeutics
  4554. Art2 mediates selective endocytosis of methionine transporters during adaptation to Sphingolipid depletion
  4555. Sphingosine 1‐phosphate lyase facilitates cancer progression through converting Sphingolipids to glycerophospholipids
  4556. Sphingolipids and HSC fitness: enigma no more
  4557. Pan-Sphingolipid profiling reveals differential functions of Sphingolipid biosynthesis isozymes of C. elegans
  4558. Sphingolipids and DHA Improve Cognitive Deficits in Aged Beagle Dogs
  4559. Insulin regulates Nedd4-2 via a PKB-dependent mechanism in HEI-OC1 auditory cells-crosstalks with Sphingolipid and cAMP signaling
  4560. Phosphorylation of the LCB1 subunit of Arabidopsis serine palmitoyltransferase stimulates its activity and modulates Sphingolipid biosynthesis
  4561. Isoform-Dependent Effects of Apolipoprotein E on Sphingolipid Metabolism in Neural Cells
  4562. Metabolic Depletion of Sphingolipids Does Not Alter Cell Cycle Progression in Chinese Hamster Ovary Cells
  4563. Myriocin remodels Sphingolipids and modulates proteostasis networks to enhance longevity
  4564. 332 Association of Sphingolipid de novo synthesis with airway response to magnesium
  4565. Lipid composition of microglial cells and effects of a remyelination-promoting antibody on the Sphingolipid patterns
  4566. Mass spectrometry detects Sphingolipid metabolites for discovery of new strategy for cancer therapy from the aspect of programmed cell death
  4567. Peripheral Sphingolipids as Potential Biomarkers of Parkinson disease Including Sex-Related Differences (P3-11.007)
  4568. Trifunctional sphinganine: a new tool to dissect Sphingolipid function
  4569. Sphingolipid metabolism is spatially regulated in the developing embryo by SOXE genes
  4570. Tricarboxylic acid (TCA) cycle, Sphingolipid, and phosphatidylcholine metabolism are dysregulated in T. gondii infection-induced cachexia
  4571. Using BODIPY FL-Sphingolipid Analogs to Study Sphingolipid Metabolism in Mouse Embryonic Stem Cells
  4572. Phase behaviour of C18-N-acyl Sphingolipids, the prevalent species in human brain
  4573. Fatty Acid 2-Hydroxylase and 2-Hydroxylated Sphingolipids: Metabolism and Function in Health and Diseases
  4574. Ocular surface Sphingolipids associate with the refractory nature of vernal keratoconjunctivitis: newer insights in VKC pathogenesis
  4575. Sphingolipids AS POTENTIAL SURROGATES OF MYOCARDIAL RECOVERY IN LEFT VENTRICULAR ASSIST DEVICE PATIENTS
  4576. Biochemical and Microscopic Analyses for Sphingolipids and Its Related Molecules in Phagosomes
  4577. Sphingolipid metabolism dysfunction in cancer
  4578. Ceramide-1-phosphate transfer protein promotes Sphingolipid reorientation needed for binding during membrane interaction
  4579. Quantitative Dynamic Analysis of de novo Sphingolipid Biosynthesis in Arabidopsis thaliana
  4580. SARS‐CoV‐2 ORF3a expression in brain disrupts the autophagy–lysosomal pathway, impairs Sphingolipid homeostasis, and drives neuropathogenesis
  4581. Construction of Sphingolipid Remodeled Cells by Genome Editing
  4582. Sphingolipid Metabolism in Cancer: Potential Therapeutic Target
  4583. The Sphingolipid inhibitors ceranib-2 and SKI-II reduce measles virus replication in primary human lymphocytes: effects on mTORC1 downstream signaling
  4584. Disease Progression and Sphingolipids and Neurofilament Light Chain in Early Idiopathic Parkinson’s Disease
  4585. ReTimeML: A retention time predictor that supports the LC-MS/MS analysis of Sphingolipids.
  4586. MHP1 and MHL generate odd-chain fatty acids from 2-hydroxy fatty acids in Sphingolipids and are related to immunity in Arabidopsis thaliana
  4587. Resveratrol alters Sphingolipid metabolism in ras-transformed 3T3 fibroblasts
  4588. A united-atom representation for Sphingolipids in the CHARMM force field
  4589. Study of fingolimod, nitric oxide inhibitor, and P-glycoprotein inhibitor in modulating the P-glycoprotein expression via an endothelin–Sphingolipid pathway in an …
  4590. Recurrent de-novo gain-of-function mutation in SPTLC2 confirms dysregulated Sphingolipid production to cause juvenile amyotrophic lateral sclerosis
  4591. Sphingolipids in Adipose: Kin or Foe?
  4592. Complex Sphingolipid Profiling and Identification of an Inositol Phosphorylceramide Synthase in Dictyostelium discoideum
  4593. Spatial organization of bacterial Sphingolipid synthesis enzymes
  4594. Dysregulation of Acid Ceramidase-mediated Sphingolipid Metabolism Contributes to Tumor Progression in Tuberous Sclerosis Complex
  4595. “Stick a Fork in Me; I’m Done”: Epithelial Cell Expression of ORMDL Sphingolipid Biosynthesis Regulator 3 Mediates Autophagic Cell Death
  4596. Revealing Sphingolipids composition in extracellular vesicles and paternal β-cells after persistent hyperglycemia
  4597. Disorders of Sphingolipid Synthesis, Sphingolipidoses, Niemann-Pick Disease Type C and Sphingolipid Metabolism disorders Neuronal Ceroid Lipofuscinoses …
  4598. An intestinal Sphingolipid promotes neuronal health across generations
  4599. The Sphingolipids Metabolism Mechanism and Associated Molecular Biomarker Investigation in Keloid
  4600. ACETYLCYSTEINE MODULATES Sphingolipid LEVELS BY INHIBITING NEUTRAL SPHINGOMYELINASE DURING AGING IN RAT TISSUES.
  4601. Expression of ceramide synthases in mice and their roles in regulating acyl-chain Sphingolipids: A framework for baseline levels and future implications in aging and …
  4602. Yeast lipid droplet dynamics are coupled to Sphingolipid biosynthesis via Tsc3p
  4603. Transcriptional regulation of Dyskerin via canonical WNT signaling modulates Sphingolipid biosynthesis and drives colorectal cancer.
  4604. Fatty liver? Microbiome Sphingolipids to the rescue
  4605. Gut Sphingolipid metabolites in infants with atopic dermatitis are associated with food allergy
  4606. Sphingolipids in hepatic metabolism
  4607. FANNING THE FLAMES OF ER STRESS: Can Sphingolipid metabolism be targeted to enhance ER stress associated immunogenic cell death in cancer?
  4608. Targeting endolysosomal trafficking with synthetic Sphingolipid analogs to improve the delivery of oligonucleotide therapeutics
  4609. Vitamin C Modifies the Phenotype of Hormone Receptor Positive/HER2 Negative Breast Cancer Cells and Induces Changes in Sphingolipid Metabolism
  4610. Canonical WNT signaling-driven DKC1 dysregulates Sphingolipid biosynthesis and drives colorectal cancer.
  4611. An Altered Sphingolipid Profile as a Risk Factor for Progressive Neurodegeneration in Long-Chain 3-Hydroxyacyl-CoA Deficiency (LCHADD)
  4612. Sphingolipid long-chain base phosphate degradation can be a rate-limiting step in long-chain base homeostasis
  4613. The Finer Points of Podocyte Sphingolipid Metabolism in Diabetic Kidney Disease
  4614. Caulobacter requires anionic Sphingolipids and deactivation of fur to lose lipid A
  4615. Identification of specific Sphingolipid-bama interactions using coarse-grained molecular dynamics simulation of the C. crescentus outer membrane
  4616. SPTLC1 variants associated with childhood onset amyotrophic lateral sclerosis produce distinct Sphingolipid signatures through impaired interaction with ORMDL …
  4617. IL-10 constrains Sphingolipid metabolism via fatty acid desaturation to limit inflammation
  4618. Sphingolipids in Asthma Pathogenesis
  4619. Sphingolipids Exosomal Pathway in Vascular Calcification Role of Exosomal miRNAs
  4620. Inhibition of Sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicity
  4621. Sphingolipids protect ergosterol in the Leishmania major membrane from sterol-binding toxins
  4622. Sphingolipid metabolism and its relationship with cardiovascular, renal and metabolic diseases
  4623. Endothelial-derived Sphingolipids are required for vascular development and systemic lipid homeostasis
  4624. Repetitive and compulsive behavior after Early-Life-Pain associated with reduced long-chain Sphingolipid species
  4625. Sphingolipid depletion inhibits bulk endocytosis while triggering selective clearance of the methionine transporter Mup1
  4626. Integrated microbiome-metabolome reveals thiram aggravates tibial dyschondroplasia through disturbing Sphingolipid metabolism
  4627. The integration of quantitative metabolic and proteomic analysis uncovers an augmentation of the Sphingolipid biosynthesis pathway during T-cell differentiation
  4628. Impaired biosynthesis of ergosterol confers resistance to complex Sphingolipid biosynthesis inhibitor aureobasidin A in a PDR16-dependent manner
  4629. Metabolic and physiological functions of Sphingolipid biosynthetic flux in cardiovascular disease
  4630. Insulin-inducible THRSP maintains mitochondrial function and regulates Sphingolipid metabolism in human adipocytes
  4631. Role of transcriptional and posttranscriptional regulation of Sphingolipid genes in molecular heterogeneity of breast cancer
  4632. SMPD4 mediated Sphingolipid metabolism regulates brain and primary cilia development
  4633. Fingolimod as a Sphingolipid modulator in hepatopulmonary syndrome: a critical review
  4634. Metabolism of Sphingolipids in tumor cells
  4635. Sphingolipid metabolism orchestrates the establishment of the adult hair follicle stem cell niche to control skin homeostasis
  4636. The Sphingolipid inhibitor myriocin increases susceptibility of Candida auris to amphotericin B
  4637. Addiction to Small Gtpase ARF6-Mediated Sphingolipid Homeostasis By AML but Not the Host
  4638. Intergenerational Neuroprotection by an Intestinal Sphingolipid in Caenorhabditis elegans
  4639. Membrane contact sites regulate vacuolar fission via Sphingolipid metabolism
  4640. Dysregulated Sphingolipid metabolism contributes to NASH-HCC disease progression
  4641. A United-Atom Representation for Sphingolipids in the CHARMM Molecular Dynamics Force Field
  4642. Metabolic indicators of an altered Sphingolipid metabolism are biomarkers for non-alcoholic fatty liver disease
  4643. DDDR-09. TARGETED DYSREGULATION OF Sphingolipid RHEOSTAT BALANCE IN IDH1MUT GLIOMAS TRIGGERS PRO-APOPTOTIC METABOLIC AND …
  4644. LARP6 induces Sphingolipid metabolism imbalance to suppress colorectal cancer metastasis by post-transcriptional regulation
  4645. Regulation of mitocho Sphingolipids
  4646. Sphingolipid profile in three walnut kinds of nuts based on UHPLC Q-Exactive MS
  4647. Ocular Surface Sphingomyelinases, Meibum and Tear Sphingolipids, and Clinical Parameters of Meibomian Gland Dysfunction
  4648. Sphingolipids protect ergosterol in the Leishmania major membrane from sterol-binding toxins
  4649. Induction of trained immunity by particulate β-glucan controls cancer metastasis through the Sphingolipids-mediated mitochondrial fission pathway.
  4650. STARD3: A Sphingolipid Transporter at Lysosome-ER Contact Sites
  4651. Plasma membrane effects of Sphingolipid-synthesis inhibition by myriocin in CHO cells: a biophysical and lipidomic study
  4652. Sphingolipid METABOLISM AND ITS EFFECT ON INTESTINAL HEALTH IN RELATION TO INFLAMMATORY BOWEL DISEASE
  4653. Chemical imaging of Sphingolipids and phospholipids at the single amyloid-β plaque level in post-mortem human Alzheimer’s disease brain
  4654. Nasal Fluid Sphingolipids as a Marker for Asthma in Children
  4655. Lipoprotein (a) level depending on clinical features and level of plasma Sphingolipids in patients with early atherosclerosis
  4656. ORM-mediated regulation of Sphingolipid biosynthesis is essential for nodule formation in Aeschynomene evenia
  4657. INVOLVEMENT OF Sphingolipids IN THE CELL METABOLISM AND VARIOUS PATHOLOGIES
  4658. Restoring the Sphingolipid Balance in Glioblastoma
  4659. Maturation and detoxification of synphilin-1 inclusion bodies regulated by Sphingolipids
  4660. m6A modification-tuned Sphingolipid metabolism regulates postnatal liver development
  4661. Analysis of Sphingolipid activator protein activity for Sphingolipid hydrolases
  4662. Sphingolipid imbalances inflame the bowel
  4663. I. 08 Motor neuron disease caused by excess Sphingolipid synthesis
  4664. Metabolic labeling of Sphingolipids
  4665. Sphingolipids and Asthma 10
  4666. … of Immune Modulators Targeting Autoimmune Disorders and Pulmonary Injury: Design, Synthesis, and Biological Evaluation of Sphingolipid-Derived Sphingosine-1 …
  4667. GABAergic, GDNF and Sphingolipid pathways are potentially druggable targets in neurodegenerative diseases: lumping is better than splitting
  4668. The Role of Sphingolipids in Therapy-Induced Senescence
  4669. Lipidomic Analysis of Epithelium Reveals Unique Sphingolipid Profile in Eosinophilic Esophagitis
  4670. Sphingolipid metabolism and complement signaling in cancer progression
  4671. Targeting Sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells …
  4672. Fumonisins alone or mixed with other fusariotoxins increase the C22–24: C16 Sphingolipid ratios in chickens and ducks, while deoxynivalenol and zearalenone have …
  4673. Metabolic and Sphingolipid changes associated with the adiponectin mediated protection from endothelial dysfunction: An in vitro study
  4674. Sphingolipid Metabolism and Metabolic Disease
  4675. Clonorchis sinensis infection induces hepatobiliary injury via disturbing Sphingolipid metabolism and activating sphingosine 1-phosphate receptor 2
  4676. Sphingolipid classes and the interrelationship with pediatric asthma risk factors and clinical asthma phenotypes
  4677. Inhibition of Sphingolipid Synthesis Decreases SARS-CoV-2 Infection in Human Airway Epithelial Cells
  4678. Dysregulated Sphingolipid Expression in Diabetic Myopathy
  4679. Sphingolipids AND Δ8-Sphingolipid DESATURASE FROM THE PICOALGA OSTREOCOCCUS TAURI AND INVOLVEMENT IN TEMPERATURE ACCLIMATION
  4680. PO. 1.9 Serum Sphingolipids as a potential biomarker in patients with systemic lupus erythematosus
  4681. Sphingolipids contribute to sex-specific differences in COPD pathologies
  4682. Hydrolysis of glycoSphingolipids by a Sphingolipid ceramide N-deacylase (SCDase)
  4683. Sphingolipid Metabolism and Metabolic
  4684. Association of Sphingolipid De-novo Synthesis With Airway Reactivity in Response to Magnesium Sulfate
  4685. Altered Sphingolipid metabolism in childhood asthma and obesity
  4686. Targeting acid ceramidase-1 to inhibit Sphingolipid metabolism and tumor growth in pancreatic ductal carcinoma
  4687. BXQ-350: A novel biologic with an innovative mechanism of action targeting Sphingolipid metabolism that induces cancer cell death and repolarizes the tumor …
  4688. Serum Sphingolipids Aid in Diagnosing Adult HIV-Negative Patients with Pulmonary Cryptococcosis: A Clinical Cohort Study
  4689. Glycostructures and Sphingolipids in Infectious diseases
  4690. Targeting Sphingolipid Metabolism in Atherosclerosis
  4691. Sphingolipid biosynthetic inhibitor, SPT-I, prevents oxidative-stress-mediated cell death in mouse photoreceptor-derived 661W cells
  4692. Identification of a Detoxification Requirement During De Novo Sphingolipid Biosynthesis in Cancer Cells
  4693. Plasma Sphingolipids, Lung Function, and Obstructive Lung Disease: The Cardiovascular Health Study
  4694. Sphingolipid metabolism in the pathogenesis of advanced non-small cell lung cancer
  4695. Sphingolipids AND DELTA8-Sphingolipid DESATURASE FROM THE PICOALGA O. TAURI AND INVOLVEMENT IN TEMPERATURE ACCLIMATION
  4696. Publisher Correction: Ramadan intermittent fasting is associated with ameliorated inflammatory markers and improved plasma Sphingolipids/ceramides in subjects …
  4697. Comprehensive Profiling of Glycerides, Glycerophospholipids and Sphingolipids in Koumiss with High-Performance Liquid Chromatography/Quadrupole-Time-Of …
  4698. A Meal Rich in Palm Oil or Butter Modifies the Sphingolipid Profile of Postprandial Triglyceride-Rich Lipoproteins From Type 2 Diabetic Patients
  4699. Elexacaftor tezacaftor ivacaftor therapy alters plasma Sphingolipid profiles in people with cystic fibrosis
  4700. Fa2H Controls Cool Temperature Sensing Through Modifying Membrane Sphingolipids in Drosophila
  4701. A Connecting Link Between Sphingolipid Metabolism and the Complement System in Cancer Metastasis
  4702. Shotgun Lipidomics Elucidates the Lipidome Alterations of the Mcl-1 Inhibitor S63845 in AML Cell Lines with a Focus on Sphingolipids
  4703. Glial control of Sphingolipid levels sculpts diurnal remodeling of sleep circuitry
  4704. Late Breaking Abstract-Sex-specific Differences in COPD Presentation Are Associated with Sphingolipids Metabolism
  4705. Early Sphingolipid Changes in the Development of Niemann-Pick Disease (NPD) in Mice and the Impact on Acute Lung Inflammation
  4706. Sphingolipids Imbalanced in Brain Microvessel of Predisposed Reduced Uterine Perfusion Mice
  4707. Synthesis of DES1 inhibitors to study the Sphingolipid metabolism in non-alcoholic fatty liver disease
  4708. Sphingolipids analysis by LC-MS/MS after treatment with xanthine oxidase inhibitors of nephrotoxicity induced by adenine
  4709. Three main short-chain fatty acids attenuate 5-FU-induced THP-1 cells inflammation via glycerolphospholipid and Sphingolipid metabolism
  4710. Correction: Hydroxychloroquine Causes Early Inner Retinal Toxicity and Affects Autophagosome–Lysosomal Pathway and Sphingolipid Metabolism in the Retina
  4711. Sphingolipid Regulation of Lysosomal Initiation of Autophagy in Human Lung Microvascular Endothelial Cells Exposed to Cigarette Smoke
  4712. Mechanosensing and Sphingolipid-Docking Mediate Lipopetide-Induced Immunity in Arabidopsis
  4713. Investigation of Kaftrio secondary effects on Sphingolipid synthesis
  4714. Regulatory Role of Sphingolipid Metabolites in Immunogenic Cancer Cell Death
  4715. Sphingolipids: A double-edged sword in the defense against Mycobacterium tuberculosis.
  4716. Sphingolipids ALTERATIONS IN ALZHEIMER’S DEMENTIA AND VASCULAR COGNITIVE IMPAIRMENT
  4717. Quantitative Determination of Sphingolipids by HPLC-ESI/MSn
  4718. Suppression of Sphingolipid Catabolism by a Nuclear Hormone Receptor Promotes Pathogen Resistance in C. elegans
  4719. LSO-044 Sphingolipids are potential diagnostic biomarkers for Korean patients with systemic lupus erythematosus
  4720. 1077 Sphingolipid profile in human uterus at term.
  4721. Sphingolipid Regulation of Lysosomal Fitness in Human Lung Microvascular Endothelial Cells During Homeostasis and Cigarette Smoke Exposure
  4722. Abstract P330: Nogo-B Regulates Vascular Sphingolipids To Impact Hepatic Gluconeogenesis And Blood Pressure
  4723. … Analysis of TRPC1 Ca2+-Permeable Channel-Knock Out Mouse Demonstrates a Vital Role in Placental Tissue Sphingolipid and Triacylglycerol Homeostasis Under …
  4724. Research progress of Sphingolipids in atherosclerosis
  4725. KLF5 defines the secretory lineage and governs Sphingolipid metabolism in the skin
  4726. Effect of Subacute Angiotensin II Elevations on Sphingolipid Levels and Lung Injury in Mice
  4727. Ichthyosis linked to sphingosine 1-phosphate lyase insufficiency is due to aberrant Sphingolipid and calcium regulation
  4728. TMET-36. ACID CERAMIDASE INHIBITION EXPLOITS Sphingolipid VULNERABILITIES IN IDH MUTANT GLIOMAS
  4729. Tumor Suppressor Tuberin (TSC2) Negatively Regulates the Expression of Sphingolipid Metabolism Genes and Functions
  4730. Targeting the Sphingolipid biosynthesis pathway of protozoan parasites as drug targets
  4731. Total synthesis of new microbial Sphingolipid-type signaling molecules
  4732. 164-LB: Association of Ceramide and Sphingolipid Species with Incident Prediabetes among Offspring of Parents with Type 2 Diabetes
  4733. 251-LB: Association of Plasma Sphingolipids with Insulin Secretion and Insulin Sensitivity in Healthy Black and White Adults
  4734. Role of Sphingolipid metabolism in osimertinib-resistance in EGFR-mutated NSCLC models
  4735. A phase 1, safety and dose escalation study of BXQ-350, a nanovesicle formulation of saposin c, a modulator of Sphingolipid metabolism, in patients with advanced …
  4736. Dysregulation of Sphingolipid metabolic enzymes leads to high levels of sphingosine-1-phosphate and ceramide in human hepatocellular carcinoma
  4737. 189-LB: Plasma Sphingolipids in Healthy Black and White Adults With or Without Parental Type 2 Diabetes
Related Posts

Crosslink Breaker

Lipotoxicity

Mitohormesis

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping